data_1h7v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1h7v _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mttm . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.179 0.514 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.666 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 9.3 m-85 -118.7 140.55 49.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 110.58 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.515 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 2.5 tm-20 -119.84 142.62 48.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.811 . . . . 0.0 109.464 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.4 t -77.8 115.58 17.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 0.0 110.299 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -15.68 63.85 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.749 -1.219 . . . . 0.0 108.522 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -60.76 1.95 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.608 -0.682 . . . . 0.0 110.699 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.2 p -108.21 -4.35 17.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.093 . . . . 0.0 110.91 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 82.74 3.53 90.46 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.648 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.611 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 65.3 t80 -49.25 173.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.429 . . . . 0.0 109.255 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.611 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 12.2 mm -144.41 110.6 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.025 -1.047 . . . . 0.0 110.525 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 54.9 t80 -83.69 128.48 34.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.916 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -110.16 121.15 42.47 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.2 Cg_endo -71.8 -34.06 9.35 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.859 1.452 . . . . 0.0 110.239 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.93 -14.78 62.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 0.0 109.902 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 8.3 mttp -113.26 -18.51 12.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 110.049 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.486 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 85.35 170.66 47.4 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.534 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.16 49.96 1.85 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -1.069 . . . . 0.0 109.855 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.97 -54.82 2.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.41 -0.806 . . . . 0.0 110.393 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CD1' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -47.51 -37.02 11.16 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 110.2 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -90.1 -65.96 0.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.06 51.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.534 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 2.1 mp -133.48 147.38 64.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.277 -1.131 . . . . 0.0 109.888 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -70.3 161.07 47.33 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.955 1.503 . . . . 0.0 110.255 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.486 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.9 Cg_endo -72.03 163.78 37.72 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.01 1.531 . . . . 0.0 110.841 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.03 11.04 85.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 18.0 m -100.41 122.12 50.97 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.299 -1.119 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 45.2 Cg_endo -72.49 143.3 38.23 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.873 1.46 . . . . 0.0 110.71 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.666 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 30.5 t80 -54.52 -18.86 4.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.901 . . . . 0.0 109.796 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 15.1 m -70.5 -13.88 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.381 -0.824 . . . . 0.0 109.68 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.8 -7.16 56.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.0 110.363 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.428 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 19.2 mt -72.23 148.72 45.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.053 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.463 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -77.35 163.69 26.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.909 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -7.06 21.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.983 . . . . 0.0 110.174 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.06 2.68 35.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.339 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 48.0 t80 -58.72 136.31 57.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.757 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 30.0 mtt -119.46 145.85 45.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.019 -1.051 . . . . 0.0 110.025 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 34.6 t -58.88 128.28 84.31 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 110.194 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 45.8 Cg_endo -72.14 -10.16 25.49 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.857 1.451 . . . . 0.0 109.775 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.99 -58.78 2.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.467 -0.771 . . . . 0.0 110.452 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.519 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.9 p -108.29 5.38 25.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.882 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.35 17.46 9.42 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.201 -0.937 . . . . 0.0 112.049 178.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.465 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 3.9 m -70.46 167.93 23.09 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.91 -1.118 . . . . 0.0 109.833 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.2 Cg_endo -72.88 141.46 33.51 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.967 1.509 . . . . 0.0 110.527 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.575 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 7.9 tttm -48.4 -26.33 2.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.886 . . . . 0.0 109.832 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -63.85 -11.1 24.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 109.977 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -91.79 -1.41 57.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.331 -0.855 . . . . 0.0 109.6 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -88.08 138.66 31.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.519 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -129.03 144.43 51.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -0.84 . . . . 0.0 109.686 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.939 -1.101 . . . . 0.0 110.711 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.205 0.526 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.603 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 31.0 m-85 -124.06 145.64 49.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.976 . . . . 0.0 110.62 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.458 ' HG3' ' HB3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -116.78 139.58 50.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 0.0 109.703 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.0 t -76.91 115.96 17.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.085 -1.01 . . . . 0.0 110.596 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -16.2 64.04 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.955 -1.091 . . . . 0.0 108.583 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.16 -58.73 2.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.571 -0.705 . . . . 0.0 110.654 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.89 -4.02 16.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.053 -1.029 . . . . 0.0 110.932 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 80.09 7.06 88.86 Favored Glycine 0 N--CA 1.497 2.727 0 O-C-N 121.101 -0.999 . . . . 0.0 111.583 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 53.8 t80 -59.65 142.81 52.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.758 -1.436 . . . . 0.0 110.051 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -114.94 113.82 44.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.16 -0.962 . . . . 0.0 110.638 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.8 t80 -82.41 132.21 35.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.833 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.24 116.95 41.7 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 110.3 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -70.38 -26.48 24.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.879 1.463 . . . . 0.0 110.343 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -72.5 -12.47 61.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.365 -0.835 . . . . 0.0 109.784 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -114.25 -39.72 3.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.525 -0.734 . . . . 0.0 109.857 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.67 167.64 22.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.574 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.6 OUTLIER -85.13 53.75 2.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.559 -0.965 . . . . 0.0 109.819 179.255 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.82 -57.94 1.46 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 110.634 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 64.7 m-85 -47.61 -34.83 8.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.366 -0.834 . . . . 0.0 110.328 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -90.5 -65.88 0.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.374 -0.829 . . . . 0.0 110.083 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.22 52.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.525 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -130.76 144.98 55.68 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.213 -1.169 . . . . 0.0 109.93 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.458 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.5 Cg_endo -70.28 161.86 44.45 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.946 1.498 . . . . 0.0 110.533 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.0 Cg_endo -72.94 162.75 40.22 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.05 1.553 . . . . 0.0 110.902 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.98 11.91 85.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 92.2 m -97.02 124.76 48.59 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.223 -1.163 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 46.0 Cg_endo -72.77 138.8 29.59 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.799 1.421 . . . . 0.0 110.553 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.575 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 27.6 t80 -52.47 -41.91 63.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 0.0 110.066 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 15.9 m -53.66 -17.98 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 110.233 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.411 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 28.4 t0 -83.9 -7.31 59.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.965 . . . . 0.0 110.391 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.473 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 18.6 mt -70.03 154.37 42.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 110.028 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.54 151.42 36.35 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.18 -0.95 . . . . 0.0 109.885 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.95 -14.49 6.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.071 -1.018 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 p -97.65 5.17 49.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 110.381 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.8 t80 -59.68 137.62 57.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.142 -0.974 . . . . 0.0 109.873 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.2 mtt -117.18 143.73 45.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' ' 47' ' ' ARG . 49.4 t -58.88 125.7 78.49 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.0 110.093 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 43.6 Cg_endo -70.61 -10.17 27.32 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.943 1.496 . . . . 0.0 109.93 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . . . -92.82 -52.51 4.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.468 -0.77 . . . . 0.0 110.294 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 48' ' ' SER . 8.8 p -119.32 8.89 11.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.705 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' CYS . 8.7 ttm-85 62.51 13.52 6.25 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.277 -0.89 . . . . 0.0 112.243 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 16.6 p -66.0 166.96 13.26 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.886 -1.134 . . . . 0.0 109.921 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.2 Cg_endo -73.0 142.49 34.73 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.679 1.357 . . . . 0.0 110.373 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.565 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 24.2 tttm -49.04 -29.82 5.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 109.951 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -63.89 -10.8 22.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.333 -0.854 . . . . 0.0 109.806 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.53 -4.81 58.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.268 -0.895 . . . . 0.0 109.757 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.423 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 29.0 m-85 -79.99 132.75 36.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.584 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HB3' ' HG3' ' A' ' 9' ' ' GLU . 42.9 tttt -105.16 130.14 53.4 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.603 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 110.342 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 mttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.234 0.54 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.6 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 29.9 m-85 -123.06 147.14 47.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 0.0 110.647 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 27.3 tt0 -117.24 137.34 52.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.429 -0.794 . . . . 0.0 109.549 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.484 ' O ' ' N ' ' A' ' 14' ' ' GLY . 3.3 t -75.87 117.87 18.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.032 -1.042 . . . . 0.0 110.775 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -16.41 63.54 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.901 -1.124 . . . . 0.0 108.46 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.22 -57.68 2.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.672 -0.643 . . . . 0.0 110.48 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -110.75 -2.98 15.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.092 -1.005 . . . . 0.0 110.927 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 77.39 8.46 87.06 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.095 -1.003 . . . . 0.0 111.467 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 42.9 t80 -61.1 144.86 52.75 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.903 -1.351 . . . . 0.0 109.838 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.508 HD11 ' N ' ' A' ' 16' ' ' ILE . 2.3 mp -114.85 113.47 43.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.133 -0.979 . . . . 0.0 110.485 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.4 t80 -81.75 127.66 33.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.747 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -106.47 117.69 56.46 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.467 -0.77 . . . . 0.0 110.27 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.9 Cg_endo -70.04 -30.64 20.68 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.937 1.493 . . . . 0.0 110.198 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.04 -11.09 60.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.97 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 6.0 mtpt -110.62 -42.05 4.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 110.051 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.17 165.77 21.28 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.531 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.22 56.39 3.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.516 -0.991 . . . . 0.0 109.893 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.12 -57.23 1.72 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.825 . . . . 0.0 110.809 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 94.8 m-85 -47.13 -33.6 5.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.587 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -93.67 -64.3 1.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.189 -0.944 . . . . 0.0 110.399 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.0 53.68 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.1 mp -128.76 144.97 54.39 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.34 -1.094 . . . . 0.0 109.82 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD2' HG22 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -71.35 160.31 49.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.997 1.524 . . . . 0.0 110.421 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.11 163.16 39.61 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.004 1.529 . . . . 0.0 110.777 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.78 13.01 84.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.6 m -99.98 127.42 33.61 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.205 -1.173 . . . . 0.0 110.214 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 47.8 Cg_endo -73.15 140.15 30.57 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.969 1.51 . . . . 0.0 110.717 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.572 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.5 t80 -52.03 -41.92 62.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.138 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -17.65 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 110.476 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 4.3 t0 -84.07 -7.4 59.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.989 . . . . 0.0 110.249 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 mt -69.35 155.68 40.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.055 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -76.2 148.67 37.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.96 . . . . 0.0 109.785 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -15.81 5.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.996 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.7 5.63 49.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 110.346 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.523 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 54.8 t80 -60.0 139.89 57.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.207 -0.933 . . . . 0.0 109.904 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -118.23 143.31 46.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.07 -1.019 . . . . 0.0 110.027 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 47' ' ' ARG . 48.7 t -58.7 126.23 79.42 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.898 . . . . 0.0 110.139 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.582 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 43.8 Cg_endo -70.97 -10.48 27.67 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.911 1.48 . . . . 0.0 109.898 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HB1' ' SG ' ' A' ' 43' ' ' CYS . . . -92.89 -52.42 4.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.46 -0.775 . . . . 0.0 110.34 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.489 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.6 p -118.98 9.15 11.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.684 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.79 13.72 5.65 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.248 -0.908 . . . . 0.0 112.209 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.467 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.5 m -66.47 169.13 8.07 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.832 -1.168 . . . . 0.0 109.878 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 48.0 Cg_endo -74.11 141.79 29.99 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.793 1.417 . . . . 0.0 110.405 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 26.6 tttm -49.85 -30.9 10.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 109.806 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -62.9 -11.9 21.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.16 -3.65 59.07 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.404 -0.81 . . . . 0.0 109.77 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 15.2 m-85 -79.94 132.49 36.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 110.399 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.24 129.46 50.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.009 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.6 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 110.368 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 tttt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.243 0.544 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.606 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 37.6 m-85 -121.37 143.71 49.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.26 -0.9 . . . . 0.0 110.351 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' O ' ' CG ' ' A' ' 54' ' ' LYS . 7.4 mt-10 -117.04 139.83 50.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.366 -0.834 . . . . 0.0 110.374 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -76.31 113.01 13.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.999 -1.063 . . . . 0.0 110.412 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.6 -15.52 61.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.808 -1.183 . . . . 0.0 108.606 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.2 -61.73 1.7 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.565 -0.709 . . . . 0.0 110.634 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.492 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -107.19 -3.25 20.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 110.97 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 79.02 7.54 88.39 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.434 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 29.0 t80 -59.49 142.02 53.45 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.836 -1.391 . . . . 0.0 109.692 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 1.9 mp -114.6 115.46 49.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.57 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 32.1 t80 -83.78 137.82 33.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -116.28 119.76 36.0 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 110.43 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.2 Cg_endo -69.95 -33.24 16.27 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.905 1.476 . . . . 0.0 110.115 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.32 -12.89 61.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.838 . . . . 0.0 109.788 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -14.85 11.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.913 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.432 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 79.97 172.91 44.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.546 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.15 49.56 1.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -1.048 . . . . 0.0 109.759 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ASP . 16.8 ttmt -39.7 -59.0 1.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.57 -0.706 . . . . 0.0 110.442 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.535 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 1.1 m-85 -44.51 -32.83 1.52 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.376 -0.827 . . . . 0.0 110.088 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -93.79 -61.92 1.45 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 0.0 110.263 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.28 51.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.546 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -134.01 143.75 48.64 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.286 -1.126 . . . . 0.0 109.944 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.478 ' HD2' HG21 ' A' ' 28' ' ' ILE . 43.1 Cg_endo -68.52 160.95 47.11 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.004 1.529 . . . . 0.0 110.277 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 44.2 Cg_endo -71.76 162.93 40.53 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.027 1.541 . . . . 0.0 111.034 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 81.31 13.29 80.89 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 3.7 m -102.97 121.58 48.59 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.24 -1.153 . . . . 0.0 110.136 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.461 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 46.1 Cg_endo -72.52 135.11 23.59 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.799 1.42 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.576 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 8.0 t80 -47.89 -39.91 20.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.281 -0.887 . . . . 0.0 110.161 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 m -53.54 -22.12 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.401 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 21.2 t0 -84.31 -5.79 59.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 110.367 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.502 ' CB ' ' HD2' ' A' ' 50' ' ' LYS . 17.0 mt -72.31 123.34 22.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 110.271 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 7.2 m -41.4 151.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -0.828 . . . . 0.0 110.205 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -63.91 -10.0 18.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -100.02 5.38 45.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.579 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.504 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 55.5 t80 -59.77 138.05 57.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.791 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.0 mtm -122.46 148.06 45.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.978 -1.076 . . . . 0.0 109.936 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 2.0 t -55.75 129.95 71.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 110.5 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.535 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -72.59 -12.55 26.97 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 123.835 1.439 . . . . 0.0 109.114 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.24 -67.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.592 -0.692 . . . . 0.0 110.667 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.492 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.7 p -93.82 1.18 56.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 111.113 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 2.6 ttm180 61.06 31.12 19.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.083 -1.011 . . . . 0.0 111.764 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.473 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.4 m -85.01 168.62 19.7 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.775 -1.203 . . . . 0.0 109.883 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.1 Cg_endo -72.42 138.84 30.64 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.959 1.505 . . . . 0.0 110.457 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.572 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 20.9 tttm -51.0 -31.16 17.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.047 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -63.33 -12.11 27.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 109.73 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -85.04 -5.96 59.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.73 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 23.2 m-85 -79.99 137.96 36.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 110.553 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.508 ' CG ' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -109.71 132.75 53.86 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.384 -0.823 . . . . 0.0 108.997 178.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.606 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.6 0 O-C-N 121.072 -1.018 . . . . 0.0 110.443 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 tttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.609 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 30.7 m-85 -128.92 146.69 50.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.125 -0.984 . . . . 0.0 110.808 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 4.0 mt-10 -116.95 143.2 45.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 0.0 109.578 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 4.3 t -78.13 114.38 16.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.913 -1.117 . . . . 0.0 110.709 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.32 -15.68 63.83 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.915 -1.116 . . . . 0.0 108.41 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -59.62 2.28 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.728 -0.608 . . . . 0.0 110.712 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.13 -4.87 16.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.976 -1.078 . . . . 0.0 110.972 -178.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 84.27 3.63 88.63 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.957 -1.089 . . . . 0.0 111.728 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.54 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 77.7 t80 -52.46 174.34 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.748 -1.443 . . . . 0.0 109.564 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.54 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 1.2 mp -148.12 110.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.991 . . . . 0.0 110.227 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 49.0 t80 -81.21 123.47 28.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.829 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -107.87 116.91 56.49 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 110.197 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.8 Cg_endo -70.05 -27.46 25.08 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.812 1.427 . . . . 0.0 110.401 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -73.07 -15.18 61.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.342 -0.849 . . . . 0.0 109.998 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 -12.06 12.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.788 . . . . 0.0 109.973 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 80.99 165.74 34.48 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.534 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.21 50.16 1.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -1.064 . . . . 0.0 109.897 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.78 -51.62 2.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.5 -0.75 . . . . 0.0 110.374 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -49.41 -38.7 30.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.385 -0.822 . . . . 0.0 110.28 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.64 -67.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -0.881 . . . . 0.0 110.404 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.73 51.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.534 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 2.1 mp -133.69 147.09 63.08 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.27 -1.135 . . . . 0.0 109.921 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.9 Cg_endo -71.42 165.49 32.31 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.987 1.519 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.471 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.9 Cg_endo -72.04 162.51 41.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.96 1.505 . . . . 0.0 110.832 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.81 12.49 82.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 21.7 m -92.32 122.97 63.67 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -1.139 . . . . 0.0 110.19 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.51 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 46.5 Cg_endo -72.7 139.07 30.25 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.879 1.463 . . . . 0.0 110.651 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.573 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 79.8 t80 -55.9 -17.78 7.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.887 . . . . 0.0 109.819 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 14.2 m -73.78 -7.47 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.67 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -95.31 -7.58 38.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 110.383 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.457 HD13 ' CD1' ' A' ' 34' ' ' PHE . 18.3 mt -70.94 147.61 48.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.97 . . . . 0.0 109.978 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.7 m -75.49 155.41 36.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.843 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -58.7 -14.19 7.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.129 -0.982 . . . . 0.0 110.268 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.23 5.43 50.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 110.55 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.527 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.6 t80 -59.01 135.74 57.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.682 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.0 mtp -118.24 146.05 44.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.057 -1.027 . . . . 0.0 110.351 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' ARG . 42.5 t -61.22 124.27 79.67 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.408 -0.808 . . . . 0.0 110.097 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.581 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.0 Cg_endo -70.48 -7.87 22.29 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.883 1.465 . . . . 0.0 109.823 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.463 ' HB1' ' CD1' ' A' ' 15' ' ' TYR . . . -94.0 -54.84 3.44 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 10.3 p -115.99 7.02 14.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.438 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' CYS . 6.0 ttm180 63.21 15.94 9.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.241 -0.912 . . . . 0.0 112.171 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 20.6 p -68.64 166.56 25.51 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 0.0 109.811 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.2 Cg_endo -72.29 142.01 36.66 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.733 1.386 . . . . 0.0 110.495 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 10.5 tttm -48.51 -28.47 3.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 109.961 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.99 -10.42 21.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -0.87 . . . . 0.0 109.886 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.66 -4.19 58.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.276 -0.89 . . . . 0.0 109.695 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 19.1 m-85 -80.18 132.34 35.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 110.589 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.48 128.83 53.77 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.609 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.567 0 O-C-N 121.059 -1.026 . . . . 0.0 110.02 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.199 0.523 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 22.4 m-85 -120.05 146.99 45.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.295 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.522 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 70.7 tt0 -121.4 139.89 52.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.7 t -77.11 117.01 18.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.025 . . . . 0.0 110.398 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -68.07 -16.53 64.06 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.785 -1.197 . . . . 0.0 108.617 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.13 -59.14 2.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.637 -0.664 . . . . 0.0 110.574 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.37 -3.76 16.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.006 -1.059 . . . . 0.0 110.918 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 79.4 6.13 89.02 Favored Glycine 0 N--CA 1.496 2.696 0 O-C-N 121.081 -1.012 . . . . 0.0 111.43 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 17.7 t80 -56.79 144.2 33.9 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.927 -1.337 . . . . 0.0 109.829 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 13.3 mm -115.99 111.27 34.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.651 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.9 t80 -81.24 121.42 26.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.835 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -101.84 118.48 59.38 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.251 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -72.0 -29.25 15.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.968 1.509 . . . . 0.0 110.166 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.08 -9.23 58.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 110.224 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 2.5 mmmp? -111.81 -45.48 3.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.273 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.52 159.57 12.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.545 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.19 55.18 3.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -1.06 . . . . 0.0 109.882 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.54 -51.59 2.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 110.499 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 65.3 m-85 -51.25 -37.95 49.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.844 . . . . 0.0 110.294 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.54 -68.52 0.78 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 110.183 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.43 53.85 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.545 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.84 143.37 48.8 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.232 -1.158 . . . . 0.0 109.949 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' O ' ' OG1' ' A' ' 32' ' ' THR . 45.5 Cg_endo -72.0 168.67 23.32 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.012 1.533 . . . . 0.0 110.36 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.2 Cg_endo -72.25 161.38 44.65 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.889 1.468 . . . . 0.0 110.88 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.67 15.47 80.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 29' ' ' PRO . 31.4 m -95.54 122.59 58.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.263 -1.139 . . . . 0.0 110.227 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.26 138.72 28.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.862 1.454 . . . . 0.0 110.58 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.576 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 13.7 t80 -53.13 -40.18 64.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.115 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG21 ' N ' ' A' ' 36' ' ' ASP . 11.4 m -53.77 -18.09 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 110.177 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' N ' HG21 ' A' ' 35' ' ' VAL . 27.1 t70 -83.51 -7.16 59.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.107 -0.996 . . . . 0.0 110.337 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.465 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.2 mt -71.86 151.87 43.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.944 . . . . 0.0 110.077 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -76.95 158.68 30.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -10.85 15.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 0.0 110.158 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 4.12 45.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.398 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 50.0 t80 -59.47 134.73 57.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -0.945 . . . . 0.0 109.845 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -118.81 146.86 44.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.048 -1.033 . . . . 0.0 109.853 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.9 t -56.89 130.01 78.48 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 110.422 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.531 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -72.05 -11.85 27.61 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.865 1.455 . . . . 0.0 109.51 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.42 -64.9 1.0 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 110.751 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.52 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.3 p -98.69 3.34 47.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 0.0 111.109 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 6.0 ttm180 62.09 21.68 12.56 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.05 -1.031 . . . . 0.0 111.994 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.468 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.7 m -74.98 168.24 29.36 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.776 -1.202 . . . . 0.0 109.931 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.5 Cg_endo -73.53 141.87 32.0 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.917 1.483 . . . . 0.0 110.561 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.571 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 41.3 tttm -50.19 -30.24 11.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.005 . . . . 0.0 109.968 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.04 -12.46 19.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.28 -0.888 . . . . 0.0 109.872 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.44 -2.37 58.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.279 -0.888 . . . . 0.0 109.798 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -86.15 139.1 31.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 110.688 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 138.24 54.37 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.0 t . . . . . 0 C--N 1.301 -1.525 0 O-C-N 120.66 -1.275 . . . . 0.0 110.787 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.6 mttt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.195 0.521 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.2 m-85 -118.37 138.41 52.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 110.701 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -116.04 140.25 49.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.436 -0.79 . . . . 0.0 109.554 179.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.7 t -75.93 115.55 15.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.954 . . . . 0.0 110.148 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -16.12 63.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.789 -1.194 . . . . 0.0 108.684 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.16 -60.8 1.93 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.593 -0.692 . . . . 0.0 110.552 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.512 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.2 p -108.31 -2.97 18.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.001 . . . . 0.0 111.001 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 78.65 6.95 88.33 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.013 -1.054 . . . . 0.0 111.418 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 15' ' ' TYR . 4.8 t80 -58.16 142.76 46.32 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.968 -1.313 . . . . 0.0 109.695 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.507 HD11 ' N ' ' A' ' 16' ' ' ILE . 2.2 mp -110.53 113.62 44.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.481 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 50.9 t80 -82.89 121.29 26.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 109.882 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -100.0 118.24 61.93 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 110.318 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -71.32 -35.93 7.72 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.82 1.432 . . . . 0.0 110.114 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -71.62 -10.51 59.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.801 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 -12.83 13.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.971 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.517 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 76.54 170.84 32.29 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.57 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 1.8 t70 -85.28 59.02 5.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.455 -1.026 . . . . 0.0 109.66 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -36.92 -62.99 0.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.555 -0.716 . . . . 0.0 110.699 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.515 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 18.5 m-85 -42.46 -27.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 110.32 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -101.04 -58.2 1.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.434 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.87 -10.07 1.2 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.185 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.547 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -61.27 141.2 94.27 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.061 -1.258 . . . . 0.0 109.73 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.481 ' HD2' HG21 ' A' ' 28' ' ' ILE . 43.9 Cg_endo -69.75 160.52 49.42 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.899 1.473 . . . . 0.0 110.665 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.517 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 45.1 Cg_endo -72.43 165.42 32.73 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.075 1.566 . . . . 0.0 110.702 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.15 12.83 83.23 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 20.4 m -103.79 126.33 32.18 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -1.144 . . . . 0.0 110.128 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.3 Cg_endo -73.11 142.92 35.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.889 1.468 . . . . 0.0 110.54 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.571 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.1 t80 -51.3 -36.39 42.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.885 . . . . 0.0 110.142 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.5 m -54.32 -17.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 110.403 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -84.36 -7.41 59.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 110.303 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 38.3 mt -71.22 152.79 42.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 110.076 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 1.4 m -80.15 167.85 19.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.95 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -73.59 -0.73 16.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 110.187 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 t -109.8 -0.12 18.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.168 -0.957 . . . . 0.0 110.387 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.57 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.9 t80 -59.7 138.69 57.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 109.791 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 48' ' ' SER . 11.4 mtt -120.93 145.77 47.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.129 -0.982 . . . . 0.0 110.051 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 12.9 t -55.53 131.35 71.05 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.838 . . . . 0.0 110.114 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.515 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 47.0 Cg_endo -73.38 -13.32 25.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.923 1.486 . . . . 0.0 109.609 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.78 -59.42 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.775 . . . . 0.0 110.95 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.512 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.0 p -105.15 5.06 31.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 111.076 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER 61.79 17.8 9.13 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.195 -0.94 . . . . 0.0 112.251 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 21.4 p -70.29 165.96 39.1 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.161 . . . . 0.0 109.672 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 45.8 Cg_endo -72.23 142.71 38.18 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.692 1.364 . . . . 0.0 110.388 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.563 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 27.3 tttm -48.78 -27.72 3.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 109.927 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.96 -11.18 26.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.35 -0.844 . . . . 0.0 109.825 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.84 -2.96 58.32 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.379 -0.825 . . . . 0.0 109.589 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 24.3 m-85 -87.7 139.22 30.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -132.08 147.88 52.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.651 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 3.2 p . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.023 . . . . 0.0 110.468 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.143 0.497 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 16.6 m-85 -123.55 152.91 41.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.207 -0.933 . . . . 0.0 110.405 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -125.64 141.19 52.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.418 -0.801 . . . . 0.0 109.527 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 5.0 t -78.01 117.32 19.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.506 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -16.36 63.92 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.595 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.12 -59.56 2.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.683 -0.636 . . . . 0.0 110.595 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.28 -3.91 16.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.992 -1.067 . . . . 0.0 110.775 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 79.95 5.67 89.44 Favored Glycine 0 N--CA 1.497 2.707 0 O-C-N 121.136 -0.977 . . . . 0.0 111.587 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.461 ' CD2' ' HB1' ' A' ' 45' ' ' ALA . 41.7 t80 -57.13 144.47 34.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.862 -1.375 . . . . 0.0 109.937 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -115.96 111.28 34.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.23 -0.919 . . . . 0.0 110.601 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 38.3 t80 -80.83 123.17 28.03 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.264 -0.897 . . . . 0.0 109.574 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -106.95 116.73 58.1 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 110.226 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' THR . 44.3 Cg_endo -71.19 -24.97 22.76 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.792 1.417 . . . . 0.0 110.24 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -73.14 -9.94 59.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.08 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.1 tttp -114.78 -43.26 3.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.125 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.98 159.51 13.13 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.538 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.09 55.18 3.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.445 -1.032 . . . . 0.0 109.94 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.74 -50.16 3.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.596 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 26.1 m-85 -52.12 -39.25 59.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 110.354 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -89.55 -69.22 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.213 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.28 54.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.0 144.22 52.68 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.236 -1.156 . . . . 0.0 110.04 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HD2' HG22 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -71.39 166.63 28.72 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.015 1.534 . . . . 0.0 110.505 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.3 Cg_endo -72.34 161.9 43.07 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.915 1.481 . . . . 0.0 110.819 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 73.58 13.65 80.1 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 19' ' ' PRO . 16.9 m -94.69 121.97 61.78 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.266 -1.138 . . . . 0.0 110.19 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.441 ' HB2' HG21 ' A' ' 35' ' ' VAL . 44.3 Cg_endo -71.89 141.4 36.96 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.81 1.426 . . . . 0.0 110.669 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.557 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 85.5 t80 -56.06 -18.1 8.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 33' ' ' PRO . 4.3 m -70.63 -11.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.38 -0.825 . . . . 0.0 109.47 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -89.35 -6.87 56.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.503 -0.748 . . . . 0.0 110.265 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.557 HD13 ' CD1' ' A' ' 34' ' ' PHE . 19.1 mt -73.63 144.75 45.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.143 -0.973 . . . . 0.0 110.044 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.2 t -75.46 160.38 30.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 110.096 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -62.27 -11.55 15.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.217 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.17 4.89 46.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.359 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.526 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 51.8 t80 -59.89 135.58 57.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.119 -0.988 . . . . 0.0 109.876 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -118.78 146.49 44.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.066 -1.022 . . . . 0.0 109.868 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.6 t -55.93 131.61 73.5 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.579 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 44.6 Cg_endo -72.4 -12.61 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.901 1.474 . . . . 0.0 109.585 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -98.88 -65.74 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.502 -0.749 . . . . 0.0 110.866 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.52 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.6 p -96.62 2.87 52.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 0.0 111.205 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER 61.88 22.37 12.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.133 -0.979 . . . . 0.0 111.997 178.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.468 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 3.9 m -75.73 168.16 30.22 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.786 -1.196 . . . . 0.0 109.92 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.1 Cg_endo -73.37 141.91 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.796 1.419 . . . . 0.0 110.494 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 11.9 tttm -50.17 -29.3 8.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 1.9 m-20 -62.4 -12.36 21.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.874 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.54 -1.58 58.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.284 -0.885 . . . . 0.0 109.727 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 3.2 m-85 -85.71 137.75 32.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.921 . . . . 0.0 110.421 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.42 137.99 54.47 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.0 t . . . . . 0 C--N 1.3 -1.565 0 O-C-N 120.761 -1.212 . . . . 0.0 110.454 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.228 0.537 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.654 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 9.8 m-85 -115.57 138.46 51.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 110.44 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.0 mt-10 -117.98 140.24 50.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 109.561 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 14' ' ' GLY . 5.3 t -77.14 115.77 17.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 110.283 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -16.19 63.96 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.773 -1.205 . . . . 0.0 108.638 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.12 -60.68 1.97 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.6 -0.687 . . . . 0.0 110.689 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.518 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.21 -3.72 18.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.067 -1.02 . . . . 0.0 110.909 -179.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.529 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 80.14 6.02 89.38 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.059 -1.025 . . . . 0.0 111.591 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 41.9 t80 -57.53 143.2 41.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.798 -1.413 . . . . 0.0 109.872 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -114.34 112.93 42.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.231 -0.918 . . . . 0.0 110.752 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 38.2 t80 -81.49 125.16 30.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.562 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -101.12 117.58 62.02 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.468 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.1 Cg_endo -71.24 -36.38 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.877 1.462 . . . . 0.0 109.98 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -9.69 54.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 109.747 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HE3' ' HE3' ' A' ' 24' ' ' LYS . 1.7 tmtm? -117.09 -17.55 10.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.474 -0.766 . . . . 0.0 109.724 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.489 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 83.19 172.61 48.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.578 ' OD2' ' CE1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -85.12 49.81 1.82 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -1.04 . . . . 0.0 109.784 179.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.9 ttmt -39.3 -58.32 1.23 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.0 -33.08 1.89 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -93.55 -62.68 1.32 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.901 . . . . 0.0 110.243 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.16 51.16 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.544 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -131.22 146.82 63.69 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.238 -1.154 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 28' ' ' ILE . 43.5 Cg_endo -69.78 155.44 65.86 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.891 1.469 . . . . 0.0 110.228 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.489 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 44.0 Cg_endo -71.17 165.34 32.71 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.871 1.458 . . . . 0.0 110.788 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 79.03 11.28 85.33 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 13.0 m -103.51 125.44 34.89 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.294 -1.121 . . . . 0.0 110.193 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 46.7 Cg_endo -73.06 142.29 34.23 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.87 1.458 . . . . 0.0 110.473 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 31.7 t80 -51.92 -39.2 58.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 110.033 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 m -55.14 -17.08 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.424 -0.797 . . . . 0.0 110.119 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.22 -6.87 59.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 110.253 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.43 HD12 ' OD2' ' A' ' 23' ' ' ASP . 17.9 mt -72.26 155.71 39.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 109.937 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.7 t -78.74 164.23 24.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.922 . . . . 0.0 110.071 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -5.88 21.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.9 m -103.4 1.49 32.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.203 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 41.2 t80 -58.53 133.7 56.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.048 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 48' ' ' SER . 4.6 mtm -120.84 147.54 45.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 109.965 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.5 t -56.34 128.38 73.15 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.357 -0.84 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.533 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.1 Cg_endo -70.84 -11.42 29.41 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.785 1.413 . . . . 0.0 109.267 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.23 -67.95 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.487 -0.758 . . . . 0.0 110.663 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.518 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.7 p -94.53 2.06 55.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 111.06 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.56 23.78 14.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.143 -0.973 . . . . 0.0 111.892 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 52' ' ' GLN . 2.2 t -75.79 160.72 78.26 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.755 -1.216 . . . . 0.0 109.909 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 43.2 Cg_endo -69.85 144.39 53.38 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.677 1.356 . . . . 0.0 110.323 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.566 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 18.3 tttm -49.22 -26.7 3.1 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.292 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -64.07 -11.62 31.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.896 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.523 ' CB ' ' OG ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -91.96 -0.85 57.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.616 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 8.3 m-85 -89.54 138.77 31.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.683 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -128.1 143.6 51.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 109.522 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.653 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.7 p . . . . . 0 N--CA 1.492 1.651 0 O-C-N 120.885 -1.135 . . . . 0.0 110.923 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.211 0.529 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.676 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 13.8 m-85 -116.5 143.9 45.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.94 . . . . 0.0 110.424 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.53 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -121.34 139.11 53.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.942 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.8 t -76.53 116.85 17.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.95 . . . . 0.0 110.327 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.09 -16.19 63.91 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.732 -1.23 . . . . 0.0 108.566 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -59.68 2.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.602 -0.686 . . . . 0.0 110.566 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.513 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.83 -3.45 17.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.967 -1.083 . . . . 0.0 110.916 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 79.06 6.11 88.88 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.343 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 42.2 t80 -56.29 143.62 33.32 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.875 -1.368 . . . . 0.0 109.796 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 14.9 mm -115.39 111.56 36.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.325 -0.859 . . . . 0.0 110.639 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 44.1 t80 -81.13 122.56 27.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.828 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -101.97 117.18 62.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 110.243 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.6 Cg_endo -71.8 -31.1 13.41 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.849 1.447 . . . . 0.0 110.234 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.4 -5.06 25.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.159 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -120.38 -38.45 2.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.81 167.42 23.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.534 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.7 OUTLIER -85.15 56.13 3.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.969 . . . . 0.0 109.894 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -40.14 -58.58 1.43 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.776 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 2.2 t80 -48.01 -32.94 7.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.594 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.456 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -92.25 -65.4 1.01 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.082 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.25 53.34 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.534 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -131.02 144.71 54.67 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.286 -1.126 . . . . 0.0 109.817 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -71.11 162.4 42.74 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.929 1.489 . . . . 0.0 110.425 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.29 163.44 38.66 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.91 1.479 . . . . 0.0 110.772 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.24 14.81 82.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -100.74 124.31 42.63 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.268 -1.137 . . . . 0.0 110.197 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 47.0 Cg_endo -73.32 140.38 30.43 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.92 1.484 . . . . 0.0 110.551 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.676 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 18.4 t80 -53.58 -40.38 65.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.361 -0.837 . . . . 0.0 110.319 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.1 m -53.86 -18.3 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.408 -0.808 . . . . 0.0 110.368 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 1.2 t0 -85.61 -6.81 59.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.394 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 38' ' ' SER . 16.2 mt -73.15 121.95 21.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 37' ' ' LEU . 47.4 t -42.02 155.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 110.381 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -9.19 21.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 110.292 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -98.26 4.6 48.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.333 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.513 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 46.1 t80 -59.72 136.31 57.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 110.222 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.9 mtp -120.33 145.7 46.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 109.69 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.5 t -54.82 131.81 66.21 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 110.333 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 45.5 Cg_endo -72.61 -13.88 27.35 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.899 1.473 . . . . 0.0 109.534 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.99 -65.29 0.97 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.486 -0.758 . . . . 0.0 110.908 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.5 p -96.28 2.91 53.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 111.167 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 3.1 ttm180 61.59 22.49 12.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.123 -0.986 . . . . 0.0 111.963 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.472 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.4 m -74.49 167.3 37.34 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.826 -1.172 . . . . 0.0 109.923 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.521 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 47.4 Cg_endo -73.51 142.96 33.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.946 1.498 . . . . 0.0 110.433 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.575 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 21.9 tttm -49.93 -30.08 9.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 49' ' ' PRO . 26.5 p30 -62.9 -11.74 20.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.119 -0.988 . . . . 0.0 109.968 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -89.27 -2.52 58.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.885 . . . . 0.0 109.54 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 7.3 m-85 -87.04 139.29 30.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.398 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -123.54 140.56 52.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.166 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 35.0 p . . . . . 0 N--CA 1.489 1.52 0 O-C-N 120.836 -1.165 . . . . 0.0 111.266 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.5 mttm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.244 0.545 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 21.2 m-85 -123.8 148.84 46.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.529 ' CG ' HD12 ' A' ' 16' ' ' ILE . 83.6 tt0 -122.85 142.7 50.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 109.535 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.5 t -79.39 115.74 19.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 110.645 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -15.28 63.52 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.372 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.25 -60.93 1.89 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.631 -0.668 . . . . 0.0 110.555 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -107.94 -4.74 17.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.957 -1.089 . . . . 0.0 110.717 -178.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 82.62 3.1 90.65 Favored Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.101 -0.999 . . . . 0.0 111.417 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.51 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . 89.6 t80 -49.53 172.39 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.854 -1.38 . . . . 0.0 109.421 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.529 HD12 ' CG ' ' A' ' 9' ' ' GLU . 10.4 mm -146.13 108.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.04 -1.038 . . . . 0.0 110.396 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.3 t80 -81.55 129.03 34.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 110.011 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -111.68 118.29 47.15 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 110.263 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -71.85 -29.29 15.57 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.885 1.466 . . . . 0.0 110.309 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 5.3 tp10 -71.59 -10.61 60.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.007 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 6.2 mttt -115.68 -39.65 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.381 -0.824 . . . . 0.0 110.003 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.46 164.59 20.95 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.538 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.8 OUTLIER -85.1 55.76 3.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -1.075 . . . . 0.0 109.844 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -41.1 -54.41 2.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.359 -0.838 . . . . 0.0 110.504 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 97.8 m-85 -49.63 -36.71 25.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.398 -0.814 . . . . 0.0 110.42 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -90.56 -67.47 0.85 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.04 54.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -133.36 141.73 41.59 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 109.98 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD2' HG21 ' A' ' 28' ' ' ILE . 44.7 Cg_endo -69.96 165.11 32.3 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.018 1.536 . . . . 0.0 110.432 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.0 Cg_endo -71.92 162.77 40.91 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.039 1.547 . . . . 0.0 110.841 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.11 12.04 84.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.8 m -98.87 123.2 50.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.286 -1.126 . . . . 0.0 110.232 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.2 Cg_endo -72.89 143.48 36.87 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.924 1.486 . . . . 0.0 110.75 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.575 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 7.7 t80 -57.54 -15.86 8.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.902 . . . . 0.0 110.041 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 m -69.97 -26.21 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.73 -5.51 55.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.41 -0.806 . . . . 0.0 110.409 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' SER . 11.1 mt -74.1 115.61 13.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.234 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 37' ' ' LEU . 63.9 m -41.68 151.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 110.378 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.64 -12.88 11.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 110.123 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 t -95.93 8.05 44.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.422 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.52 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.8 t80 -61.0 138.56 58.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.02 . . . . 0.0 109.894 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.2 mtt -121.34 147.48 45.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.031 . . . . 0.0 109.731 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.9 t -56.56 131.67 77.32 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 110.509 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 45.3 Cg_endo -72.42 -12.45 27.3 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.797 1.42 . . . . 0.0 109.561 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.5 -67.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 110.822 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.522 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.6 p -93.59 1.4 56.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.06 -1.025 . . . . 0.0 111.097 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.96 24.34 14.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.171 -0.956 . . . . 0.0 111.932 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.467 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 4.1 m -77.67 167.94 31.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.828 -1.17 . . . . 0.0 109.835 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.9 Cg_endo -72.64 140.92 33.44 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.801 1.422 . . . . 0.0 110.481 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.565 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 11.2 tttm -49.28 -27.21 3.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.005 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 0.7 OUTLIER -63.14 -11.86 23.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.956 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -90.72 -0.86 57.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.292 -0.88 . . . . 0.0 109.604 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -87.12 137.88 31.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.656 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -119.79 136.34 54.49 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.6 t . . . . . 0 C--N 1.3 -1.586 0 O-C-N 120.724 -1.235 . . . . 0.0 110.81 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.5 m-85 -118.43 142.1 47.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.953 . . . . 0.0 110.8 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 6.6 tm-20 -119.22 140.26 50.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -0.809 . . . . 0.0 109.439 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' GLY . 5.0 t -76.57 116.75 17.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.15 -0.969 . . . . 0.0 110.233 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -16.59 64.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.767 -1.208 . . . . 0.0 108.713 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -59.8 2.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.578 -0.702 . . . . 0.0 110.599 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.95 -3.46 17.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.031 -1.043 . . . . 0.0 110.966 -179.032 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 79.37 6.29 88.97 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.153 -1.022 . . . . 0.0 111.458 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 40.5 t80 -57.57 143.59 40.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.918 -1.342 . . . . 0.0 109.698 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -114.17 112.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.281 -0.887 . . . . 0.0 110.647 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 33.9 t80 -82.21 128.05 33.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.651 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -109.49 117.2 53.36 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.872 . . . . 0.0 110.184 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.8 Cg_endo -71.28 -28.97 17.74 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.827 1.435 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.78 -5.83 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 110.053 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -119.82 -39.13 2.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 110.185 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.19 166.13 22.11 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.56 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -85.12 54.61 3.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -1.043 . . . . 0.0 109.899 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASP . 18.4 mmtt -39.74 -56.66 1.68 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.378 -0.826 . . . . 0.0 110.695 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.49 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 65.2 m-85 -47.34 -33.91 6.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -93.98 -64.63 1.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 110.484 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.98 52.83 0.02 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.545 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.11 145.22 55.79 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.274 -1.133 . . . . 0.0 109.82 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.6 Cg_endo -70.95 160.95 47.74 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.948 1.499 . . . . 0.0 110.43 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.6 Cg_endo -71.9 163.27 39.39 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.963 1.507 . . . . 0.0 110.765 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.11 15.34 81.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 26.7 m -102.46 124.2 40.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.265 -1.138 . . . . 0.0 110.254 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 48.0 Cg_endo -73.65 140.26 29.25 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.874 1.46 . . . . 0.0 110.561 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.581 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.7 t80 -50.42 -41.04 51.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.035 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.52 -17.14 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 110.266 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -84.42 -7.06 59.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.24 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.8 mt -71.65 155.86 40.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.952 . . . . 0.0 110.044 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 156.59 30.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.9 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -11.33 13.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.136 -0.978 . . . . 0.0 110.363 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.2 m -99.64 3.87 45.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.946 . . . . 0.0 110.418 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.56 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 44.8 t80 -59.68 136.37 57.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 109.964 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 48' ' ' SER . 6.8 mtt -120.0 146.37 45.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.077 -1.015 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.9 t -55.94 130.62 73.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 110.319 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.49 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.9 Cg_endo -71.99 -12.7 28.51 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.875 1.461 . . . . 0.0 109.526 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.35 -64.26 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.453 -0.779 . . . . 0.0 110.842 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.525 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.8 p -98.77 3.76 47.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 111.173 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.7 OUTLIER 61.69 20.53 11.42 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.111 -0.993 . . . . 0.0 112.036 178.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.463 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -73.05 167.31 35.42 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.769 -1.207 . . . . 0.0 109.786 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.3 Cg_endo -73.21 142.78 34.5 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.863 1.454 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 22.8 tttm -49.37 -27.67 4.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 109.834 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -63.04 -12.2 24.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.873 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -1.8 57.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.612 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 15.5 m-85 -88.53 139.65 30.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 110.379 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -130.74 146.27 52.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.702 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 p . . . . . 0 N--CA 1.491 1.596 0 O-C-N 120.908 -1.12 . . . . 0.0 110.44 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 tptm . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.137 0.494 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.0 m-85 -117.78 139.5 50.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 110.661 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.486 ' HB3' ' CD1' ' A' ' 16' ' ' ILE . 14.3 pt-20 -116.76 139.18 50.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.308 -0.87 . . . . 0.0 109.615 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -76.55 117.03 17.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 110.426 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -16.3 64.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.868 -1.145 . . . . 0.0 108.668 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.401 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.2 -59.49 2.31 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.649 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.93 -3.49 17.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.951 -179.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 78.28 7.74 87.71 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 30.6 t80 -58.76 142.56 49.76 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.807 -1.408 . . . . 0.0 109.636 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.486 ' CD1' ' HB3' ' A' ' 9' ' ' GLU . 24.5 mm -113.8 114.75 47.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.274 -0.891 . . . . 0.0 110.777 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.57 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 24.6 t80 -83.22 133.03 35.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 109.719 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -110.89 119.43 46.05 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 110.224 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -71.31 -34.51 9.73 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.861 1.453 . . . . 0.0 110.217 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -70.06 -6.76 36.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.398 -0.814 . . . . 0.0 110.028 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 14.5 tttt -117.96 -36.45 3.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.109 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.92 171.53 28.81 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.542 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 1.7 t70 -85.31 57.98 4.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.515 -0.991 . . . . 0.0 109.767 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ASP . 1.1 tptt -37.58 -63.0 0.48 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.554 -0.716 . . . . 0.0 110.727 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 17.7 m-85 -43.27 -27.13 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.393 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -100.26 -58.42 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.267 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.92 -7.52 1.06 Allowed Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.495 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.539 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.8 mp -64.93 142.27 98.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.344 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.61 162.49 42.01 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.997 1.524 . . . . 0.0 110.611 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -72.59 163.86 37.28 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.991 1.522 . . . . 0.0 110.775 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.53 13.37 83.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 60.5 m -105.75 126.59 30.36 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.274 -1.133 . . . . 0.0 110.168 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.517 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 47.6 Cg_endo -72.56 142.15 35.86 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.839 1.442 . . . . 0.0 110.603 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.57 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 2.9 t80 -53.21 -38.71 63.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.133 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.517 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 20.3 m -54.76 -17.68 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 110.051 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -83.12 -6.17 59.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.3 mt -70.23 156.34 39.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 0.0 109.996 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.58 162.63 25.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.872 . . . . 0.0 109.858 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -69.97 -3.91 18.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.252 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.0 m -106.7 0.67 24.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.542 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 44.7 t80 -59.98 136.58 58.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.978 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.466 ' HA ' ' O ' ' A' ' 48' ' ' SER . 21.7 mtp -119.62 146.06 45.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.12 -0.988 . . . . 0.0 109.908 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.4 t -54.86 129.64 65.46 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.266 -0.896 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.533 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.6 Cg_endo -71.27 -13.53 30.88 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.819 1.431 . . . . 0.0 109.47 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.98 -63.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.752 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.527 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.4 p -98.84 3.78 47.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.192 -0.942 . . . . 0.0 111.156 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.24 21.37 11.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.165 -0.96 . . . . 0.0 112.087 178.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.468 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.5 m -73.93 166.9 40.33 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.828 -1.17 . . . . 0.0 109.808 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.7 Cg_endo -72.91 142.68 35.43 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.818 1.431 . . . . 0.0 110.33 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.523 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 7.4 tttt -49.58 -25.64 2.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -66.26 -11.86 52.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.793 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.401 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -89.05 -3.23 58.75 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.35 -0.844 . . . . 0.0 109.492 179.279 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.522 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 4.6 m-85 -88.62 140.56 29.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.433 -0.792 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 5.1 mttt -129.89 146.35 51.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.491 1.584 0 O-C-N 120.936 -1.103 . . . . 0.0 110.705 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' SER . 9.4 mttt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.609 ' CE1' ' HB3' ' A' ' 55' ' ' SER . 9.3 m-85 -121.12 137.82 54.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 111.089 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.522 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 83.2 tt0 -118.43 145.64 45.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.0 109.393 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 6.6 t -79.05 115.21 18.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.05 -1.031 . . . . 0.0 110.442 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.76 -15.23 63.41 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.508 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -61.14 1.84 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.703 -0.623 . . . . 0.0 110.771 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -108.39 -5.04 16.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.03 -1.044 . . . . 0.0 111.102 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 83.99 3.01 89.4 Favored Glycine 0 N--CA 1.497 2.75 0 O-C-N 120.973 -1.08 . . . . 0.0 111.419 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 29.3 t80 -50.64 173.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.827 -1.396 . . . . 0.0 109.17 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 12.1 mm -144.31 132.81 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.924 -1.11 . . . . 0.0 110.684 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 40.3 t80 -106.1 132.55 52.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.349 -0.844 . . . . 0.0 109.65 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 3.3 mt-10 -113.96 119.98 39.79 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.895 . . . . 0.0 110.372 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.5 Cg_endo -69.95 -35.73 11.57 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.861 1.453 . . . . 0.0 110.333 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.06 -10.24 56.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 109.844 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -116.33 -30.46 5.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.859 . . . . 0.0 109.936 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.08 171.58 33.93 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.534 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.2 51.01 2.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -1.061 . . . . 0.0 109.736 179.189 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.09 -56.87 1.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.805 . . . . 0.0 110.455 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.53 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.05 -33.95 2.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.785 . . . . 0.0 110.229 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -94.3 -62.38 1.35 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.381 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.67 52.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.534 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -131.72 145.71 58.7 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.243 -1.151 . . . . 0.0 110.014 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' A' ' 28' ' ' ILE . 43.6 Cg_endo -70.08 160.17 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.952 1.501 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -72.3 163.87 37.34 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.983 1.517 . . . . 0.0 110.837 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 79.98 13.72 81.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 58.9 m -107.55 126.04 30.87 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.195 -1.18 . . . . 0.0 110.222 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.7 Cg_endo -73.22 142.71 34.33 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.837 1.441 . . . . 0.0 110.636 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.574 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 t80 -51.22 -40.09 58.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.299 -0.876 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -16.93 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 110.309 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.24 -6.87 59.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 18.7 mt -70.13 157.14 38.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -0.949 . . . . 0.0 109.946 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -77.81 157.54 29.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.206 -0.934 . . . . 0.0 109.811 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.37 -9.92 14.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.15 -0.969 . . . . 0.0 110.262 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -100.48 2.92 42.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 110.428 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.9 t80 -58.2 132.8 54.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 109.77 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.7 mtt -118.81 147.24 44.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 110.06 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 8.0 t -58.08 127.41 79.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.319 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.53 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.15 -10.43 27.34 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.784 1.413 . . . . 0.0 109.565 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.57 -62.74 1.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.588 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.527 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.8 p -102.02 3.73 39.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.153 -0.967 . . . . 0.0 110.911 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER 62.26 20.85 12.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.196 -0.94 . . . . 0.0 112.063 178.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.465 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 25.5 p -73.83 165.52 52.47 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.864 -1.148 . . . . 0.0 109.781 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.1 Cg_endo -71.95 142.78 39.43 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.816 1.429 . . . . 0.0 110.377 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.559 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 43.2 tttm -48.29 -23.94 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 109.931 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.63 -10.8 39.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.852 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -91.7 -1.93 57.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.245 -0.909 . . . . 0.0 109.614 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 20.1 m-85 -88.57 138.12 31.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 110.506 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 2.5 tptp -130.7 146.52 52.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.339 -0.851 . . . . 0.0 109.662 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.609 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.2 p . . . . . 0 N--CA 1.492 1.626 0 O-C-N 120.901 -1.124 . . . . 0.0 110.435 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.169 0.509 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 29.8 m-85 -125.67 145.09 50.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.572 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.524 ' HG2' ' CD1' ' A' ' 16' ' ' ILE . 14.5 mt-10 -117.67 142.63 47.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.399 -0.813 . . . . 0.0 109.901 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.4 t -77.56 113.61 15.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.975 -1.078 . . . . 0.0 110.584 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -15.1 63.31 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.912 -1.118 . . . . 0.0 108.441 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.06 -60.96 1.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.577 -0.702 . . . . 0.0 110.59 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.524 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.62 -4.4 17.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.972 -1.08 . . . . 0.0 110.887 -178.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 82.0 3.43 90.58 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.33 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.577 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 29.3 t80 -49.96 172.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.032 -1.275 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.577 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 24.5 mm -141.12 130.01 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.005 -1.059 . . . . 0.0 110.455 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 66.7 t80 -103.06 124.38 48.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.689 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -109.34 116.33 55.06 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.33 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.5 Cg_endo -69.34 -31.41 22.46 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.969 1.51 . . . . 0.0 110.075 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.08 -12.31 61.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 109.826 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.89 -12.69 10.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.89 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.464 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 81.3 167.41 38.26 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.551 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 1.2 t0 -85.18 50.6 1.98 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -1.032 . . . . 0.0 109.774 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.3 mmtt -39.31 -53.84 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.347 -0.845 . . . . 0.0 110.534 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.53 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -47.13 -36.5 8.49 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.428 -0.795 . . . . 0.0 110.225 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -92.27 -64.34 1.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 0.0 110.377 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.22 52.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.551 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.88 145.7 58.6 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -1.097 . . . . 0.0 109.939 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HD2' HG22 ' A' ' 28' ' ' ILE . 43.7 Cg_endo -70.49 161.85 44.55 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.962 1.507 . . . . 0.0 110.198 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.464 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.2 Cg_endo -71.64 162.78 41.09 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.973 1.512 . . . . 0.0 110.853 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.12 12.59 84.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 21.9 m -97.73 125.1 45.8 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.239 -1.153 . . . . 0.0 110.179 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.89 139.29 30.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.867 1.456 . . . . 0.0 110.605 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.574 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 62.5 t80 -52.11 -41.46 62.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.074 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG21 ' N ' ' A' ' 36' ' ' ASP . 6.1 m -53.52 -17.59 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.432 -0.793 . . . . 0.0 110.384 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.2 t0 -83.96 -7.6 59.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.127 -0.983 . . . . 0.0 110.4 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.456 ' CB ' ' HD2' ' A' ' 50' ' ' LYS . 17.9 mt -69.43 153.21 43.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 109.9 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.0 155.36 32.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.716 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -11.22 12.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 110.212 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.47 4.1 43.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 110.509 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.54 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 50.1 t80 -59.7 134.86 57.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.016 -1.052 . . . . 0.0 109.576 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.3 mtp -119.23 148.42 43.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.986 -1.071 . . . . 0.0 110.458 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 6.2 t -58.63 126.93 81.32 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.45 -0.781 . . . . 0.0 110.38 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.53 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.0 Cg_endo -70.69 -9.65 26.21 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.814 1.428 . . . . 0.0 109.486 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.36 -64.86 1.0 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.512 -0.743 . . . . 0.0 110.464 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.524 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.2 p -99.37 2.64 45.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.954 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.0 OUTLIER 63.04 22.34 13.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.153 -0.967 . . . . 0.0 112.094 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 29.9 p -76.31 166.11 47.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.735 -1.228 . . . . 0.0 109.859 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 45.2 Cg_endo -71.72 142.13 39.04 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.766 1.403 . . . . 0.0 110.437 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.567 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 10.1 tttm -48.64 -27.65 2.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.901 . . . . 0.0 110.0 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.06 -10.15 27.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.817 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -87.64 -5.57 58.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.306 -0.871 . . . . 0.0 109.628 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 23.7 m-85 -79.96 133.62 36.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 110.566 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.08 131.25 54.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.467 -0.771 . . . . 0.0 108.93 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.596 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 110.194 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.441 ' HE2' ' CG2' ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.182 0.515 . . . . 0.0 109.918 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 18.0 m-85 -120.03 146.65 45.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.176 -0.953 . . . . 0.0 110.372 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 4.6 mt-10 -121.07 140.08 52.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 109.565 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.3 t -76.42 118.44 19.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.117 -0.99 . . . . 0.0 110.399 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.84 -16.74 63.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.852 -1.155 . . . . 0.0 108.644 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -58.93 2.49 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.681 -0.637 . . . . 0.0 110.547 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.486 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -109.61 -3.09 17.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 110.931 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.521 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 78.27 6.73 87.84 Favored Glycine 0 N--CA 1.495 2.622 0 O-C-N 120.999 -1.063 . . . . 0.0 111.414 177.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 43.2 t80 -57.87 144.59 38.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.943 -1.328 . . . . 0.0 109.78 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -114.44 111.6 36.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.294 -0.879 . . . . 0.0 110.584 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 49.3 t80 -82.07 122.38 27.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.905 . . . . 0.0 109.984 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -107.0 119.65 50.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.832 . . . . 0.0 110.088 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.3 Cg_endo -71.47 -24.45 22.42 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.902 1.475 . . . . 0.0 110.299 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -72.05 -16.0 62.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 109.948 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -109.95 -37.75 5.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.05 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.54 166.05 24.5 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.541 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.21 50.41 1.94 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -1.051 . . . . 0.0 109.644 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 4.4 tttm -38.91 -53.02 1.76 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.492 -0.755 . . . . 0.0 110.618 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.505 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 13.9 m-85 -48.88 -36.46 17.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.378 -0.826 . . . . 0.0 110.295 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -91.58 -66.25 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.329 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.95 51.46 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.541 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.16 144.7 53.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.238 -1.154 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 28' ' ' ILE . 45.6 Cg_endo -70.89 163.03 40.62 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.956 1.503 . . . . 0.0 110.31 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -71.89 161.82 43.79 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.949 1.5 . . . . 0.0 110.905 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.34 13.13 83.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 37.4 m -93.89 123.11 60.51 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.3 -1.118 . . . . 0.0 110.174 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.4 Cg_endo -73.45 141.5 31.7 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.821 1.432 . . . . 0.0 110.641 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.578 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 30.3 t80 -55.53 -18.02 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.948 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -72.84 -10.6 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -91.84 -7.62 48.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.29 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.22 146.23 47.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.056 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.81 158.75 31.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.068 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -60.96 -12.93 12.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 0.0 110.158 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 97.2 p -99.27 4.84 46.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.449 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 52.3 t80 -58.96 139.57 56.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.101 -0.999 . . . . 0.0 109.984 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.7 mmm -119.79 143.8 47.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.985 -1.072 . . . . 0.0 110.049 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' ARG . 49.5 t -59.91 125.17 79.9 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 110.14 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.505 ' HB2' ' CB ' ' A' ' 25' ' ' PHE . 43.9 Cg_endo -70.67 -8.87 24.59 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.858 1.452 . . . . 0.0 109.871 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . . . -93.34 -53.66 4.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.482 -0.761 . . . . 0.0 110.167 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.486 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.5 p -118.15 8.47 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 110.707 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.81 14.18 7.13 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.255 -0.903 . . . . 0.0 112.162 178.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 52' ' ' GLN . 2.2 t -66.8 161.39 61.71 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.834 -1.166 . . . . 0.0 110.044 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 42.9 Cg_endo -69.29 143.38 52.91 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.608 1.32 . . . . 0.0 110.25 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.578 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 17.4 tttm -50.21 -28.86 8.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.129 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -63.01 -11.94 22.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.118 -0.989 . . . . 0.0 109.786 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.523 ' CB ' ' OG ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -88.67 -2.52 58.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.879 . . . . 0.0 109.85 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 43' ' ' CYS . 25.4 m-85 -83.93 135.38 34.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.583 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' NZ ' ' O ' ' A' ' 55' ' ' SER . 0.5 OUTLIER -120.67 138.14 54.09 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.734 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.3 t . . . . . 0 C--N 1.3 -1.564 0 O-C-N 120.819 -1.176 . . . . 0.0 110.535 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 12.1 m-85 -120.7 144.14 48.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.937 . . . . 0.0 110.949 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.6 pp20? -118.85 140.24 50.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 0.0 109.513 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.4 t -77.31 117.99 19.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.056 -1.028 . . . . 0.0 110.534 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.439 ' CA ' ' OE1' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -69.11 -16.57 63.7 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.833 -1.167 . . . . 0.0 108.525 178.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -59.21 2.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.594 -0.691 . . . . 0.0 110.547 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.03 -3.21 17.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.98 -1.075 . . . . 0.0 110.815 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 78.24 6.14 87.62 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.081 -1.012 . . . . 0.0 111.404 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 47.6 t80 -56.83 144.89 31.4 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.957 -1.32 . . . . 0.0 109.744 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.404 ' CD1' ' CB ' ' A' ' 9' ' ' GLU . 22.2 mm -115.71 110.58 32.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.234 -0.917 . . . . 0.0 110.5 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 45.8 t80 -81.26 121.47 26.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.81 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.03 121.13 50.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.386 -0.821 . . . . 0.0 110.213 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.5 Cg_endo -70.78 -27.68 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.935 1.492 . . . . 0.0 110.277 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.91 -18.87 62.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 110.234 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -104.24 -39.61 6.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.151 -0.968 . . . . 0.0 110.175 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.81 164.67 24.18 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.526 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -85.18 51.38 2.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.449 -1.03 . . . . 0.0 109.83 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -40.12 -51.54 2.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.345 -0.847 . . . . 0.0 110.67 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 26.1 m-85 -48.98 -36.63 18.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.352 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.97 -66.13 0.95 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.246 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.76 53.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.526 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -131.86 143.93 51.11 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.378 -1.072 . . . . 0.0 110.038 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD2' HG22 ' A' ' 28' ' ' ILE . 45.1 Cg_endo -72.04 165.43 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.108 1.583 . . . . 0.0 110.311 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.424 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.8 Cg_endo -72.24 163.06 39.83 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.932 1.491 . . . . 0.0 110.833 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.47 12.07 82.38 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 25.1 m -94.38 123.61 58.06 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.238 -1.154 . . . . 0.0 110.2 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.527 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 46.9 Cg_endo -73.18 141.3 32.23 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.811 1.427 . . . . 0.0 110.585 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.577 ' CE1' ' HE2' ' A' ' 50' ' ' LYS . 47.6 t80 -55.38 -38.97 69.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.29 -0.881 . . . . 0.0 110.186 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 17.0 m -54.1 -18.47 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.407 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.5 OUTLIER -83.16 -6.72 59.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.408 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.573 HD13 ' CD2' ' A' ' 34' ' ' PHE . 19.3 mt -73.05 150.65 42.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.114 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.45 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -76.71 159.52 30.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 109.996 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -10.23 18.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.211 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 p -100.28 4.33 44.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.264 -0.897 . . . . 0.0 110.327 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.9 t80 -60.42 137.77 58.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 110.038 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 48' ' ' SER . 18.3 mtm -119.84 146.14 46.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.178 -0.951 . . . . 0.0 110.093 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 10.9 t -56.91 130.26 78.77 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.793 . . . . 0.0 110.443 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 45.6 Cg_endo -72.25 -12.1 27.41 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.921 1.485 . . . . 0.0 109.698 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.6 -61.95 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 110.708 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.519 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.5 p -102.51 4.37 38.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 111.128 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.1 tpt180 62.12 18.96 10.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.136 -0.977 . . . . 0.0 112.102 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.465 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.7 m -71.83 168.1 25.42 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.831 -1.168 . . . . 0.0 109.759 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.9 Cg_endo -73.8 142.75 32.38 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.817 1.43 . . . . 0.0 110.406 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.9 tttm -49.37 -28.38 4.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 109.784 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -63.13 -11.94 23.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 109.856 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -89.5 -2.39 58.35 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.595 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -87.56 139.18 30.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 110.43 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.16 139.13 54.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.458 -0.776 . . . . 0.0 108.94 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 40.8 p . . . . . 0 C--N 1.302 -1.457 0 O-C-N 120.854 -1.154 . . . . 0.0 110.632 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.8 mttp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.129 0.49 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.4 m-85 -125.56 148.68 48.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.95 . . . . 0.0 110.859 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.522 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 32.6 tt0 -119.04 140.27 50.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.839 . . . . 0.0 109.424 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.6 t -77.33 117.45 18.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.047 -1.033 . . . . 0.0 110.421 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -16.42 63.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.822 -1.174 . . . . 0.0 108.585 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.401 ' HB3' ' NE2' ' A' ' 52' ' ' GLN . . . -85.18 -59.12 2.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.579 -0.701 . . . . 0.0 110.551 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.39 -3.8 16.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.009 -1.057 . . . . 0.0 110.906 -179.041 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 79.41 6.25 88.99 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.537 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 34.0 t80 -57.01 143.58 37.63 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.797 -1.413 . . . . 0.0 109.807 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 17.8 mm -115.19 111.86 37.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.342 -0.848 . . . . 0.0 110.65 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.0 t80 -81.38 122.21 27.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.773 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -102.28 117.78 60.41 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 0.0 110.226 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.8 Cg_endo -71.16 -30.37 16.16 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.87 1.458 . . . . 0.0 110.307 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -72.48 -7.91 52.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.304 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -114.4 -43.56 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.285 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.1 163.34 18.08 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.54 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.16 56.17 3.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.453 -1.027 . . . . 0.0 109.983 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' ASP . 9.5 mtpt -40.92 -55.5 2.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 110.502 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 27.1 m-85 -48.45 -34.86 11.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.375 -0.828 . . . . 0.0 110.506 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 23' ' ' ASP . . . -92.8 -65.75 0.98 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 110.3 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.46 54.34 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.54 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -132.1 144.07 51.6 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.296 -1.12 . . . . 0.0 109.993 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 28' ' ' ILE . 45.2 Cg_endo -71.59 165.05 33.71 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.956 1.503 . . . . 0.0 110.391 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.448 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.06 162.9 40.41 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.017 1.535 . . . . 0.0 110.804 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.11 15.02 81.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 15.8 m -97.65 123.29 52.51 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.283 -1.127 . . . . 0.0 110.198 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 47.6 Cg_endo -73.75 139.9 28.44 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.873 1.46 . . . . 0.0 110.586 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.573 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 12.4 t80 -53.42 -40.61 65.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.273 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 27.3 m -53.17 -18.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 110.467 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 3.8 t70 -85.52 -7.1 59.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 0.0 110.386 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.493 HD12 ' CD1' ' A' ' 41' ' ' PHE . 13.7 mt -73.99 120.06 19.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 37' ' ' LEU . 18.5 t -42.21 159.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.457 -0.777 . . . . 0.0 110.335 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.45 -7.7 27.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 0.0 110.161 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 p -99.03 4.19 47.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.493 ' CD1' HD12 ' A' ' 37' ' ' LEU . 49.1 t80 -58.61 134.76 57.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.193 -0.942 . . . . 0.0 110.157 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -120.13 146.15 46.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.139 -0.975 . . . . 0.0 109.718 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.9 t -56.46 130.06 75.91 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 110.493 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.469 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -71.93 -12.4 28.36 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.845 1.445 . . . . 0.0 109.477 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.04 -65.81 0.94 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.576 -0.703 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.523 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.1 p -96.66 2.39 52.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.162 -0.961 . . . . 0.0 111.126 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.04 23.33 13.74 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.101 -0.999 . . . . 0.0 111.878 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.471 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -76.29 167.46 36.5 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.866 -1.146 . . . . 0.0 109.907 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.0 Cg_endo -73.75 142.77 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.972 1.512 . . . . 0.0 110.525 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.561 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 9.4 tttm -49.85 -29.53 8.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.105 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -63.16 -11.99 24.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.856 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -88.73 -2.65 58.7 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 109.673 179.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.82 138.69 31.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.943 . . . . 0.0 110.658 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.54 138.57 54.25 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.8 t . . . . . 0 C--N 1.301 -1.528 0 O-C-N 120.622 -1.299 . . . . 0.0 110.51 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.4 m-85 -126.68 151.24 48.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.945 . . . . 0.0 110.766 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -121.95 141.38 51.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.398 -0.814 . . . . 0.0 109.424 179.113 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -78.11 117.73 19.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -0.996 . . . . 0.0 110.521 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.85 -16.34 63.74 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.831 -1.168 . . . . 0.0 108.515 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -59.2 2.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.603 -0.685 . . . . 0.0 110.411 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.478 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.33 -3.43 17.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.961 -1.087 . . . . 0.0 110.774 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.515 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 78.66 5.79 88.28 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.155 -0.965 . . . . 0.0 111.474 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.549 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 52.9 t80 -58.12 146.04 34.72 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.855 -1.38 . . . . 0.0 109.92 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.515 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.4 mp -116.42 110.44 31.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.214 -0.929 . . . . 0.0 110.443 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.518 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 36.8 t80 -80.94 121.63 26.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -106.33 120.12 49.71 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.437 -0.789 . . . . 0.0 110.027 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.5 Cg_endo -72.09 -23.14 21.83 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.99 1.521 . . . . 0.0 110.524 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -72.35 -16.22 61.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.113 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -109.69 -39.71 5.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 110.112 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.5 163.05 20.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.539 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.19 51.86 2.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -1.048 . . . . 0.0 109.866 179.016 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.5 mmtt -39.8 -50.01 2.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.441 -0.787 . . . . 0.0 110.65 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 41.1 m-85 -51.05 -39.5 56.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.269 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -88.77 -68.93 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.191 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.44 52.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.539 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.05 144.15 52.38 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.298 -1.119 . . . . 0.0 109.997 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' O ' ' OG1' ' A' ' 32' ' ' THR . 45.9 Cg_endo -72.01 166.54 29.3 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.875 1.461 . . . . 0.0 110.407 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.2 Cg_endo -72.48 160.86 45.73 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.91 1.479 . . . . 0.0 110.861 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.65 12.45 84.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 19' ' ' PRO . 25.9 m -92.92 121.04 66.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.18 -1.188 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.526 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 47.4 Cg_endo -73.18 142.48 34.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.859 1.452 . . . . 0.0 110.553 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.574 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 31.0 t80 -56.01 -21.39 21.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.294 -0.879 . . . . 0.0 110.024 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 32.3 m -72.11 -9.02 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -0.874 . . . . 0.0 109.784 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.54 -7.17 44.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.984 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.416 ' CB ' ' HD2' ' A' ' 50' ' ' LYS . 23.7 mt -72.91 146.16 46.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.013 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -73.58 151.38 40.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.879 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.0 -17.15 3.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.55 7.83 45.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 0.0 110.427 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.503 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 55.0 t80 -60.8 139.84 57.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 109.81 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 48' ' ' SER . 32.9 mtm -118.4 144.47 45.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.024 -1.048 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.453 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 42.5 t -59.31 127.56 84.46 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.402 -0.811 . . . . 0.0 110.284 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.525 ' HB2' ' CB ' ' A' ' 25' ' ' PHE . 44.1 Cg_endo -71.46 -10.0 26.15 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.002 1.528 . . . . 0.0 110.0 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -94.33 -54.87 3.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.461 -0.774 . . . . 0.0 110.327 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.478 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 10.0 p -115.3 7.47 15.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 110.773 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 63.01 14.39 7.53 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.28 -0.887 . . . . 0.0 112.171 178.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 3.6 m -67.56 169.3 9.42 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.857 -1.152 . . . . 0.0 109.894 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.3 Cg_endo -74.19 141.36 29.13 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.788 1.415 . . . . 0.0 110.461 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.574 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 10.5 tttm -50.05 -29.55 9.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 109.892 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -61.88 -12.52 18.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.866 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.64 -1.92 58.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.788 179.475 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -84.6 137.32 33.36 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.725 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -120.5 137.23 54.47 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.1 t . . . . . 0 C--N 1.3 -1.552 0 O-C-N 120.621 -1.299 . . . . 0.0 110.537 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.162 0.506 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 18.8 m-85 -123.18 148.5 45.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 110.897 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.578 ' CG ' ' CD1' ' A' ' 16' ' ' ILE . 14.4 mt-10 -120.46 139.71 52.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.426 -0.796 . . . . 0.0 109.608 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.6 t -76.57 117.21 17.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.127 -0.983 . . . . 0.0 110.417 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -16.54 63.97 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.857 -1.152 . . . . 0.0 108.597 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.1 -58.82 2.53 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.647 -0.658 . . . . 0.0 110.683 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.63 -3.56 16.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.884 -1.135 . . . . 0.0 110.984 -179.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 79.34 6.47 88.91 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.058 -1.026 . . . . 0.0 111.392 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 26.9 t80 -56.59 143.1 37.04 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.942 -1.328 . . . . 0.0 109.687 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.578 ' CD1' ' CG ' ' A' ' 9' ' ' GLU . 16.4 mm -115.66 112.05 38.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.259 -0.9 . . . . 0.0 110.704 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.58 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.0 t80 -81.82 130.06 34.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.741 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -110.14 119.34 47.4 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 110.288 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -70.65 -30.2 18.5 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.892 1.469 . . . . 0.0 110.09 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.71 -13.82 61.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.833 . . . . 0.0 110.043 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -111.79 -38.23 4.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.381 -0.825 . . . . 0.0 110.049 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.36 168.94 25.76 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.568 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.6 OUTLIER -85.09 53.09 2.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.454 -1.027 . . . . 0.0 109.944 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -40.3 -57.4 1.75 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.375 -0.828 . . . . 0.0 110.533 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.474 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 27.0 m-85 -47.73 -34.35 8.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.47 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -90.99 -65.83 0.98 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.032 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.15 52.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.13 145.19 56.68 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.225 -1.162 . . . . 0.0 109.889 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -70.3 160.94 47.83 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.038 1.546 . . . . 0.0 110.47 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -71.93 163.14 39.77 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.049 1.552 . . . . 0.0 110.848 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.4 12.37 84.32 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 94.1 m -98.64 125.93 40.88 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.248 -1.148 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.74 139.76 28.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.016 1.535 . . . . 0.0 110.593 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.58 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 3.0 t80 -52.66 -40.0 62.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.017 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.3 m -53.76 -17.87 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -0.823 . . . . 0.0 110.282 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -83.53 -7.12 59.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 110.404 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.522 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.0 mt -71.42 153.86 41.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.086 -1.009 . . . . 0.0 109.98 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.22 157.99 30.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.979 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -11.52 15.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.267 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -99.52 4.01 45.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 110.435 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.568 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 48.7 t80 -59.65 132.81 55.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 109.832 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 48' ' ' SER . 10.4 mtp -117.08 147.01 42.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.052 -1.03 . . . . 0.0 109.966 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.6 t -56.59 129.97 76.66 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.321 -0.862 . . . . 0.0 110.458 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.474 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -72.22 -11.7 27.13 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.892 1.469 . . . . 0.0 109.4 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.64 -65.02 0.99 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.518 -0.739 . . . . 0.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.529 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.7 p -98.3 3.21 48.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.92 . . . . 0.0 111.151 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER 62.06 22.39 13.06 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.079 -1.013 . . . . 0.0 112.06 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.472 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.7 m -75.78 168.37 28.35 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.806 -1.184 . . . . 0.0 109.994 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.4 Cg_endo -74.08 142.57 31.19 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.907 1.478 . . . . 0.0 110.431 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 42.0 tttm -50.48 -29.41 10.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 109.944 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -62.95 -12.34 24.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.743 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -87.54 -3.08 59.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.786 179.515 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -86.45 139.63 30.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.748 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.55 139.86 53.43 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.2 t . . . . . 0 C--N 1.3 -1.575 0 O-C-N 120.677 -1.265 . . . . 0.0 110.566 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 10.0 m-85 -119.77 145.8 46.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.051 -1.03 . . . . 0.0 111.2 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.526 ' HB3' ' CD1' ' A' ' 16' ' ' ILE . 6.5 pt-20 -121.16 139.64 53.08 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.552 -0.717 . . . . 0.0 109.145 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.9 t -76.94 116.79 17.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.025 -1.047 . . . . 0.0 110.314 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.43 -16.52 64.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.84 -1.162 . . . . 0.0 108.601 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -59.53 2.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.662 -0.649 . . . . 0.0 110.563 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.44 -3.46 17.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.057 . . . . 0.0 110.986 -179.074 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 79.82 5.98 89.25 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.138 -1.029 . . . . 0.0 111.385 177.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 45.8 t80 -56.93 143.56 37.22 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.901 -1.353 . . . . 0.0 109.767 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 9' ' ' GLU . 21.7 mm -115.14 111.84 37.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 121.294 -0.879 . . . . 0.0 110.718 -179.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.1 t80 -82.17 129.34 34.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.867 . . . . 0.0 109.739 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -109.25 121.43 42.68 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.875 . . . . 0.0 110.202 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -71.66 -30.97 13.97 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.189 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.42 -14.81 62.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.082 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.406 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 5.2 ttpp -108.88 -38.58 5.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 110.157 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.32 169.04 25.81 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.523 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.07 54.73 3.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.462 -1.022 . . . . 0.0 109.886 179.212 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -40.37 -58.03 1.63 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.396 -0.815 . . . . 0.0 110.756 -179.528 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 47.5 m-85 -46.31 -33.34 3.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -93.07 -63.75 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.003 . . . . 0.0 110.292 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.59 53.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.523 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.92 144.96 55.14 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.279 -1.13 . . . . 0.0 109.819 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.3 Cg_endo -70.65 161.13 47.14 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.966 1.508 . . . . 0.0 110.366 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.6 Cg_endo -72.19 162.87 40.42 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.999 1.526 . . . . 0.0 110.787 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.41 13.33 83.67 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 83.7 m -99.85 124.06 45.22 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.269 -1.136 . . . . 0.0 110.15 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 46.4 Cg_endo -73.25 139.95 30.01 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.915 1.482 . . . . 0.0 110.644 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.577 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 1.3 t80 -50.96 -41.61 59.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.897 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -53.98 -17.55 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.418 -0.801 . . . . 0.0 110.423 -179.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.439 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 9.6 t0 -84.29 -7.44 59.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -0.992 . . . . 0.0 110.178 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.8 mt -71.14 154.99 41.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.018 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.68 149.63 38.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 109.823 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -55.67 -16.48 4.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.152 -0.967 . . . . 0.0 110.294 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -95.57 6.3 49.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.6 t80 -60.13 136.98 58.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.142 -0.974 . . . . 0.0 109.913 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 48' ' ' SER . 4.7 mtm -119.77 146.55 45.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 110.01 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 8.2 t -56.07 131.05 74.28 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 110.448 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.469 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.7 Cg_endo -72.21 -12.67 27.96 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.872 1.459 . . . . 0.0 109.583 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.34 -64.31 1.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.463 -0.773 . . . . 0.0 110.82 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.523 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.2 p -98.84 3.83 47.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.899 . . . . 0.0 111.206 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 14.2 mtm180 61.6 20.77 11.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.134 -0.979 . . . . 0.0 112.103 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.469 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.7 m -73.71 168.36 26.51 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.72 -1.238 . . . . 0.0 109.767 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.6 Cg_endo -73.57 142.27 32.46 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.951 1.5 . . . . 0.0 110.383 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 28.0 tttm -50.01 -29.22 8.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 109.807 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -61.23 -13.24 16.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.0 110.013 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.59 -1.08 57.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.328 -0.857 . . . . 0.0 109.681 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 13.3 m-85 -87.98 139.32 30.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 110.477 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 3.3 mttt -127.36 143.18 51.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.455 -0.778 . . . . 0.0 109.449 179.246 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 12.0 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.76 -1.213 . . . . 0.0 110.709 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 mttt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.167 0.508 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 11.4 m-85 -114.25 140.36 48.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 110.469 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 9.9 pt-20 -117.63 136.75 53.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 109.562 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.468 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 3.6 t -74.87 120.0 19.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.7 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -16.67 63.27 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.751 -1.218 . . . . 0.0 108.481 178.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -58.78 2.55 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.561 -0.712 . . . . 0.0 110.564 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.5 p -109.52 -1.2 18.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.953 -1.092 . . . . 0.0 110.814 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . 73.52 10.38 79.32 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 120.176 -1.012 . . . . 0.0 111.505 177.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.57 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 41.0 t80 -62.19 147.69 46.99 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.775 -1.427 . . . . 0.0 109.331 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.513 HD11 ' N ' ' A' ' 16' ' ' ILE . 2.3 mp -116.08 114.32 45.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.539 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 34' ' ' PHE . 18.5 t80 -83.16 134.68 34.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -111.23 119.18 46.15 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.432 -0.792 . . . . 0.0 110.07 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.2 Cg_endo -71.26 -31.71 13.91 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.955 1.503 . . . . 0.0 110.265 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.76 -8.52 56.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.371 -0.83 . . . . 0.0 109.972 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.3 tttt -110.06 -47.03 3.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.9 . . . . 0.0 110.16 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.21 162.84 14.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.525 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.17 56.68 4.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.509 -0.995 . . . . 0.0 109.927 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 23' ' ' ASP . 10.1 mmtt -40.14 -57.22 1.73 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.432 -0.793 . . . . 0.0 110.703 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.519 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -45.45 -34.01 2.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.398 -0.814 . . . . 0.0 110.604 -179.809 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 23' ' ' ASP . . . -95.38 -61.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 110.405 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.24 55.77 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.525 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.1 mp -129.94 143.67 50.0 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.269 -1.136 . . . . 0.0 109.953 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.474 ' HD2' HG21 ' A' ' 28' ' ' ILE . 44.0 Cg_endo -70.5 162.9 40.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.943 1.496 . . . . 0.0 110.533 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.465 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.4 Cg_endo -72.41 161.68 43.62 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.983 1.517 . . . . 0.0 110.92 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.85 14.98 82.02 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 97.7 m -102.04 125.87 35.42 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.177 . . . . 0.0 110.187 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 46.6 Cg_endo -72.95 136.94 25.89 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.855 1.45 . . . . 0.0 110.528 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.584 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 15.1 t80 -53.06 -39.17 63.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.179 -0.951 . . . . 0.0 110.174 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 32.8 m -53.32 -18.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.119 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.446 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 15.2 t0 -82.41 -5.88 58.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 110.416 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.478 HD13 ' CD2' ' A' ' 34' ' ' PHE . 22.2 mt -70.06 157.35 37.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.917 . . . . 0.0 110.067 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.05 155.95 30.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.2 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -60.48 -13.67 15.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.211 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.2 m -98.25 2.21 48.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 110.077 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 44.7 t80 -56.06 133.13 51.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.865 . . . . 0.0 110.139 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 35.4 mtt -111.03 138.29 47.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.006 -1.059 . . . . 0.0 109.307 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . 43.9 t -47.08 136.42 8.42 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 110.73 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.7 Cg_endo -82.8 36.18 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.124 1.592 . . . . 0.0 110.08 179.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB1' ' SG ' ' A' ' 43' ' ' CYS . . . -151.92 -50.31 0.11 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.247 -0.908 . . . . 0.0 109.588 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.476 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.5 p -118.17 8.41 12.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.389 -0.819 . . . . 0.0 110.128 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 27.3 mtp180 61.1 15.02 5.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.486 -0.759 . . . . 0.0 112.084 178.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.463 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.6 m -64.81 166.76 10.97 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.874 -1.141 . . . . 0.0 109.815 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.3 Cg_endo -73.25 142.32 33.62 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.932 1.49 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.493 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.2 tttm -49.85 -31.54 12.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.777 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -62.42 -12.26 20.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 109.808 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.56 -2.14 58.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.835 . . . . 0.0 109.745 179.505 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.477 ' CZ ' ' HA ' ' A' ' 43' ' ' CYS . 13.7 m-85 -88.11 139.82 30.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 110.508 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 20.1 tttt -126.12 142.45 51.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 109.371 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.667 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 9.3 p . . . . . 0 N--CA 1.491 1.616 0 O-C-N 120.936 -1.103 . . . . 0.0 111.023 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.602 ' CE1' ' HB3' ' A' ' 55' ' ' SER . 8.6 m-85 -120.6 140.22 51.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 0.0 111.144 -178.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 45.6 tt0 -117.03 141.54 48.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.538 -0.726 . . . . 0.0 109.358 179.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.9 t -77.13 116.54 17.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.072 -1.017 . . . . 0.0 110.309 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -16.25 64.19 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.787 -1.195 . . . . 0.0 108.663 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -60.1 2.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.575 -0.703 . . . . 0.0 110.605 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.509 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.55 -3.61 17.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.061 -1.024 . . . . 0.0 110.945 -178.984 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 79.27 6.87 88.79 Favored Glycine 0 N--CA 1.496 2.685 0 O-C-N 121.09 -1.006 . . . . 0.0 111.611 177.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 28.0 t80 -59.17 143.01 50.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.736 -1.45 . . . . 0.0 109.723 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.4 mp -113.99 113.87 45.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.215 -0.928 . . . . 0.0 110.746 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 25.6 t80 -84.64 137.43 33.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -0.852 . . . . 0.0 109.593 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -114.73 122.6 33.53 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.788 . . . . 0.0 110.222 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.6 Cg_endo -71.08 -34.07 10.82 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.811 1.427 . . . . 0.0 110.089 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.31 -11.27 60.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 110.053 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -111.68 -38.2 4.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.28 170.98 28.28 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD1' ' CG2' ' A' ' 28' ' ' ILE . 0.8 OUTLIER -85.19 57.15 4.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.493 -1.004 . . . . 0.0 109.702 179.099 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' ASP . 14.6 tptm -38.94 -61.33 0.75 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.454 -0.779 . . . . 0.0 110.532 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 27.2 m-85 -45.88 -30.38 1.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.835 . . . . 0.0 110.459 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -95.11 -63.5 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 0.0 110.276 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.43 54.24 0.02 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.524 ' CG2' ' OD1' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -129.95 144.17 51.99 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.212 -1.169 . . . . 0.0 109.662 179.798 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.47 ' HD2' HG21 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -70.44 159.0 54.38 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.982 1.517 . . . . 0.0 110.522 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.33 164.3 36.04 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.996 1.524 . . . . 0.0 110.741 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 80.22 13.98 81.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.8 m -105.19 126.69 30.34 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.176 -1.191 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.97 141.73 33.63 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.897 1.472 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.573 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 51.9 t80 -52.62 -41.37 63.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 110.177 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.46 HG21 ' N ' ' A' ' 36' ' ' ASP . 5.8 m -54.76 -17.17 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.337 -0.852 . . . . 0.0 110.305 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.46 ' N ' HG21 ' A' ' 35' ' ' VAL . 29.6 t70 -86.7 -6.78 58.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 110.272 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.504 HD12 ' CD1' ' A' ' 41' ' ' PHE . 17.7 mt -72.81 124.76 26.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.195 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' LEU . 16.0 m -43.01 164.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.172 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -72.77 -2.01 18.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.0 110.182 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' ' SD ' ' A' ' 42' ' ' MET . 7.9 p -103.11 1.49 33.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.416 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.504 ' CD1' HD12 ' A' ' 37' ' ' LEU . 47.5 t80 -56.79 130.21 44.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 110.225 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -119.21 146.09 45.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.681 179.594 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.4 t -55.36 129.53 68.84 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 110.494 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.583 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.49 -13.34 30.2 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.895 1.471 . . . . 0.0 109.461 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.69 -65.16 0.98 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.558 -0.714 . . . . 0.0 110.917 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.509 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.2 p -97.0 2.85 52.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.191 -0.943 . . . . 0.0 111.159 -179.121 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.2 tpp180 61.65 22.99 13.38 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.137 -0.977 . . . . 0.0 111.945 178.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.469 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.2 m -74.38 165.48 53.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.839 -1.163 . . . . 0.0 109.94 179.438 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.36 143.86 35.74 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.947 1.498 . . . . 0.0 110.44 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 12.5 tttt -49.16 -25.33 2.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 110.032 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -66.74 -11.2 53.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.88 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -90.75 -2.32 57.81 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.359 -0.838 . . . . 0.0 109.538 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 6.5 m-85 -89.09 138.87 31.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -0.77 . . . . 0.0 110.52 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 20.3 mmtt -130.83 146.92 52.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 109.586 179.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.602 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 4.0 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.835 -1.165 . . . . 0.0 110.456 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.3 m-85 -125.73 150.14 47.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.926 -179.289 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 29.1 tt0 -120.32 140.2 51.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 109.243 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.3 t -77.4 116.81 18.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.06 -1.025 . . . . 0.0 110.562 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.14 -16.15 63.88 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.897 -1.127 . . . . 0.0 108.511 178.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.11 -59.48 2.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.65 -0.656 . . . . 0.0 110.539 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -109.27 -3.4 17.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.058 -1.026 . . . . 0.0 110.788 -179.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 79.06 6.82 88.75 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 121.118 -0.989 . . . . 0.0 111.571 177.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 51.5 t80 -58.98 144.33 45.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.83 -1.394 . . . . 0.0 109.894 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -116.05 113.07 42.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.761 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 40.7 t80 -81.55 123.23 28.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.743 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -102.21 118.01 59.96 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.47 -0.769 . . . . 0.0 110.294 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 46.5 Cg_endo -71.53 -30.67 14.73 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.902 1.475 . . . . 0.0 110.288 179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.82 -7.09 36.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.07 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 9.5 mttt -118.99 -35.73 3.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.884 . . . . 0.0 110.065 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.31 168.73 25.8 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.549 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -85.19 54.99 3.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.419 -1.047 . . . . 0.0 109.903 179.195 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -39.78 -58.13 1.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.574 -179.539 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -47.58 -34.05 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.412 -0.805 . . . . 0.0 110.537 -179.847 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -91.97 -65.3 1.02 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 110.239 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.96 52.99 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.54 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -132.49 142.59 45.46 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 0.0 109.908 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD2' HG21 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -69.97 161.95 44.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.871 1.458 . . . . 0.0 110.304 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.3 Cg_endo -71.92 162.99 40.24 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.993 1.523 . . . . 0.0 110.866 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 80.31 12.74 82.8 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 29' ' ' PRO . 2.2 m -101.71 126.19 34.88 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.147 -1.208 . . . . 0.0 110.219 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 46.9 Cg_endo -73.88 140.51 28.93 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.834 1.439 . . . . 0.0 110.613 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.583 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -52.13 -41.67 62.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.985 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 36' ' ' ASP . 1.4 p -53.22 -18.71 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.445 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 8.7 t70 -84.91 -6.66 59.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.237 -0.914 . . . . 0.0 110.118 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.457 HD12 ' OD2' ' A' ' 23' ' ' ASP . 16.9 mt -73.67 121.94 21.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.345 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -41.34 152.74 0.05 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.413 -0.804 . . . . 0.0 110.336 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.19 -11.81 16.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 110.266 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.03 5.8 49.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.437 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.549 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.7 t80 -58.91 137.38 57.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 110.155 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.8 mtt -117.94 143.11 46.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 109.558 179.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 47' ' ' ARG . 43.2 t -59.62 125.71 80.63 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 110.169 -179.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.8 Cg_endo -71.15 -9.75 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.891 1.469 . . . . 0.0 109.899 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.439 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . . . -93.19 -53.44 4.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -0.824 . . . . 0.0 110.193 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.476 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.8 p -117.64 8.3 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.615 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 43' ' ' CYS . 11.7 ttp180 61.81 15.44 7.06 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.245 -0.91 . . . . 0.0 112.097 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.467 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -68.29 168.64 12.94 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.858 -1.151 . . . . 0.0 109.895 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 48.0 Cg_endo -73.92 141.95 30.84 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.834 1.439 . . . . 0.0 110.524 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.7 tttm -50.21 -28.9 8.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -0.926 . . . . 0.0 109.956 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.78 -12.17 22.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.847 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.67 -2.21 58.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.339 -0.851 . . . . 0.0 109.737 179.41 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 26.8 m-85 -85.24 136.78 33.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.717 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.87 137.31 54.09 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.6 t . . . . . 0 C--N 1.3 -1.545 0 O-C-N 120.76 -1.212 . . . . 0.0 110.489 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.171 0.51 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.605 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 23.9 m-85 -116.4 139.46 50.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.109 -0.994 . . . . 0.0 110.22 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.492 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -113.96 135.22 54.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 109.969 179.594 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 14' ' ' GLY . 2.5 t -72.67 117.77 14.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.543 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -68.57 -15.76 63.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.776 -1.202 . . . . 0.0 108.513 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.24 -59.02 2.45 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.501 -0.75 . . . . 0.0 110.406 179.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.496 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.5 p -109.69 -0.65 18.46 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.863 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 72.7 11.84 77.74 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.075 -1.015 . . . . 0.0 111.496 177.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.58 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 17.4 t80 -63.92 147.32 52.24 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.781 -1.423 . . . . 0.0 109.685 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.492 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 15.1 mm -112.4 115.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.027 -1.046 . . . . 0.0 110.513 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 41.7 t80 -83.09 131.44 35.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.784 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -111.48 118.19 47.69 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.779 . . . . 0.0 110.198 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.5 Cg_endo -70.25 -30.16 20.4 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.884 1.465 . . . . 0.0 110.068 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.5 -11.61 60.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.835 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 11.7 tptt -110.48 -44.01 3.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.425 -0.797 . . . . 0.0 109.944 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.52 168.59 21.87 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.571 ' OD2' ' CZ ' ' A' ' 41' ' ' PHE . 0.5 OUTLIER -85.2 52.46 2.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.514 -0.992 . . . . 0.0 109.748 178.974 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 1.4 ttpp -39.11 -60.4 0.89 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 110.627 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.523 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 32.0 m-85 -44.7 -31.22 1.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.798 . . . . 0.0 110.346 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.453 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -95.08 -62.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.277 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.75 51.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.528 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -128.53 143.8 49.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 109.725 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HD2' HG21 ' A' ' 28' ' ' ILE . 43.6 Cg_endo -69.88 159.69 52.39 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.958 1.504 . . . . 0.0 110.478 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.35 161.35 44.62 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.038 1.546 . . . . 0.0 111.006 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.83 13.77 82.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 91.2 m -99.02 125.58 41.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.231 -1.158 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.434 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 46.7 Cg_endo -73.03 136.66 25.2 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.905 1.476 . . . . 0.0 110.481 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.573 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 11.8 t80 -50.09 -42.87 50.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.1 m -53.63 -17.0 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 110.621 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 12.0 t70 -86.56 -7.84 58.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.01 -1.056 . . . . 0.0 110.281 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.453 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.3 mt -68.16 158.02 34.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 110.109 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.6 m -77.86 152.71 33.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 110.002 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -61.27 -12.19 12.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.24 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.24 2.98 35.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.898 . . . . 0.0 110.552 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CZ ' ' OD2' ' A' ' 23' ' ' ASP . 46.6 t80 -58.11 137.71 56.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.015 -1.053 . . . . 0.0 109.755 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.75 137.61 47.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.85 -1.156 . . . . 0.0 109.837 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.4 t -46.66 136.55 7.57 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.284 -0.885 . . . . 0.0 110.569 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.5 Cg_endo -81.73 34.81 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.126 1.592 . . . . 0.0 110.379 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -150.81 -48.72 0.12 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.226 -0.921 . . . . 0.0 109.526 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.496 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.6 p -120.04 9.28 11.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 110.183 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.19 14.04 5.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.406 -0.809 . . . . 0.0 112.116 178.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.465 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.8 m -64.98 169.0 6.09 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.498 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.47 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.4 Cg_endo -74.21 142.69 30.88 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.762 1.401 . . . . 0.0 110.151 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 11.3 tttm -50.73 -31.81 17.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.074 -1.016 . . . . 0.0 109.618 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -64.03 -11.61 30.86 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.356 -0.84 . . . . 0.0 109.316 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -85.54 -4.1 59.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.361 -0.837 . . . . 0.0 109.865 179.641 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -79.9 133.15 36.21 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.854 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -102.92 133.3 48.25 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.221 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.642 0 O-C-N 121.029 -1.045 . . . . 0.0 110.191 -179.537 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 tptm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.193 0.521 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.9 m-85 -124.51 149.44 46.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 110.596 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -118.85 138.3 52.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.328 179.023 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.471 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 3.0 t -76.52 118.88 19.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.021 . . . . 0.0 111.042 -179.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.44 -16.26 63.45 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.361 178.036 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.13 -59.7 2.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.631 -0.668 . . . . 0.0 110.587 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.465 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.6 p -107.99 -1.78 20.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.962 -1.086 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 74.07 10.26 80.95 Favored Glycine 0 N--CA 1.494 2.559 0 O-C-N 121.092 -1.005 . . . . 0.0 111.458 177.471 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 39.3 t80 -65.1 149.65 49.51 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.819 -1.4 . . . . 0.0 110.001 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 1.8 mp -114.79 112.41 39.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.221 -0.925 . . . . 0.0 110.113 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.552 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 38.0 t80 -80.79 119.94 24.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.688 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.32 118.04 57.78 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.354 -0.841 . . . . 0.0 110.061 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 32' ' ' THR . 44.6 Cg_endo -72.19 -22.44 22.35 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.931 1.49 . . . . 0.0 110.423 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -10.49 59.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -112.63 -47.32 3.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.922 . . . . 0.0 110.199 -179.979 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.66 159.36 11.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.553 ' OD2' ' CZ ' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -85.1 57.08 4.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -1.063 . . . . 0.0 109.983 179.415 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' ASP . 57.8 mttm -40.18 -52.97 2.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.448 -0.782 . . . . 0.0 110.464 -179.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -50.11 -39.96 44.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.487 -0.758 . . . . 0.0 110.427 -179.918 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 23' ' ' ASP . . . -88.77 -67.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.09 55.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.85 144.5 53.28 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.319 -1.107 . . . . 0.0 109.925 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.3 Cg_endo -71.03 166.33 29.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.974 1.513 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.46 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.1 Cg_endo -72.0 158.81 51.74 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.873 1.459 . . . . 0.0 111.024 -179.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.54 14.71 82.18 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 19' ' ' PRO . 41.2 m -92.69 119.39 67.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 110.256 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 45.2 Cg_endo -72.68 141.56 34.39 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.876 1.461 . . . . 0.0 110.617 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.558 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 43.7 t80 -56.84 -18.48 13.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 110.028 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 14.6 m -73.51 -8.36 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.938 179.693 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -95.55 -7.37 38.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.423 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 22.5 mt -71.69 147.55 47.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 110.212 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.81 153.49 36.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.59 -16.35 5.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 p -96.96 5.01 51.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 110.303 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.553 ' CZ ' ' OD2' ' A' ' 23' ' ' ASP . 53.8 t80 -57.95 137.01 57.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.123 -0.986 . . . . 0.0 109.893 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.5 mmt -111.79 138.98 47.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.948 -1.095 . . . . 0.0 109.526 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . 39.9 t -47.46 136.55 9.5 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 0.0 110.721 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -82.76 36.39 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.017 1.535 . . . . 0.0 110.109 178.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.83 -49.36 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.877 . . . . 0.0 109.491 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.465 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.6 p -119.53 8.56 11.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.423 -0.798 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.74 15.38 5.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -0.805 . . . . 0.0 112.176 178.576 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.464 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.2 m -66.34 169.03 8.07 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.794 -1.191 . . . . 0.0 109.681 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.7 Cg_endo -73.08 140.13 30.75 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.944 1.497 . . . . 0.0 110.413 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.558 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 32.5 tttt -50.24 -31.92 15.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.123 -0.985 . . . . 0.0 109.694 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -62.14 -12.57 20.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.319 -0.863 . . . . 0.0 109.707 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.13 -3.35 59.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.759 179.399 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 43' ' ' CYS . 19.7 m-85 -84.99 139.21 31.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 110.592 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.61 137.45 53.85 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.4 t . . . . . 0 C--N 1.301 -1.534 0 O-C-N 120.564 -1.335 . . . . 0.0 110.653 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.247 0.546 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.65 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 16.1 m-85 -113.85 139.91 48.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.145 -0.972 . . . . 0.0 110.04 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -118.06 137.43 52.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.104 -0.997 . . . . 0.0 109.828 179.563 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.0 t -74.82 116.64 15.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 110.359 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -67.4 -15.99 63.99 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.761 -1.212 . . . . 0.0 108.62 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.22 -59.99 2.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.618 -0.676 . . . . 0.0 110.463 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.482 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.3 p -109.03 -1.93 18.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.039 -1.038 . . . . 0.0 110.967 -179.102 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 76.4 8.61 85.81 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.374 177.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 31.3 t80 -59.11 144.27 46.15 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.849 -1.383 . . . . 0.0 109.578 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.513 HD11 ' N ' ' A' ' 16' ' ' ILE . 2.1 mp -113.35 113.68 44.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.221 -0.925 . . . . 0.0 110.574 -179.318 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.567 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 35.8 t80 -82.74 131.23 35.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.305 -0.872 . . . . 0.0 109.739 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 12.2 mt-10 -108.15 119.68 49.1 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.7 Cg_endo -71.73 -35.61 7.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.839 1.442 . . . . 0.0 110.055 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 31.4 tt0 -70.29 -6.23 33.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 110.037 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 5.4 mmtt -117.56 -37.13 3.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.094 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.97 172.36 28.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 1.1 t70 -85.23 58.52 5.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -1.013 . . . . 0.0 109.756 178.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -36.83 -64.6 0.34 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.542 -0.723 . . . . 0.0 110.728 -179.535 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 1.6 m-85 -42.53 -26.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.847 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -99.98 -58.03 2.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.875 . . . . 0.0 109.952 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.65 -8.07 1.54 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.318 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.8 mt -61.79 143.36 94.23 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.251 . . . . 0.0 109.927 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.6 Cg_endo -71.08 160.38 49.37 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.926 1.487 . . . . 0.0 110.659 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.4 Cg_endo -72.83 163.66 37.8 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.13 1.595 . . . . 0.0 110.801 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.72 14.12 82.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 86.4 m -105.73 127.23 28.87 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.28 -1.129 . . . . 0.0 110.134 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 46.9 Cg_endo -73.13 140.75 31.56 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.959 1.505 . . . . 0.0 110.492 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 2.6 t80 -50.05 -38.06 36.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.991 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.473 HG21 ' N ' ' A' ' 36' ' ' ASP . 6.3 m -54.4 -17.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 110.363 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.473 ' N ' HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -85.05 -7.15 59.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.091 -1.006 . . . . 0.0 110.234 179.949 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.5 mt -69.06 155.94 39.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.0 110.089 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.25 156.13 29.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.136 -0.977 . . . . 0.0 109.819 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -9.64 16.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.029 -1.044 . . . . 0.0 110.317 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 t -103.65 2.76 33.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.473 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.577 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.1 t80 -59.82 138.95 57.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.122 -0.987 . . . . 0.0 109.885 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.0 mtt -117.09 142.72 46.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.866 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 47' ' ' ARG . 41.9 t -56.3 128.32 72.82 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.24 -0.913 . . . . 0.0 110.008 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.533 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.9 Cg_endo -71.45 -12.66 29.78 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.924 1.486 . . . . 0.0 109.856 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.34 -51.45 4.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 110.675 -179.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.482 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 7.5 p -118.83 9.39 12.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.117 -0.989 . . . . 0.0 110.939 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.44 12.68 4.52 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.285 -0.885 . . . . 0.0 112.296 178.347 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 19.0 p -65.12 166.41 13.08 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.832 -1.167 . . . . 0.0 109.765 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 44.4 Cg_endo -71.87 142.38 38.94 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.665 1.35 . . . . 0.0 110.097 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.598 ' CE ' ' CZ ' ' A' ' 34' ' ' PHE . 23.1 tttt -50.41 -28.9 9.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.772 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -62.76 -12.58 25.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.206 -0.933 . . . . 0.0 109.741 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.42 -3.45 59.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -0.809 . . . . 0.0 109.664 179.433 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 21.7 m-85 -84.01 136.99 33.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 110.362 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.27 139.6 52.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.882 . . . . 0.0 109.268 179.198 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.65 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 53.1 p . . . . . 0 C--N 1.302 -1.498 0 O-C-N 120.885 -1.134 . . . . 0.0 111.355 -179.392 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 55' ' ' SER . 11.7 mtmt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 10.6 m-85 -121.34 143.44 49.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.139 -0.975 . . . . 0.0 111.254 -178.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 3.3 tm-20 -121.39 143.69 49.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 4.7 t -78.67 116.57 19.12 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.997 -1.064 . . . . 0.0 110.531 -179.544 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -15.77 63.67 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.767 -1.208 . . . . 0.0 108.415 178.295 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 52' ' ' GLN . . . -85.02 -61.56 1.74 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.688 -0.632 . . . . 0.0 110.445 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -106.43 -3.95 20.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.931 -1.105 . . . . 0.0 110.559 -179.221 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 80.62 2.42 89.77 Favored Glycine 0 N--CA 1.496 2.696 0 O-C-N 121.086 -1.009 . . . . 0.0 111.19 177.536 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 22.5 t80 -50.43 171.65 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.998 -1.295 . . . . 0.0 109.7 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 23.2 mm -139.48 130.48 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 110.344 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.552 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 55.8 t80 -105.12 120.6 41.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.363 -0.836 . . . . 0.0 109.927 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -108.88 119.0 50.27 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.099 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -70.72 -24.29 25.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.929 1.489 . . . . 0.0 110.316 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.428 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 8.0 tp10 -72.64 -15.53 61.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.242 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 9.9 tttt -109.84 -40.7 4.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.42 156.39 12.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.558 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.5 OUTLIER -85.3 62.2 7.34 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.375 -1.074 . . . . 0.0 108.995 178.463 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -39.68 -48.57 2.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.467 -0.771 . . . . 0.0 111.039 -179.061 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.452 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 13.4 m-85 -80.96 13.22 2.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 0.0 110.907 -179.338 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' A' ' 28' ' ' ILE . . . -131.55 -3.77 3.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.0 110.71 -179.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.86 38.53 7.97 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.954 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.529 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.7 mp -133.21 136.46 27.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.838 -1.389 . . . . 0.0 110.25 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HD2' HG21 ' A' ' 28' ' ' ILE . 46.6 Cg_endo -72.79 174.12 12.35 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.016 1.535 . . . . 0.0 110.486 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.6 Cg_endo -72.85 160.52 45.91 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.969 1.51 . . . . 0.0 111.039 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.8 11.5 84.55 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.524 HG22 ' CG2' ' A' ' 28' ' ' ILE . 54.4 m -94.54 121.38 63.4 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.232 -1.157 . . . . 0.0 110.299 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.461 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.7 Cg_endo -72.96 143.53 36.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.838 1.441 . . . . 0.0 110.456 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 37.9 t80 -55.97 -37.16 68.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.908 . . . . 0.0 110.05 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 33.9 m -55.33 -18.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.454 -0.779 . . . . 0.0 109.872 179.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 7.7 t70 -83.42 -6.66 59.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.819 . . . . 0.0 110.242 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.492 HD12 ' CE1' ' A' ' 41' ' ' PHE . 22.2 mt -73.67 146.15 44.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.128 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -75.62 162.32 28.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.841 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -64.16 -9.75 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.151 -0.968 . . . . 0.0 110.259 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 t -100.16 4.32 44.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.468 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.558 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 51.4 t80 -58.38 137.13 57.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 109.792 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.0 mtt -120.75 146.08 46.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.008 -1.058 . . . . 0.0 110.122 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 47.0 t -59.23 127.43 84.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 110.265 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.452 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 45.7 Cg_endo -71.47 -9.98 26.1 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.931 1.49 . . . . 0.0 109.754 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.504 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -95.09 -56.7 2.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 110.582 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.9 p -111.61 5.99 19.71 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.122 -0.986 . . . . 0.0 110.691 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.6 OUTLIER 62.54 16.56 8.85 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.337 -0.852 . . . . 0.0 112.072 178.512 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -69.05 167.69 19.29 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.835 -1.166 . . . . 0.0 109.804 179.47 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.7 Cg_endo -72.74 140.89 33.03 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.897 1.472 . . . . 0.0 110.625 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 9.6 tttm -48.25 -26.8 2.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -0.916 . . . . 0.0 109.99 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 -11.23 16.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.799 . . . . 0.0 110.156 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.406 ' NE2' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -93.64 0.3 56.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.257 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 13.0 m-85 -87.85 137.12 32.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 110.616 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -125.2 140.11 53.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 0.0 109.476 179.268 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 5.5 p . . . . . 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.162 . . . . 0.0 110.626 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt . . . . . 0 N--CA 1.505 2.291 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 5.9 m-85 -111.32 134.04 53.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 109.886 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.476 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 74.3 tt0 -119.72 141.69 49.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 0.0 110.111 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 6.5 t -77.9 114.24 16.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 0.0 110.402 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -14.9 62.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.805 -1.184 . . . . 0.0 108.524 178.593 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.492 ' HB3' ' NE2' ' A' ' 52' ' ' GLN . . . -85.18 -61.87 1.67 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.598 -0.689 . . . . 0.0 110.731 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.3 p -107.77 -4.5 18.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.015 -1.053 . . . . 0.0 110.952 -178.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 15' ' ' TYR . . . 83.18 3.83 90.03 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.622 177.463 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.588 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 69.3 t80 -48.39 173.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.719 -1.459 . . . . 0.0 109.023 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.588 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 11.9 mm -145.77 112.78 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.895 -1.128 . . . . 0.0 110.712 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.567 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 53.1 t80 -94.17 148.28 22.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.86 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -130.75 126.53 21.89 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -71.45 -33.58 10.73 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.852 1.448 . . . . 0.0 110.285 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -72.87 -2.32 20.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 5.3 ttmt -121.7 -43.08 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.047 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.72 168.17 20.89 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.19 56.44 3.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -1.015 . . . . 0.0 110.007 179.479 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' ASP . 32.2 tttt -41.19 -61.91 0.93 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.396 -0.815 . . . . 0.0 110.48 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.576 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -43.07 -30.41 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.804 . . . . 0.0 110.341 -179.981 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 23' ' ' ASP . . . -97.09 -60.11 1.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.344 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.86 54.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.518 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -132.96 142.05 43.24 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.314 -1.11 . . . . 0.0 109.87 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD2' HG21 ' A' ' 28' ' ' ILE . 44.0 Cg_endo -69.69 160.72 48.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.914 1.481 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.469 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 42.9 Cg_endo -71.43 162.16 43.22 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.072 1.564 . . . . 0.0 111.027 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 82.74 14.17 76.25 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 64.7 m -107.44 125.79 31.51 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.263 -1.14 . . . . 0.0 110.039 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 45.5 Cg_endo -71.91 138.09 30.69 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.884 1.465 . . . . 0.0 110.685 -179.791 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.642 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -52.98 -41.45 64.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -55.39 -17.48 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.354 -0.841 . . . . 0.0 110.19 -179.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.46 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -85.26 -5.23 59.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 109.922 179.687 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.466 HD12 ' OD2' ' A' ' 23' ' ' ASP . 22.1 mt -72.13 127.79 33.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 109.922 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 7.9 t -42.06 155.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 110.161 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 10.8 m-20 -66.72 -7.23 19.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.78 3.37 42.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.568 -179.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.497 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 51.7 t80 -58.21 132.6 54.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.126 -0.984 . . . . 0.0 109.956 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -118.81 146.71 44.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.0 109.992 179.744 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.3 t -56.84 128.69 76.86 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 110.16 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.36 -11.92 29.11 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.777 1.409 . . . . 0.0 109.628 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HB1' ' CD1' ' A' ' 15' ' ' TYR . . . -97.82 -62.57 1.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 110.675 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.527 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.9 p -100.8 3.35 41.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.217 -0.927 . . . . 0.0 111.017 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 2.8 tpp180 61.54 21.64 12.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.198 -0.939 . . . . 0.0 112.046 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.468 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 27.2 p -74.45 165.24 55.28 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.8 -1.188 . . . . 0.0 109.702 179.259 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 44.9 Cg_endo -71.38 142.45 41.03 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.722 1.38 . . . . 0.0 110.335 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 7.4 tttm -48.09 -24.84 1.22 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.012 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.87 -9.73 31.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.932 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.498 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -92.37 -2.21 56.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.262 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.584 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 3.2 m-85 -89.91 140.04 30.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.297 -0.877 . . . . 0.0 110.443 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 47.1 tttt -129.04 145.13 51.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 109.634 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.616 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 2.7 p . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.015 -1.053 . . . . 0.0 110.889 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.257 0.551 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 179.7 89.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 110.214 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.55 ' CG1' ' N ' ' A' ' 4' ' ' ASP . 1.2 tt -177.72 171.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.55 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 8.4 m-20 -149.85 130.13 13.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.473 -0.767 . . . . 0.0 110.234 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 3.3 tp10 179.8 -141.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.55 27.33 21.0 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HB3' HG12 ' A' ' 56' ' ' ILE . 1.3 mttm -79.97 121.76 25.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -1.137 . . . . 0.0 109.677 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.666 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 9.3 m-85 -118.7 140.55 49.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 110.58 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 2.5 tm-20 -119.84 142.62 48.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.811 . . . . 0.0 109.464 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.4 t -77.8 115.58 17.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 0.0 110.299 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -15.68 63.85 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.749 -1.219 . . . . 0.0 108.522 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -60.76 1.95 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.608 -0.682 . . . . 0.0 110.699 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.2 p -108.21 -4.35 17.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.093 . . . . 0.0 110.91 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 82.74 3.53 90.46 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.648 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.611 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 65.3 t80 -49.25 173.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.429 . . . . 0.0 109.255 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.611 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 12.2 mm -144.41 110.6 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.025 -1.047 . . . . 0.0 110.525 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 54.9 t80 -83.69 128.48 34.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.916 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -110.16 121.15 42.47 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.2 Cg_endo -71.8 -34.06 9.35 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.859 1.452 . . . . 0.0 110.239 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.93 -14.78 62.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 0.0 109.902 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 8.3 mttp -113.26 -18.51 12.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 110.049 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.486 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 85.35 170.66 47.4 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.534 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.16 49.96 1.85 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -1.069 . . . . 0.0 109.855 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.97 -54.82 2.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.41 -0.806 . . . . 0.0 110.393 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CD1' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -47.51 -37.02 11.16 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 110.2 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -90.1 -65.96 0.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.06 51.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.534 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 2.1 mp -133.48 147.38 64.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.277 -1.131 . . . . 0.0 109.888 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -70.3 161.07 47.33 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.955 1.503 . . . . 0.0 110.255 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.486 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.9 Cg_endo -72.03 163.78 37.72 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.01 1.531 . . . . 0.0 110.841 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.03 11.04 85.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 18.0 m -100.41 122.12 50.97 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.299 -1.119 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 45.2 Cg_endo -72.49 143.3 38.23 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.873 1.46 . . . . 0.0 110.71 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.666 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 30.5 t80 -54.52 -18.86 4.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.901 . . . . 0.0 109.796 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 15.1 m -70.5 -13.88 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.381 -0.824 . . . . 0.0 109.68 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.8 -7.16 56.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.0 110.363 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.428 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 19.2 mt -72.23 148.72 45.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.053 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.463 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -77.35 163.69 26.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.909 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -7.06 21.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.983 . . . . 0.0 110.174 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.06 2.68 35.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.339 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 48.0 t80 -58.72 136.31 57.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.757 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 30.0 mtt -119.46 145.85 45.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.019 -1.051 . . . . 0.0 110.025 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 34.6 t -58.88 128.28 84.31 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 110.194 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 45.8 Cg_endo -72.14 -10.16 25.49 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.857 1.451 . . . . 0.0 109.775 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.99 -58.78 2.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.467 -0.771 . . . . 0.0 110.452 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.519 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.9 p -108.29 5.38 25.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.882 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.35 17.46 9.42 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.201 -0.937 . . . . 0.0 112.049 178.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.465 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 3.9 m -70.46 167.93 23.09 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.91 -1.118 . . . . 0.0 109.833 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.2 Cg_endo -72.88 141.46 33.51 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.967 1.509 . . . . 0.0 110.527 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.575 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 7.9 tttm -48.4 -26.33 2.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.886 . . . . 0.0 109.832 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -63.85 -11.1 24.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 109.977 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -91.79 -1.41 57.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.331 -0.855 . . . . 0.0 109.6 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -88.08 138.66 31.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.519 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -129.03 144.43 51.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -0.84 . . . . 0.0 109.686 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.9 p -81.35 167.06 19.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.939 -1.101 . . . . 0.0 110.711 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.461 HG12 ' HB3' ' A' ' 7' ' ' LYS . 2.5 pt -122.2 72.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.614 -0.679 . . . . 0.0 110.096 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -106.74 65.88 0.68 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 110.237 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -142.97 152.61 42.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.271 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.415 HG11 ' N ' ' A' ' 3' ' ' ILE . 27.6 m -144.41 124.73 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.6 mt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.237 179.939 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.274 0.559 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' O ' HG21 ' A' ' 3' ' ' ILE . 7.7 mp0 -116.53 114.09 23.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.153 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.463 HD13 HD11 ' A' ' 56' ' ' ILE . 4.5 pt -144.21 136.47 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.204 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -160.2 126.15 4.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 110.183 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.518 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.3 mt-10 -178.11 64.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.049 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 43.89 26.02 0.73 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 5' ' ' GLU . 27.3 mtmt -87.12 127.38 35.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.182 -1.187 . . . . 0.0 109.845 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.603 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 31.0 m-85 -124.06 145.64 49.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.976 . . . . 0.0 110.62 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.458 ' HG3' ' HB3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -116.78 139.58 50.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 0.0 109.703 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.0 t -76.91 115.96 17.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.085 -1.01 . . . . 0.0 110.596 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -16.2 64.04 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.955 -1.091 . . . . 0.0 108.583 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.16 -58.73 2.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.571 -0.705 . . . . 0.0 110.654 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.89 -4.02 16.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.053 -1.029 . . . . 0.0 110.932 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 80.09 7.06 88.86 Favored Glycine 0 N--CA 1.497 2.727 0 O-C-N 121.101 -0.999 . . . . 0.0 111.583 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 53.8 t80 -59.65 142.81 52.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.758 -1.436 . . . . 0.0 110.051 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -114.94 113.82 44.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.16 -0.962 . . . . 0.0 110.638 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.8 t80 -82.41 132.21 35.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.833 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.24 116.95 41.7 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 110.3 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 44.0 Cg_endo -70.38 -26.48 24.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.879 1.463 . . . . 0.0 110.343 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -72.5 -12.47 61.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.365 -0.835 . . . . 0.0 109.784 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -114.25 -39.72 3.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.525 -0.734 . . . . 0.0 109.857 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.67 167.64 22.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.574 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.6 OUTLIER -85.13 53.75 2.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.559 -0.965 . . . . 0.0 109.819 179.255 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.82 -57.94 1.46 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 110.634 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 64.7 m-85 -47.61 -34.83 8.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.366 -0.834 . . . . 0.0 110.328 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -90.5 -65.88 0.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.374 -0.829 . . . . 0.0 110.083 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.22 52.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.525 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -130.76 144.98 55.68 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.213 -1.169 . . . . 0.0 109.93 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.458 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.5 Cg_endo -70.28 161.86 44.45 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.946 1.498 . . . . 0.0 110.533 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.0 Cg_endo -72.94 162.75 40.22 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.05 1.553 . . . . 0.0 110.902 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.98 11.91 85.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 92.2 m -97.02 124.76 48.59 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.223 -1.163 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 46.0 Cg_endo -72.77 138.8 29.59 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.799 1.421 . . . . 0.0 110.553 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.575 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 27.6 t80 -52.47 -41.91 63.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 0.0 110.066 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 15.9 m -53.66 -17.98 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 110.233 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.411 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 28.4 t0 -83.9 -7.31 59.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.965 . . . . 0.0 110.391 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.473 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 18.6 mt -70.03 154.37 42.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 110.028 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.54 151.42 36.35 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.18 -0.95 . . . . 0.0 109.885 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.95 -14.49 6.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.071 -1.018 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 p -97.65 5.17 49.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 110.381 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.8 t80 -59.68 137.62 57.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.142 -0.974 . . . . 0.0 109.873 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.2 mtt -117.18 143.73 45.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.501 ' O ' ' N ' ' A' ' 47' ' ' ARG . 49.4 t -58.88 125.7 78.49 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.0 110.093 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 43.6 Cg_endo -70.61 -10.17 27.32 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.943 1.496 . . . . 0.0 109.93 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . . . -92.82 -52.51 4.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.468 -0.77 . . . . 0.0 110.294 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 48' ' ' SER . 8.8 p -119.32 8.89 11.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.705 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' CYS . 8.7 ttm-85 62.51 13.52 6.25 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.277 -0.89 . . . . 0.0 112.243 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 16.6 p -66.0 166.96 13.26 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.886 -1.134 . . . . 0.0 109.921 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.2 Cg_endo -73.0 142.49 34.73 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.679 1.357 . . . . 0.0 110.373 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.565 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 24.2 tttm -49.04 -29.82 5.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 109.951 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -63.89 -10.8 22.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.333 -0.854 . . . . 0.0 109.806 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.53 -4.81 58.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.268 -0.895 . . . . 0.0 109.757 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.423 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 29.0 m-85 -79.99 132.75 36.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.584 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HB3' ' HG3' ' A' ' 9' ' ' GLU . 42.9 tttt -105.16 130.14 53.4 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.603 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -80.6 160.35 25.13 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 110.342 -179.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.463 HD11 HD13 ' A' ' 3' ' ' ILE . 2.7 pt -147.46 68.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 0.0 110.336 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -97.84 61.46 1.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -0.89 . . . . 0.0 110.06 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -82.67 107.14 15.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.03 55.24 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.878 . . . . 0.0 110.085 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.442 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 33.6 mm . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.181 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.26 0.553 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.503 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 0.8 OUTLIER -110.98 71.79 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.21 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.503 ' CG2' ' O ' ' A' ' 2' ' ' GLU . 8.3 pt -156.17 -176.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.131 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 3.8 m-20 -149.86 128.24 12.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.198 -0.939 . . . . 0.0 110.256 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.432 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -176.49 -144.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 110.153 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.477 ' CA ' ' HG3' ' A' ' 19' ' ' PRO . . . -101.13 29.44 12.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' HD2' ' HB3' ' A' ' 5' ' ' GLU . 1.6 mttt -85.78 121.34 28.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -1.126 . . . . 0.0 109.831 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.6 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 29.9 m-85 -123.06 147.14 47.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 0.0 110.647 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 27.3 tt0 -117.24 137.34 52.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.429 -0.794 . . . . 0.0 109.549 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.484 ' O ' ' N ' ' A' ' 14' ' ' GLY . 3.3 t -75.87 117.87 18.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.032 -1.042 . . . . 0.0 110.775 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -16.41 63.54 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.901 -1.124 . . . . 0.0 108.46 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.22 -57.68 2.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.672 -0.643 . . . . 0.0 110.48 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -110.75 -2.98 15.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.092 -1.005 . . . . 0.0 110.927 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 77.39 8.46 87.06 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.095 -1.003 . . . . 0.0 111.467 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 42.9 t80 -61.1 144.86 52.75 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.903 -1.351 . . . . 0.0 109.838 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.508 HD11 ' N ' ' A' ' 16' ' ' ILE . 2.3 mp -114.85 113.47 43.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.133 -0.979 . . . . 0.0 110.485 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.4 t80 -81.75 127.66 33.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.747 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -106.47 117.69 56.46 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.467 -0.77 . . . . 0.0 110.27 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.9 Cg_endo -70.04 -30.64 20.68 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.937 1.493 . . . . 0.0 110.198 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.04 -11.09 60.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.97 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 6.0 mtpt -110.62 -42.05 4.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 110.051 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.17 165.77 21.28 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.531 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.22 56.39 3.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.516 -0.991 . . . . 0.0 109.893 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.12 -57.23 1.72 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.825 . . . . 0.0 110.809 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 94.8 m-85 -47.13 -33.6 5.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.587 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -93.67 -64.3 1.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.189 -0.944 . . . . 0.0 110.399 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.0 53.68 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.1 mp -128.76 144.97 54.39 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.34 -1.094 . . . . 0.0 109.82 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD2' HG22 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -71.35 160.31 49.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.997 1.524 . . . . 0.0 110.421 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.11 163.16 39.61 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.004 1.529 . . . . 0.0 110.777 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.78 13.01 84.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.6 m -99.98 127.42 33.61 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.205 -1.173 . . . . 0.0 110.214 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 47.8 Cg_endo -73.15 140.15 30.57 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.969 1.51 . . . . 0.0 110.717 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.572 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.5 t80 -52.03 -41.92 62.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.138 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -17.65 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 110.476 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 4.3 t0 -84.07 -7.4 59.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.989 . . . . 0.0 110.249 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 mt -69.35 155.68 40.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.055 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -76.2 148.67 37.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.96 . . . . 0.0 109.785 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -15.81 5.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.996 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.7 5.63 49.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 110.346 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.523 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 54.8 t80 -60.0 139.89 57.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.207 -0.933 . . . . 0.0 109.904 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -118.23 143.31 46.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.07 -1.019 . . . . 0.0 110.027 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 47' ' ' ARG . 48.7 t -58.7 126.23 79.42 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.898 . . . . 0.0 110.139 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.582 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 43.8 Cg_endo -70.97 -10.48 27.67 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.911 1.48 . . . . 0.0 109.898 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HB1' ' SG ' ' A' ' 43' ' ' CYS . . . -92.89 -52.42 4.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.46 -0.775 . . . . 0.0 110.34 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.489 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.6 p -118.98 9.15 11.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.684 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.79 13.72 5.65 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.248 -0.908 . . . . 0.0 112.209 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.467 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.5 m -66.47 169.13 8.07 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.832 -1.168 . . . . 0.0 109.878 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 48.0 Cg_endo -74.11 141.79 29.99 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.793 1.417 . . . . 0.0 110.405 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 26.6 tttm -49.85 -30.9 10.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 109.806 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -62.9 -11.9 21.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.16 -3.65 59.07 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.404 -0.81 . . . . 0.0 109.77 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 15.2 m-85 -79.94 132.49 36.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 110.399 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.24 129.46 50.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.009 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.6 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -81.89 160.83 23.33 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 110.368 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 pp -136.59 76.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.833 . . . . 0.0 110.219 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -102.97 63.16 0.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.16 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HG2' ' CD1' ' A' ' 60' ' ' ILE . 0.4 OUTLIER -132.63 157.69 44.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 110.266 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 48.7 t -125.21 61.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.0 110.167 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.481 ' CD1' ' HG2' ' A' ' 58' ' ' LYS . 3.4 mp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.208 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' O ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.235 0.541 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.504 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 1.2 tt0 -83.0 65.19 8.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.504 ' CG2' ' O ' ' A' ' 2' ' ' GLU . 1.2 pt -158.09 135.29 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.502 ' OD2' ' CG2' ' A' ' 59' ' ' VAL . 36.5 m-20 -128.62 126.14 39.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.336 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -164.85 52.91 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.297 -0.877 . . . . 0.0 109.966 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 43.24 26.27 0.54 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 5' ' ' GLU . 10.5 tttt -86.3 130.8 34.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.031 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.606 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 37.6 m-85 -121.37 143.71 49.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.26 -0.9 . . . . 0.0 110.351 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' O ' ' CG ' ' A' ' 54' ' ' LYS . 7.4 mt-10 -117.04 139.83 50.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.366 -0.834 . . . . 0.0 110.374 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -76.31 113.01 13.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.999 -1.063 . . . . 0.0 110.412 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.6 -15.52 61.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.808 -1.183 . . . . 0.0 108.606 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.2 -61.73 1.7 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.565 -0.709 . . . . 0.0 110.634 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.492 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -107.19 -3.25 20.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 110.97 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 79.02 7.54 88.39 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.434 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 29.0 t80 -59.49 142.02 53.45 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.836 -1.391 . . . . 0.0 109.692 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 1.9 mp -114.6 115.46 49.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.57 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 32.1 t80 -83.78 137.82 33.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -116.28 119.76 36.0 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 110.43 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.2 Cg_endo -69.95 -33.24 16.27 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.905 1.476 . . . . 0.0 110.115 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.32 -12.89 61.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.838 . . . . 0.0 109.788 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -14.85 11.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.913 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.432 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 79.97 172.91 44.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.546 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.15 49.56 1.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -1.048 . . . . 0.0 109.759 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ASP . 16.8 ttmt -39.7 -59.0 1.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.57 -0.706 . . . . 0.0 110.442 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.535 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 1.1 m-85 -44.51 -32.83 1.52 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.376 -0.827 . . . . 0.0 110.088 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -93.79 -61.92 1.45 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 0.0 110.263 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.28 51.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.546 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -134.01 143.75 48.64 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.286 -1.126 . . . . 0.0 109.944 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.478 ' HD2' HG21 ' A' ' 28' ' ' ILE . 43.1 Cg_endo -68.52 160.95 47.11 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.004 1.529 . . . . 0.0 110.277 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 44.2 Cg_endo -71.76 162.93 40.53 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.027 1.541 . . . . 0.0 111.034 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 81.31 13.29 80.89 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 3.7 m -102.97 121.58 48.59 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.24 -1.153 . . . . 0.0 110.136 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.461 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 46.1 Cg_endo -72.52 135.11 23.59 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.799 1.42 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.576 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 8.0 t80 -47.89 -39.91 20.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.281 -0.887 . . . . 0.0 110.161 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 m -53.54 -22.12 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.401 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 21.2 t0 -84.31 -5.79 59.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 110.367 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.502 ' CB ' ' HD2' ' A' ' 50' ' ' LYS . 17.0 mt -72.31 123.34 22.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 110.271 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 7.2 m -41.4 151.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -0.828 . . . . 0.0 110.205 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -63.91 -10.0 18.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -100.02 5.38 45.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.579 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.504 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 55.5 t80 -59.77 138.05 57.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.791 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.0 mtm -122.46 148.06 45.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.978 -1.076 . . . . 0.0 109.936 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 2.0 t -55.75 129.95 71.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 110.5 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.535 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -72.59 -12.55 26.97 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 123.835 1.439 . . . . 0.0 109.114 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.24 -67.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.592 -0.692 . . . . 0.0 110.667 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.492 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.7 p -93.82 1.18 56.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 111.113 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 2.6 ttm180 61.06 31.12 19.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.083 -1.011 . . . . 0.0 111.764 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.473 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.4 m -85.01 168.62 19.7 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.775 -1.203 . . . . 0.0 109.883 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.1 Cg_endo -72.42 138.84 30.64 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.959 1.505 . . . . 0.0 110.457 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.572 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 20.9 tttm -51.0 -31.16 17.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.047 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -63.33 -12.11 27.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 109.73 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -85.04 -5.96 59.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.73 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 23.2 m-85 -79.99 137.96 36.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 110.553 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.508 ' CG ' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -109.71 132.75 53.86 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.384 -0.823 . . . . 0.0 108.997 178.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.606 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -81.13 161.64 24.01 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.072 -1.018 . . . . 0.0 110.443 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.88 62.71 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.394 -0.816 . . . . 0.0 110.109 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 4' ' ' ASP . 4.1 tttt -97.47 60.83 1.62 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.244 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 1' ' ' MET . 7.1 mmtt -119.52 140.86 49.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.868 . . . . 0.0 110.186 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.502 ' CG2' ' OD2' ' A' ' 4' ' ' ASP . 45.9 t -123.33 62.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 110.187 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.416 ' OXT' HG13 ' A' ' 60' ' ' ILE . 3.1 pt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.181 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.253 0.549 . . . . 0.0 110.276 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' O ' HG21 ' A' ' 3' ' ' ILE . 1.5 pp20? -48.01 153.31 0.67 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 110.212 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.462 HG21 ' O ' ' A' ' 2' ' ' GLU . 6.3 pt -146.36 135.22 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 15.9 t0 -92.45 -149.57 0.25 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.3 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.502 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 32.4 tt0 175.42 -23.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 0.0 110.615 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.36 4.58 17.75 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . 4.0 tttt -85.68 118.21 25.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -1.195 . . . . 0.0 109.664 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.609 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 30.7 m-85 -128.92 146.69 50.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.125 -0.984 . . . . 0.0 110.808 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 4.0 mt-10 -116.95 143.2 45.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 0.0 109.578 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 4.3 t -78.13 114.38 16.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.913 -1.117 . . . . 0.0 110.709 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.32 -15.68 63.83 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.915 -1.116 . . . . 0.0 108.41 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -59.62 2.28 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.728 -0.608 . . . . 0.0 110.712 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.13 -4.87 16.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.976 -1.078 . . . . 0.0 110.972 -178.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 84.27 3.63 88.63 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.957 -1.089 . . . . 0.0 111.728 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.54 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 77.7 t80 -52.46 174.34 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.748 -1.443 . . . . 0.0 109.564 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.54 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 1.2 mp -148.12 110.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.991 . . . . 0.0 110.227 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 49.0 t80 -81.21 123.47 28.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.829 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -107.87 116.91 56.49 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 110.197 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.8 Cg_endo -70.05 -27.46 25.08 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.812 1.427 . . . . 0.0 110.401 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -73.07 -15.18 61.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.342 -0.849 . . . . 0.0 109.998 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 -12.06 12.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.788 . . . . 0.0 109.973 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 80.99 165.74 34.48 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.534 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.21 50.16 1.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -1.064 . . . . 0.0 109.897 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.78 -51.62 2.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.5 -0.75 . . . . 0.0 110.374 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -49.41 -38.7 30.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.385 -0.822 . . . . 0.0 110.28 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.64 -67.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -0.881 . . . . 0.0 110.404 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.73 51.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.534 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 2.1 mp -133.69 147.09 63.08 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.27 -1.135 . . . . 0.0 109.921 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.9 Cg_endo -71.42 165.49 32.31 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.987 1.519 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.471 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.9 Cg_endo -72.04 162.51 41.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.96 1.505 . . . . 0.0 110.832 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.81 12.49 82.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 21.7 m -92.32 122.97 63.67 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -1.139 . . . . 0.0 110.19 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.51 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 46.5 Cg_endo -72.7 139.07 30.25 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.879 1.463 . . . . 0.0 110.651 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.573 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 79.8 t80 -55.9 -17.78 7.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.887 . . . . 0.0 109.819 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 14.2 m -73.78 -7.47 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.67 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -95.31 -7.58 38.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 110.383 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.457 HD13 ' CD1' ' A' ' 34' ' ' PHE . 18.3 mt -70.94 147.61 48.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.97 . . . . 0.0 109.978 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.7 m -75.49 155.41 36.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.843 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -58.7 -14.19 7.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.129 -0.982 . . . . 0.0 110.268 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.23 5.43 50.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 110.55 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.527 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.6 t80 -59.01 135.74 57.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.682 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.0 mtp -118.24 146.05 44.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.057 -1.027 . . . . 0.0 110.351 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' ARG . 42.5 t -61.22 124.27 79.67 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.408 -0.808 . . . . 0.0 110.097 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.581 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.0 Cg_endo -70.48 -7.87 22.29 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.883 1.465 . . . . 0.0 109.823 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.463 ' HB1' ' CD1' ' A' ' 15' ' ' TYR . . . -94.0 -54.84 3.44 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 10.3 p -115.99 7.02 14.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.438 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' CYS . 6.0 ttm180 63.21 15.94 9.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.241 -0.912 . . . . 0.0 112.171 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 20.6 p -68.64 166.56 25.51 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 0.0 109.811 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.2 Cg_endo -72.29 142.01 36.66 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.733 1.386 . . . . 0.0 110.495 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 10.5 tttm -48.51 -28.47 3.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 109.961 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.99 -10.42 21.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -0.87 . . . . 0.0 109.886 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.66 -4.19 58.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.276 -0.89 . . . . 0.0 109.695 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 19.1 m-85 -80.18 132.34 35.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 110.589 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.48 128.83 53.77 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.609 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -79.16 160.78 26.83 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.059 -1.026 . . . . 0.0 110.02 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.503 ' CG1' ' N ' ' A' ' 57' ' ' LYS . 7.4 pt -96.45 -40.81 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.473 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.503 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 9.1 ttmt 58.87 94.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.978 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.502 ' NZ ' ' OE1' ' A' ' 5' ' ' GLU . 6.9 mttp -74.58 165.1 25.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.409 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 14.8 p -125.24 138.42 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 110.184 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.464 HG21 ' O ' ' A' ' 1' ' ' MET . 5.3 tt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.189 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' O ' ' HB3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.254 0.55 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.518 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -101.83 82.72 2.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.153 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 2' ' ' GLU . 19.8 pt -157.83 152.62 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 110.245 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -160.77 134.61 6.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.268 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 6' ' ' GLY . 2.2 tt0 -173.15 60.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.054 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 44.36 25.82 0.86 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 5' ' ' GLU . 22.2 mtpt -86.77 127.95 35.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 0.0 110.007 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 22.4 m-85 -120.05 146.99 45.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.295 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.522 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 70.7 tt0 -121.4 139.89 52.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.7 t -77.11 117.01 18.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.025 . . . . 0.0 110.398 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -68.07 -16.53 64.06 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.785 -1.197 . . . . 0.0 108.617 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.13 -59.14 2.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.637 -0.664 . . . . 0.0 110.574 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.37 -3.76 16.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.006 -1.059 . . . . 0.0 110.918 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 79.4 6.13 89.02 Favored Glycine 0 N--CA 1.496 2.696 0 O-C-N 121.081 -1.012 . . . . 0.0 111.43 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 17.7 t80 -56.79 144.2 33.9 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.927 -1.337 . . . . 0.0 109.829 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 13.3 mm -115.99 111.27 34.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.651 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.9 t80 -81.24 121.42 26.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.835 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -101.84 118.48 59.38 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.251 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -72.0 -29.25 15.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.968 1.509 . . . . 0.0 110.166 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.08 -9.23 58.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 110.224 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 2.5 mmmp? -111.81 -45.48 3.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.273 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.52 159.57 12.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.545 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.19 55.18 3.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -1.06 . . . . 0.0 109.882 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.54 -51.59 2.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 110.499 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 65.3 m-85 -51.25 -37.95 49.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.844 . . . . 0.0 110.294 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.54 -68.52 0.78 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 110.183 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.43 53.85 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.545 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.84 143.37 48.8 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.232 -1.158 . . . . 0.0 109.949 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' O ' ' OG1' ' A' ' 32' ' ' THR . 45.5 Cg_endo -72.0 168.67 23.32 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.012 1.533 . . . . 0.0 110.36 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.2 Cg_endo -72.25 161.38 44.65 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.889 1.468 . . . . 0.0 110.88 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.67 15.47 80.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 29' ' ' PRO . 31.4 m -95.54 122.59 58.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.263 -1.139 . . . . 0.0 110.227 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.26 138.72 28.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.862 1.454 . . . . 0.0 110.58 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.576 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 13.7 t80 -53.13 -40.18 64.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.115 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG21 ' N ' ' A' ' 36' ' ' ASP . 11.4 m -53.77 -18.09 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 110.177 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' N ' HG21 ' A' ' 35' ' ' VAL . 27.1 t70 -83.51 -7.16 59.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.107 -0.996 . . . . 0.0 110.337 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.465 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.2 mt -71.86 151.87 43.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.944 . . . . 0.0 110.077 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -76.95 158.68 30.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -10.85 15.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 0.0 110.158 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 4.12 45.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.398 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 50.0 t80 -59.47 134.73 57.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -0.945 . . . . 0.0 109.845 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -118.81 146.86 44.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.048 -1.033 . . . . 0.0 109.853 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.9 t -56.89 130.01 78.48 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 110.422 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.531 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -72.05 -11.85 27.61 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.865 1.455 . . . . 0.0 109.51 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.42 -64.9 1.0 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 110.751 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.52 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.3 p -98.69 3.34 47.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 0.0 111.109 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 6.0 ttm180 62.09 21.68 12.56 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.05 -1.031 . . . . 0.0 111.994 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.468 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.7 m -74.98 168.24 29.36 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.776 -1.202 . . . . 0.0 109.931 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.5 Cg_endo -73.53 141.87 32.0 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.917 1.483 . . . . 0.0 110.561 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.571 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 41.3 tttm -50.19 -30.24 11.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.005 . . . . 0.0 109.968 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.04 -12.46 19.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.28 -0.888 . . . . 0.0 109.872 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.44 -2.37 58.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.279 -0.888 . . . . 0.0 109.798 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -86.15 139.1 31.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 110.688 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 138.24 54.37 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.0 t -85.4 172.79 10.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.66 -1.275 . . . . 0.0 110.787 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 56' ' ' ILE . 5.7 pt -138.33 71.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.208 0.528 . . . . 0.0 110.281 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -107.42 65.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.149 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -96.68 74.58 2.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.242 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -83.42 92.55 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.185 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.444 ' OXT' ' CG1' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.241 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 mmt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.299 0.571 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.8 OUTLIER -175.41 97.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.249 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.421 HG13 ' HB2' ' A' ' 58' ' ' LYS . 4.6 pt -151.69 126.67 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.152 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 5' ' ' GLU . 6.7 p-10 -145.71 125.56 13.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 110.301 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER 175.28 70.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.086 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 47.23 30.13 5.43 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.519 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . 9.6 mttt -77.95 119.17 21.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -1.092 . . . . 0.0 109.624 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.2 m-85 -118.37 138.41 52.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 110.701 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -116.04 140.25 49.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.436 -0.79 . . . . 0.0 109.554 179.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.7 t -75.93 115.55 15.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.954 . . . . 0.0 110.148 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -16.12 63.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.789 -1.194 . . . . 0.0 108.684 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.16 -60.8 1.93 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.593 -0.692 . . . . 0.0 110.552 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.512 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.2 p -108.31 -2.97 18.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.001 . . . . 0.0 111.001 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 78.65 6.95 88.33 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.013 -1.054 . . . . 0.0 111.418 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 15' ' ' TYR . 4.8 t80 -58.16 142.76 46.32 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.968 -1.313 . . . . 0.0 109.695 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.507 HD11 ' N ' ' A' ' 16' ' ' ILE . 2.2 mp -110.53 113.62 44.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.481 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 50.9 t80 -82.89 121.29 26.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 109.882 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -100.0 118.24 61.93 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 110.318 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -71.32 -35.93 7.72 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.82 1.432 . . . . 0.0 110.114 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -71.62 -10.51 59.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.801 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 -12.83 13.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.971 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.517 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 76.54 170.84 32.29 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.57 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 1.8 t70 -85.28 59.02 5.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.455 -1.026 . . . . 0.0 109.66 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -36.92 -62.99 0.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.555 -0.716 . . . . 0.0 110.699 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.515 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 18.5 m-85 -42.46 -27.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 110.32 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -101.04 -58.2 1.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.434 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.87 -10.07 1.2 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.185 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.547 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -61.27 141.2 94.27 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.061 -1.258 . . . . 0.0 109.73 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.481 ' HD2' HG21 ' A' ' 28' ' ' ILE . 43.9 Cg_endo -69.75 160.52 49.42 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.899 1.473 . . . . 0.0 110.665 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.517 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 45.1 Cg_endo -72.43 165.42 32.73 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.075 1.566 . . . . 0.0 110.702 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.15 12.83 83.23 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 20.4 m -103.79 126.33 32.18 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -1.144 . . . . 0.0 110.128 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.3 Cg_endo -73.11 142.92 35.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.889 1.468 . . . . 0.0 110.54 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.571 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.1 t80 -51.3 -36.39 42.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.885 . . . . 0.0 110.142 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.5 m -54.32 -17.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 110.403 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -84.36 -7.41 59.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 110.303 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 38.3 mt -71.22 152.79 42.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 110.076 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 1.4 m -80.15 167.85 19.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.95 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -73.59 -0.73 16.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 110.187 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 t -109.8 -0.12 18.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.168 -0.957 . . . . 0.0 110.387 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.57 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.9 t80 -59.7 138.69 57.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 109.791 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 48' ' ' SER . 11.4 mtt -120.93 145.77 47.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.129 -0.982 . . . . 0.0 110.051 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 12.9 t -55.53 131.35 71.05 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.838 . . . . 0.0 110.114 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.515 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 47.0 Cg_endo -73.38 -13.32 25.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.923 1.486 . . . . 0.0 109.609 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.78 -59.42 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.775 . . . . 0.0 110.95 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.512 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.0 p -105.15 5.06 31.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 111.076 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER 61.79 17.8 9.13 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.195 -0.94 . . . . 0.0 112.251 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 21.4 p -70.29 165.96 39.1 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.161 . . . . 0.0 109.672 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 45.8 Cg_endo -72.23 142.71 38.18 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.692 1.364 . . . . 0.0 110.388 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.563 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 27.3 tttm -48.78 -27.72 3.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 109.927 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.96 -11.18 26.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.35 -0.844 . . . . 0.0 109.825 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.84 -2.96 58.32 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.379 -0.825 . . . . 0.0 109.589 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 24.3 m-85 -87.7 139.22 30.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -132.08 147.88 52.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.651 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 3.2 p -83.24 166.31 18.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.023 . . . . 0.0 110.468 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.519 ' CD1' ' HB3' ' A' ' 7' ' ' LYS . 12.8 pt -118.59 -43.97 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.553 -0.717 . . . . 0.0 110.3 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.511 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 44.3 mttm 38.44 73.1 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.575 -0.703 . . . . 0.0 110.617 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -105.07 139.58 39.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.128 -0.983 . . . . 0.0 110.27 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.462 HG11 ' O ' ' A' ' 59' ' ' VAL . 2.6 p 179.9 130.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.414 HG12 ' OXT' ' A' ' 60' ' ' ILE . 13.5 tt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.902 -1.046 . . . . 0.0 110.267 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.256 0.55 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 0.4 OUTLIER -82.85 108.15 15.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.178 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.4 pt -147.19 144.17 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.176 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 5' ' ' GLU . 43.7 p-10 -160.68 136.13 7.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.261 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER 175.6 30.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.878 . . . . 0.0 110.527 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.75 30.82 12.26 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.54 125.14 33.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.196 -1.179 . . . . 0.0 109.763 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 16.6 m-85 -123.55 152.91 41.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.207 -0.933 . . . . 0.0 110.405 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -125.64 141.19 52.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.418 -0.801 . . . . 0.0 109.527 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 5.0 t -78.01 117.32 19.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.506 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -16.36 63.92 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.595 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.12 -59.56 2.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.683 -0.636 . . . . 0.0 110.595 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.28 -3.91 16.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.992 -1.067 . . . . 0.0 110.775 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 79.95 5.67 89.44 Favored Glycine 0 N--CA 1.497 2.707 0 O-C-N 121.136 -0.977 . . . . 0.0 111.587 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.461 ' CD2' ' HB1' ' A' ' 45' ' ' ALA . 41.7 t80 -57.13 144.47 34.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.862 -1.375 . . . . 0.0 109.937 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -115.96 111.28 34.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.23 -0.919 . . . . 0.0 110.601 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 38.3 t80 -80.83 123.17 28.03 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.264 -0.897 . . . . 0.0 109.574 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -106.95 116.73 58.1 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 110.226 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' THR . 44.3 Cg_endo -71.19 -24.97 22.76 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.792 1.417 . . . . 0.0 110.24 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.42 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 15.3 tt0 -73.14 -9.94 59.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.08 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.1 tttp -114.78 -43.26 3.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.125 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.98 159.51 13.13 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.538 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.09 55.18 3.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.445 -1.032 . . . . 0.0 109.94 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.74 -50.16 3.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.596 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 26.1 m-85 -52.12 -39.25 59.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 110.354 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -89.55 -69.22 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.213 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.28 54.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.0 144.22 52.68 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.236 -1.156 . . . . 0.0 110.04 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HD2' HG22 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -71.39 166.63 28.72 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.015 1.534 . . . . 0.0 110.505 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.3 Cg_endo -72.34 161.9 43.07 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.915 1.481 . . . . 0.0 110.819 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 73.58 13.65 80.1 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 19' ' ' PRO . 16.9 m -94.69 121.97 61.78 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.266 -1.138 . . . . 0.0 110.19 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.441 ' HB2' HG21 ' A' ' 35' ' ' VAL . 44.3 Cg_endo -71.89 141.4 36.96 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.81 1.426 . . . . 0.0 110.669 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.557 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 85.5 t80 -56.06 -18.1 8.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 33' ' ' PRO . 4.3 m -70.63 -11.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.38 -0.825 . . . . 0.0 109.47 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -89.35 -6.87 56.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.503 -0.748 . . . . 0.0 110.265 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.557 HD13 ' CD1' ' A' ' 34' ' ' PHE . 19.1 mt -73.63 144.75 45.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.143 -0.973 . . . . 0.0 110.044 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.2 t -75.46 160.38 30.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 110.096 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -62.27 -11.55 15.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.217 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.17 4.89 46.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.359 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.526 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 51.8 t80 -59.89 135.58 57.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.119 -0.988 . . . . 0.0 109.876 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -118.78 146.49 44.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.066 -1.022 . . . . 0.0 109.868 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.6 t -55.93 131.61 73.5 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.579 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 44.6 Cg_endo -72.4 -12.61 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.901 1.474 . . . . 0.0 109.585 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -98.88 -65.74 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.502 -0.749 . . . . 0.0 110.866 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.52 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.6 p -96.62 2.87 52.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 0.0 111.205 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER 61.88 22.37 12.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.133 -0.979 . . . . 0.0 111.997 178.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.468 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 3.9 m -75.73 168.16 30.22 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.786 -1.196 . . . . 0.0 109.92 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.1 Cg_endo -73.37 141.91 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.796 1.419 . . . . 0.0 110.494 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 11.9 tttm -50.17 -29.3 8.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 1.9 m-20 -62.4 -12.36 21.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.874 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.54 -1.58 58.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.284 -0.885 . . . . 0.0 109.727 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 3.2 m-85 -85.71 137.75 32.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.921 . . . . 0.0 110.421 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.42 137.99 54.47 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.0 t -87.14 174.19 8.78 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.761 -1.212 . . . . 0.0 110.454 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 57' ' ' LYS . 9.7 pt -130.47 -44.92 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.156 -0.617 . . . . 0.0 110.431 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' N ' HG13 ' A' ' 56' ' ' ILE . 10.2 mttt 41.85 71.42 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.359 -0.838 . . . . 0.0 110.195 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 2.4 tttt -84.96 148.16 26.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.11 -0.994 . . . . 0.0 110.276 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 11.2 p -177.04 59.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.26 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.212 0.53 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.489 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -112.12 86.61 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.901 . . . . 0.0 110.249 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.489 ' CG2' ' O ' ' A' ' 2' ' ' GLU . 1.1 pt -155.21 145.58 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 0.0 110.104 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 5' ' ' GLU . 8.4 m-20 -145.08 129.21 17.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 110.307 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.2 pt-20 178.82 29.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.805 . . . . 0.0 110.383 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.57 28.12 30.63 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . 3.3 mttt -79.69 122.84 27.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -1.051 . . . . 0.0 109.696 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.654 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 9.8 m-85 -115.57 138.46 51.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 110.44 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.5 ' HG3' ' CG2' ' A' ' 56' ' ' ILE . 5.0 mt-10 -117.98 140.24 50.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 109.561 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 14' ' ' GLY . 5.3 t -77.14 115.77 17.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 110.283 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -16.19 63.96 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.773 -1.205 . . . . 0.0 108.638 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.12 -60.68 1.97 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.6 -0.687 . . . . 0.0 110.689 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.518 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.21 -3.72 18.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.067 -1.02 . . . . 0.0 110.909 -179.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.529 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 80.14 6.02 89.38 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.059 -1.025 . . . . 0.0 111.591 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 41.9 t80 -57.53 143.2 41.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.798 -1.413 . . . . 0.0 109.872 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -114.34 112.93 42.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.231 -0.918 . . . . 0.0 110.752 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 38.2 t80 -81.49 125.16 30.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.562 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -101.12 117.58 62.02 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.468 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 43.1 Cg_endo -71.24 -36.38 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.877 1.462 . . . . 0.0 109.98 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -9.69 54.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 109.747 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HE3' ' HE3' ' A' ' 24' ' ' LYS . 1.7 tmtm? -117.09 -17.55 10.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.474 -0.766 . . . . 0.0 109.724 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.489 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 83.19 172.61 48.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.578 ' OD2' ' CE1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -85.12 49.81 1.82 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -1.04 . . . . 0.0 109.784 179.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.9 ttmt -39.3 -58.32 1.23 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.0 -33.08 1.89 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -93.55 -62.68 1.32 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.901 . . . . 0.0 110.243 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.16 51.16 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.544 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -131.22 146.82 63.69 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.238 -1.154 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 28' ' ' ILE . 43.5 Cg_endo -69.78 155.44 65.86 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.891 1.469 . . . . 0.0 110.228 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.489 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 44.0 Cg_endo -71.17 165.34 32.71 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.871 1.458 . . . . 0.0 110.788 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 79.03 11.28 85.33 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 13.0 m -103.51 125.44 34.89 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.294 -1.121 . . . . 0.0 110.193 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 46.7 Cg_endo -73.06 142.29 34.23 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.87 1.458 . . . . 0.0 110.473 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 31.7 t80 -51.92 -39.2 58.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 110.033 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 m -55.14 -17.08 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.424 -0.797 . . . . 0.0 110.119 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.22 -6.87 59.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 110.253 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.43 HD12 ' OD2' ' A' ' 23' ' ' ASP . 17.9 mt -72.26 155.71 39.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 109.937 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.7 t -78.74 164.23 24.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.922 . . . . 0.0 110.071 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -5.88 21.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.9 m -103.4 1.49 32.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.203 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 41.2 t80 -58.53 133.7 56.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.048 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 48' ' ' SER . 4.6 mtm -120.84 147.54 45.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 109.965 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.5 t -56.34 128.38 73.15 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.357 -0.84 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.533 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.1 Cg_endo -70.84 -11.42 29.41 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.785 1.413 . . . . 0.0 109.267 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.23 -67.95 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.487 -0.758 . . . . 0.0 110.663 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.518 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.7 p -94.53 2.06 55.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 111.06 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.56 23.78 14.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.143 -0.973 . . . . 0.0 111.892 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 52' ' ' GLN . 2.2 t -75.79 160.72 78.26 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.755 -1.216 . . . . 0.0 109.909 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 43.2 Cg_endo -69.85 144.39 53.38 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.677 1.356 . . . . 0.0 110.323 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.566 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 18.3 tttm -49.22 -26.7 3.1 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.292 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -64.07 -11.62 31.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.896 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.523 ' CB ' ' OG ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -91.96 -0.85 57.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.616 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 8.3 m-85 -89.54 138.77 31.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.683 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -128.1 143.6 51.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 109.522 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.653 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.7 p -81.53 167.65 19.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.885 -1.135 . . . . 0.0 110.923 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.507 ' CD1' ' HB3' ' A' ' 7' ' ' LYS . 3.1 pt -142.1 82.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.668 -0.645 . . . . 0.0 109.97 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.422 ' C ' ' OD1' ' A' ' 4' ' ' ASP . 41.8 mttm -105.87 65.61 0.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.5 158.0 19.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.376 -0.827 . . . . 0.0 110.123 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.437 ' CG2' ' OD2' ' A' ' 4' ' ' ASP . 14.4 t -136.58 56.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.162 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 tp . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.226 -179.93 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 10.3 ttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.172 0.511 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 1' ' ' MET . 4.8 tt0 177.03 115.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.311 -0.868 . . . . 0.0 110.185 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 9.4 pt -139.57 134.58 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.228 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.469 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 1.8 p30 -163.76 128.03 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.925 . . . . 0.0 110.286 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -174.82 61.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 46.07 27.61 2.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -81.68 121.46 26.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -1.159 . . . . 0.0 109.894 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.676 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 13.8 m-85 -116.5 143.9 45.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.94 . . . . 0.0 110.424 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.53 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -121.34 139.11 53.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.942 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.8 t -76.53 116.85 17.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.95 . . . . 0.0 110.327 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.09 -16.19 63.91 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.732 -1.23 . . . . 0.0 108.566 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -59.68 2.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.602 -0.686 . . . . 0.0 110.566 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.513 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.83 -3.45 17.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.967 -1.083 . . . . 0.0 110.916 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 79.06 6.11 88.88 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.343 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 42.2 t80 -56.29 143.62 33.32 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.875 -1.368 . . . . 0.0 109.796 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 14.9 mm -115.39 111.56 36.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.325 -0.859 . . . . 0.0 110.639 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 44.1 t80 -81.13 122.56 27.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.828 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -101.97 117.18 62.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 110.243 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.6 Cg_endo -71.8 -31.1 13.41 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.849 1.447 . . . . 0.0 110.234 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.4 -5.06 25.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.159 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -120.38 -38.45 2.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.81 167.42 23.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.534 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.7 OUTLIER -85.15 56.13 3.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.969 . . . . 0.0 109.894 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -40.14 -58.58 1.43 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.776 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 2.2 t80 -48.01 -32.94 7.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.594 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -92.25 -65.4 1.01 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.082 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.25 53.34 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.534 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -131.02 144.71 54.67 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.286 -1.126 . . . . 0.0 109.817 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -71.11 162.4 42.74 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.929 1.489 . . . . 0.0 110.425 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.29 163.44 38.66 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.91 1.479 . . . . 0.0 110.772 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.24 14.81 82.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -100.74 124.31 42.63 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.268 -1.137 . . . . 0.0 110.197 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 47.0 Cg_endo -73.32 140.38 30.43 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.92 1.484 . . . . 0.0 110.551 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.676 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 18.4 t80 -53.58 -40.38 65.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.361 -0.837 . . . . 0.0 110.319 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.1 m -53.86 -18.3 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.408 -0.808 . . . . 0.0 110.368 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 1.2 t0 -85.61 -6.81 59.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.394 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 38' ' ' SER . 16.2 mt -73.15 121.95 21.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 37' ' ' LEU . 47.4 t -42.02 155.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 110.381 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -9.19 21.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 110.292 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -98.26 4.6 48.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.333 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.513 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 46.1 t80 -59.72 136.31 57.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 110.222 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.9 mtp -120.33 145.7 46.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 109.69 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.5 t -54.82 131.81 66.21 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 110.333 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 45.5 Cg_endo -72.61 -13.88 27.35 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.899 1.473 . . . . 0.0 109.534 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.99 -65.29 0.97 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.486 -0.758 . . . . 0.0 110.908 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.5 p -96.28 2.91 53.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 111.167 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 3.1 ttm180 61.59 22.49 12.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.123 -0.986 . . . . 0.0 111.963 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.472 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.4 m -74.49 167.3 37.34 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.826 -1.172 . . . . 0.0 109.923 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.521 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 47.4 Cg_endo -73.51 142.96 33.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.946 1.498 . . . . 0.0 110.433 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.575 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 21.9 tttm -49.93 -30.08 9.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 49' ' ' PRO . 26.5 p30 -62.9 -11.74 20.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.119 -0.988 . . . . 0.0 109.968 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -89.27 -2.52 58.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.885 . . . . 0.0 109.54 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 7.3 m-85 -87.04 139.29 30.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.398 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -123.54 140.56 52.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.166 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 35.0 p -83.41 168.61 16.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.836 -1.165 . . . . 0.0 111.266 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -151.34 86.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.226 0.536 . . . . 0.0 109.875 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 4' ' ' ASP . 18.5 pttt -138.65 81.03 1.83 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 110.263 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 60' ' ' ILE . 10.8 tttp -162.16 167.57 23.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.357 -0.839 . . . . 0.0 110.213 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.19 126.72 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 110.258 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 58' ' ' LYS . 50.7 mt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.172 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.225 0.536 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.518 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 2.8 pt-20 -121.97 110.9 16.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 110.198 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 2' ' ' GLU . 19.7 pt -157.24 126.24 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -149.4 132.85 16.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.243 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.495 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -173.91 61.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.88 . . . . 0.0 110.145 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 44.08 26.34 0.86 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 5' ' ' GLU . 12.5 mttm -88.39 131.24 34.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -1.172 . . . . 0.0 109.877 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 21.2 m-85 -123.8 148.84 46.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.529 ' CG ' HD12 ' A' ' 16' ' ' ILE . 83.6 tt0 -122.85 142.7 50.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 109.535 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.5 t -79.39 115.74 19.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 110.645 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -15.28 63.52 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.372 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.25 -60.93 1.89 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.631 -0.668 . . . . 0.0 110.555 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -107.94 -4.74 17.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.957 -1.089 . . . . 0.0 110.717 -178.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 82.62 3.1 90.65 Favored Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.101 -0.999 . . . . 0.0 111.417 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.51 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . 89.6 t80 -49.53 172.39 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.854 -1.38 . . . . 0.0 109.421 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.529 HD12 ' CG ' ' A' ' 9' ' ' GLU . 10.4 mm -146.13 108.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.04 -1.038 . . . . 0.0 110.396 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.3 t80 -81.55 129.03 34.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 110.011 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -111.68 118.29 47.15 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 110.263 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -71.85 -29.29 15.57 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.885 1.466 . . . . 0.0 110.309 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 5.3 tp10 -71.59 -10.61 60.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.007 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 6.2 mttt -115.68 -39.65 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.381 -0.824 . . . . 0.0 110.003 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.46 164.59 20.95 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.538 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.8 OUTLIER -85.1 55.76 3.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -1.075 . . . . 0.0 109.844 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -41.1 -54.41 2.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.359 -0.838 . . . . 0.0 110.504 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 97.8 m-85 -49.63 -36.71 25.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.398 -0.814 . . . . 0.0 110.42 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -90.56 -67.47 0.85 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.04 54.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -133.36 141.73 41.59 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 109.98 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD2' HG21 ' A' ' 28' ' ' ILE . 44.7 Cg_endo -69.96 165.11 32.3 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.018 1.536 . . . . 0.0 110.432 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.0 Cg_endo -71.92 162.77 40.91 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.039 1.547 . . . . 0.0 110.841 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.11 12.04 84.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.8 m -98.87 123.2 50.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.286 -1.126 . . . . 0.0 110.232 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.2 Cg_endo -72.89 143.48 36.87 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.924 1.486 . . . . 0.0 110.75 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.575 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 7.7 t80 -57.54 -15.86 8.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.902 . . . . 0.0 110.041 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 m -69.97 -26.21 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.73 -5.51 55.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.41 -0.806 . . . . 0.0 110.409 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' SER . 11.1 mt -74.1 115.61 13.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.234 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 37' ' ' LEU . 63.9 m -41.68 151.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 110.378 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.64 -12.88 11.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 110.123 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 t -95.93 8.05 44.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.422 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.52 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.8 t80 -61.0 138.56 58.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.02 . . . . 0.0 109.894 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.2 mtt -121.34 147.48 45.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.031 . . . . 0.0 109.731 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.9 t -56.56 131.67 77.32 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 110.509 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 45.3 Cg_endo -72.42 -12.45 27.3 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.797 1.42 . . . . 0.0 109.561 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.5 -67.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 110.822 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.522 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.6 p -93.59 1.4 56.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.06 -1.025 . . . . 0.0 111.097 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.96 24.34 14.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.171 -0.956 . . . . 0.0 111.932 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.467 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 4.1 m -77.67 167.94 31.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.828 -1.17 . . . . 0.0 109.835 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.9 Cg_endo -72.64 140.92 33.44 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.801 1.422 . . . . 0.0 110.481 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.565 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 11.2 tttm -49.28 -27.21 3.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.005 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 0.7 OUTLIER -63.14 -11.86 23.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.956 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -90.72 -0.86 57.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.292 -0.88 . . . . 0.0 109.604 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -87.12 137.88 31.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.656 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -119.79 136.34 54.49 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.6 t -84.6 172.3 11.72 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.724 -1.235 . . . . 0.0 110.81 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.409 HG21 ' C ' ' A' ' 55' ' ' SER . 1.3 pt -141.3 59.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.051 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -82.04 55.23 2.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -72.66 136.37 45.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.319 -0.863 . . . . 0.0 110.175 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 59' ' ' VAL . 4.6 p -163.9 56.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 110.249 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 59' ' ' VAL . 7.3 pt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.219 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mtt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.259 0.552 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.448 ' O ' HG21 ' A' ' 3' ' ' ILE . 3.2 tm-20 -168.25 81.76 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.912 . . . . 0.0 110.143 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 58' ' ' LYS . 11.8 pt -154.49 127.23 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 110.323 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.419 ' OD2' ' CG2' ' A' ' 59' ' ' VAL . 2.9 p30 -134.21 136.03 43.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 110.024 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.4 tt0 176.74 69.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -0.982 . . . . 0.0 110.43 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 47.9 30.11 6.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . 0.7 OUTLIER -79.39 117.67 20.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -1.152 . . . . 0.0 109.437 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.5 m-85 -118.43 142.1 47.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.953 . . . . 0.0 110.8 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 6.6 tm-20 -119.22 140.26 50.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -0.809 . . . . 0.0 109.439 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' GLY . 5.0 t -76.57 116.75 17.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.15 -0.969 . . . . 0.0 110.233 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -16.59 64.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.767 -1.208 . . . . 0.0 108.713 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -59.8 2.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.578 -0.702 . . . . 0.0 110.599 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.95 -3.46 17.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.031 -1.043 . . . . 0.0 110.966 -179.032 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 79.37 6.29 88.97 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.153 -1.022 . . . . 0.0 111.458 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 40.5 t80 -57.57 143.59 40.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.918 -1.342 . . . . 0.0 109.698 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -114.17 112.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.281 -0.887 . . . . 0.0 110.647 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 33.9 t80 -82.21 128.05 33.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.651 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -109.49 117.2 53.36 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.872 . . . . 0.0 110.184 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 43.8 Cg_endo -71.28 -28.97 17.74 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.827 1.435 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.78 -5.83 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 110.053 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -119.82 -39.13 2.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 110.185 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.19 166.13 22.11 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.56 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -85.12 54.61 3.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -1.043 . . . . 0.0 109.899 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASP . 18.4 mmtt -39.74 -56.66 1.68 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.378 -0.826 . . . . 0.0 110.695 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.49 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 65.2 m-85 -47.34 -33.91 6.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -93.98 -64.63 1.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 110.484 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.98 52.83 0.02 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.545 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.11 145.22 55.79 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.274 -1.133 . . . . 0.0 109.82 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.6 Cg_endo -70.95 160.95 47.74 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.948 1.499 . . . . 0.0 110.43 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.6 Cg_endo -71.9 163.27 39.39 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.963 1.507 . . . . 0.0 110.765 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.11 15.34 81.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 26.7 m -102.46 124.2 40.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.265 -1.138 . . . . 0.0 110.254 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 48.0 Cg_endo -73.65 140.26 29.25 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.874 1.46 . . . . 0.0 110.561 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.581 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.7 t80 -50.42 -41.04 51.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.035 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.52 -17.14 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 110.266 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -84.42 -7.06 59.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.24 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.8 mt -71.65 155.86 40.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.952 . . . . 0.0 110.044 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 156.59 30.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.9 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -11.33 13.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.136 -0.978 . . . . 0.0 110.363 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.2 m -99.64 3.87 45.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.946 . . . . 0.0 110.418 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.56 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 44.8 t80 -59.68 136.37 57.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 109.964 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 48' ' ' SER . 6.8 mtt -120.0 146.37 45.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.077 -1.015 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.9 t -55.94 130.62 73.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 110.319 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.49 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.9 Cg_endo -71.99 -12.7 28.51 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.875 1.461 . . . . 0.0 109.526 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.35 -64.26 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.453 -0.779 . . . . 0.0 110.842 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.525 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.8 p -98.77 3.76 47.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 111.173 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.7 OUTLIER 61.69 20.53 11.42 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.111 -0.993 . . . . 0.0 112.036 178.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.463 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -73.05 167.31 35.42 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.769 -1.207 . . . . 0.0 109.786 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.3 Cg_endo -73.21 142.78 34.5 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.863 1.454 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 22.8 tttm -49.37 -27.67 4.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 109.834 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -63.04 -12.2 24.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.873 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -1.8 57.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.612 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 15.5 m-85 -88.53 139.65 30.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 110.379 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -130.74 146.27 52.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.702 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 p -82.96 167.66 17.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.908 -1.12 . . . . 0.0 110.44 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 7' ' ' LYS . 16.9 pt -114.04 -44.71 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 110.314 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.509 ' N ' HG13 ' A' ' 56' ' ' ILE . 0.3 OUTLIER 37.59 78.67 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.527 -0.733 . . . . 0.0 110.712 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 3' ' ' ILE . 1.1 tttp -113.4 99.89 8.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' CG2' ' OD2' ' A' ' 4' ' ' ASP . 32.6 t -129.48 82.28 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.245 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 pt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.175 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.262 0.553 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.423 ' C ' HG23 ' A' ' 3' ' ' ILE . 3.7 pt-20 -170.23 112.15 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.271 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.564 ' CG1' ' N ' ' A' ' 4' ' ' ASP . 1.3 tt 177.86 171.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -0.908 . . . . 0.0 110.305 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.564 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 10.9 m-20 -125.69 128.03 47.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 110.1 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER 169.96 -71.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 0.0 110.051 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.32 42.73 0.6 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.465 ' O ' HG23 ' A' ' 56' ' ' ILE . 2.4 tptm -78.78 118.51 20.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.425 -1.044 . . . . 0.0 109.769 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.0 m-85 -117.78 139.5 50.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 110.661 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.486 ' HB3' ' CD1' ' A' ' 16' ' ' ILE . 14.3 pt-20 -116.76 139.18 50.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.308 -0.87 . . . . 0.0 109.615 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -76.55 117.03 17.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 110.426 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -16.3 64.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.868 -1.145 . . . . 0.0 108.668 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.401 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.2 -59.49 2.31 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.649 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.93 -3.49 17.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.951 -179.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 78.28 7.74 87.71 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 30.6 t80 -58.76 142.56 49.76 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.807 -1.408 . . . . 0.0 109.636 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.486 ' CD1' ' HB3' ' A' ' 9' ' ' GLU . 24.5 mm -113.8 114.75 47.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.274 -0.891 . . . . 0.0 110.777 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.57 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 24.6 t80 -83.22 133.03 35.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 109.719 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -110.89 119.43 46.05 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 110.224 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -71.31 -34.51 9.73 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.861 1.453 . . . . 0.0 110.217 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -70.06 -6.76 36.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.398 -0.814 . . . . 0.0 110.028 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 14.5 tttt -117.96 -36.45 3.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.109 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.92 171.53 28.81 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.542 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 1.7 t70 -85.31 57.98 4.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.515 -0.991 . . . . 0.0 109.767 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ASP . 1.1 tptt -37.58 -63.0 0.48 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.554 -0.716 . . . . 0.0 110.727 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 17.7 m-85 -43.27 -27.13 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.393 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -100.26 -58.42 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.267 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.92 -7.52 1.06 Allowed Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.495 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.539 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.8 mp -64.93 142.27 98.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.344 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.61 162.49 42.01 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.997 1.524 . . . . 0.0 110.611 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -72.59 163.86 37.28 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.991 1.522 . . . . 0.0 110.775 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.53 13.37 83.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 60.5 m -105.75 126.59 30.36 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.274 -1.133 . . . . 0.0 110.168 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.517 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 47.6 Cg_endo -72.56 142.15 35.86 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.839 1.442 . . . . 0.0 110.603 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.57 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 2.9 t80 -53.21 -38.71 63.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.133 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.517 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 20.3 m -54.76 -17.68 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 110.051 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -83.12 -6.17 59.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.3 mt -70.23 156.34 39.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 0.0 109.996 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.58 162.63 25.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.872 . . . . 0.0 109.858 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -69.97 -3.91 18.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.252 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.0 m -106.7 0.67 24.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.542 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 44.7 t80 -59.98 136.58 58.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.978 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.466 ' HA ' ' O ' ' A' ' 48' ' ' SER . 21.7 mtp -119.62 146.06 45.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.12 -0.988 . . . . 0.0 109.908 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.4 t -54.86 129.64 65.46 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.266 -0.896 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.533 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.6 Cg_endo -71.27 -13.53 30.88 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.819 1.431 . . . . 0.0 109.47 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.98 -63.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.752 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.527 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.4 p -98.84 3.78 47.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.192 -0.942 . . . . 0.0 111.156 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.24 21.37 11.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.165 -0.96 . . . . 0.0 112.087 178.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.468 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.5 m -73.93 166.9 40.33 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.828 -1.17 . . . . 0.0 109.808 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.7 Cg_endo -72.91 142.68 35.43 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.818 1.431 . . . . 0.0 110.33 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.523 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 7.4 tttt -49.58 -25.64 2.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -66.26 -11.86 52.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.793 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.401 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -89.05 -3.23 58.75 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.35 -0.844 . . . . 0.0 109.492 179.279 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.522 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 4.6 m-85 -88.62 140.56 29.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.433 -0.792 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 5.1 mttt -129.89 146.35 51.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.9 p -82.76 165.67 19.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.936 -1.103 . . . . 0.0 110.705 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -139.61 -37.37 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.638 -0.664 . . . . 0.0 110.144 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 56' ' ' ILE . 2.5 tttt 40.73 83.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 110.409 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -171.81 162.98 6.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 110.357 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.6 m -131.91 142.86 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.335 -0.853 . . . . 0.0 110.094 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 60' ' ' ILE . 7.6 tp . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.237 0.541 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 24.5 tt0 -163.49 69.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 2' ' ' GLU . 1.2 pt -159.56 137.49 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.081 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.527 ' CB ' ' HA ' ' A' ' 57' ' ' LYS . 5.0 p-10 -140.51 122.45 15.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.903 . . . . 0.0 110.582 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -119.05 -88.57 0.62 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.503 -0.748 . . . . 0.0 109.715 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.39 32.18 2.43 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.52 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . 9.4 mttt -75.66 111.29 10.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -1.114 . . . . 0.0 109.295 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.609 ' CE1' ' HB3' ' A' ' 55' ' ' SER . 9.3 m-85 -121.12 137.82 54.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 111.089 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.522 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 83.2 tt0 -118.43 145.64 45.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.0 109.393 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 6.6 t -79.05 115.21 18.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.05 -1.031 . . . . 0.0 110.442 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.76 -15.23 63.41 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.508 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -61.14 1.84 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.703 -0.623 . . . . 0.0 110.771 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -108.39 -5.04 16.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.03 -1.044 . . . . 0.0 111.102 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 83.99 3.01 89.4 Favored Glycine 0 N--CA 1.497 2.75 0 O-C-N 120.973 -1.08 . . . . 0.0 111.419 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 29.3 t80 -50.64 173.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.827 -1.396 . . . . 0.0 109.17 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 12.1 mm -144.31 132.81 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.924 -1.11 . . . . 0.0 110.684 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 40.3 t80 -106.1 132.55 52.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.349 -0.844 . . . . 0.0 109.65 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 3.3 mt-10 -113.96 119.98 39.79 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.895 . . . . 0.0 110.372 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.5 Cg_endo -69.95 -35.73 11.57 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.861 1.453 . . . . 0.0 110.333 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.06 -10.24 56.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 109.844 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -116.33 -30.46 5.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.859 . . . . 0.0 109.936 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.08 171.58 33.93 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.534 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.2 51.01 2.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -1.061 . . . . 0.0 109.736 179.189 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.09 -56.87 1.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.805 . . . . 0.0 110.455 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.53 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.05 -33.95 2.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.785 . . . . 0.0 110.229 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -94.3 -62.38 1.35 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.381 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.67 52.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.534 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -131.72 145.71 58.7 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.243 -1.151 . . . . 0.0 110.014 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' A' ' 28' ' ' ILE . 43.6 Cg_endo -70.08 160.17 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.952 1.501 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -72.3 163.87 37.34 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.983 1.517 . . . . 0.0 110.837 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 79.98 13.72 81.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 58.9 m -107.55 126.04 30.87 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.195 -1.18 . . . . 0.0 110.222 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.7 Cg_endo -73.22 142.71 34.33 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.837 1.441 . . . . 0.0 110.636 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.574 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 t80 -51.22 -40.09 58.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.299 -0.876 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -16.93 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 110.309 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.24 -6.87 59.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 18.7 mt -70.13 157.14 38.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -0.949 . . . . 0.0 109.946 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -77.81 157.54 29.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.206 -0.934 . . . . 0.0 109.811 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.37 -9.92 14.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.15 -0.969 . . . . 0.0 110.262 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -100.48 2.92 42.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 110.428 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.9 t80 -58.2 132.8 54.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 109.77 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.7 mtt -118.81 147.24 44.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 110.06 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 8.0 t -58.08 127.41 79.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.319 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.53 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.15 -10.43 27.34 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.784 1.413 . . . . 0.0 109.565 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.57 -62.74 1.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.588 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.527 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.8 p -102.02 3.73 39.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.153 -0.967 . . . . 0.0 110.911 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER 62.26 20.85 12.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.196 -0.94 . . . . 0.0 112.063 178.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.465 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 25.5 p -73.83 165.52 52.47 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.864 -1.148 . . . . 0.0 109.781 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.1 Cg_endo -71.95 142.78 39.43 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.816 1.429 . . . . 0.0 110.377 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.559 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 43.2 tttm -48.29 -23.94 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 109.931 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.63 -10.8 39.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.852 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -91.7 -1.93 57.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.245 -0.909 . . . . 0.0 109.614 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 20.1 m-85 -88.57 138.12 31.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 110.506 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 2.5 tptp -130.7 146.52 52.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.339 -0.851 . . . . 0.0 109.662 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.609 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.2 p -80.55 164.95 22.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.901 -1.124 . . . . 0.0 110.435 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.541 ' CG1' ' N ' ' A' ' 57' ' ' LYS . 8.9 pt -106.72 -44.29 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.687 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 4.5 ttpt 52.4 93.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 110.087 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -77.79 58.15 1.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.158 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 74.8 t -114.03 126.07 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.158 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.22 0.533 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 54.63 55.44 7.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pt -137.62 153.3 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.21 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.524 ' CB ' ' HG3' ' A' ' 57' ' ' LYS . 12.7 p30 -170.68 142.88 2.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.954 . . . . 0.0 110.332 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.82 -153.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 110.076 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.41 33.14 5.85 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.462 ' O ' HG12 ' A' ' 56' ' ' ILE . 1.5 ttpt -87.19 129.25 35.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -1.114 . . . . 0.0 110.0 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 29.8 m-85 -125.67 145.09 50.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.572 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.524 ' HG2' ' CD1' ' A' ' 16' ' ' ILE . 14.5 mt-10 -117.67 142.63 47.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.399 -0.813 . . . . 0.0 109.901 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.4 t -77.56 113.61 15.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.975 -1.078 . . . . 0.0 110.584 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -15.1 63.31 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.912 -1.118 . . . . 0.0 108.441 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.06 -60.96 1.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.577 -0.702 . . . . 0.0 110.59 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.524 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.62 -4.4 17.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.972 -1.08 . . . . 0.0 110.887 -178.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 82.0 3.43 90.58 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.33 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.577 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 29.3 t80 -49.96 172.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.032 -1.275 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.577 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 24.5 mm -141.12 130.01 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.005 -1.059 . . . . 0.0 110.455 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 66.7 t80 -103.06 124.38 48.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.689 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -109.34 116.33 55.06 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.33 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.5 Cg_endo -69.34 -31.41 22.46 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.969 1.51 . . . . 0.0 110.075 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.08 -12.31 61.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 109.826 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.89 -12.69 10.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.89 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.464 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 81.3 167.41 38.26 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.551 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 1.2 t0 -85.18 50.6 1.98 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -1.032 . . . . 0.0 109.774 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.3 mmtt -39.31 -53.84 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.347 -0.845 . . . . 0.0 110.534 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.53 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -47.13 -36.5 8.49 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.428 -0.795 . . . . 0.0 110.225 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -92.27 -64.34 1.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 0.0 110.377 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.22 52.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.551 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.88 145.7 58.6 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -1.097 . . . . 0.0 109.939 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HD2' HG22 ' A' ' 28' ' ' ILE . 43.7 Cg_endo -70.49 161.85 44.55 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.962 1.507 . . . . 0.0 110.198 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.464 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.2 Cg_endo -71.64 162.78 41.09 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.973 1.512 . . . . 0.0 110.853 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.12 12.59 84.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 21.9 m -97.73 125.1 45.8 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.239 -1.153 . . . . 0.0 110.179 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.89 139.29 30.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.867 1.456 . . . . 0.0 110.605 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.574 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 62.5 t80 -52.11 -41.46 62.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.074 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG21 ' N ' ' A' ' 36' ' ' ASP . 6.1 m -53.52 -17.59 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.432 -0.793 . . . . 0.0 110.384 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.2 t0 -83.96 -7.6 59.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.127 -0.983 . . . . 0.0 110.4 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.456 ' CB ' ' HD2' ' A' ' 50' ' ' LYS . 17.9 mt -69.43 153.21 43.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 109.9 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.0 155.36 32.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.716 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -11.22 12.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 110.212 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.47 4.1 43.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 110.509 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.54 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 50.1 t80 -59.7 134.86 57.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.016 -1.052 . . . . 0.0 109.576 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.3 mtp -119.23 148.42 43.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.986 -1.071 . . . . 0.0 110.458 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 6.2 t -58.63 126.93 81.32 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.45 -0.781 . . . . 0.0 110.38 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.53 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.0 Cg_endo -70.69 -9.65 26.21 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.814 1.428 . . . . 0.0 109.486 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.36 -64.86 1.0 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.512 -0.743 . . . . 0.0 110.464 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.524 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.2 p -99.37 2.64 45.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.954 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.0 OUTLIER 63.04 22.34 13.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.153 -0.967 . . . . 0.0 112.094 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 29.9 p -76.31 166.11 47.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.735 -1.228 . . . . 0.0 109.859 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 45.2 Cg_endo -71.72 142.13 39.04 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.766 1.403 . . . . 0.0 110.437 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.567 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 10.1 tttm -48.64 -27.65 2.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.901 . . . . 0.0 110.0 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.06 -10.15 27.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.817 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -87.64 -5.57 58.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.306 -0.871 . . . . 0.0 109.628 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 23.7 m-85 -79.96 133.62 36.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 110.566 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.08 131.25 54.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.467 -0.771 . . . . 0.0 108.93 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.596 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -79.77 159.29 26.62 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 110.194 -179.442 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.511 ' O ' ' CB ' ' A' ' 57' ' ' LYS . 1.7 pt -101.45 -107.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.337 -0.852 . . . . 0.0 110.34 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HG3' ' CB ' ' A' ' 4' ' ' ASP . 6.8 ttpt 70.26 94.54 0.07 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.885 -1.134 . . . . 0.0 110.202 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -138.21 171.12 14.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.215 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.5 p -164.42 175.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.95 . . . . 0.0 110.204 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.402 ' O ' HG13 ' A' ' 60' ' ' ILE . 1.1 pt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.136 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.437 ' CE ' ' OE1' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.265 0.555 . . . . 0.0 110.168 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 5.6 mt-10 -141.49 72.02 1.37 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.161 -0.962 . . . . 0.0 110.182 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.519 ' CG2' ' O ' ' A' ' 2' ' ' GLU . 9.4 pt -159.4 131.28 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.287 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 5' ' ' GLU . 5.1 m-20 -105.54 132.3 51.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 110.138 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.2 mt-10 169.7 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.269 -0.894 . . . . 0.0 110.251 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 51.02 31.95 26.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.441 ' HE2' ' CG2' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -83.4 118.77 23.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.12 . . . . 0.0 109.918 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 18.0 m-85 -120.03 146.65 45.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.176 -0.953 . . . . 0.0 110.372 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 4.6 mt-10 -121.07 140.08 52.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 109.565 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.3 t -76.42 118.44 19.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.117 -0.99 . . . . 0.0 110.399 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.84 -16.74 63.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.852 -1.155 . . . . 0.0 108.644 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -58.93 2.49 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.681 -0.637 . . . . 0.0 110.547 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.486 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -109.61 -3.09 17.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 110.931 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.521 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 78.27 6.73 87.84 Favored Glycine 0 N--CA 1.495 2.622 0 O-C-N 120.999 -1.063 . . . . 0.0 111.414 177.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 43.2 t80 -57.87 144.59 38.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.943 -1.328 . . . . 0.0 109.78 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -114.44 111.6 36.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.294 -0.879 . . . . 0.0 110.584 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 49.3 t80 -82.07 122.38 27.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.905 . . . . 0.0 109.984 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -107.0 119.65 50.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.832 . . . . 0.0 110.088 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 44.3 Cg_endo -71.47 -24.45 22.42 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.902 1.475 . . . . 0.0 110.299 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -72.05 -16.0 62.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 109.948 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -109.95 -37.75 5.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.05 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.54 166.05 24.5 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.541 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.21 50.41 1.94 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -1.051 . . . . 0.0 109.644 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 4.4 tttm -38.91 -53.02 1.76 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.492 -0.755 . . . . 0.0 110.618 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.505 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 13.9 m-85 -48.88 -36.46 17.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.378 -0.826 . . . . 0.0 110.295 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -91.58 -66.25 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.329 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.95 51.46 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.541 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.16 144.7 53.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.238 -1.154 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 28' ' ' ILE . 45.6 Cg_endo -70.89 163.03 40.62 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.956 1.503 . . . . 0.0 110.31 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -71.89 161.82 43.79 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.949 1.5 . . . . 0.0 110.905 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.34 13.13 83.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 37.4 m -93.89 123.11 60.51 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.3 -1.118 . . . . 0.0 110.174 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.4 Cg_endo -73.45 141.5 31.7 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.821 1.432 . . . . 0.0 110.641 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.578 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 30.3 t80 -55.53 -18.02 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.948 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -72.84 -10.6 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -91.84 -7.62 48.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.29 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.22 146.23 47.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.056 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.81 158.75 31.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.068 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -60.96 -12.93 12.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 0.0 110.158 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 97.2 p -99.27 4.84 46.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.449 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 52.3 t80 -58.96 139.57 56.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.101 -0.999 . . . . 0.0 109.984 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.7 mmm -119.79 143.8 47.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.985 -1.072 . . . . 0.0 110.049 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' ARG . 49.5 t -59.91 125.17 79.9 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 110.14 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.505 ' HB2' ' CB ' ' A' ' 25' ' ' PHE . 43.9 Cg_endo -70.67 -8.87 24.59 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.858 1.452 . . . . 0.0 109.871 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . . . -93.34 -53.66 4.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.482 -0.761 . . . . 0.0 110.167 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.486 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.5 p -118.15 8.47 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 110.707 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.81 14.18 7.13 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.255 -0.903 . . . . 0.0 112.162 178.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 52' ' ' GLN . 2.2 t -66.8 161.39 61.71 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.834 -1.166 . . . . 0.0 110.044 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 42.9 Cg_endo -69.29 143.38 52.91 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.608 1.32 . . . . 0.0 110.25 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.578 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 17.4 tttm -50.21 -28.86 8.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.129 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -63.01 -11.94 22.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.118 -0.989 . . . . 0.0 109.786 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.523 ' CB ' ' OG ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -88.67 -2.52 58.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.879 . . . . 0.0 109.85 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 43' ' ' CYS . 25.4 m-85 -83.93 135.38 34.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.583 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' NZ ' ' O ' ' A' ' 55' ' ' SER . 0.5 OUTLIER -120.67 138.14 54.09 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.734 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.3 t -88.59 174.26 8.17 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.819 -1.176 . . . . 0.0 110.535 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 57' ' ' LYS . 1.4 tp -158.2 -45.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.388 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 56' ' ' ILE . 32.0 mtmt 40.49 80.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.401 -0.812 . . . . 0.0 110.314 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 3' ' ' ILE . 35.6 ttmt -113.29 147.7 37.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.0 110.381 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.495 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 8.9 p -153.36 55.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 110.188 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 tp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.203 -179.951 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.26 0.552 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.454 ' OE1' ' HE3' ' A' ' 57' ' ' LYS . 1.8 pt-20 -112.14 157.39 20.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.185 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 58' ' ' LYS . 13.4 mt -147.31 179.05 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -137.75 -168.2 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 110.338 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -179.47 -27.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.231 -0.918 . . . . 0.0 110.433 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' HA2' ' HG3' ' A' ' 19' ' ' PRO . . . 118.49 7.18 11.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.47 ' HB3' HG22 ' A' ' 56' ' ' ILE . 2.7 mtpp -82.21 110.79 17.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -1.128 . . . . 0.0 109.569 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 12.1 m-85 -120.7 144.14 48.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.937 . . . . 0.0 110.949 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.6 pp20? -118.85 140.24 50.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 0.0 109.513 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.4 t -77.31 117.99 19.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.056 -1.028 . . . . 0.0 110.534 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.439 ' CA ' ' OE1' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -69.11 -16.57 63.7 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.833 -1.167 . . . . 0.0 108.525 178.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -59.21 2.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.594 -0.691 . . . . 0.0 110.547 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.03 -3.21 17.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.98 -1.075 . . . . 0.0 110.815 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 78.24 6.14 87.62 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.081 -1.012 . . . . 0.0 111.404 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 47.6 t80 -56.83 144.89 31.4 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.957 -1.32 . . . . 0.0 109.744 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.404 ' CD1' ' CB ' ' A' ' 9' ' ' GLU . 22.2 mm -115.71 110.58 32.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.234 -0.917 . . . . 0.0 110.5 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 45.8 t80 -81.26 121.47 26.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.81 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.03 121.13 50.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.386 -0.821 . . . . 0.0 110.213 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.5 Cg_endo -70.78 -27.68 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.935 1.492 . . . . 0.0 110.277 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.91 -18.87 62.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 110.234 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -104.24 -39.61 6.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.151 -0.968 . . . . 0.0 110.175 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.81 164.67 24.18 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.526 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -85.18 51.38 2.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.449 -1.03 . . . . 0.0 109.83 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -40.12 -51.54 2.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.345 -0.847 . . . . 0.0 110.67 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 26.1 m-85 -48.98 -36.63 18.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.352 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.97 -66.13 0.95 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.246 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.76 53.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.526 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -131.86 143.93 51.11 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.378 -1.072 . . . . 0.0 110.038 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD2' HG22 ' A' ' 28' ' ' ILE . 45.1 Cg_endo -72.04 165.43 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.108 1.583 . . . . 0.0 110.311 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.8 Cg_endo -72.24 163.06 39.83 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.932 1.491 . . . . 0.0 110.833 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.47 12.07 82.38 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 25.1 m -94.38 123.61 58.06 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.238 -1.154 . . . . 0.0 110.2 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.527 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 46.9 Cg_endo -73.18 141.3 32.23 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.811 1.427 . . . . 0.0 110.585 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.577 ' CE1' ' HE2' ' A' ' 50' ' ' LYS . 47.6 t80 -55.38 -38.97 69.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.29 -0.881 . . . . 0.0 110.186 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 17.0 m -54.1 -18.47 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.407 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.5 OUTLIER -83.16 -6.72 59.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.408 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.573 HD13 ' CD2' ' A' ' 34' ' ' PHE . 19.3 mt -73.05 150.65 42.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.114 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.45 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -76.71 159.52 30.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 109.996 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -10.23 18.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.211 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 p -100.28 4.33 44.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.264 -0.897 . . . . 0.0 110.327 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.9 t80 -60.42 137.77 58.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 110.038 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 48' ' ' SER . 18.3 mtm -119.84 146.14 46.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.178 -0.951 . . . . 0.0 110.093 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 10.9 t -56.91 130.26 78.77 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.793 . . . . 0.0 110.443 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 45.6 Cg_endo -72.25 -12.1 27.41 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.921 1.485 . . . . 0.0 109.698 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.6 -61.95 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 110.708 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.519 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.5 p -102.51 4.37 38.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 111.128 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.1 tpt180 62.12 18.96 10.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.136 -0.977 . . . . 0.0 112.102 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.465 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.7 m -71.83 168.1 25.42 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.831 -1.168 . . . . 0.0 109.759 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.9 Cg_endo -73.8 142.75 32.38 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.817 1.43 . . . . 0.0 110.406 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.9 tttm -49.37 -28.38 4.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 109.784 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -63.13 -11.94 23.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 109.856 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -89.5 -2.39 58.35 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.595 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -87.56 139.18 30.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 110.43 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.16 139.13 54.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.458 -0.776 . . . . 0.0 108.94 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 40.8 p -82.16 168.94 17.18 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.854 -1.154 . . . . 0.0 110.632 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 7' ' ' LYS . 2.3 pp -96.65 -26.57 4.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.326 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HE3' ' OE1' ' A' ' 2' ' ' GLU . 14.7 tttt 49.32 89.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.96 . . . . 0.0 110.233 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -54.54 124.77 17.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 0.0 110.15 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.7 t -115.49 110.75 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.227 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.415 HD13 ' HD3' ' A' ' 58' ' ' LYS . 5.0 mt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.143 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.24 0.543 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 1.4 mp0 -53.17 159.22 1.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.192 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 58' ' ' LYS . 1.5 mp 63.36 167.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.137 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.503 ' N ' ' HA ' ' A' ' 57' ' ' LYS . 20.0 p-10 -78.66 126.13 30.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 110.285 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 5' ' ' GLU . 35.3 tt0 -90.23 15.47 10.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.853 . . . . 0.0 110.036 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.429 ' C ' ' HG3' ' A' ' 19' ' ' PRO . . . 114.67 8.55 15.87 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -85.14 117.82 24.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -1.149 . . . . 0.0 109.733 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.4 m-85 -125.56 148.68 48.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.95 . . . . 0.0 110.859 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.522 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 32.6 tt0 -119.04 140.27 50.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.839 . . . . 0.0 109.424 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.6 t -77.33 117.45 18.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.047 -1.033 . . . . 0.0 110.421 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -16.42 63.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.822 -1.174 . . . . 0.0 108.585 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.401 ' HB3' ' NE2' ' A' ' 52' ' ' GLN . . . -85.18 -59.12 2.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.579 -0.701 . . . . 0.0 110.551 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.39 -3.8 16.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.009 -1.057 . . . . 0.0 110.906 -179.041 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 79.41 6.25 88.99 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.537 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 34.0 t80 -57.01 143.58 37.63 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.797 -1.413 . . . . 0.0 109.807 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 17.8 mm -115.19 111.86 37.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.342 -0.848 . . . . 0.0 110.65 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.0 t80 -81.38 122.21 27.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.773 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -102.28 117.78 60.41 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 0.0 110.226 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.8 Cg_endo -71.16 -30.37 16.16 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.87 1.458 . . . . 0.0 110.307 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -72.48 -7.91 52.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.304 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -114.4 -43.56 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.285 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.1 163.34 18.08 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.54 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.16 56.17 3.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.453 -1.027 . . . . 0.0 109.983 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' ASP . 9.5 mtpt -40.92 -55.5 2.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 110.502 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 27.1 m-85 -48.45 -34.86 11.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.375 -0.828 . . . . 0.0 110.506 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 23' ' ' ASP . . . -92.8 -65.75 0.98 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 110.3 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.46 54.34 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.54 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -132.1 144.07 51.6 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.296 -1.12 . . . . 0.0 109.993 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 28' ' ' ILE . 45.2 Cg_endo -71.59 165.05 33.71 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.956 1.503 . . . . 0.0 110.391 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.06 162.9 40.41 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.017 1.535 . . . . 0.0 110.804 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.11 15.02 81.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 15.8 m -97.65 123.29 52.51 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.283 -1.127 . . . . 0.0 110.198 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 47.6 Cg_endo -73.75 139.9 28.44 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.873 1.46 . . . . 0.0 110.586 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.573 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 12.4 t80 -53.42 -40.61 65.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.273 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 27.3 m -53.17 -18.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 110.467 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 3.8 t70 -85.52 -7.1 59.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 0.0 110.386 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.493 HD12 ' CD1' ' A' ' 41' ' ' PHE . 13.7 mt -73.99 120.06 19.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 37' ' ' LEU . 18.5 t -42.21 159.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.457 -0.777 . . . . 0.0 110.335 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.45 -7.7 27.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 0.0 110.161 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 p -99.03 4.19 47.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.493 ' CD1' HD12 ' A' ' 37' ' ' LEU . 49.1 t80 -58.61 134.76 57.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.193 -0.942 . . . . 0.0 110.157 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -120.13 146.15 46.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.139 -0.975 . . . . 0.0 109.718 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.9 t -56.46 130.06 75.91 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 110.493 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.469 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -71.93 -12.4 28.36 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.845 1.445 . . . . 0.0 109.477 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.04 -65.81 0.94 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.576 -0.703 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.523 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.1 p -96.66 2.39 52.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.162 -0.961 . . . . 0.0 111.126 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.04 23.33 13.74 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.101 -0.999 . . . . 0.0 111.878 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.471 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -76.29 167.46 36.5 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.866 -1.146 . . . . 0.0 109.907 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.0 Cg_endo -73.75 142.77 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.972 1.512 . . . . 0.0 110.525 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.561 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 9.4 tttm -49.85 -29.53 8.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.105 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -63.16 -11.99 24.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.856 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -88.73 -2.65 58.7 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 109.673 179.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.82 138.69 31.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.943 . . . . 0.0 110.658 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.54 138.57 54.25 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.8 t -85.1 172.04 11.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.622 -1.299 . . . . 0.0 110.51 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.519 HG13 ' N ' ' A' ' 57' ' ' LYS . 17.6 pt -103.92 -42.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.488 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.519 ' N ' HG13 ' A' ' 56' ' ' ILE . 10.9 mttt 63.96 97.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -80.27 152.58 28.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.271 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 59' ' ' VAL . 7.0 m -143.53 93.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.968 . . . . 0.0 110.224 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.22 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 2' ' ' GLU . 23.8 mtt . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.281 0.562 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.474 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 4.6 mt-10 61.35 123.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.146 -0.971 . . . . 0.0 110.166 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -156.58 144.93 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.841 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 10.9 t0 -135.26 -153.78 0.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.62 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 19' ' ' PRO . 9.1 tp10 -178.21 58.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.375 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.469 ' HA2' ' HG3' ' A' ' 19' ' ' PRO . . . 45.72 22.52 0.75 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -87.11 118.5 26.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.045 -1.268 . . . . 0.0 109.67 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.4 m-85 -126.68 151.24 48.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.945 . . . . 0.0 110.766 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -121.95 141.38 51.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.398 -0.814 . . . . 0.0 109.424 179.113 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -78.11 117.73 19.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -0.996 . . . . 0.0 110.521 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.85 -16.34 63.74 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.831 -1.168 . . . . 0.0 108.515 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -59.2 2.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.603 -0.685 . . . . 0.0 110.411 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.478 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.33 -3.43 17.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.961 -1.087 . . . . 0.0 110.774 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.515 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 78.66 5.79 88.28 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.155 -0.965 . . . . 0.0 111.474 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.549 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 52.9 t80 -58.12 146.04 34.72 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.855 -1.38 . . . . 0.0 109.92 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.515 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.4 mp -116.42 110.44 31.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.214 -0.929 . . . . 0.0 110.443 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.518 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 36.8 t80 -80.94 121.63 26.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -106.33 120.12 49.71 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.437 -0.789 . . . . 0.0 110.027 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.5 Cg_endo -72.09 -23.14 21.83 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.99 1.521 . . . . 0.0 110.524 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -72.35 -16.22 61.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.113 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -109.69 -39.71 5.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 110.112 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.5 163.05 20.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.539 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.19 51.86 2.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -1.048 . . . . 0.0 109.866 179.016 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.5 mmtt -39.8 -50.01 2.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.441 -0.787 . . . . 0.0 110.65 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 41.1 m-85 -51.05 -39.5 56.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.269 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -88.77 -68.93 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.191 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.44 52.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.539 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.05 144.15 52.38 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.298 -1.119 . . . . 0.0 109.997 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' O ' ' OG1' ' A' ' 32' ' ' THR . 45.9 Cg_endo -72.01 166.54 29.3 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.875 1.461 . . . . 0.0 110.407 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.2 Cg_endo -72.48 160.86 45.73 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.91 1.479 . . . . 0.0 110.861 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.65 12.45 84.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 19' ' ' PRO . 25.9 m -92.92 121.04 66.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.18 -1.188 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.526 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 47.4 Cg_endo -73.18 142.48 34.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.859 1.452 . . . . 0.0 110.553 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.574 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 31.0 t80 -56.01 -21.39 21.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.294 -0.879 . . . . 0.0 110.024 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 32.3 m -72.11 -9.02 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -0.874 . . . . 0.0 109.784 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.54 -7.17 44.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.984 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.416 ' CB ' ' HD2' ' A' ' 50' ' ' LYS . 23.7 mt -72.91 146.16 46.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.013 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -73.58 151.38 40.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.879 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.0 -17.15 3.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.55 7.83 45.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 0.0 110.427 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.503 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 55.0 t80 -60.8 139.84 57.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 109.81 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 48' ' ' SER . 32.9 mtm -118.4 144.47 45.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.024 -1.048 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.453 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 42.5 t -59.31 127.56 84.46 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.402 -0.811 . . . . 0.0 110.284 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.525 ' HB2' ' CB ' ' A' ' 25' ' ' PHE . 44.1 Cg_endo -71.46 -10.0 26.15 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.002 1.528 . . . . 0.0 110.0 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -94.33 -54.87 3.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.461 -0.774 . . . . 0.0 110.327 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.478 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 10.0 p -115.3 7.47 15.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 110.773 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 63.01 14.39 7.53 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.28 -0.887 . . . . 0.0 112.171 178.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 3.6 m -67.56 169.3 9.42 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.857 -1.152 . . . . 0.0 109.894 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.3 Cg_endo -74.19 141.36 29.13 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.788 1.415 . . . . 0.0 110.461 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.574 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 10.5 tttm -50.05 -29.55 9.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 109.892 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -61.88 -12.52 18.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.866 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.64 -1.92 58.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.788 179.475 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -84.6 137.32 33.36 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.725 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -120.5 137.23 54.47 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.1 t -84.74 172.64 11.33 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.621 -1.299 . . . . 0.0 110.537 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.486 ' CG1' ' N ' ' A' ' 57' ' ' LYS . 11.9 pt -110.35 -44.42 5.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.826 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.486 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 7.4 ttmt 50.97 92.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.135 -0.978 . . . . 0.0 109.886 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -64.75 171.96 3.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 110.378 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 16.4 m -141.19 93.92 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 0.0 110.156 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.23 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.198 0.523 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 5.0 mt-10 57.07 177.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.337 -0.852 . . . . 0.0 110.254 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.514 ' CG2' ' O ' ' A' ' 2' ' ' GLU . 5.1 pt -158.28 140.54 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 2.1 p30 -86.18 -162.29 0.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 2.4 tt0 178.7 -26.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.895 . . . . 0.0 110.513 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.511 ' CA ' ' HG3' ' A' ' 19' ' ' PRO . . . 119.2 7.42 10.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.66 111.67 19.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -1.17 . . . . 0.0 109.653 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 18.8 m-85 -123.18 148.5 45.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 110.897 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.578 ' CG ' ' CD1' ' A' ' 16' ' ' ILE . 14.4 mt-10 -120.46 139.71 52.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.426 -0.796 . . . . 0.0 109.608 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.6 t -76.57 117.21 17.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.127 -0.983 . . . . 0.0 110.417 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -16.54 63.97 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.857 -1.152 . . . . 0.0 108.597 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.1 -58.82 2.53 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.647 -0.658 . . . . 0.0 110.683 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.63 -3.56 16.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.884 -1.135 . . . . 0.0 110.984 -179.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 79.34 6.47 88.91 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.058 -1.026 . . . . 0.0 111.392 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 26.9 t80 -56.59 143.1 37.04 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.942 -1.328 . . . . 0.0 109.687 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.578 ' CD1' ' CG ' ' A' ' 9' ' ' GLU . 16.4 mm -115.66 112.05 38.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.259 -0.9 . . . . 0.0 110.704 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.58 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.0 t80 -81.82 130.06 34.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.741 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -110.14 119.34 47.4 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 110.288 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -70.65 -30.2 18.5 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.892 1.469 . . . . 0.0 110.09 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.71 -13.82 61.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.833 . . . . 0.0 110.043 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -111.79 -38.23 4.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.381 -0.825 . . . . 0.0 110.049 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.36 168.94 25.76 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.568 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.6 OUTLIER -85.09 53.09 2.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.454 -1.027 . . . . 0.0 109.944 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -40.3 -57.4 1.75 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.375 -0.828 . . . . 0.0 110.533 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.474 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 27.0 m-85 -47.73 -34.35 8.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.47 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -90.99 -65.83 0.98 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.032 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.15 52.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.13 145.19 56.68 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.225 -1.162 . . . . 0.0 109.889 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -70.3 160.94 47.83 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.038 1.546 . . . . 0.0 110.47 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -71.93 163.14 39.77 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.049 1.552 . . . . 0.0 110.848 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.4 12.37 84.32 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 94.1 m -98.64 125.93 40.88 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.248 -1.148 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.74 139.76 28.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.016 1.535 . . . . 0.0 110.593 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.58 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 3.0 t80 -52.66 -40.0 62.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.017 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.3 m -53.76 -17.87 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -0.823 . . . . 0.0 110.282 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -83.53 -7.12 59.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 110.404 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.522 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.0 mt -71.42 153.86 41.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.086 -1.009 . . . . 0.0 109.98 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.22 157.99 30.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.979 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -11.52 15.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.267 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -99.52 4.01 45.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 110.435 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.568 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 48.7 t80 -59.65 132.81 55.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 109.832 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 48' ' ' SER . 10.4 mtp -117.08 147.01 42.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.052 -1.03 . . . . 0.0 109.966 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.6 t -56.59 129.97 76.66 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.321 -0.862 . . . . 0.0 110.458 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.474 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -72.22 -11.7 27.13 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.892 1.469 . . . . 0.0 109.4 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.64 -65.02 0.99 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.518 -0.739 . . . . 0.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.529 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.7 p -98.3 3.21 48.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.92 . . . . 0.0 111.151 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER 62.06 22.39 13.06 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.079 -1.013 . . . . 0.0 112.06 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.472 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.7 m -75.78 168.37 28.35 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.806 -1.184 . . . . 0.0 109.994 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.4 Cg_endo -74.08 142.57 31.19 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.907 1.478 . . . . 0.0 110.431 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 42.0 tttm -50.48 -29.41 10.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 109.944 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -62.95 -12.34 24.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.743 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -87.54 -3.08 59.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.786 179.515 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -86.45 139.63 30.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.748 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.55 139.86 53.43 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.2 t -85.41 172.08 11.32 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.677 -1.265 . . . . 0.0 110.566 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.495 HG13 ' N ' ' A' ' 57' ' ' LYS . 40.0 pt -106.02 -31.13 2.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.236 0.541 . . . . 0.0 110.465 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.495 ' N ' HG13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER 61.26 95.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.103 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 2' ' ' GLU . 3.1 mttt -63.97 149.78 46.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 34.4 m -111.13 164.8 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 110.229 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.488 ' CD1' ' O ' ' A' ' 60' ' ' ILE . 1.7 pp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.204 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 2' ' ' GLU . 1.5 mtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.221 0.534 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 26.3 tp10 57.94 109.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.279 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -146.5 151.45 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.196 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.519 ' N ' ' HA ' ' A' ' 57' ' ' LYS . 7.1 p-10 -91.4 127.83 36.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 5' ' ' GLU . 2.0 tt0 -84.43 13.34 5.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.041 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' HA2' ' HG3' ' A' ' 19' ' ' PRO . . . 116.25 7.44 14.42 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' CB ' HG12 ' A' ' 56' ' ' ILE . 20.9 mmtt -79.43 110.2 14.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.122 . . . . 0.0 109.145 179.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 10.0 m-85 -119.77 145.8 46.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.051 -1.03 . . . . 0.0 111.2 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.526 ' HB3' ' CD1' ' A' ' 16' ' ' ILE . 6.5 pt-20 -121.16 139.64 53.08 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.552 -0.717 . . . . 0.0 109.145 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.9 t -76.94 116.79 17.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.025 -1.047 . . . . 0.0 110.314 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.43 -16.52 64.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.84 -1.162 . . . . 0.0 108.601 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -59.53 2.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.662 -0.649 . . . . 0.0 110.563 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.44 -3.46 17.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.057 . . . . 0.0 110.986 -179.074 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 79.82 5.98 89.25 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.138 -1.029 . . . . 0.0 111.385 177.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 45.8 t80 -56.93 143.56 37.22 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.901 -1.353 . . . . 0.0 109.767 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 9' ' ' GLU . 21.7 mm -115.14 111.84 37.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 121.294 -0.879 . . . . 0.0 110.718 -179.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.1 t80 -82.17 129.34 34.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.867 . . . . 0.0 109.739 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -109.25 121.43 42.68 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.875 . . . . 0.0 110.202 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -71.66 -30.97 13.97 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.189 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.42 -14.81 62.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.082 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.406 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 5.2 ttpp -108.88 -38.58 5.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 110.157 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.32 169.04 25.81 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.523 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.07 54.73 3.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.462 -1.022 . . . . 0.0 109.886 179.212 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -40.37 -58.03 1.63 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.396 -0.815 . . . . 0.0 110.756 -179.528 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 47.5 m-85 -46.31 -33.34 3.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -93.07 -63.75 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.003 . . . . 0.0 110.292 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.59 53.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.523 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.92 144.96 55.14 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.279 -1.13 . . . . 0.0 109.819 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.3 Cg_endo -70.65 161.13 47.14 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.966 1.508 . . . . 0.0 110.366 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.6 Cg_endo -72.19 162.87 40.42 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.999 1.526 . . . . 0.0 110.787 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.41 13.33 83.67 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 83.7 m -99.85 124.06 45.22 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.269 -1.136 . . . . 0.0 110.15 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 46.4 Cg_endo -73.25 139.95 30.01 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.915 1.482 . . . . 0.0 110.644 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.577 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 1.3 t80 -50.96 -41.61 59.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.897 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -53.98 -17.55 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.418 -0.801 . . . . 0.0 110.423 -179.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.439 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 9.6 t0 -84.29 -7.44 59.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -0.992 . . . . 0.0 110.178 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.8 mt -71.14 154.99 41.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.018 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.68 149.63 38.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 109.823 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -55.67 -16.48 4.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.152 -0.967 . . . . 0.0 110.294 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -95.57 6.3 49.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.6 t80 -60.13 136.98 58.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.142 -0.974 . . . . 0.0 109.913 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 48' ' ' SER . 4.7 mtm -119.77 146.55 45.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 110.01 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 8.2 t -56.07 131.05 74.28 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 110.448 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.469 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.7 Cg_endo -72.21 -12.67 27.96 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.872 1.459 . . . . 0.0 109.583 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.34 -64.31 1.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.463 -0.773 . . . . 0.0 110.82 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.523 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.2 p -98.84 3.83 47.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.899 . . . . 0.0 111.206 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 14.2 mtm180 61.6 20.77 11.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.134 -0.979 . . . . 0.0 112.103 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.469 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.7 m -73.71 168.36 26.51 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.72 -1.238 . . . . 0.0 109.767 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.6 Cg_endo -73.57 142.27 32.46 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.951 1.5 . . . . 0.0 110.383 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 28.0 tttm -50.01 -29.22 8.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 109.807 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -61.23 -13.24 16.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.0 110.013 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.59 -1.08 57.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.328 -0.857 . . . . 0.0 109.681 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 13.3 m-85 -87.98 139.32 30.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 110.477 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 3.3 mttt -127.36 143.18 51.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.455 -0.778 . . . . 0.0 109.449 179.246 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 12.0 p -82.06 168.84 17.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.76 -1.213 . . . . 0.0 110.709 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.521 HG12 ' CB ' ' A' ' 7' ' ' LYS . 14.8 pt -105.22 -26.07 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.666 -0.646 . . . . 0.0 110.454 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HA ' ' N ' ' A' ' 4' ' ' ASP . 2.4 tptt 66.99 98.39 0.05 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.0 110.158 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -90.94 154.0 19.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.915 . . . . 0.0 110.153 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 11.9 p -75.19 164.2 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.947 . . . . 0.0 110.22 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.175 179.988 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mtt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.229 0.537 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.484 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 3.1 pt-20 -131.69 64.62 1.59 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.237 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 2' ' ' GLU . 20.1 pt -156.61 177.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 110.073 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -152.6 126.25 8.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.43 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -174.23 60.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.715 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 43.62 25.98 0.63 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.508 ' HB2' ' CG1' ' A' ' 56' ' ' ILE . 37.0 mttt -80.74 120.91 25.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -1.194 . . . . 0.0 109.744 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 11.4 m-85 -114.25 140.36 48.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 110.469 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 9.9 pt-20 -117.63 136.75 53.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 109.562 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.468 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 3.6 t -74.87 120.0 19.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.7 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -16.67 63.27 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.751 -1.218 . . . . 0.0 108.481 178.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -58.78 2.55 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.561 -0.712 . . . . 0.0 110.564 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.5 p -109.52 -1.2 18.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.953 -1.092 . . . . 0.0 110.814 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . 73.52 10.38 79.32 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 120.176 -1.012 . . . . 0.0 111.505 177.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.57 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 41.0 t80 -62.19 147.69 46.99 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.775 -1.427 . . . . 0.0 109.331 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.513 HD11 ' N ' ' A' ' 16' ' ' ILE . 2.3 mp -116.08 114.32 45.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.539 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 34' ' ' PHE . 18.5 t80 -83.16 134.68 34.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -111.23 119.18 46.15 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.432 -0.792 . . . . 0.0 110.07 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.2 Cg_endo -71.26 -31.71 13.91 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.955 1.503 . . . . 0.0 110.265 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.76 -8.52 56.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.371 -0.83 . . . . 0.0 109.972 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.3 tttt -110.06 -47.03 3.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.9 . . . . 0.0 110.16 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.21 162.84 14.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.525 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.17 56.68 4.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.509 -0.995 . . . . 0.0 109.927 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 23' ' ' ASP . 10.1 mmtt -40.14 -57.22 1.73 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.432 -0.793 . . . . 0.0 110.703 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -45.45 -34.01 2.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.398 -0.814 . . . . 0.0 110.604 -179.809 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 23' ' ' ASP . . . -95.38 -61.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 110.405 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.24 55.77 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.525 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.1 mp -129.94 143.67 50.0 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.269 -1.136 . . . . 0.0 109.953 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.474 ' HD2' HG21 ' A' ' 28' ' ' ILE . 44.0 Cg_endo -70.5 162.9 40.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.943 1.496 . . . . 0.0 110.533 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.465 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.4 Cg_endo -72.41 161.68 43.62 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.983 1.517 . . . . 0.0 110.92 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.85 14.98 82.02 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 97.7 m -102.04 125.87 35.42 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.177 . . . . 0.0 110.187 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 46.6 Cg_endo -72.95 136.94 25.89 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.855 1.45 . . . . 0.0 110.528 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.584 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 15.1 t80 -53.06 -39.17 63.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.179 -0.951 . . . . 0.0 110.174 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 32.8 m -53.32 -18.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.119 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.446 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 15.2 t0 -82.41 -5.88 58.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 110.416 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.478 HD13 ' CD2' ' A' ' 34' ' ' PHE . 22.2 mt -70.06 157.35 37.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.917 . . . . 0.0 110.067 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.05 155.95 30.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.2 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -60.48 -13.67 15.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.211 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.2 m -98.25 2.21 48.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 110.077 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 44.7 t80 -56.06 133.13 51.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.865 . . . . 0.0 110.139 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 35.4 mtt -111.03 138.29 47.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.006 -1.059 . . . . 0.0 109.307 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . 43.9 t -47.08 136.42 8.42 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 110.73 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.7 Cg_endo -82.8 36.18 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.124 1.592 . . . . 0.0 110.08 179.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB1' ' SG ' ' A' ' 43' ' ' CYS . . . -151.92 -50.31 0.11 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.247 -0.908 . . . . 0.0 109.588 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.476 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.5 p -118.17 8.41 12.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.389 -0.819 . . . . 0.0 110.128 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 27.3 mtp180 61.1 15.02 5.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.486 -0.759 . . . . 0.0 112.084 178.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.463 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.6 m -64.81 166.76 10.97 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.874 -1.141 . . . . 0.0 109.815 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.3 Cg_endo -73.25 142.32 33.62 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.932 1.49 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.493 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.2 tttm -49.85 -31.54 12.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.777 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -62.42 -12.26 20.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 109.808 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.56 -2.14 58.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.835 . . . . 0.0 109.745 179.505 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.477 ' CZ ' ' HA ' ' A' ' 43' ' ' CYS . 13.7 m-85 -88.11 139.82 30.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 110.508 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 20.1 tttt -126.12 142.45 51.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 109.371 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.667 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 9.3 p -83.29 169.44 15.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.936 -1.103 . . . . 0.0 111.023 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.508 ' CG1' ' HB2' ' A' ' 7' ' ' LYS . 1.1 pt -131.98 53.37 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.797 -0.565 . . . . 0.0 110.055 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.438 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 5.2 tttm -91.8 58.52 3.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.893 . . . . 0.0 110.239 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -116.4 63.76 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 110.258 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 59' ' ' VAL . 8.7 p -65.44 137.12 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.222 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.474 HD12 HG22 ' A' ' 60' ' ' ILE . 57.3 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.226 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ttp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.215 0.531 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 3' ' ' ILE . 1.8 pt-20 -143.6 128.47 18.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 110.23 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.553 ' CG1' ' N ' ' A' ' 4' ' ' ASP . 1.0 OUTLIER 171.29 171.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 109.973 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.553 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 3.7 p30 -144.6 121.18 11.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.757 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -117.5 -88.68 0.6 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 109.807 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.3 32.41 2.25 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.459 ' HD2' HD13 ' A' ' 56' ' ' ILE . 30.9 mtmt -76.9 113.5 14.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 109.278 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.602 ' CE1' ' HB3' ' A' ' 55' ' ' SER . 8.6 m-85 -120.6 140.22 51.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 0.0 111.144 -178.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 45.6 tt0 -117.03 141.54 48.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.538 -0.726 . . . . 0.0 109.358 179.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.9 t -77.13 116.54 17.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.072 -1.017 . . . . 0.0 110.309 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -16.25 64.19 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.787 -1.195 . . . . 0.0 108.663 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -60.1 2.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.575 -0.703 . . . . 0.0 110.605 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.509 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.55 -3.61 17.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.061 -1.024 . . . . 0.0 110.945 -178.984 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 79.27 6.87 88.79 Favored Glycine 0 N--CA 1.496 2.685 0 O-C-N 121.09 -1.006 . . . . 0.0 111.611 177.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 28.0 t80 -59.17 143.01 50.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.736 -1.45 . . . . 0.0 109.723 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.4 mp -113.99 113.87 45.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.215 -0.928 . . . . 0.0 110.746 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 25.6 t80 -84.64 137.43 33.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -0.852 . . . . 0.0 109.593 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -114.73 122.6 33.53 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.788 . . . . 0.0 110.222 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.6 Cg_endo -71.08 -34.07 10.82 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.811 1.427 . . . . 0.0 110.089 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.31 -11.27 60.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 110.053 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -111.68 -38.2 4.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.28 170.98 28.28 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD1' ' CG2' ' A' ' 28' ' ' ILE . 0.8 OUTLIER -85.19 57.15 4.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.493 -1.004 . . . . 0.0 109.702 179.099 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' ASP . 14.6 tptm -38.94 -61.33 0.75 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.454 -0.779 . . . . 0.0 110.532 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 27.2 m-85 -45.88 -30.38 1.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.835 . . . . 0.0 110.459 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -95.11 -63.5 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 0.0 110.276 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.43 54.24 0.02 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.524 ' CG2' ' OD1' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -129.95 144.17 51.99 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.212 -1.169 . . . . 0.0 109.662 179.798 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.47 ' HD2' HG21 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -70.44 159.0 54.38 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.982 1.517 . . . . 0.0 110.522 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.33 164.3 36.04 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.996 1.524 . . . . 0.0 110.741 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 80.22 13.98 81.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.8 m -105.19 126.69 30.34 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.176 -1.191 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.97 141.73 33.63 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.897 1.472 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.573 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 51.9 t80 -52.62 -41.37 63.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 110.177 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.46 HG21 ' N ' ' A' ' 36' ' ' ASP . 5.8 m -54.76 -17.17 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.337 -0.852 . . . . 0.0 110.305 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' N ' HG21 ' A' ' 35' ' ' VAL . 29.6 t70 -86.7 -6.78 58.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 110.272 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.504 HD12 ' CD1' ' A' ' 41' ' ' PHE . 17.7 mt -72.81 124.76 26.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.195 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' LEU . 16.0 m -43.01 164.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.172 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -72.77 -2.01 18.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.0 110.182 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' ' SD ' ' A' ' 42' ' ' MET . 7.9 p -103.11 1.49 33.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.416 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.504 ' CD1' HD12 ' A' ' 37' ' ' LEU . 47.5 t80 -56.79 130.21 44.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 110.225 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -119.21 146.09 45.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.681 179.594 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.4 t -55.36 129.53 68.84 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 110.494 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.583 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.49 -13.34 30.2 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.895 1.471 . . . . 0.0 109.461 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.69 -65.16 0.98 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.558 -0.714 . . . . 0.0 110.917 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.509 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.2 p -97.0 2.85 52.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.191 -0.943 . . . . 0.0 111.159 -179.121 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.2 tpp180 61.65 22.99 13.38 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.137 -0.977 . . . . 0.0 111.945 178.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.469 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.2 m -74.38 165.48 53.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.839 -1.163 . . . . 0.0 109.94 179.438 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.36 143.86 35.74 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.947 1.498 . . . . 0.0 110.44 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 12.5 tttt -49.16 -25.33 2.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 110.032 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -66.74 -11.2 53.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.88 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -90.75 -2.32 57.81 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.359 -0.838 . . . . 0.0 109.538 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 6.5 m-85 -89.09 138.87 31.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -0.77 . . . . 0.0 110.52 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 20.3 mmtt -130.83 146.92 52.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 109.586 179.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.602 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 4.0 p -82.55 166.17 19.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.835 -1.165 . . . . 0.0 110.456 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.544 ' CG1' ' N ' ' A' ' 57' ' ' LYS . 9.1 pt -111.51 -44.14 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.545 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.544 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 2.6 mtpt 55.15 94.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -92.77 70.53 4.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 0.0 110.191 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.5 t -106.35 89.32 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.192 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.436 ' O ' ' OE1' ' A' ' 2' ' ' GLU . 84.8 mt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.202 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.217 0.532 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -175.54 174.06 2.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.22 179.923 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.518 HG13 ' CB ' ' A' ' 58' ' ' LYS . 1.4 pt -146.34 -179.41 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 110.128 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 1.0 OUTLIER -116.09 -167.68 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 110.398 -179.858 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 0.4 OUTLIER 175.26 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.822 . . . . 0.0 110.418 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.479 ' CA ' ' HG3' ' A' ' 19' ' ' PRO . . . 119.45 7.61 9.79 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.52 ' CB ' HD12 ' A' ' 56' ' ' ILE . 1.4 mmmp? -84.26 112.12 20.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -1.112 . . . . 0.0 109.506 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.3 m-85 -125.73 150.14 47.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.926 -179.289 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 29.1 tt0 -120.32 140.2 51.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 109.243 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.3 t -77.4 116.81 18.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.06 -1.025 . . . . 0.0 110.562 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.14 -16.15 63.88 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.897 -1.127 . . . . 0.0 108.511 178.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.11 -59.48 2.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.65 -0.656 . . . . 0.0 110.539 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -109.27 -3.4 17.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.058 -1.026 . . . . 0.0 110.788 -179.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 79.06 6.82 88.75 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 121.118 -0.989 . . . . 0.0 111.571 177.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 51.5 t80 -58.98 144.33 45.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.83 -1.394 . . . . 0.0 109.894 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -116.05 113.07 42.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.761 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 40.7 t80 -81.55 123.23 28.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.743 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -102.21 118.01 59.96 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.47 -0.769 . . . . 0.0 110.294 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 46.5 Cg_endo -71.53 -30.67 14.73 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.902 1.475 . . . . 0.0 110.288 179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.82 -7.09 36.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.07 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 9.5 mttt -118.99 -35.73 3.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.884 . . . . 0.0 110.065 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.31 168.73 25.8 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -85.19 54.99 3.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.419 -1.047 . . . . 0.0 109.903 179.195 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -39.78 -58.13 1.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.574 -179.539 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -47.58 -34.05 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.412 -0.805 . . . . 0.0 110.537 -179.847 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -91.97 -65.3 1.02 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 110.239 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.96 52.99 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.54 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -132.49 142.59 45.46 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 0.0 109.908 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD2' HG21 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -69.97 161.95 44.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.871 1.458 . . . . 0.0 110.304 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.3 Cg_endo -71.92 162.99 40.24 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.993 1.523 . . . . 0.0 110.866 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 80.31 12.74 82.8 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 29' ' ' PRO . 2.2 m -101.71 126.19 34.88 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.147 -1.208 . . . . 0.0 110.219 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 46.9 Cg_endo -73.88 140.51 28.93 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.834 1.439 . . . . 0.0 110.613 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.583 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -52.13 -41.67 62.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.985 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 36' ' ' ASP . 1.4 p -53.22 -18.71 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.445 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 8.7 t70 -84.91 -6.66 59.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.237 -0.914 . . . . 0.0 110.118 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.457 HD12 ' OD2' ' A' ' 23' ' ' ASP . 16.9 mt -73.67 121.94 21.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.345 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -41.34 152.74 0.05 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.413 -0.804 . . . . 0.0 110.336 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.19 -11.81 16.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 110.266 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.03 5.8 49.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.437 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.549 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.7 t80 -58.91 137.38 57.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 110.155 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.8 mtt -117.94 143.11 46.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 109.558 179.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 47' ' ' ARG . 43.2 t -59.62 125.71 80.63 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 110.169 -179.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.8 Cg_endo -71.15 -9.75 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.891 1.469 . . . . 0.0 109.899 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.439 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . . . -93.19 -53.44 4.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -0.824 . . . . 0.0 110.193 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.476 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.8 p -117.64 8.3 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.615 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 43' ' ' CYS . 11.7 ttp180 61.81 15.44 7.06 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.245 -0.91 . . . . 0.0 112.097 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.467 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -68.29 168.64 12.94 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.858 -1.151 . . . . 0.0 109.895 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 48.0 Cg_endo -73.92 141.95 30.84 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.834 1.439 . . . . 0.0 110.524 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.7 tttm -50.21 -28.9 8.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -0.926 . . . . 0.0 109.956 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.78 -12.17 22.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.847 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.67 -2.21 58.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.339 -0.851 . . . . 0.0 109.737 179.41 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 26.8 m-85 -85.24 136.78 33.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.717 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.87 137.31 54.09 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.6 t -85.32 172.24 11.25 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.76 -1.212 . . . . 0.0 110.489 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.52 HD12 ' CB ' ' A' ' 7' ' ' LYS . 5.9 pt -113.16 -20.54 6.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.259 0.552 . . . . 0.0 110.379 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER 60.15 95.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.006 -179.904 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.518 ' CB ' HG13 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -49.32 116.1 1.58 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.186 -179.89 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 94.6 t -102.45 129.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.293 -0.879 . . . . 0.0 110.282 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 tt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.164 179.935 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' CG ' ' A' ' 2' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.222 0.534 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 1' ' ' MET . 1.6 mt-10 174.67 104.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.25 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.532 ' O ' ' CB ' ' A' ' 4' ' ' ASP . 32.2 mm -134.79 170.6 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.936 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER 165.68 -20.51 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.381 -0.824 . . . . 0.0 110.584 179.969 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.8 pm0 -73.49 59.1 0.59 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 110.366 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.32 31.7 13.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HB3' HG22 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -80.43 119.95 23.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -1.127 . . . . 0.0 109.928 179.662 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.605 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 23.9 m-85 -116.4 139.46 50.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.109 -0.994 . . . . 0.0 110.22 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.492 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -113.96 135.22 54.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 109.969 179.594 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 14' ' ' GLY . 2.5 t -72.67 117.77 14.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.543 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -68.57 -15.76 63.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.776 -1.202 . . . . 0.0 108.513 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.24 -59.02 2.45 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.501 -0.75 . . . . 0.0 110.406 179.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.496 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.5 p -109.69 -0.65 18.46 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.863 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 72.7 11.84 77.74 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.075 -1.015 . . . . 0.0 111.496 177.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.58 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 17.4 t80 -63.92 147.32 52.24 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.781 -1.423 . . . . 0.0 109.685 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.492 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 15.1 mm -112.4 115.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.027 -1.046 . . . . 0.0 110.513 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 41.7 t80 -83.09 131.44 35.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.784 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -111.48 118.19 47.69 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.779 . . . . 0.0 110.198 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 43.5 Cg_endo -70.25 -30.16 20.4 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.884 1.465 . . . . 0.0 110.068 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.5 -11.61 60.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.835 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 11.7 tptt -110.48 -44.01 3.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.425 -0.797 . . . . 0.0 109.944 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.52 168.59 21.87 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.571 ' OD2' ' CZ ' ' A' ' 41' ' ' PHE . 0.5 OUTLIER -85.2 52.46 2.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.514 -0.992 . . . . 0.0 109.748 178.974 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 1.4 ttpp -39.11 -60.4 0.89 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 110.627 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.523 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 32.0 m-85 -44.7 -31.22 1.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.798 . . . . 0.0 110.346 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.453 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -95.08 -62.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.277 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.75 51.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.528 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -128.53 143.8 49.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 109.725 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HD2' HG21 ' A' ' 28' ' ' ILE . 43.6 Cg_endo -69.88 159.69 52.39 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.958 1.504 . . . . 0.0 110.478 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.35 161.35 44.62 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.038 1.546 . . . . 0.0 111.006 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.83 13.77 82.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 91.2 m -99.02 125.58 41.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.231 -1.158 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.434 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 46.7 Cg_endo -73.03 136.66 25.2 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.905 1.476 . . . . 0.0 110.481 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.573 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 11.8 t80 -50.09 -42.87 50.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.1 m -53.63 -17.0 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 110.621 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 12.0 t70 -86.56 -7.84 58.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.01 -1.056 . . . . 0.0 110.281 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.453 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.3 mt -68.16 158.02 34.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 110.109 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.6 m -77.86 152.71 33.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 110.002 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -61.27 -12.19 12.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.24 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.24 2.98 35.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.898 . . . . 0.0 110.552 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CZ ' ' OD2' ' A' ' 23' ' ' ASP . 46.6 t80 -58.11 137.71 56.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.015 -1.053 . . . . 0.0 109.755 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.75 137.61 47.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.85 -1.156 . . . . 0.0 109.837 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.4 t -46.66 136.55 7.57 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.284 -0.885 . . . . 0.0 110.569 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.5 Cg_endo -81.73 34.81 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.126 1.592 . . . . 0.0 110.379 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -150.81 -48.72 0.12 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.226 -0.921 . . . . 0.0 109.526 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.496 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.6 p -120.04 9.28 11.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 110.183 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.19 14.04 5.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.406 -0.809 . . . . 0.0 112.116 178.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.465 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.8 m -64.98 169.0 6.09 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.498 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.47 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.4 Cg_endo -74.21 142.69 30.88 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.762 1.401 . . . . 0.0 110.151 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 11.3 tttm -50.73 -31.81 17.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.074 -1.016 . . . . 0.0 109.618 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -64.03 -11.61 30.86 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.356 -0.84 . . . . 0.0 109.316 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -85.54 -4.1 59.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.361 -0.837 . . . . 0.0 109.865 179.641 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -79.9 133.15 36.21 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.854 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -102.92 133.3 48.25 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.221 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -86.05 159.61 19.53 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.029 -1.045 . . . . 0.0 110.191 -179.537 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.47 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -153.57 89.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 110.028 -179.936 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -113.66 64.18 0.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 110.245 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.8 162.62 18.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.4 t -148.77 116.7 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 110.248 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.426 ' OXT' ' CG2' ' A' ' 60' ' ' ILE . 21.6 mm . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.202 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.214 0.531 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.526 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 4.7 mm-40 46.28 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 2' ' ' GLU . 10.7 pt -159.09 -170.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 110.204 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 4' ' ' ASP . 24.3 p30 -142.37 158.52 43.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 110.275 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.511 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.2 tt0 -145.39 38.3 1.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.478 ' CA ' ' HG3' ' A' ' 19' ' ' PRO . . . 45.45 23.92 0.94 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' HG2' HD11 ' A' ' 56' ' ' ILE . 1.6 tptm -87.47 119.93 28.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -1.21 . . . . 0.0 109.854 179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.9 m-85 -124.51 149.44 46.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 110.596 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -118.85 138.3 52.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.328 179.023 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.471 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 3.0 t -76.52 118.88 19.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.021 . . . . 0.0 111.042 -179.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.44 -16.26 63.45 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.361 178.036 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.13 -59.7 2.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.631 -0.668 . . . . 0.0 110.587 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.465 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.6 p -107.99 -1.78 20.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.962 -1.086 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 74.07 10.26 80.95 Favored Glycine 0 N--CA 1.494 2.559 0 O-C-N 121.092 -1.005 . . . . 0.0 111.458 177.471 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 39.3 t80 -65.1 149.65 49.51 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.819 -1.4 . . . . 0.0 110.001 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 14' ' ' GLY . 1.8 mp -114.79 112.41 39.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.221 -0.925 . . . . 0.0 110.113 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.552 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 38.0 t80 -80.79 119.94 24.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.688 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.32 118.04 57.78 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.354 -0.841 . . . . 0.0 110.061 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 32' ' ' THR . 44.6 Cg_endo -72.19 -22.44 22.35 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.931 1.49 . . . . 0.0 110.423 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -10.49 59.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -112.63 -47.32 3.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.922 . . . . 0.0 110.199 -179.979 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.66 159.36 11.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.553 ' OD2' ' CZ ' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -85.1 57.08 4.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -1.063 . . . . 0.0 109.983 179.415 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' ASP . 57.8 mttm -40.18 -52.97 2.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.448 -0.782 . . . . 0.0 110.464 -179.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -50.11 -39.96 44.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.487 -0.758 . . . . 0.0 110.427 -179.918 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 23' ' ' ASP . . . -88.77 -67.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.09 55.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.85 144.5 53.28 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.319 -1.107 . . . . 0.0 109.925 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.3 Cg_endo -71.03 166.33 29.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.974 1.513 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.46 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.1 Cg_endo -72.0 158.81 51.74 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.873 1.459 . . . . 0.0 111.024 -179.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.54 14.71 82.18 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 19' ' ' PRO . 41.2 m -92.69 119.39 67.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 110.256 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 45.2 Cg_endo -72.68 141.56 34.39 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.876 1.461 . . . . 0.0 110.617 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.558 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 43.7 t80 -56.84 -18.48 13.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 110.028 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 14.6 m -73.51 -8.36 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.938 179.693 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -95.55 -7.37 38.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.423 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 22.5 mt -71.69 147.55 47.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 110.212 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.81 153.49 36.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.59 -16.35 5.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 p -96.96 5.01 51.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 110.303 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.553 ' CZ ' ' OD2' ' A' ' 23' ' ' ASP . 53.8 t80 -57.95 137.01 57.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.123 -0.986 . . . . 0.0 109.893 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.5 mmt -111.79 138.98 47.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.948 -1.095 . . . . 0.0 109.526 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . 39.9 t -47.46 136.55 9.5 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 0.0 110.721 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -82.76 36.39 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.017 1.535 . . . . 0.0 110.109 178.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.83 -49.36 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.877 . . . . 0.0 109.491 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.465 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.6 p -119.53 8.56 11.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.423 -0.798 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.74 15.38 5.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -0.805 . . . . 0.0 112.176 178.576 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.464 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.2 m -66.34 169.03 8.07 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.794 -1.191 . . . . 0.0 109.681 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.7 Cg_endo -73.08 140.13 30.75 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.944 1.497 . . . . 0.0 110.413 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.558 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 32.5 tttt -50.24 -31.92 15.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.123 -0.985 . . . . 0.0 109.694 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -62.14 -12.57 20.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.319 -0.863 . . . . 0.0 109.707 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.13 -3.35 59.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.759 179.399 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 43' ' ' CYS . 19.7 m-85 -84.99 139.21 31.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 110.592 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.61 137.45 53.85 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.4 t -85.24 172.26 11.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.564 -1.335 . . . . 0.0 110.653 -179.467 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.543 ' CG1' ' N ' ' A' ' 57' ' ' LYS . 9.1 pt -108.74 -43.82 6.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.564 -179.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.543 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 0.2 OUTLIER 58.84 97.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -62.42 74.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 -179.767 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 57' ' ' LYS . 12.6 p -96.79 73.77 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 110.296 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.8 tt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.137 -179.959 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.281 0.563 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.9 OUTLIER 51.52 88.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 110.256 179.974 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.526 ' HB ' ' CD1' ' A' ' 56' ' ' ILE . 8.1 pt -145.13 124.6 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 110.156 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 58' ' ' LYS . 2.6 m-20 -150.92 11.48 0.65 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.461 -0.774 . . . . 0.0 110.692 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 4.6 pt-20 -75.57 59.24 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -0.86 . . . . 0.0 110.799 -179.377 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.07 31.74 11.44 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.525 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -80.74 124.32 28.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -1.119 . . . . 0.0 110.148 179.836 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.65 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 16.1 m-85 -113.85 139.91 48.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.145 -0.972 . . . . 0.0 110.04 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -118.06 137.43 52.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.104 -0.997 . . . . 0.0 109.828 179.563 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.0 t -74.82 116.64 15.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 110.359 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -67.4 -15.99 63.99 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.761 -1.212 . . . . 0.0 108.62 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.22 -59.99 2.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.618 -0.676 . . . . 0.0 110.463 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.482 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.3 p -109.03 -1.93 18.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.039 -1.038 . . . . 0.0 110.967 -179.102 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . 76.4 8.61 85.81 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.374 177.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 31.3 t80 -59.11 144.27 46.15 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.849 -1.383 . . . . 0.0 109.578 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.513 HD11 ' N ' ' A' ' 16' ' ' ILE . 2.1 mp -113.35 113.68 44.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.221 -0.925 . . . . 0.0 110.574 -179.318 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.567 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 35.8 t80 -82.74 131.23 35.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.305 -0.872 . . . . 0.0 109.739 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 12.2 mt-10 -108.15 119.68 49.1 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.521 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 43.7 Cg_endo -71.73 -35.61 7.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.839 1.442 . . . . 0.0 110.055 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 31.4 tt0 -70.29 -6.23 33.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 110.037 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 5.4 mmtt -117.56 -37.13 3.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.094 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.97 172.36 28.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 1.1 t70 -85.23 58.52 5.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -1.013 . . . . 0.0 109.756 178.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -36.83 -64.6 0.34 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.542 -0.723 . . . . 0.0 110.728 -179.535 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 1.6 m-85 -42.53 -26.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.847 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -99.98 -58.03 2.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.875 . . . . 0.0 109.952 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.65 -8.07 1.54 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.318 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.8 mt -61.79 143.36 94.23 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.251 . . . . 0.0 109.927 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 28' ' ' ILE . 44.6 Cg_endo -71.08 160.38 49.37 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.926 1.487 . . . . 0.0 110.659 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.4 Cg_endo -72.83 163.66 37.8 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.13 1.595 . . . . 0.0 110.801 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.72 14.12 82.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 86.4 m -105.73 127.23 28.87 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.28 -1.129 . . . . 0.0 110.134 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 46.9 Cg_endo -73.13 140.75 31.56 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.959 1.505 . . . . 0.0 110.492 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 2.6 t80 -50.05 -38.06 36.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.991 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.473 HG21 ' N ' ' A' ' 36' ' ' ASP . 6.3 m -54.4 -17.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 110.363 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.473 ' N ' HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -85.05 -7.15 59.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.091 -1.006 . . . . 0.0 110.234 179.949 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.5 mt -69.06 155.94 39.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.0 110.089 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.25 156.13 29.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.136 -0.977 . . . . 0.0 109.819 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -9.64 16.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.029 -1.044 . . . . 0.0 110.317 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 t -103.65 2.76 33.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.473 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.577 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.1 t80 -59.82 138.95 57.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.122 -0.987 . . . . 0.0 109.885 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.0 mtt -117.09 142.72 46.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.866 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 47' ' ' ARG . 41.9 t -56.3 128.32 72.82 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.24 -0.913 . . . . 0.0 110.008 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.533 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.9 Cg_endo -71.45 -12.66 29.78 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.924 1.486 . . . . 0.0 109.856 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.34 -51.45 4.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 110.675 -179.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.482 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 7.5 p -118.83 9.39 12.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.117 -0.989 . . . . 0.0 110.939 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.44 12.68 4.52 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.285 -0.885 . . . . 0.0 112.296 178.347 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 19.0 p -65.12 166.41 13.08 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.832 -1.167 . . . . 0.0 109.765 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 44.4 Cg_endo -71.87 142.38 38.94 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.665 1.35 . . . . 0.0 110.097 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.598 ' CE ' ' CZ ' ' A' ' 34' ' ' PHE . 23.1 tttt -50.41 -28.9 9.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.772 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -62.76 -12.58 25.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.206 -0.933 . . . . 0.0 109.741 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.42 -3.45 59.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -0.809 . . . . 0.0 109.664 179.433 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 21.7 m-85 -84.01 136.99 33.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 110.362 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.27 139.6 52.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.882 . . . . 0.0 109.268 179.198 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.65 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 53.1 p -85.55 168.38 14.55 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.885 -1.134 . . . . 0.0 111.355 -179.392 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.526 ' CD1' ' HB ' ' A' ' 3' ' ' ILE . 1.0 OUTLIER -139.21 83.04 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.381 0.61 . . . . 0.0 109.826 179.709 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER -106.31 68.62 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.46 -0.775 . . . . 0.0 109.881 -179.887 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.524 ' N ' ' OD2' ' A' ' 4' ' ' ASP . 6.9 mmtt -126.01 170.49 11.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 110.355 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 4.1 p -166.42 130.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 0.0 110.211 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 mm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.064 -0.969 . . . . 0.0 110.205 -179.959 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 19.6 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.215 0.531 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.458 ' O ' HG21 ' A' ' 3' ' ' ILE . 3.8 mt-10 54.4 -176.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.504 ' CD1' ' O ' ' A' ' 3' ' ' ILE . 2.6 pp -153.26 126.35 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 57' ' ' LYS . 15.2 p-10 -96.2 133.38 40.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 110.147 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.31 13.95 4.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.13 -0.981 . . . . 0.0 110.118 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.447 ' HA2' ' HG3' ' A' ' 19' ' ' PRO . . . 113.0 10.97 14.7 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HB3' HG22 ' A' ' 56' ' ' ILE . 11.7 mtmt -79.11 111.47 15.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -1.173 . . . . 0.0 109.131 179.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 10.6 m-85 -121.34 143.44 49.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.139 -0.975 . . . . 0.0 111.254 -178.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 3.3 tm-20 -121.39 143.69 49.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 4.7 t -78.67 116.57 19.12 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.997 -1.064 . . . . 0.0 110.531 -179.544 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -15.77 63.67 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.767 -1.208 . . . . 0.0 108.415 178.295 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 52' ' ' GLN . . . -85.02 -61.56 1.74 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.688 -0.632 . . . . 0.0 110.445 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -106.43 -3.95 20.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.931 -1.105 . . . . 0.0 110.559 -179.221 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 80.62 2.42 89.77 Favored Glycine 0 N--CA 1.496 2.696 0 O-C-N 121.086 -1.009 . . . . 0.0 111.19 177.536 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 22.5 t80 -50.43 171.65 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.998 -1.295 . . . . 0.0 109.7 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 23.2 mm -139.48 130.48 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 110.344 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.552 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 55.8 t80 -105.12 120.6 41.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.363 -0.836 . . . . 0.0 109.927 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -108.88 119.0 50.27 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.099 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -70.72 -24.29 25.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.929 1.489 . . . . 0.0 110.316 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.428 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 8.0 tp10 -72.64 -15.53 61.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.242 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 9.9 tttt -109.84 -40.7 4.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.42 156.39 12.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.558 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.5 OUTLIER -85.3 62.2 7.34 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.375 -1.074 . . . . 0.0 108.995 178.463 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -39.68 -48.57 2.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.467 -0.771 . . . . 0.0 111.039 -179.061 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.452 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 13.4 m-85 -80.96 13.22 2.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 0.0 110.907 -179.338 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' A' ' 28' ' ' ILE . . . -131.55 -3.77 3.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.0 110.71 -179.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.86 38.53 7.97 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.954 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.529 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.7 mp -133.21 136.46 27.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.838 -1.389 . . . . 0.0 110.25 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HD2' HG21 ' A' ' 28' ' ' ILE . 46.6 Cg_endo -72.79 174.12 12.35 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.016 1.535 . . . . 0.0 110.486 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.6 Cg_endo -72.85 160.52 45.91 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.969 1.51 . . . . 0.0 111.039 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.8 11.5 84.55 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.524 HG22 ' CG2' ' A' ' 28' ' ' ILE . 54.4 m -94.54 121.38 63.4 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.232 -1.157 . . . . 0.0 110.299 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.461 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.7 Cg_endo -72.96 143.53 36.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.838 1.441 . . . . 0.0 110.456 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 37.9 t80 -55.97 -37.16 68.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.908 . . . . 0.0 110.05 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 33.9 m -55.33 -18.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.454 -0.779 . . . . 0.0 109.872 179.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 7.7 t70 -83.42 -6.66 59.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.819 . . . . 0.0 110.242 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.492 HD12 ' CE1' ' A' ' 41' ' ' PHE . 22.2 mt -73.67 146.15 44.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.128 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -75.62 162.32 28.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.841 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -64.16 -9.75 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.151 -0.968 . . . . 0.0 110.259 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 t -100.16 4.32 44.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.468 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.558 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 51.4 t80 -58.38 137.13 57.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 109.792 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.0 mtt -120.75 146.08 46.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.008 -1.058 . . . . 0.0 110.122 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 47.0 t -59.23 127.43 84.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 110.265 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.452 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 45.7 Cg_endo -71.47 -9.98 26.1 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.931 1.49 . . . . 0.0 109.754 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.504 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -95.09 -56.7 2.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 110.582 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.9 p -111.61 5.99 19.71 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.122 -0.986 . . . . 0.0 110.691 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.6 OUTLIER 62.54 16.56 8.85 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.337 -0.852 . . . . 0.0 112.072 178.512 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -69.05 167.69 19.29 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.835 -1.166 . . . . 0.0 109.804 179.47 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.7 Cg_endo -72.74 140.89 33.03 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.897 1.472 . . . . 0.0 110.625 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 9.6 tttm -48.25 -26.8 2.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -0.916 . . . . 0.0 109.99 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 -11.23 16.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.799 . . . . 0.0 110.156 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.406 ' NE2' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -93.64 0.3 56.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.257 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 13.0 m-85 -87.85 137.12 32.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 110.616 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -125.2 140.11 53.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 0.0 109.476 179.268 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 5.5 p -79.88 168.02 19.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.162 . . . . 0.0 110.626 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 58' ' ' LYS . 2.0 pp -97.07 -27.06 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.661 -0.649 . . . . 0.0 110.49 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.46 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 21.9 mtpp 52.18 87.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 110.2 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.508 ' N ' HD13 ' A' ' 56' ' ' ILE . 1.6 tttt -92.69 128.0 38.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.447 ' HB ' ' HG2' ' A' ' 2' ' ' GLU . 14.9 p -61.15 152.4 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.175 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.199 179.964 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.286 0.565 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -100.47 79.96 2.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.555 ' CG1' ' N ' ' A' ' 4' ' ' ASP . 0.9 OUTLIER -174.3 171.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 110.193 -179.917 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.555 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 18.0 p-10 -166.22 125.46 1.58 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.542 -0.724 . . . . 0.0 110.349 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 19.9 tt0 -179.03 36.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 109.806 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . 92.92 -50.44 2.53 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.559 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.561 ' C ' ' O ' ' A' ' 6' ' ' GLY . 5.9 mmmt 8.51 108.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 5.9 m-85 -111.32 134.04 53.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 109.886 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.476 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 74.3 tt0 -119.72 141.69 49.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 0.0 110.111 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 6.5 t -77.9 114.24 16.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 0.0 110.402 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -14.9 62.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.805 -1.184 . . . . 0.0 108.524 178.593 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.492 ' HB3' ' NE2' ' A' ' 52' ' ' GLN . . . -85.18 -61.87 1.67 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.598 -0.689 . . . . 0.0 110.731 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.3 p -107.77 -4.5 18.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.015 -1.053 . . . . 0.0 110.952 -178.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 15' ' ' TYR . . . 83.18 3.83 90.03 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.622 177.463 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.588 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 69.3 t80 -48.39 173.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.719 -1.459 . . . . 0.0 109.023 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.588 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 11.9 mm -145.77 112.78 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.895 -1.128 . . . . 0.0 110.712 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.567 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 53.1 t80 -94.17 148.28 22.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.86 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -130.75 126.53 21.89 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 44.1 Cg_endo -71.45 -33.58 10.73 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.852 1.448 . . . . 0.0 110.285 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -72.87 -2.32 20.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 5.3 ttmt -121.7 -43.08 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.047 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.72 168.17 20.89 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.19 56.44 3.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -1.015 . . . . 0.0 110.007 179.479 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' ASP . 32.2 tttt -41.19 -61.91 0.93 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.396 -0.815 . . . . 0.0 110.48 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.576 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -43.07 -30.41 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.804 . . . . 0.0 110.341 -179.981 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 23' ' ' ASP . . . -97.09 -60.11 1.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.344 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.86 54.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.518 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -132.96 142.05 43.24 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.314 -1.11 . . . . 0.0 109.87 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD2' HG21 ' A' ' 28' ' ' ILE . 44.0 Cg_endo -69.69 160.72 48.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.914 1.481 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.469 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 42.9 Cg_endo -71.43 162.16 43.22 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.072 1.564 . . . . 0.0 111.027 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 82.74 14.17 76.25 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 64.7 m -107.44 125.79 31.51 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.263 -1.14 . . . . 0.0 110.039 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 45.5 Cg_endo -71.91 138.09 30.69 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.884 1.465 . . . . 0.0 110.685 -179.791 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.642 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -52.98 -41.45 64.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -55.39 -17.48 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.354 -0.841 . . . . 0.0 110.19 -179.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -85.26 -5.23 59.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 109.922 179.687 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.466 HD12 ' OD2' ' A' ' 23' ' ' ASP . 22.1 mt -72.13 127.79 33.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 109.922 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 7.9 t -42.06 155.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 110.161 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 10.8 m-20 -66.72 -7.23 19.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.78 3.37 42.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.568 -179.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.497 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 51.7 t80 -58.21 132.6 54.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.126 -0.984 . . . . 0.0 109.956 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -118.81 146.71 44.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.0 109.992 179.744 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.3 t -56.84 128.69 76.86 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 110.16 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.36 -11.92 29.11 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.777 1.409 . . . . 0.0 109.628 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HB1' ' CD1' ' A' ' 15' ' ' TYR . . . -97.82 -62.57 1.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 110.675 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.527 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.9 p -100.8 3.35 41.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.217 -0.927 . . . . 0.0 111.017 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 2.8 tpp180 61.54 21.64 12.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.198 -0.939 . . . . 0.0 112.046 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.468 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 27.2 p -74.45 165.24 55.28 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.8 -1.188 . . . . 0.0 109.702 179.259 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 44.9 Cg_endo -71.38 142.45 41.03 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.722 1.38 . . . . 0.0 110.335 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 7.4 tttm -48.09 -24.84 1.22 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.012 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.87 -9.73 31.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.932 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.498 ' NE2' ' O ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -92.37 -2.21 56.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.262 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.584 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 3.2 m-85 -89.91 140.04 30.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.297 -0.877 . . . . 0.0 110.443 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 47.1 tttt -129.04 145.13 51.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 109.634 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.616 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 2.7 p -81.48 165.75 20.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.015 -1.053 . . . . 0.0 110.889 -179.638 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 7' ' ' LYS . 3.1 tt -158.6 90.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.759 -0.588 . . . . 0.0 110.024 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -134.54 78.99 1.78 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 110.134 -179.897 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.61 161.89 27.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -0.85 . . . . 0.0 110.21 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.83 80.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 110.2 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 pt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.203 -179.925 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mttm . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.179 0.514 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.666 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 9.3 m-85 -118.7 140.55 49.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 110.58 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.5 tm-20 -119.84 142.62 48.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.811 . . . . 0.0 109.464 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.4 t -77.8 115.58 17.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 0.0 110.299 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -15.68 63.85 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.749 -1.219 . . . . 0.0 108.522 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -60.76 1.95 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.608 -0.682 . . . . 0.0 110.699 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.2 p -108.21 -4.35 17.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.093 . . . . 0.0 110.91 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 82.74 3.53 90.46 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.648 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.715 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 65.3 t80 -49.25 173.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.429 . . . . 0.0 109.255 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.611 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 12.2 mm -144.41 110.6 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.025 -1.047 . . . . 0.0 110.525 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 54.9 t80 -83.69 128.48 34.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.916 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -110.16 121.15 42.47 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.2 Cg_endo -71.8 -34.06 9.35 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.859 1.452 . . . . 0.0 110.239 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.93 -14.78 62.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 0.0 109.902 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -113.26 -18.51 12.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 110.049 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 85.35 170.66 47.4 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.695 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.16 49.96 1.85 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -1.069 . . . . 0.0 109.855 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.97 -54.82 2.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.41 -0.806 . . . . 0.0 110.393 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -47.51 -37.02 11.16 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 110.2 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.1 -65.96 0.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.06 51.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.701 HG23 ' HD2' ' A' ' 29' ' ' PRO . 2.1 mp -133.48 147.38 64.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.277 -1.131 . . . . 0.0 109.888 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.701 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -70.3 161.07 47.33 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.955 1.503 . . . . 0.0 110.255 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.9 Cg_endo -72.03 163.78 37.72 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.01 1.531 . . . . 0.0 110.841 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.03 11.04 85.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 18.0 m -100.41 122.12 50.97 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.299 -1.119 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.903 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.2 Cg_endo -72.49 143.3 38.23 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.873 1.46 . . . . 0.0 110.71 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.666 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 30.5 t80 -54.52 -18.86 4.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.901 . . . . 0.0 109.796 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.903 HG22 ' HB2' ' A' ' 33' ' ' PRO . 15.1 m -70.5 -13.88 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.381 -0.824 . . . . 0.0 109.68 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.8 -7.16 56.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.0 110.363 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.56 HD12 ' CD1' ' A' ' 34' ' ' PHE . 19.2 mt -72.23 148.72 45.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.053 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.486 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -77.35 163.69 26.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.909 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -7.06 21.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.983 . . . . 0.0 110.174 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.06 2.68 35.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.339 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 48.0 t80 -58.72 136.31 57.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.757 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 48' ' ' SER . 30.0 mtt -119.46 145.85 45.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.019 -1.051 . . . . 0.0 110.025 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 34.6 t -58.88 128.28 84.31 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 110.194 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 45.8 Cg_endo -72.14 -10.16 25.49 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.857 1.451 . . . . 0.0 109.775 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.715 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -95.99 -58.78 2.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.467 -0.771 . . . . 0.0 110.452 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.533 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.9 p -108.29 5.38 25.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.882 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.35 17.46 9.42 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.201 -0.937 . . . . 0.0 112.049 178.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.451 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.9 m -70.46 167.93 23.09 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.91 -1.118 . . . . 0.0 109.833 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.2 Cg_endo -72.88 141.46 33.51 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.967 1.509 . . . . 0.0 110.527 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.591 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 7.9 tttm -48.4 -26.33 2.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.886 . . . . 0.0 109.832 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -63.85 -11.1 24.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 109.977 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.79 -1.41 57.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.331 -0.855 . . . . 0.0 109.6 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -88.08 138.66 31.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.519 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -129.03 144.43 51.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -0.84 . . . . 0.0 109.686 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.939 -1.101 . . . . 0.0 110.711 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.205 0.526 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.647 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 31.0 m-85 -124.06 145.64 49.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.976 . . . . 0.0 110.62 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -116.78 139.58 50.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 0.0 109.703 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.0 t -76.91 115.96 17.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.085 -1.01 . . . . 0.0 110.596 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -16.2 64.04 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.955 -1.091 . . . . 0.0 108.583 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.16 -58.73 2.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.571 -0.705 . . . . 0.0 110.654 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.89 -4.02 16.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.053 -1.029 . . . . 0.0 110.932 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.755 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 80.09 7.06 88.86 Favored Glycine 0 N--CA 1.497 2.727 0 O-C-N 121.101 -0.999 . . . . 0.0 111.583 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.704 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 53.8 t80 -59.65 142.81 52.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.758 -1.436 . . . . 0.0 110.051 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -114.94 113.82 44.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.16 -0.962 . . . . 0.0 110.638 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.582 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.8 t80 -82.41 132.21 35.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.833 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.24 116.95 41.7 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 110.3 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -70.38 -26.48 24.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.879 1.463 . . . . 0.0 110.343 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -72.5 -12.47 61.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.365 -0.835 . . . . 0.0 109.784 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -114.25 -39.72 3.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.525 -0.734 . . . . 0.0 109.857 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.67 167.64 22.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.632 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.13 53.75 2.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.559 -0.965 . . . . 0.0 109.819 179.255 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.82 -57.94 1.46 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 110.634 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.527 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 64.7 m-85 -47.61 -34.83 8.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.366 -0.834 . . . . 0.0 110.328 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.5 -65.88 0.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.374 -0.829 . . . . 0.0 110.083 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.22 52.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.632 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -130.76 144.98 55.68 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.213 -1.169 . . . . 0.0 109.93 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.593 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.5 Cg_endo -70.28 161.86 44.45 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.946 1.498 . . . . 0.0 110.533 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.0 Cg_endo -72.94 162.75 40.22 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.05 1.553 . . . . 0.0 110.902 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.98 11.91 85.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 92.2 m -97.02 124.76 48.59 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.223 -1.163 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.669 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.0 Cg_endo -72.77 138.8 29.59 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.799 1.421 . . . . 0.0 110.553 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.582 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 27.6 t80 -52.47 -41.91 63.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 0.0 110.066 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' A' ' 33' ' ' PRO . 15.9 m -53.66 -17.98 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 110.233 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 28.4 t0 -83.9 -7.31 59.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.965 . . . . 0.0 110.391 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.517 HD12 ' CD1' ' A' ' 34' ' ' PHE . 18.6 mt -70.03 154.37 42.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 110.028 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.54 151.42 36.35 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.18 -0.95 . . . . 0.0 109.885 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.95 -14.49 6.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.071 -1.018 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 p -97.65 5.17 49.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 110.381 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.8 t80 -59.68 137.62 57.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.142 -0.974 . . . . 0.0 109.873 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.2 mtt -117.18 143.73 45.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 47' ' ' ARG . 49.4 t -58.88 125.7 78.49 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.0 110.093 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 43.6 Cg_endo -70.61 -10.17 27.32 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.943 1.496 . . . . 0.0 109.93 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.704 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -92.82 -52.51 4.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.468 -0.77 . . . . 0.0 110.294 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.8 p -119.32 8.89 11.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.705 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' CYS . 8.7 ttm-85 62.51 13.52 6.25 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.277 -0.89 . . . . 0.0 112.243 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.495 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 16.6 p -66.0 166.96 13.26 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.886 -1.134 . . . . 0.0 109.921 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.2 Cg_endo -73.0 142.49 34.73 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.679 1.357 . . . . 0.0 110.373 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.545 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 24.2 tttm -49.04 -29.82 5.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 109.951 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -63.89 -10.8 22.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.333 -0.854 . . . . 0.0 109.806 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -87.53 -4.81 58.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.268 -0.895 . . . . 0.0 109.757 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 29.0 m-85 -79.99 132.75 36.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.584 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HB3' ' OE2' ' A' ' 9' ' ' GLU . 42.9 tttt -105.16 130.14 53.4 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.647 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 110.342 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 mttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.234 0.54 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.638 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 29.9 m-85 -123.06 147.14 47.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 0.0 110.647 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 27.3 tt0 -117.24 137.34 52.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.429 -0.794 . . . . 0.0 109.549 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' GLY . 3.3 t -75.87 117.87 18.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.032 -1.042 . . . . 0.0 110.775 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -16.41 63.54 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.901 -1.124 . . . . 0.0 108.46 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.22 -57.68 2.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.672 -0.643 . . . . 0.0 110.48 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.503 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -110.75 -2.98 15.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.092 -1.005 . . . . 0.0 110.927 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.709 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 77.39 8.46 87.06 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.095 -1.003 . . . . 0.0 111.467 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 42.9 t80 -61.1 144.86 52.75 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.903 -1.351 . . . . 0.0 109.838 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -114.85 113.47 43.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.133 -0.979 . . . . 0.0 110.485 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.4 t80 -81.75 127.66 33.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.747 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -106.47 117.69 56.46 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.467 -0.77 . . . . 0.0 110.27 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.9 Cg_endo -70.04 -30.64 20.68 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.937 1.493 . . . . 0.0 110.198 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.04 -11.09 60.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.97 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 6.0 mtpt -110.62 -42.05 4.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 110.051 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.17 165.77 21.28 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.577 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.22 56.39 3.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.516 -0.991 . . . . 0.0 109.893 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.12 -57.23 1.72 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.825 . . . . 0.0 110.809 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 94.8 m-85 -47.13 -33.6 5.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.587 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.67 -64.3 1.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.189 -0.944 . . . . 0.0 110.399 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.0 53.68 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.577 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.1 mp -128.76 144.97 54.39 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.34 -1.094 . . . . 0.0 109.82 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -71.35 160.31 49.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.997 1.524 . . . . 0.0 110.421 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.11 163.16 39.61 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.004 1.529 . . . . 0.0 110.777 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.78 13.01 84.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.6 m -99.98 127.42 33.61 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.205 -1.173 . . . . 0.0 110.214 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 47.8 Cg_endo -73.15 140.15 30.57 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.969 1.51 . . . . 0.0 110.717 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.577 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.5 t80 -52.03 -41.92 62.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.138 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -17.65 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 110.476 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 4.3 t0 -84.07 -7.4 59.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.989 . . . . 0.0 110.249 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 mt -69.35 155.68 40.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.055 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -76.2 148.67 37.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.96 . . . . 0.0 109.785 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -15.81 5.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.996 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.7 5.63 49.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 110.346 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.523 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 54.8 t80 -60.0 139.89 57.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.207 -0.933 . . . . 0.0 109.904 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -118.23 143.31 46.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.07 -1.019 . . . . 0.0 110.027 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 47' ' ' ARG . 48.7 t -58.7 126.23 79.42 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.898 . . . . 0.0 110.139 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.582 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 43.8 Cg_endo -70.97 -10.48 27.67 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.911 1.48 . . . . 0.0 109.898 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -92.89 -52.42 4.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.46 -0.775 . . . . 0.0 110.34 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.6 p -118.98 9.15 11.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.684 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.79 13.72 5.65 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.248 -0.908 . . . . 0.0 112.209 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.5 m -66.47 169.13 8.07 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.832 -1.168 . . . . 0.0 109.878 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 48.0 Cg_endo -74.11 141.79 29.99 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.793 1.417 . . . . 0.0 110.405 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.568 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 26.6 tttm -49.85 -30.9 10.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 109.806 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -62.9 -11.9 21.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -87.16 -3.65 59.07 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.404 -0.81 . . . . 0.0 109.77 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 15.2 m-85 -79.94 132.49 36.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 110.399 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.24 129.46 50.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.009 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.638 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 110.368 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 tttt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.243 0.544 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.663 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 37.6 m-85 -121.37 143.71 49.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.26 -0.9 . . . . 0.0 110.351 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' O ' ' CG ' ' A' ' 54' ' ' LYS . 7.4 mt-10 -117.04 139.83 50.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.366 -0.834 . . . . 0.0 110.374 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -76.31 113.01 13.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.999 -1.063 . . . . 0.0 110.412 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.6 -15.52 61.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.808 -1.183 . . . . 0.0 108.606 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.2 -61.73 1.7 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.565 -0.709 . . . . 0.0 110.634 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.508 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -107.19 -3.25 20.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 110.97 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.791 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.02 7.54 88.39 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.434 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 29.0 t80 -59.49 142.02 53.45 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.836 -1.391 . . . . 0.0 109.692 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.791 HD12 ' O ' ' A' ' 14' ' ' GLY . 1.9 mp -114.6 115.46 49.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 32.1 t80 -83.78 137.82 33.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -116.28 119.76 36.0 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 110.43 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.2 Cg_endo -69.95 -33.24 16.27 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.905 1.476 . . . . 0.0 110.115 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.32 -12.89 61.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.838 . . . . 0.0 109.788 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -14.85 11.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.913 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 79.97 172.91 44.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.656 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.15 49.56 1.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -1.048 . . . . 0.0 109.759 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ASP . 16.8 ttmt -39.7 -59.0 1.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.57 -0.706 . . . . 0.0 110.442 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.549 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 1.1 m-85 -44.51 -32.83 1.52 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.376 -0.827 . . . . 0.0 110.088 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -93.79 -61.92 1.45 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 0.0 110.263 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.28 51.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.656 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -134.01 143.75 48.64 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.286 -1.126 . . . . 0.0 109.944 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.515 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.1 Cg_endo -68.52 160.95 47.11 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.004 1.529 . . . . 0.0 110.277 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 44.2 Cg_endo -71.76 162.93 40.53 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.027 1.541 . . . . 0.0 111.034 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 81.31 13.29 80.89 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 3.7 m -102.97 121.58 48.59 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.24 -1.153 . . . . 0.0 110.136 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.772 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.1 Cg_endo -72.52 135.11 23.59 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.799 1.42 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 8.0 t80 -47.89 -39.91 20.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.281 -0.887 . . . . 0.0 110.161 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 33' ' ' PRO . 10.6 m -53.54 -22.12 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.401 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 21.2 t0 -84.31 -5.79 59.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 110.367 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.511 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 17.0 mt -72.31 123.34 22.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 110.271 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 7.2 m -41.4 151.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -0.828 . . . . 0.0 110.205 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -63.91 -10.0 18.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -100.02 5.38 45.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.579 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.504 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 55.5 t80 -59.77 138.05 57.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.791 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.0 mtm -122.46 148.06 45.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.978 -1.076 . . . . 0.0 109.936 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 2.0 t -55.75 129.95 71.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 110.5 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.549 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -72.59 -12.55 26.97 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 123.835 1.439 . . . . 0.0 109.114 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.24 -67.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.592 -0.692 . . . . 0.0 110.667 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.508 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.7 p -93.82 1.18 56.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 111.113 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 2.6 ttm180 61.06 31.12 19.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.083 -1.011 . . . . 0.0 111.764 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.4 m -85.01 168.62 19.7 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.775 -1.203 . . . . 0.0 109.883 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.1 Cg_endo -72.42 138.84 30.64 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.959 1.505 . . . . 0.0 110.457 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.614 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 20.9 tttm -51.0 -31.16 17.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.047 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -63.33 -12.11 27.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 109.73 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -85.04 -5.96 59.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.73 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.614 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 23.2 m-85 -79.99 137.96 36.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 110.553 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.508 ' CG ' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -109.71 132.75 53.86 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.384 -0.823 . . . . 0.0 108.997 178.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.663 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.6 0 O-C-N 121.072 -1.018 . . . . 0.0 110.443 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 tttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.609 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 30.7 m-85 -128.92 146.69 50.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.125 -0.984 . . . . 0.0 110.808 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 4.0 mt-10 -116.95 143.2 45.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 0.0 109.578 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 4.3 t -78.13 114.38 16.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.913 -1.117 . . . . 0.0 110.709 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.32 -15.68 63.83 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.915 -1.116 . . . . 0.0 108.41 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -59.62 2.28 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.728 -0.608 . . . . 0.0 110.712 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -109.13 -4.87 16.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.976 -1.078 . . . . 0.0 110.972 -178.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.682 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 84.27 3.63 88.63 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.957 -1.089 . . . . 0.0 111.728 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.848 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 77.7 t80 -52.46 174.34 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.748 -1.443 . . . . 0.0 109.564 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.682 HD12 ' O ' ' A' ' 14' ' ' GLY . 1.2 mp -148.12 110.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.991 . . . . 0.0 110.227 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 49.0 t80 -81.21 123.47 28.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.829 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -107.87 116.91 56.49 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 110.197 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.8 Cg_endo -70.05 -27.46 25.08 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.812 1.427 . . . . 0.0 110.401 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -73.07 -15.18 61.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.342 -0.849 . . . . 0.0 109.998 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 -12.06 12.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.788 . . . . 0.0 109.973 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 80.99 165.74 34.48 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.683 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.21 50.16 1.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -1.064 . . . . 0.0 109.897 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.78 -51.62 2.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.5 -0.75 . . . . 0.0 110.374 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -49.41 -38.7 30.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.385 -0.822 . . . . 0.0 110.28 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.64 -67.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -0.881 . . . . 0.0 110.404 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.73 51.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.825 HG21 HG21 ' A' ' 32' ' ' THR . 2.1 mp -133.69 147.09 63.08 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.27 -1.135 . . . . 0.0 109.921 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.705 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.9 Cg_endo -71.42 165.49 32.31 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.987 1.519 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.9 Cg_endo -72.04 162.51 41.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.96 1.505 . . . . 0.0 110.832 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.81 12.49 82.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.825 HG21 HG21 ' A' ' 28' ' ' ILE . 21.7 m -92.32 122.97 63.67 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -1.139 . . . . 0.0 110.19 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.99 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.5 Cg_endo -72.7 139.07 30.25 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.879 1.463 . . . . 0.0 110.651 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.588 ' CE2' ' HE2' ' A' ' 50' ' ' LYS . 79.8 t80 -55.9 -17.78 7.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.887 . . . . 0.0 109.819 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.99 HG22 ' HB2' ' A' ' 33' ' ' PRO . 14.2 m -73.78 -7.47 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.67 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -95.31 -7.58 38.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 110.383 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.553 HD12 ' CD1' ' A' ' 34' ' ' PHE . 18.3 mt -70.94 147.61 48.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.97 . . . . 0.0 109.978 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.7 m -75.49 155.41 36.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.843 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -58.7 -14.19 7.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.129 -0.982 . . . . 0.0 110.268 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.23 5.43 50.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 110.55 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.527 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.6 t80 -59.01 135.74 57.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.682 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.0 mtp -118.24 146.05 44.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.057 -1.027 . . . . 0.0 110.351 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 47' ' ' ARG . 42.5 t -61.22 124.27 79.67 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.408 -0.808 . . . . 0.0 110.097 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.602 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.0 Cg_endo -70.48 -7.87 22.29 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.883 1.465 . . . . 0.0 109.823 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.848 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -94.0 -54.84 3.44 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.477 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 10.3 p -115.99 7.02 14.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.438 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 43' ' ' CYS . 6.0 ttm180 63.21 15.94 9.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.241 -0.912 . . . . 0.0 112.171 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 20.6 p -68.64 166.56 25.51 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 0.0 109.811 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.2 Cg_endo -72.29 142.01 36.66 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.733 1.386 . . . . 0.0 110.495 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.588 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 10.5 tttm -48.51 -28.47 3.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 109.961 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.99 -10.42 21.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -0.87 . . . . 0.0 109.886 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -88.66 -4.19 58.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.276 -0.89 . . . . 0.0 109.695 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 19.1 m-85 -80.18 132.34 35.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 110.589 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.48 128.83 53.77 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.609 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.567 0 O-C-N 121.059 -1.026 . . . . 0.0 110.02 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.199 0.523 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.614 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 22.4 m-85 -120.05 146.99 45.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.295 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 70.7 tt0 -121.4 139.89 52.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.7 t -77.11 117.01 18.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.025 . . . . 0.0 110.398 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -68.07 -16.53 64.06 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.785 -1.197 . . . . 0.0 108.617 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.13 -59.14 2.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.637 -0.664 . . . . 0.0 110.574 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.37 -3.76 16.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.006 -1.059 . . . . 0.0 110.918 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.4 6.13 89.02 Favored Glycine 0 N--CA 1.496 2.696 0 O-C-N 121.081 -1.012 . . . . 0.0 111.43 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 17.7 t80 -56.79 144.2 33.9 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.927 -1.337 . . . . 0.0 109.829 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 13.3 mm -115.99 111.27 34.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.651 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.9 t80 -81.24 121.42 26.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.835 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -101.84 118.48 59.38 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.251 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -72.0 -29.25 15.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.968 1.509 . . . . 0.0 110.166 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.08 -9.23 58.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 110.224 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.5 mmmp? -111.81 -45.48 3.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.273 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.52 159.57 12.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.553 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.19 55.18 3.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -1.06 . . . . 0.0 109.882 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.54 -51.59 2.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 110.499 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 65.3 m-85 -51.25 -37.95 49.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.844 . . . . 0.0 110.294 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.54 -68.52 0.78 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 110.183 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.43 53.85 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.651 ' CG2' HG21 ' A' ' 32' ' ' THR . 1.4 mp -131.84 143.37 48.8 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.232 -1.158 . . . . 0.0 109.949 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -72.0 168.67 23.32 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.012 1.533 . . . . 0.0 110.36 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.2 Cg_endo -72.25 161.38 44.65 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.889 1.468 . . . . 0.0 110.88 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.67 15.47 80.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.651 HG21 ' CG2' ' A' ' 28' ' ' ILE . 31.4 m -95.54 122.59 58.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.263 -1.139 . . . . 0.0 110.227 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.785 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -73.26 138.72 28.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.862 1.454 . . . . 0.0 110.58 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.584 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 13.7 t80 -53.13 -40.18 64.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.115 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.785 HG22 ' HB2' ' A' ' 33' ' ' PRO . 11.4 m -53.77 -18.09 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 110.177 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.51 -7.16 59.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.107 -0.996 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.485 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.2 mt -71.86 151.87 43.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.944 . . . . 0.0 110.077 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -76.95 158.68 30.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -10.85 15.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 0.0 110.158 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 4.12 45.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.398 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.483 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 50.0 t80 -59.47 134.73 57.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -0.945 . . . . 0.0 109.845 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -118.81 146.86 44.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.048 -1.033 . . . . 0.0 109.853 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.9 t -56.89 130.01 78.48 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 110.422 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.531 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -72.05 -11.85 27.61 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.865 1.455 . . . . 0.0 109.51 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.42 -64.9 1.0 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 110.751 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.534 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.3 p -98.69 3.34 47.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 0.0 111.109 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 6.0 ttm180 62.09 21.68 12.56 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.05 -1.031 . . . . 0.0 111.994 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.7 m -74.98 168.24 29.36 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.776 -1.202 . . . . 0.0 109.931 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.5 Cg_endo -73.53 141.87 32.0 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.917 1.483 . . . . 0.0 110.561 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 41.3 tttm -50.19 -30.24 11.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.005 . . . . 0.0 109.968 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.04 -12.46 19.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.28 -0.888 . . . . 0.0 109.872 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -88.44 -2.37 58.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.279 -0.888 . . . . 0.0 109.798 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -86.15 139.1 31.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 110.688 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 138.24 54.37 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.0 t . . . . . 0 C--N 1.301 -1.525 0 O-C-N 120.66 -1.275 . . . . 0.0 110.787 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.6 mttt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.195 0.521 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.625 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.2 m-85 -118.37 138.41 52.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 110.701 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -116.04 140.25 49.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.436 -0.79 . . . . 0.0 109.554 179.321 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.7 t -75.93 115.55 15.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.954 . . . . 0.0 110.148 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -16.12 63.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.789 -1.194 . . . . 0.0 108.684 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.16 -60.8 1.93 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.593 -0.692 . . . . 0.0 110.552 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.2 p -108.31 -2.97 18.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.001 . . . . 0.0 111.001 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.723 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 78.65 6.95 88.33 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.013 -1.054 . . . . 0.0 111.418 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 4.8 t80 -58.16 142.76 46.32 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.968 -1.313 . . . . 0.0 109.695 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.723 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -110.53 113.62 44.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.481 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 50.9 t80 -82.89 121.29 26.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 109.882 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -100.0 118.24 61.93 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 110.318 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -71.32 -35.93 7.72 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.82 1.432 . . . . 0.0 110.114 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -71.62 -10.51 59.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.801 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 -12.83 13.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.971 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.502 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 76.54 170.84 32.29 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.57 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 1.8 t70 -85.28 59.02 5.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.455 -1.026 . . . . 0.0 109.66 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -36.92 -62.99 0.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.555 -0.716 . . . . 0.0 110.699 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.538 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 18.5 m-85 -42.46 -27.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 110.32 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -101.04 -58.2 1.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.434 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.87 -10.07 1.2 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.185 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.558 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -61.27 141.2 94.27 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.061 -1.258 . . . . 0.0 109.73 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.9 Cg_endo -69.75 160.52 49.42 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.899 1.473 . . . . 0.0 110.665 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 45.1 Cg_endo -72.43 165.42 32.73 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.075 1.566 . . . . 0.0 110.702 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.15 12.83 83.23 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 20.4 m -103.79 126.33 32.18 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -1.144 . . . . 0.0 110.128 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.764 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.3 Cg_endo -73.11 142.92 35.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.889 1.468 . . . . 0.0 110.54 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.575 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.1 t80 -51.3 -36.39 42.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.885 . . . . 0.0 110.142 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.764 HG22 ' HB2' ' A' ' 33' ' ' PRO . 12.5 m -54.32 -17.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -84.36 -7.41 59.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 110.303 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.572 HD12 ' CD2' ' A' ' 34' ' ' PHE . 38.3 mt -71.22 152.79 42.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 110.076 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.461 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 1.4 m -80.15 167.85 19.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.95 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -73.59 -0.73 16.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 110.187 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 t -109.8 -0.12 18.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.168 -0.957 . . . . 0.0 110.387 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.57 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.9 t80 -59.7 138.69 57.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 109.791 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 48' ' ' SER . 11.4 mtt -120.93 145.77 47.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.129 -0.982 . . . . 0.0 110.051 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.472 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 12.9 t -55.53 131.35 71.05 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.838 . . . . 0.0 110.114 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.538 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 47.0 Cg_endo -73.38 -13.32 25.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.923 1.486 . . . . 0.0 109.609 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.78 -59.42 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.775 . . . . 0.0 110.95 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.526 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.0 p -105.15 5.06 31.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 111.076 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER 61.79 17.8 9.13 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.195 -0.94 . . . . 0.0 112.251 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 21.4 p -70.29 165.96 39.1 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.161 . . . . 0.0 109.672 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 45.8 Cg_endo -72.23 142.71 38.18 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.692 1.364 . . . . 0.0 110.388 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.548 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 27.3 tttm -48.78 -27.72 3.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 109.927 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.96 -11.18 26.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.35 -0.844 . . . . 0.0 109.825 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.3 mm-40 -89.84 -2.96 58.32 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.379 -0.825 . . . . 0.0 109.589 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 24.3 m-85 -87.7 139.22 30.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -132.08 147.88 52.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.651 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 3.2 p . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.023 . . . . 0.0 110.468 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.143 0.497 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 16.6 m-85 -123.55 152.91 41.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.207 -0.933 . . . . 0.0 110.405 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -125.64 141.19 52.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.418 -0.801 . . . . 0.0 109.527 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 5.0 t -78.01 117.32 19.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.506 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -16.36 63.92 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.595 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.12 -59.56 2.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.683 -0.636 . . . . 0.0 110.595 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.28 -3.91 16.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.992 -1.067 . . . . 0.0 110.775 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.766 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.95 5.67 89.44 Favored Glycine 0 N--CA 1.497 2.707 0 O-C-N 121.136 -0.977 . . . . 0.0 111.587 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 41.7 t80 -57.13 144.47 34.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.862 -1.375 . . . . 0.0 109.937 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.766 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -115.96 111.28 34.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.23 -0.919 . . . . 0.0 110.601 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 38.3 t80 -80.83 123.17 28.03 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.264 -0.897 . . . . 0.0 109.574 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -106.95 116.73 58.1 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 110.226 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' THR . 44.3 Cg_endo -71.19 -24.97 22.76 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.792 1.417 . . . . 0.0 110.24 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -73.14 -9.94 59.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.08 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.1 tttp -114.78 -43.26 3.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.125 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.98 159.51 13.13 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.556 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.09 55.18 3.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.445 -1.032 . . . . 0.0 109.94 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.74 -50.16 3.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.596 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 26.1 m-85 -52.12 -39.25 59.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 110.354 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.55 -69.22 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.213 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.28 54.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.69 HG21 HG21 ' A' ' 32' ' ' THR . 1.4 mp -131.0 144.22 52.68 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.236 -1.156 . . . . 0.0 110.04 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.599 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -71.39 166.63 28.72 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.015 1.534 . . . . 0.0 110.505 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.3 Cg_endo -72.34 161.9 43.07 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.915 1.481 . . . . 0.0 110.819 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 73.58 13.65 80.1 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.69 HG21 HG21 ' A' ' 28' ' ' ILE . 16.9 m -94.69 121.97 61.78 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.266 -1.138 . . . . 0.0 110.19 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.79 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.3 Cg_endo -71.89 141.4 36.96 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.81 1.426 . . . . 0.0 110.669 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.749 ' CD1' HD12 ' A' ' 37' ' ' LEU . 85.5 t80 -56.06 -18.1 8.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 33' ' ' PRO . 4.3 m -70.63 -11.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.38 -0.825 . . . . 0.0 109.47 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -89.35 -6.87 56.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.503 -0.748 . . . . 0.0 110.265 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.749 HD12 ' CD1' ' A' ' 34' ' ' PHE . 19.1 mt -73.63 144.75 45.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.143 -0.973 . . . . 0.0 110.044 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.2 t -75.46 160.38 30.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 110.096 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -62.27 -11.55 15.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.217 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.17 4.89 46.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.359 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.526 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 51.8 t80 -59.89 135.58 57.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.119 -0.988 . . . . 0.0 109.876 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -118.78 146.49 44.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.066 -1.022 . . . . 0.0 109.868 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.6 t -55.93 131.61 73.5 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.579 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 44.6 Cg_endo -72.4 -12.61 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.901 1.474 . . . . 0.0 109.585 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.88 -65.74 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.502 -0.749 . . . . 0.0 110.866 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.6 p -96.62 2.87 52.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 0.0 111.205 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HB3' ' O ' ' A' ' 46' ' ' CYS . 0.1 OUTLIER 61.88 22.37 12.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.133 -0.979 . . . . 0.0 111.997 178.635 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.9 m -75.73 168.16 30.22 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.786 -1.196 . . . . 0.0 109.92 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.1 Cg_endo -73.37 141.91 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.796 1.419 . . . . 0.0 110.494 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 11.9 tttm -50.17 -29.3 8.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 1.9 m-20 -62.4 -12.36 21.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.874 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -89.54 -1.58 58.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.284 -0.885 . . . . 0.0 109.727 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 3.2 m-85 -85.71 137.75 32.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.921 . . . . 0.0 110.421 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.42 137.99 54.47 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.0 t . . . . . 0 C--N 1.3 -1.565 0 O-C-N 120.761 -1.212 . . . . 0.0 110.454 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.228 0.537 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 9.8 m-85 -115.57 138.46 51.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 110.44 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.0 mt-10 -117.98 140.24 50.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 109.561 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 14' ' ' GLY . 5.3 t -77.14 115.77 17.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 110.283 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -16.19 63.96 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.773 -1.205 . . . . 0.0 108.638 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.12 -60.68 1.97 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.6 -0.687 . . . . 0.0 110.689 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.21 -3.72 18.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.067 -1.02 . . . . 0.0 110.909 -179.034 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.773 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 80.14 6.02 89.38 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.059 -1.025 . . . . 0.0 111.591 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 41.9 t80 -57.53 143.2 41.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.798 -1.413 . . . . 0.0 109.872 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.773 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -114.34 112.93 42.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.231 -0.918 . . . . 0.0 110.752 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 38.2 t80 -81.49 125.16 30.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.562 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -101.12 117.58 62.02 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.468 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.466 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 43.1 Cg_endo -71.24 -36.38 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.877 1.462 . . . . 0.0 109.98 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -9.69 54.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 109.747 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE3' ' HE3' ' A' ' 24' ' ' LYS . 1.7 tmtm? -117.09 -17.55 10.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.474 -0.766 . . . . 0.0 109.724 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.486 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 83.19 172.61 48.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.744 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -85.12 49.81 1.82 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -1.04 . . . . 0.0 109.784 179.13 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.9 ttmt -39.3 -58.32 1.23 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.535 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.0 -33.08 1.89 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.55 -62.68 1.32 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.901 . . . . 0.0 110.243 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.16 51.16 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.744 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -131.22 146.82 63.69 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.238 -1.154 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.648 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.5 Cg_endo -69.78 155.44 65.86 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.891 1.469 . . . . 0.0 110.228 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.486 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 44.0 Cg_endo -71.17 165.34 32.71 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.871 1.458 . . . . 0.0 110.788 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 79.03 11.28 85.33 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 13.0 m -103.51 125.44 34.89 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.294 -1.121 . . . . 0.0 110.193 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.736 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.7 Cg_endo -73.06 142.29 34.23 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.87 1.458 . . . . 0.0 110.473 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 31.7 t80 -51.92 -39.2 58.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 110.033 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 33' ' ' PRO . 11.4 m -55.14 -17.08 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.424 -0.797 . . . . 0.0 110.119 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 8.9 t70 -84.22 -6.87 59.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 110.253 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.509 HD13 ' CD1' ' A' ' 41' ' ' PHE . 17.9 mt -72.26 155.71 39.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 109.937 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.7 t -78.74 164.23 24.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.922 . . . . 0.0 110.071 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -5.88 21.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.9 m -103.4 1.49 32.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.203 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 37' ' ' LEU . 41.2 t80 -58.53 133.7 56.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.048 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' SER . 4.6 mtm -120.84 147.54 45.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 109.965 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.5 t -56.34 128.38 73.15 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.357 -0.84 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.535 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.1 Cg_endo -70.84 -11.42 29.41 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.785 1.413 . . . . 0.0 109.267 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.23 -67.95 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.487 -0.758 . . . . 0.0 110.663 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.533 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.7 p -94.53 2.06 55.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 111.06 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.56 23.78 14.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.143 -0.973 . . . . 0.0 111.892 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 52' ' ' GLN . 2.2 t -75.79 160.72 78.26 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.755 -1.216 . . . . 0.0 109.909 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 43.2 Cg_endo -69.85 144.39 53.38 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.677 1.356 . . . . 0.0 110.323 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.567 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 18.3 tttm -49.22 -26.7 3.1 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.292 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -64.07 -11.62 31.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.896 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.523 ' CB ' ' OG ' ' A' ' 48' ' ' SER . 1.3 tm0? -91.96 -0.85 57.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.616 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 8.3 m-85 -89.54 138.77 31.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.683 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -128.1 143.6 51.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 109.522 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.67 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.7 p . . . . . 0 N--CA 1.492 1.651 0 O-C-N 120.885 -1.135 . . . . 0.0 110.923 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.211 0.529 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.676 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 13.8 m-85 -116.5 143.9 45.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.94 . . . . 0.0 110.424 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -121.34 139.11 53.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.942 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.8 t -76.53 116.85 17.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.95 . . . . 0.0 110.327 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.09 -16.19 63.91 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.732 -1.23 . . . . 0.0 108.566 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -59.68 2.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.602 -0.686 . . . . 0.0 110.566 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.83 -3.45 17.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.967 -1.083 . . . . 0.0 110.916 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.06 6.11 88.88 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.343 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 42.2 t80 -56.29 143.62 33.32 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.875 -1.368 . . . . 0.0 109.796 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 14.9 mm -115.39 111.56 36.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.325 -0.859 . . . . 0.0 110.639 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 44.1 t80 -81.13 122.56 27.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.828 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -101.97 117.18 62.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 110.243 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.6 Cg_endo -71.8 -31.1 13.41 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.849 1.447 . . . . 0.0 110.234 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.4 -5.06 25.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.159 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -120.38 -38.45 2.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.81 167.42 23.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -85.15 56.13 3.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.969 . . . . 0.0 109.894 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -40.14 -58.58 1.43 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.776 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.605 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 2.2 t80 -48.01 -32.94 7.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.594 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -92.25 -65.4 1.01 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.082 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.25 53.34 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.572 HG23 ' HD2' ' A' ' 29' ' ' PRO . 1.2 mp -131.02 144.71 54.67 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.286 -1.126 . . . . 0.0 109.817 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -71.11 162.4 42.74 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.929 1.489 . . . . 0.0 110.425 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.29 163.44 38.66 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.91 1.479 . . . . 0.0 110.772 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.24 14.81 82.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -100.74 124.31 42.63 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.268 -1.137 . . . . 0.0 110.197 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.699 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.0 Cg_endo -73.32 140.38 30.43 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.92 1.484 . . . . 0.0 110.551 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.676 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 18.4 t80 -53.58 -40.38 65.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.361 -0.837 . . . . 0.0 110.319 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.699 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.1 m -53.86 -18.3 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.408 -0.808 . . . . 0.0 110.368 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 1.2 t0 -85.61 -6.81 59.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.394 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.435 HD13 ' CD1' ' A' ' 41' ' ' PHE . 16.2 mt -73.15 121.95 21.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 37' ' ' LEU . 47.4 t -42.02 155.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 110.381 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -9.19 21.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 110.292 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -98.26 4.6 48.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.333 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.513 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 46.1 t80 -59.72 136.31 57.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 110.222 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.466 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.9 mtp -120.33 145.7 46.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 109.69 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.5 t -54.82 131.81 66.21 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 110.333 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.605 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 45.5 Cg_endo -72.61 -13.88 27.35 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.899 1.473 . . . . 0.0 109.534 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.99 -65.29 0.97 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.486 -0.758 . . . . 0.0 110.908 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.526 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.5 p -96.28 2.91 53.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 111.167 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 3.1 ttm180 61.59 22.49 12.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.123 -0.986 . . . . 0.0 111.963 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.4 m -74.49 167.3 37.34 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.826 -1.172 . . . . 0.0 109.923 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 47.4 Cg_endo -73.51 142.96 33.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.946 1.498 . . . . 0.0 110.433 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 21.9 tttm -49.93 -30.08 9.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.53 ' ND2' ' HB2' ' A' ' 49' ' ' PRO . 26.5 p30 -62.9 -11.74 20.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.119 -0.988 . . . . 0.0 109.968 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.2 mm-40 -89.27 -2.52 58.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.885 . . . . 0.0 109.54 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 7.3 m-85 -87.04 139.29 30.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.398 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -123.54 140.56 52.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.166 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 35.0 p . . . . . 0 N--CA 1.489 1.52 0 O-C-N 120.836 -1.165 . . . . 0.0 111.266 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HG2' ' HD2' ' A' ' 19' ' ' PRO . 12.5 mttm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.244 0.545 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 21.2 m-85 -123.8 148.84 46.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 83.6 tt0 -122.85 142.7 50.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 109.535 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.5 t -79.39 115.74 19.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 110.645 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -15.28 63.52 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.372 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.25 -60.93 1.89 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.631 -0.668 . . . . 0.0 110.555 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -107.94 -4.74 17.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.957 -1.089 . . . . 0.0 110.717 -178.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 82.62 3.1 90.65 Favored Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.101 -0.999 . . . . 0.0 111.417 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.544 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . 89.6 t80 -49.53 172.39 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.854 -1.38 . . . . 0.0 109.421 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.501 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 10.4 mm -146.13 108.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.04 -1.038 . . . . 0.0 110.396 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.3 t80 -81.55 129.03 34.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 110.011 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -111.68 118.29 47.15 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 110.263 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -71.85 -29.29 15.57 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.885 1.466 . . . . 0.0 110.309 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -71.59 -10.61 60.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.007 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 6.2 mttt -115.68 -39.65 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.381 -0.824 . . . . 0.0 110.003 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.46 164.59 20.95 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.558 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -85.1 55.76 3.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -1.075 . . . . 0.0 109.844 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -41.1 -54.41 2.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.359 -0.838 . . . . 0.0 110.504 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 97.8 m-85 -49.63 -36.71 25.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.398 -0.814 . . . . 0.0 110.42 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.56 -67.47 0.85 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.04 54.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.558 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -133.36 141.73 41.59 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 109.98 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.7 Cg_endo -69.96 165.11 32.3 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.018 1.536 . . . . 0.0 110.432 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.0 Cg_endo -71.92 162.77 40.91 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.039 1.547 . . . . 0.0 110.841 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.11 12.04 84.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.8 m -98.87 123.2 50.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.286 -1.126 . . . . 0.0 110.232 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.644 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.89 143.48 36.87 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.924 1.486 . . . . 0.0 110.75 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.583 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 7.7 t80 -57.54 -15.86 8.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.902 . . . . 0.0 110.041 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 33' ' ' PRO . 3.9 m -69.97 -26.21 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.73 -5.51 55.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.41 -0.806 . . . . 0.0 110.409 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.434 HD13 ' CD1' ' A' ' 41' ' ' PHE . 11.1 mt -74.1 115.61 13.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.234 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 37' ' ' LEU . 63.9 m -41.68 151.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 110.378 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.64 -12.88 11.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 110.123 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 t -95.93 8.05 44.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.422 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.52 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.8 t80 -61.0 138.56 58.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.02 . . . . 0.0 109.894 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.2 mtt -121.34 147.48 45.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.031 . . . . 0.0 109.731 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.9 t -56.56 131.67 77.32 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 110.509 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 45.3 Cg_endo -72.42 -12.45 27.3 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.797 1.42 . . . . 0.0 109.561 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.5 -67.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 110.822 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.6 p -93.59 1.4 56.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.06 -1.025 . . . . 0.0 111.097 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.96 24.34 14.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.171 -0.956 . . . . 0.0 111.932 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 42' ' ' MET . 4.1 m -77.67 167.94 31.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.828 -1.17 . . . . 0.0 109.835 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.9 Cg_endo -72.64 140.92 33.44 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.801 1.422 . . . . 0.0 110.481 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.549 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 11.2 tttm -49.28 -27.21 3.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.005 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -63.14 -11.86 23.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.956 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.3 mm-40 -90.72 -0.86 57.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.292 -0.88 . . . . 0.0 109.604 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -87.12 137.88 31.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.656 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -119.79 136.34 54.49 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.6 t . . . . . 0 C--N 1.3 -1.586 0 O-C-N 120.724 -1.235 . . . . 0.0 110.81 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.5 m-85 -118.43 142.1 47.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.953 . . . . 0.0 110.8 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 6.6 tm-20 -119.22 140.26 50.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -0.809 . . . . 0.0 109.439 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' GLY . 5.0 t -76.57 116.75 17.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.15 -0.969 . . . . 0.0 110.233 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -16.59 64.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.767 -1.208 . . . . 0.0 108.713 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -59.8 2.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.578 -0.702 . . . . 0.0 110.599 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.95 -3.46 17.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.031 -1.043 . . . . 0.0 110.966 -179.032 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.762 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.37 6.29 88.97 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.153 -1.022 . . . . 0.0 111.458 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 40.5 t80 -57.57 143.59 40.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.918 -1.342 . . . . 0.0 109.698 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -114.17 112.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.281 -0.887 . . . . 0.0 110.647 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 33.9 t80 -82.21 128.05 33.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.651 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -109.49 117.2 53.36 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.872 . . . . 0.0 110.184 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 43.8 Cg_endo -71.28 -28.97 17.74 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.827 1.435 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.78 -5.83 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 110.053 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -119.82 -39.13 2.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 110.185 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.19 166.13 22.11 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.56 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -85.12 54.61 3.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -1.043 . . . . 0.0 109.899 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASP . 18.4 mmtt -39.74 -56.66 1.68 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.378 -0.826 . . . . 0.0 110.695 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 65.2 m-85 -47.34 -33.91 6.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.98 -64.63 1.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 110.484 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.98 52.83 0.02 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.574 HG23 ' HD2' ' A' ' 29' ' ' PRO . 1.2 mp -129.11 145.22 55.79 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.274 -1.133 . . . . 0.0 109.82 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.574 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.6 Cg_endo -70.95 160.95 47.74 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.948 1.499 . . . . 0.0 110.43 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.446 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.6 Cg_endo -71.9 163.27 39.39 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.963 1.507 . . . . 0.0 110.765 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.11 15.34 81.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 26.7 m -102.46 124.2 40.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.265 -1.138 . . . . 0.0 110.254 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 48.0 Cg_endo -73.65 140.26 29.25 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.874 1.46 . . . . 0.0 110.561 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.59 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.7 t80 -50.42 -41.04 51.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.035 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.52 -17.14 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 110.266 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -84.42 -7.06 59.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.24 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 41' ' ' PHE . 17.8 mt -71.65 155.86 40.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.952 . . . . 0.0 110.044 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 156.59 30.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.9 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -11.33 13.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.136 -0.978 . . . . 0.0 110.363 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.2 m -99.64 3.87 45.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.946 . . . . 0.0 110.418 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.56 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 44.8 t80 -59.68 136.37 57.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 109.964 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 48' ' ' SER . 6.8 mtt -120.0 146.37 45.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.077 -1.015 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.9 t -55.94 130.62 73.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 110.319 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.525 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.9 Cg_endo -71.99 -12.7 28.51 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.875 1.461 . . . . 0.0 109.526 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.35 -64.26 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.453 -0.779 . . . . 0.0 110.842 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.54 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.8 p -98.77 3.76 47.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 111.173 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.7 OUTLIER 61.69 20.53 11.42 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.111 -0.993 . . . . 0.0 112.036 178.522 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.6 m -73.05 167.31 35.42 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.769 -1.207 . . . . 0.0 109.786 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.3 Cg_endo -73.21 142.78 34.5 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.863 1.454 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 22.8 tttm -49.37 -27.67 4.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 109.834 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -63.04 -12.2 24.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.873 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -90.27 -1.8 57.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.612 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 15.5 m-85 -88.53 139.65 30.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 110.379 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -130.74 146.27 52.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.702 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 p . . . . . 0 N--CA 1.491 1.596 0 O-C-N 120.908 -1.12 . . . . 0.0 110.44 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 tptm . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.137 0.494 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.0 m-85 -117.78 139.5 50.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 110.661 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.585 ' HA ' HD13 ' A' ' 16' ' ' ILE . 14.3 pt-20 -116.76 139.18 50.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.308 -0.87 . . . . 0.0 109.615 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -76.55 117.03 17.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 110.426 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -16.3 64.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.868 -1.145 . . . . 0.0 108.668 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.2 -59.49 2.31 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.649 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.93 -3.49 17.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.951 -179.032 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 78.28 7.74 87.71 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 30.6 t80 -58.76 142.56 49.76 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.807 -1.408 . . . . 0.0 109.636 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.585 HD13 ' HA ' ' A' ' 9' ' ' GLU . 24.5 mm -113.8 114.75 47.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.274 -0.891 . . . . 0.0 110.777 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 24.6 t80 -83.22 133.03 35.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 109.719 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -110.89 119.43 46.05 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 110.224 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -71.31 -34.51 9.73 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.861 1.453 . . . . 0.0 110.217 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -70.06 -6.76 36.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.398 -0.814 . . . . 0.0 110.028 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 14.5 tttt -117.96 -36.45 3.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.109 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.92 171.53 28.81 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.549 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 1.7 t70 -85.31 57.98 4.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.515 -0.991 . . . . 0.0 109.767 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ASP . 1.1 tptt -37.58 -63.0 0.48 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.554 -0.716 . . . . 0.0 110.727 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.556 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 17.7 m-85 -43.27 -27.13 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.393 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.26 -58.42 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.267 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.92 -7.52 1.06 Allowed Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.495 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.549 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.8 mp -64.93 142.27 98.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.344 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.543 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.2 Cg_endo -71.61 162.49 42.01 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.997 1.524 . . . . 0.0 110.611 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -72.59 163.86 37.28 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.991 1.522 . . . . 0.0 110.775 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.53 13.37 83.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 60.5 m -105.75 126.59 30.36 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.274 -1.133 . . . . 0.0 110.168 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.786 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -72.56 142.15 35.86 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.839 1.442 . . . . 0.0 110.603 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.581 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 2.9 t80 -53.21 -38.71 63.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.133 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.786 HG22 ' HB2' ' A' ' 33' ' ' PRO . 20.3 m -54.76 -17.68 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 110.051 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -83.12 -6.17 59.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 37' ' ' LEU . 22.3 mt -70.23 156.34 39.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.58 162.63 25.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.872 . . . . 0.0 109.858 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -69.97 -3.91 18.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.252 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.0 m -106.7 0.67 24.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.542 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 44.7 t80 -59.98 136.58 58.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.978 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 48' ' ' SER . 21.7 mtp -119.62 146.06 45.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.12 -0.988 . . . . 0.0 109.908 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.4 t -54.86 129.64 65.46 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.266 -0.896 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.6 Cg_endo -71.27 -13.53 30.88 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.819 1.431 . . . . 0.0 109.47 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.98 -63.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.752 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.4 p -98.84 3.78 47.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.192 -0.942 . . . . 0.0 111.156 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.24 21.37 11.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.165 -0.96 . . . . 0.0 112.087 178.597 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.5 m -73.93 166.9 40.33 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.828 -1.17 . . . . 0.0 109.808 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.7 Cg_endo -72.91 142.68 35.43 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.818 1.431 . . . . 0.0 110.33 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.549 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 7.4 tttt -49.58 -25.64 2.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -66.26 -11.86 52.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.793 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -89.05 -3.23 58.75 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.35 -0.844 . . . . 0.0 109.492 179.279 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.522 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 4.6 m-85 -88.62 140.56 29.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.433 -0.792 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 5.1 mttt -129.89 146.35 51.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.491 1.584 0 O-C-N 120.936 -1.103 . . . . 0.0 110.705 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 55' ' ' SER . 9.4 mttt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.625 ' CE1' ' HB3' ' A' ' 55' ' ' SER . 9.3 m-85 -121.12 137.82 54.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 111.089 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.517 ' HA ' HD13 ' A' ' 16' ' ' ILE . 83.2 tt0 -118.43 145.64 45.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.0 109.393 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 6.6 t -79.05 115.21 18.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.05 -1.031 . . . . 0.0 110.442 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.76 -15.23 63.41 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.508 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -61.14 1.84 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.703 -0.623 . . . . 0.0 110.771 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -108.39 -5.04 16.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.03 -1.044 . . . . 0.0 111.102 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.424 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 83.99 3.01 89.4 Favored Glycine 0 N--CA 1.497 2.75 0 O-C-N 120.973 -1.08 . . . . 0.0 111.419 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 29.3 t80 -50.64 173.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.827 -1.396 . . . . 0.0 109.17 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 12.1 mm -144.31 132.81 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.924 -1.11 . . . . 0.0 110.684 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 40.3 t80 -106.1 132.55 52.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.349 -0.844 . . . . 0.0 109.65 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 3.3 mt-10 -113.96 119.98 39.79 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.895 . . . . 0.0 110.372 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.511 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 43.5 Cg_endo -69.95 -35.73 11.57 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.861 1.453 . . . . 0.0 110.333 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.06 -10.24 56.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 109.844 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -116.33 -30.46 5.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.859 . . . . 0.0 109.936 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.08 171.58 33.93 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.713 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.2 51.01 2.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -1.061 . . . . 0.0 109.736 179.189 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.09 -56.87 1.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.805 . . . . 0.0 110.455 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.534 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.05 -33.95 2.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.785 . . . . 0.0 110.229 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -94.3 -62.38 1.35 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.381 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.67 52.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.713 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -131.72 145.71 58.7 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.243 -1.151 . . . . 0.0 110.014 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.614 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.6 Cg_endo -70.08 160.17 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.952 1.501 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.3 163.87 37.34 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.983 1.517 . . . . 0.0 110.837 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 79.98 13.72 81.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 58.9 m -107.55 126.04 30.87 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.195 -1.18 . . . . 0.0 110.222 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.511 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.7 Cg_endo -73.22 142.71 34.33 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.837 1.441 . . . . 0.0 110.636 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.579 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 t80 -51.22 -40.09 58.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.299 -0.876 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -16.93 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 110.309 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -84.24 -6.87 59.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.517 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 18.7 mt -70.13 157.14 38.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -0.949 . . . . 0.0 109.946 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -77.81 157.54 29.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.206 -0.934 . . . . 0.0 109.811 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.37 -9.92 14.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.15 -0.969 . . . . 0.0 110.262 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 42' ' ' MET . 2.4 m -100.48 2.92 42.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 110.428 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.9 t80 -58.2 132.8 54.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 109.77 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.447 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.7 mtt -118.81 147.24 44.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 110.06 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 8.0 t -58.08 127.41 79.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.319 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.534 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.15 -10.43 27.34 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.784 1.413 . . . . 0.0 109.565 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.57 -62.74 1.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.588 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.8 p -102.02 3.73 39.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.153 -0.967 . . . . 0.0 110.911 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER 62.26 20.85 12.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.196 -0.94 . . . . 0.0 112.063 178.677 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 25.5 p -73.83 165.52 52.47 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.864 -1.148 . . . . 0.0 109.781 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.1 Cg_endo -71.95 142.78 39.43 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.816 1.429 . . . . 0.0 110.377 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.543 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 43.2 tttm -48.29 -23.94 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 109.931 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.63 -10.8 39.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.852 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.7 -1.93 57.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.245 -0.909 . . . . 0.0 109.614 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 20.1 m-85 -88.57 138.12 31.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 110.506 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 2.5 tptp -130.7 146.52 52.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.339 -0.851 . . . . 0.0 109.662 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.625 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.2 p . . . . . 0 N--CA 1.492 1.626 0 O-C-N 120.901 -1.124 . . . . 0.0 110.435 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.169 0.509 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 29.8 m-85 -125.67 145.09 50.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.572 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HG2' ' CD1' ' A' ' 16' ' ' ILE . 14.5 mt-10 -117.67 142.63 47.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.399 -0.813 . . . . 0.0 109.901 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.4 t -77.56 113.61 15.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.975 -1.078 . . . . 0.0 110.584 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -15.1 63.31 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.912 -1.118 . . . . 0.0 108.441 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.06 -60.96 1.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.577 -0.702 . . . . 0.0 110.59 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.62 -4.4 17.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.972 -1.08 . . . . 0.0 110.887 -178.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 82.0 3.43 90.58 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.33 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.577 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 29.3 t80 -49.96 172.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.032 -1.275 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.577 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 24.5 mm -141.12 130.01 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.005 -1.059 . . . . 0.0 110.455 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 66.7 t80 -103.06 124.38 48.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.689 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -109.34 116.33 55.06 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.33 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.5 Cg_endo -69.34 -31.41 22.46 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.969 1.51 . . . . 0.0 110.075 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.08 -12.31 61.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 109.826 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.89 -12.69 10.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.89 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 81.3 167.41 38.26 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.624 ' CB ' HD13 ' A' ' 28' ' ' ILE . 1.2 t0 -85.18 50.6 1.98 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -1.032 . . . . 0.0 109.774 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.3 mmtt -39.31 -53.84 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.347 -0.845 . . . . 0.0 110.534 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.528 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -47.13 -36.5 8.49 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.428 -0.795 . . . . 0.0 110.225 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -92.27 -64.34 1.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 0.0 110.377 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.22 52.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.624 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.88 145.7 58.6 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -1.097 . . . . 0.0 109.939 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.616 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.7 Cg_endo -70.49 161.85 44.55 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.962 1.507 . . . . 0.0 110.198 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.2 Cg_endo -71.64 162.78 41.09 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.973 1.512 . . . . 0.0 110.853 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.12 12.59 84.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 21.9 m -97.73 125.1 45.8 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.239 -1.153 . . . . 0.0 110.179 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.736 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.89 139.29 30.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.867 1.456 . . . . 0.0 110.605 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.574 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 62.5 t80 -52.11 -41.46 62.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.074 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.1 m -53.52 -17.59 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.432 -0.793 . . . . 0.0 110.384 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 36' ' ' ASP . 59.2 t0 -83.96 -7.6 59.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.127 -0.983 . . . . 0.0 110.4 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.498 HD12 ' CD1' ' A' ' 34' ' ' PHE . 17.9 mt -69.43 153.21 43.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 109.9 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.0 155.36 32.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.716 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -11.22 12.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 110.212 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.47 4.1 43.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 110.509 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.54 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 50.1 t80 -59.7 134.86 57.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.016 -1.052 . . . . 0.0 109.576 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.3 mtp -119.23 148.42 43.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.986 -1.071 . . . . 0.0 110.458 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.473 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 6.2 t -58.63 126.93 81.32 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.45 -0.781 . . . . 0.0 110.38 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.528 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.0 Cg_endo -70.69 -9.65 26.21 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.814 1.428 . . . . 0.0 109.486 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.36 -64.86 1.0 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.512 -0.743 . . . . 0.0 110.464 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.538 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.2 p -99.37 2.64 45.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.954 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.0 OUTLIER 63.04 22.34 13.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.153 -0.967 . . . . 0.0 112.094 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 29.9 p -76.31 166.11 47.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.735 -1.228 . . . . 0.0 109.859 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 45.2 Cg_endo -71.72 142.13 39.04 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.766 1.403 . . . . 0.0 110.437 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.567 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 10.1 tttm -48.64 -27.65 2.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.901 . . . . 0.0 110.0 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.06 -10.15 27.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.817 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -87.64 -5.57 58.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.306 -0.871 . . . . 0.0 109.628 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 23.7 m-85 -79.96 133.62 36.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 110.566 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.08 131.25 54.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.467 -0.771 . . . . 0.0 108.93 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.596 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 110.194 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.448 ' HE2' ' CG2' ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.182 0.515 . . . . 0.0 109.918 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 18.0 m-85 -120.03 146.65 45.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.176 -0.953 . . . . 0.0 110.372 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 4.6 mt-10 -121.07 140.08 52.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 109.565 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.3 t -76.42 118.44 19.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.117 -0.99 . . . . 0.0 110.399 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.84 -16.74 63.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.852 -1.155 . . . . 0.0 108.644 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -58.93 2.49 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.681 -0.637 . . . . 0.0 110.547 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.498 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -109.61 -3.09 17.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 110.931 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.748 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 78.27 6.73 87.84 Favored Glycine 0 N--CA 1.495 2.622 0 O-C-N 120.999 -1.063 . . . . 0.0 111.414 177.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 43.2 t80 -57.87 144.59 38.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.943 -1.328 . . . . 0.0 109.78 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.748 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -114.44 111.6 36.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.294 -0.879 . . . . 0.0 110.584 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 49.3 t80 -82.07 122.38 27.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.905 . . . . 0.0 109.984 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -107.0 119.65 50.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.832 . . . . 0.0 110.088 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.3 Cg_endo -71.47 -24.45 22.42 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.902 1.475 . . . . 0.0 110.299 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -72.05 -16.0 62.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 109.948 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -109.95 -37.75 5.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.05 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.54 166.05 24.5 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.608 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.21 50.41 1.94 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -1.051 . . . . 0.0 109.644 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 4.4 tttm -38.91 -53.02 1.76 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.492 -0.755 . . . . 0.0 110.618 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.536 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 13.9 m-85 -48.88 -36.46 17.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.378 -0.826 . . . . 0.0 110.295 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -91.58 -66.25 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.329 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.95 51.46 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.608 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.16 144.7 53.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.238 -1.154 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.573 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.6 Cg_endo -70.89 163.03 40.62 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.956 1.503 . . . . 0.0 110.31 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -71.89 161.82 43.79 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.949 1.5 . . . . 0.0 110.905 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.34 13.13 83.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.464 HG21 ' CG2' ' A' ' 28' ' ' ILE . 37.4 m -93.89 123.11 60.51 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.3 -1.118 . . . . 0.0 110.174 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.773 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.4 Cg_endo -73.45 141.5 31.7 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.821 1.432 . . . . 0.0 110.641 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.576 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 30.3 t80 -55.53 -18.02 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.948 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.773 HG22 ' HB2' ' A' ' 33' ' ' PRO . 3.8 m -72.84 -10.6 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 109.687 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -91.84 -7.62 48.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.29 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.465 HD12 ' CD2' ' A' ' 34' ' ' PHE . 20.9 mt -72.22 146.23 47.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.056 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.81 158.75 31.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.068 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -60.96 -12.93 12.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 0.0 110.158 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 97.2 p -99.27 4.84 46.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.449 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 52.3 t80 -58.96 139.57 56.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.101 -0.999 . . . . 0.0 109.984 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.7 mmm -119.79 143.8 47.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.985 -1.072 . . . . 0.0 110.049 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 45' ' ' ALA . 49.5 t -59.91 125.17 79.9 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 110.14 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.536 ' HB2' ' CB ' ' A' ' 25' ' ' PHE . 43.9 Cg_endo -70.67 -8.87 24.59 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.858 1.452 . . . . 0.0 109.871 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -93.34 -53.66 4.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.482 -0.761 . . . . 0.0 110.167 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 48' ' ' SER . 9.5 p -118.15 8.47 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 110.707 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.81 14.18 7.13 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.255 -0.903 . . . . 0.0 112.162 178.635 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 52' ' ' GLN . 2.2 t -66.8 161.39 61.71 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.834 -1.166 . . . . 0.0 110.044 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 42.9 Cg_endo -69.29 143.38 52.91 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.608 1.32 . . . . 0.0 110.25 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.559 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 17.4 tttm -50.21 -28.86 8.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.129 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -63.01 -11.94 22.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.118 -0.989 . . . . 0.0 109.786 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.523 ' CB ' ' OG ' ' A' ' 48' ' ' SER . 0.8 OUTLIER -88.67 -2.52 58.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.879 . . . . 0.0 109.85 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.422 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 25.4 m-85 -83.93 135.38 34.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.583 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' NZ ' ' O ' ' A' ' 55' ' ' SER . 0.5 OUTLIER -120.67 138.14 54.09 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.734 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.3 t . . . . . 0 C--N 1.3 -1.564 0 O-C-N 120.819 -1.176 . . . . 0.0 110.535 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 12.1 m-85 -120.7 144.14 48.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.937 . . . . 0.0 110.949 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.6 pp20? -118.85 140.24 50.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 0.0 109.513 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.4 t -77.31 117.99 19.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.056 -1.028 . . . . 0.0 110.534 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.439 ' OE1' ' CA ' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -69.11 -16.57 63.7 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.833 -1.167 . . . . 0.0 108.525 178.46 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -59.21 2.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.594 -0.691 . . . . 0.0 110.547 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.03 -3.21 17.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.98 -1.075 . . . . 0.0 110.815 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 78.24 6.14 87.62 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.081 -1.012 . . . . 0.0 111.404 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 47.6 t80 -56.83 144.89 31.4 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.957 -1.32 . . . . 0.0 109.744 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.505 HD13 ' CB ' ' A' ' 9' ' ' GLU . 22.2 mm -115.71 110.58 32.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.234 -0.917 . . . . 0.0 110.5 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 45.8 t80 -81.26 121.47 26.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.81 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.03 121.13 50.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.386 -0.821 . . . . 0.0 110.213 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.5 Cg_endo -70.78 -27.68 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.935 1.492 . . . . 0.0 110.277 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.91 -18.87 62.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 110.234 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -39.61 6.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.151 -0.968 . . . . 0.0 110.175 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.81 164.67 24.18 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.622 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -85.18 51.38 2.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.449 -1.03 . . . . 0.0 109.83 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -40.12 -51.54 2.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.345 -0.847 . . . . 0.0 110.67 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 26.1 m-85 -48.98 -36.63 18.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.352 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.97 -66.13 0.95 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.246 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.76 53.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.622 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -131.86 143.93 51.11 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.378 -1.072 . . . . 0.0 110.038 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.1 Cg_endo -72.04 165.43 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.108 1.583 . . . . 0.0 110.311 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.24 163.06 39.83 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.932 1.491 . . . . 0.0 110.833 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.47 12.07 82.38 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 25.1 m -94.38 123.61 58.06 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.238 -1.154 . . . . 0.0 110.2 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.733 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.9 Cg_endo -73.18 141.3 32.23 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.811 1.427 . . . . 0.0 110.585 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.573 ' CE1' ' HE2' ' A' ' 50' ' ' LYS . 47.6 t80 -55.38 -38.97 69.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.29 -0.881 . . . . 0.0 110.186 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.733 HG22 ' HB2' ' A' ' 33' ' ' PRO . 17.0 m -54.1 -18.47 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -6.72 59.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.408 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.501 HD12 ' CD2' ' A' ' 34' ' ' PHE . 19.3 mt -73.05 150.65 42.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.114 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.472 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -76.71 159.52 30.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 109.996 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -10.23 18.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.211 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 p -100.28 4.33 44.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.264 -0.897 . . . . 0.0 110.327 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.9 t80 -60.42 137.77 58.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 110.038 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' SER . 18.3 mtm -119.84 146.14 46.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.178 -0.951 . . . . 0.0 110.093 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 10.9 t -56.91 130.26 78.77 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.793 . . . . 0.0 110.443 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 45.6 Cg_endo -72.25 -12.1 27.41 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.921 1.485 . . . . 0.0 109.698 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.6 -61.95 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 110.708 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.5 p -102.51 4.37 38.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 111.128 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.1 tpt180 62.12 18.96 10.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.136 -0.977 . . . . 0.0 112.102 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.7 m -71.83 168.1 25.42 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.831 -1.168 . . . . 0.0 109.759 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.9 Cg_endo -73.8 142.75 32.38 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.817 1.43 . . . . 0.0 110.406 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.9 tttm -49.37 -28.38 4.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 109.784 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -63.13 -11.94 23.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 109.856 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -89.5 -2.39 58.35 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.595 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -87.56 139.18 30.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 110.43 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.16 139.13 54.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.458 -0.776 . . . . 0.0 108.94 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 40.8 p . . . . . 0 C--N 1.302 -1.457 0 O-C-N 120.854 -1.154 . . . . 0.0 110.632 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.8 mttp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.129 0.49 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.4 m-85 -125.56 148.68 48.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.95 . . . . 0.0 110.859 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 32.6 tt0 -119.04 140.27 50.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.839 . . . . 0.0 109.424 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.6 t -77.33 117.45 18.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.047 -1.033 . . . . 0.0 110.421 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -16.42 63.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.822 -1.174 . . . . 0.0 108.585 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.18 -59.12 2.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.579 -0.701 . . . . 0.0 110.551 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.39 -3.8 16.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.009 -1.057 . . . . 0.0 110.906 -179.041 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.471 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.41 6.25 88.99 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.537 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 34.0 t80 -57.01 143.58 37.63 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.797 -1.413 . . . . 0.0 109.807 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.505 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 17.8 mm -115.19 111.86 37.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.342 -0.848 . . . . 0.0 110.65 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.0 t80 -81.38 122.21 27.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.773 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -102.28 117.78 60.41 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 0.0 110.226 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.8 Cg_endo -71.16 -30.37 16.16 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.87 1.458 . . . . 0.0 110.307 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -72.48 -7.91 52.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.304 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -114.4 -43.56 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.285 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.1 163.34 18.08 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.547 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.16 56.17 3.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.453 -1.027 . . . . 0.0 109.983 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' ASP . 9.5 mtpt -40.92 -55.5 2.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 110.502 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 27.1 m-85 -48.45 -34.86 11.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.375 -0.828 . . . . 0.0 110.506 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -92.8 -65.75 0.98 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 110.3 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.46 54.34 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.605 HG21 HG21 ' A' ' 32' ' ' THR . 1.3 mp -132.1 144.07 51.6 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.296 -1.12 . . . . 0.0 109.993 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.563 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.2 Cg_endo -71.59 165.05 33.71 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.956 1.503 . . . . 0.0 110.391 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.06 162.9 40.41 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.017 1.535 . . . . 0.0 110.804 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.11 15.02 81.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.605 HG21 HG21 ' A' ' 28' ' ' ILE . 15.8 m -97.65 123.29 52.51 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.283 -1.127 . . . . 0.0 110.198 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.782 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -73.75 139.9 28.44 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.873 1.46 . . . . 0.0 110.586 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.577 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 12.4 t80 -53.42 -40.61 65.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.273 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 33' ' ' PRO . 27.3 m -53.17 -18.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 110.467 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 3.8 t70 -85.52 -7.1 59.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 0.0 110.386 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.556 HD13 ' CD1' ' A' ' 41' ' ' PHE . 13.7 mt -73.99 120.06 19.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 37' ' ' LEU . 18.5 t -42.21 159.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.457 -0.777 . . . . 0.0 110.335 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.45 -7.7 27.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 0.0 110.161 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 p -99.03 4.19 47.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' A' ' 37' ' ' LEU . 49.1 t80 -58.61 134.76 57.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.193 -0.942 . . . . 0.0 110.157 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -120.13 146.15 46.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.139 -0.975 . . . . 0.0 109.718 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.9 t -56.46 130.06 75.91 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 110.493 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -71.93 -12.4 28.36 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.845 1.445 . . . . 0.0 109.477 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.04 -65.81 0.94 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.576 -0.703 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.1 p -96.66 2.39 52.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.162 -0.961 . . . . 0.0 111.126 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.04 23.33 13.74 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.101 -0.999 . . . . 0.0 111.878 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.462 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -76.29 167.46 36.5 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.866 -1.146 . . . . 0.0 109.907 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.0 Cg_endo -73.75 142.77 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.972 1.512 . . . . 0.0 110.525 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 9.4 tttm -49.85 -29.53 8.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.105 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -63.16 -11.99 24.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.856 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -88.73 -2.65 58.7 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 109.673 179.342 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.82 138.69 31.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.943 . . . . 0.0 110.658 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.54 138.57 54.25 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.8 t . . . . . 0 C--N 1.301 -1.528 0 O-C-N 120.622 -1.299 . . . . 0.0 110.51 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.4 m-85 -126.68 151.24 48.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.945 . . . . 0.0 110.766 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -121.95 141.38 51.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.398 -0.814 . . . . 0.0 109.424 179.113 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -78.11 117.73 19.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -0.996 . . . . 0.0 110.521 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.85 -16.34 63.74 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.831 -1.168 . . . . 0.0 108.515 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -59.2 2.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.603 -0.685 . . . . 0.0 110.411 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.491 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.33 -3.43 17.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.961 -1.087 . . . . 0.0 110.774 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.729 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 78.66 5.79 88.28 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.155 -0.965 . . . . 0.0 111.474 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.579 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 52.9 t80 -58.12 146.04 34.72 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.855 -1.38 . . . . 0.0 109.92 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.4 mp -116.42 110.44 31.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.214 -0.929 . . . . 0.0 110.443 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.515 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 36.8 t80 -80.94 121.63 26.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -106.33 120.12 49.71 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.437 -0.789 . . . . 0.0 110.027 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 45.5 Cg_endo -72.09 -23.14 21.83 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.99 1.521 . . . . 0.0 110.524 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -72.35 -16.22 61.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.113 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.69 -39.71 5.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 110.112 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.5 163.05 20.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.603 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.19 51.86 2.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -1.048 . . . . 0.0 109.866 179.016 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 3.5 mmtt -39.8 -50.01 2.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.441 -0.787 . . . . 0.0 110.65 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.558 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 41.1 m-85 -51.05 -39.5 56.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.269 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.77 -68.93 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.191 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.44 52.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.603 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.05 144.15 52.38 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.298 -1.119 . . . . 0.0 109.997 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.587 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.9 Cg_endo -72.01 166.54 29.3 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.875 1.461 . . . . 0.0 110.407 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.48 160.86 45.73 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.91 1.479 . . . . 0.0 110.861 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.65 12.45 84.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.523 HG21 ' CG2' ' A' ' 28' ' ' ILE . 25.9 m -92.92 121.04 66.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.18 -1.188 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.955 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.4 Cg_endo -73.18 142.48 34.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.859 1.452 . . . . 0.0 110.553 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.56 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 31.0 t80 -56.01 -21.39 21.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.294 -0.879 . . . . 0.0 110.024 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.955 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.3 m -72.11 -9.02 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -0.874 . . . . 0.0 109.784 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.54 -7.17 44.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.984 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 50' ' ' LYS . 23.7 mt -72.91 146.16 46.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.013 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -73.58 151.38 40.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.879 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.0 -17.15 3.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.55 7.83 45.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 0.0 110.427 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.503 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 55.0 t80 -60.8 139.84 57.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 109.81 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 48' ' ' SER . 32.9 mtm -118.4 144.47 45.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.024 -1.048 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 42.5 t -59.31 127.56 84.46 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.402 -0.811 . . . . 0.0 110.284 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HB2' ' CB ' ' A' ' 25' ' ' PHE . 44.1 Cg_endo -71.46 -10.0 26.15 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.002 1.528 . . . . 0.0 110.0 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.579 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -94.33 -54.87 3.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.461 -0.774 . . . . 0.0 110.327 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.491 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 10.0 p -115.3 7.47 15.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 110.773 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 63.01 14.39 7.53 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.28 -0.887 . . . . 0.0 112.171 178.488 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.46 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 3.6 m -67.56 169.3 9.42 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.857 -1.152 . . . . 0.0 109.894 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.3 Cg_endo -74.19 141.36 29.13 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.788 1.415 . . . . 0.0 110.461 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 10.5 tttm -50.05 -29.55 9.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 109.892 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -61.88 -12.52 18.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.866 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -88.64 -1.92 58.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.788 179.475 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 24.5 m-85 -84.6 137.32 33.36 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.725 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -120.5 137.23 54.47 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.1 t . . . . . 0 C--N 1.3 -1.552 0 O-C-N 120.621 -1.299 . . . . 0.0 110.537 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.162 0.506 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 18.8 m-85 -123.18 148.5 45.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 110.897 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.578 ' CG ' ' CD1' ' A' ' 16' ' ' ILE . 14.4 mt-10 -120.46 139.71 52.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.426 -0.796 . . . . 0.0 109.608 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.461 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.6 t -76.57 117.21 17.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.127 -0.983 . . . . 0.0 110.417 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -16.54 63.97 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.857 -1.152 . . . . 0.0 108.597 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.1 -58.82 2.53 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.647 -0.658 . . . . 0.0 110.683 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.63 -3.56 16.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.884 -1.135 . . . . 0.0 110.984 -179.096 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.461 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.34 6.47 88.91 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.058 -1.026 . . . . 0.0 111.392 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 26.9 t80 -56.59 143.1 37.04 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.942 -1.328 . . . . 0.0 109.687 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.578 ' CD1' ' CG ' ' A' ' 9' ' ' GLU . 16.4 mm -115.66 112.05 38.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.259 -0.9 . . . . 0.0 110.704 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.588 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.0 t80 -81.82 130.06 34.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.741 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -110.14 119.34 47.4 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 110.288 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -70.65 -30.2 18.5 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.892 1.469 . . . . 0.0 110.09 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.71 -13.82 61.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.833 . . . . 0.0 110.043 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -111.79 -38.23 4.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.381 -0.825 . . . . 0.0 110.049 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.36 168.94 25.76 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.665 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.09 53.09 2.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.454 -1.027 . . . . 0.0 109.944 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -40.3 -57.4 1.75 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.375 -0.828 . . . . 0.0 110.533 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.526 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 27.0 m-85 -47.73 -34.35 8.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.47 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.99 -65.83 0.98 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.032 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.15 52.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.665 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.13 145.19 56.68 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.225 -1.162 . . . . 0.0 109.889 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -70.3 160.94 47.83 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.038 1.546 . . . . 0.0 110.47 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -71.93 163.14 39.77 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.049 1.552 . . . . 0.0 110.848 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.4 12.37 84.32 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 94.1 m -98.64 125.93 40.88 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.248 -1.148 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.749 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -73.74 139.76 28.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.016 1.535 . . . . 0.0 110.593 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.588 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 3.0 t80 -52.66 -40.0 62.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.017 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.3 m -53.76 -17.87 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -0.823 . . . . 0.0 110.282 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 63.3 t0 -83.53 -7.12 59.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 110.404 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.544 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.0 mt -71.42 153.86 41.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.086 -1.009 . . . . 0.0 109.98 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.22 157.99 30.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.979 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -11.52 15.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.267 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -99.52 4.01 45.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 110.435 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.568 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 48.7 t80 -59.65 132.81 55.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 109.832 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 48' ' ' SER . 10.4 mtp -117.08 147.01 42.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.052 -1.03 . . . . 0.0 109.966 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.6 t -56.59 129.97 76.66 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.321 -0.862 . . . . 0.0 110.458 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -72.22 -11.7 27.13 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.892 1.469 . . . . 0.0 109.4 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.64 -65.02 0.99 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.518 -0.739 . . . . 0.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.7 p -98.3 3.21 48.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.92 . . . . 0.0 111.151 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER 62.06 22.39 13.06 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.079 -1.013 . . . . 0.0 112.06 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.7 m -75.78 168.37 28.35 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.806 -1.184 . . . . 0.0 109.994 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.4 Cg_endo -74.08 142.57 31.19 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.907 1.478 . . . . 0.0 110.431 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 42.0 tttm -50.48 -29.41 10.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 109.944 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -62.95 -12.34 24.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.743 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -87.54 -3.08 59.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.786 179.515 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -86.45 139.63 30.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.748 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -122.55 139.86 53.43 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.729 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.2 t . . . . . 0 C--N 1.3 -1.575 0 O-C-N 120.677 -1.265 . . . . 0.0 110.566 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 10.0 m-85 -119.77 145.8 46.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.051 -1.03 . . . . 0.0 111.2 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 16' ' ' ILE . 6.5 pt-20 -121.16 139.64 53.08 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.552 -0.717 . . . . 0.0 109.145 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.9 t -76.94 116.79 17.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.025 -1.047 . . . . 0.0 110.314 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.43 -16.52 64.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.84 -1.162 . . . . 0.0 108.601 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -59.53 2.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.662 -0.649 . . . . 0.0 110.563 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.44 -3.46 17.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.057 . . . . 0.0 110.986 -179.074 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.46 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.82 5.98 89.25 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.138 -1.029 . . . . 0.0 111.385 177.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 45.8 t80 -56.93 143.56 37.22 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.901 -1.353 . . . . 0.0 109.767 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.55 HD13 ' HA ' ' A' ' 9' ' ' GLU . 21.7 mm -115.14 111.84 37.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 121.294 -0.879 . . . . 0.0 110.718 -179.323 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.1 t80 -82.17 129.34 34.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.867 . . . . 0.0 109.739 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -109.25 121.43 42.68 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.875 . . . . 0.0 110.202 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -71.66 -30.97 13.97 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.189 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.42 -14.81 62.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.082 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -108.88 -38.58 5.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 110.157 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.32 169.04 25.81 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.679 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.671 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.07 54.73 3.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.462 -1.022 . . . . 0.0 109.886 179.212 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -40.37 -58.03 1.63 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.396 -0.815 . . . . 0.0 110.756 -179.528 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.527 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 47.5 m-85 -46.31 -33.34 3.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.07 -63.75 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.003 . . . . 0.0 110.292 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.59 53.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.671 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.92 144.96 55.14 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.279 -1.13 . . . . 0.0 109.819 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.3 Cg_endo -70.65 161.13 47.14 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.966 1.508 . . . . 0.0 110.366 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.19 162.87 40.42 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.999 1.526 . . . . 0.0 110.787 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.41 13.33 83.67 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 83.7 m -99.85 124.06 45.22 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.269 -1.136 . . . . 0.0 110.15 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 46.4 Cg_endo -73.25 139.95 30.01 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.915 1.482 . . . . 0.0 110.644 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.583 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 t80 -50.96 -41.61 59.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.897 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -53.98 -17.55 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.418 -0.801 . . . . 0.0 110.423 -179.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 9.6 t0 -84.29 -7.44 59.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -0.992 . . . . 0.0 110.178 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 37' ' ' LEU . 19.8 mt -71.14 154.99 41.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.018 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.68 149.63 38.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 109.823 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -55.67 -16.48 4.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.152 -0.967 . . . . 0.0 110.294 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -95.57 6.3 49.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.6 t80 -60.13 136.98 58.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.142 -0.974 . . . . 0.0 109.913 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' SER . 4.7 mtm -119.77 146.55 45.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 110.01 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 8.2 t -56.07 131.05 74.28 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 110.448 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.7 Cg_endo -72.21 -12.67 27.96 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.872 1.459 . . . . 0.0 109.583 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.34 -64.31 1.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.463 -0.773 . . . . 0.0 110.82 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.538 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.2 p -98.84 3.83 47.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.899 . . . . 0.0 111.206 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 14.2 mtm180 61.6 20.77 11.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.134 -0.979 . . . . 0.0 112.103 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.7 m -73.71 168.36 26.51 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.72 -1.238 . . . . 0.0 109.767 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.6 Cg_endo -73.57 142.27 32.46 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.951 1.5 . . . . 0.0 110.383 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 28.0 tttm -50.01 -29.22 8.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 109.807 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -61.23 -13.24 16.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.0 110.013 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.59 -1.08 57.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.328 -0.857 . . . . 0.0 109.681 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 13.3 m-85 -87.98 139.32 30.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 110.477 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 3.3 mttt -127.36 143.18 51.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.455 -0.778 . . . . 0.0 109.449 179.246 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 12.0 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.76 -1.213 . . . . 0.0 110.709 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 mttt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.167 0.508 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.688 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 11.4 m-85 -114.25 140.36 48.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 110.469 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 9.9 pt-20 -117.63 136.75 53.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 109.562 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 3.6 t -74.87 120.0 19.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.7 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -16.67 63.27 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.751 -1.218 . . . . 0.0 108.481 178.249 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -58.78 2.55 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.561 -0.712 . . . . 0.0 110.564 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.488 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.5 p -109.52 -1.2 18.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.953 -1.092 . . . . 0.0 110.814 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.685 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 73.52 10.38 79.32 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 120.176 -1.012 . . . . 0.0 111.505 177.538 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 41.0 t80 -62.19 147.69 46.99 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.775 -1.427 . . . . 0.0 109.331 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -116.08 114.32 45.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.539 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 34' ' ' PHE . 18.5 t80 -83.16 134.68 34.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -111.23 119.18 46.15 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.432 -0.792 . . . . 0.0 110.07 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.2 Cg_endo -71.26 -31.71 13.91 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.955 1.503 . . . . 0.0 110.265 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.76 -8.52 56.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.371 -0.83 . . . . 0.0 109.972 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.3 tttt -110.06 -47.03 3.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.9 . . . . 0.0 110.16 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.21 162.84 14.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.554 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.17 56.68 4.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.509 -0.995 . . . . 0.0 109.927 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 23' ' ' ASP . 10.1 mmtt -40.14 -57.22 1.73 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.432 -0.793 . . . . 0.0 110.703 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -45.45 -34.01 2.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.398 -0.814 . . . . 0.0 110.604 -179.809 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -95.38 -61.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 110.405 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.24 55.77 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.554 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.1 mp -129.94 143.67 50.0 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.269 -1.136 . . . . 0.0 109.953 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.0 Cg_endo -70.5 162.9 40.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.943 1.496 . . . . 0.0 110.533 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.4 Cg_endo -72.41 161.68 43.62 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.983 1.517 . . . . 0.0 110.92 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.85 14.98 82.02 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 97.7 m -102.04 125.87 35.42 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.177 . . . . 0.0 110.187 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.811 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.6 Cg_endo -72.95 136.94 25.89 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.855 1.45 . . . . 0.0 110.528 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.606 ' CD2' HD12 ' A' ' 37' ' ' LEU . 15.1 t80 -53.06 -39.17 63.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.179 -0.951 . . . . 0.0 110.174 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.8 m -53.32 -18.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.119 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.46 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 15.2 t0 -82.41 -5.88 58.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 110.416 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 41' ' ' PHE . 22.2 mt -70.06 157.35 37.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.917 . . . . 0.0 110.067 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.05 155.95 30.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.2 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -60.48 -13.67 15.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.211 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.2 m -98.25 2.21 48.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 110.077 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.628 ' CD1' HD13 ' A' ' 37' ' ' LEU . 44.7 t80 -56.06 133.13 51.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.865 . . . . 0.0 110.139 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 35.4 mtt -111.03 138.29 47.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.006 -1.059 . . . . 0.0 109.307 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . 43.9 t -47.08 136.42 8.42 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 110.73 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.7 Cg_endo -82.8 36.18 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.124 1.592 . . . . 0.0 110.08 179.061 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.522 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -151.92 -50.31 0.11 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.247 -0.908 . . . . 0.0 109.588 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.488 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.5 p -118.17 8.41 12.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.389 -0.819 . . . . 0.0 110.128 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 27.3 mtp180 61.1 15.02 5.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.486 -0.759 . . . . 0.0 112.084 178.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.452 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.6 m -64.81 166.76 10.97 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.874 -1.141 . . . . 0.0 109.815 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.3 Cg_endo -73.25 142.32 33.62 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.932 1.49 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.2 tttm -49.85 -31.54 12.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.777 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -62.42 -12.26 20.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 109.808 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -89.56 -2.14 58.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.835 . . . . 0.0 109.745 179.505 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 13.7 m-85 -88.11 139.82 30.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 110.508 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 20.1 tttt -126.12 142.45 51.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 109.371 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.688 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 9.3 p . . . . . 0 N--CA 1.491 1.616 0 O-C-N 120.936 -1.103 . . . . 0.0 111.023 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.62 ' CE1' ' HB3' ' A' ' 55' ' ' SER . 8.6 m-85 -120.6 140.22 51.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 0.0 111.144 -178.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 45.6 tt0 -117.03 141.54 48.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.538 -0.726 . . . . 0.0 109.358 179.198 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.462 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.9 t -77.13 116.54 17.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.072 -1.017 . . . . 0.0 110.309 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -16.25 64.19 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.787 -1.195 . . . . 0.0 108.663 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -60.1 2.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.575 -0.703 . . . . 0.0 110.605 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.55 -3.61 17.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.061 -1.024 . . . . 0.0 110.945 -178.984 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.749 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.27 6.87 88.79 Favored Glycine 0 N--CA 1.496 2.685 0 O-C-N 121.09 -1.006 . . . . 0.0 111.611 177.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 28.0 t80 -59.17 143.01 50.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.736 -1.45 . . . . 0.0 109.723 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.4 mp -113.99 113.87 45.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.215 -0.928 . . . . 0.0 110.746 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 25.6 t80 -84.64 137.43 33.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -0.852 . . . . 0.0 109.593 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -114.73 122.6 33.53 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.788 . . . . 0.0 110.222 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.6 Cg_endo -71.08 -34.07 10.82 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.811 1.427 . . . . 0.0 110.089 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.31 -11.27 60.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 110.053 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -111.68 -38.2 4.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.28 170.98 28.28 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.624 ' OD1' HG21 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -85.19 57.15 4.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.493 -1.004 . . . . 0.0 109.702 179.099 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' ASP . 14.6 tptm -38.94 -61.33 0.75 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.454 -0.779 . . . . 0.0 110.532 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 27.2 m-85 -45.88 -30.38 1.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.835 . . . . 0.0 110.459 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -95.11 -63.5 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 0.0 110.276 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.43 54.24 0.02 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.624 HG21 ' OD1' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -129.95 144.17 51.99 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.212 -1.169 . . . . 0.0 109.662 179.798 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -70.44 159.0 54.38 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.982 1.517 . . . . 0.0 110.522 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.33 164.3 36.04 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.996 1.524 . . . . 0.0 110.741 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 80.22 13.98 81.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.8 m -105.19 126.69 30.34 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.176 -1.191 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.679 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.1 Cg_endo -72.97 141.73 33.63 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.897 1.472 . . . . 0.0 110.533 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.572 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 51.9 t80 -52.62 -41.37 63.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 110.177 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 33' ' ' PRO . 5.8 m -54.76 -17.17 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.337 -0.852 . . . . 0.0 110.305 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 29.6 t70 -86.7 -6.78 58.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 110.272 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.606 HD13 ' CD1' ' A' ' 41' ' ' PHE . 17.7 mt -72.81 124.76 26.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.195 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' LEU . 16.0 m -43.01 164.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.172 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -72.77 -2.01 18.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.0 110.182 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' ' SD ' ' A' ' 42' ' ' MET . 7.9 p -103.11 1.49 33.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.416 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.606 ' CD1' HD13 ' A' ' 37' ' ' LEU . 47.5 t80 -56.79 130.21 44.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 110.225 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -119.21 146.09 45.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.681 179.594 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.4 t -55.36 129.53 68.84 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 110.494 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.583 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.49 -13.34 30.2 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.895 1.471 . . . . 0.0 109.461 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.69 -65.16 0.98 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.558 -0.714 . . . . 0.0 110.917 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.523 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.2 p -97.0 2.85 52.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.191 -0.943 . . . . 0.0 111.159 -179.121 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.2 tpp180 61.65 22.99 13.38 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.137 -0.977 . . . . 0.0 111.945 178.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.459 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.2 m -74.38 165.48 53.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.839 -1.163 . . . . 0.0 109.94 179.438 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.9 Cg_endo -73.36 143.86 35.74 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.947 1.498 . . . . 0.0 110.44 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 12.5 tttt -49.16 -25.33 2.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 110.032 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -66.74 -11.2 53.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.88 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.2 mm-40 -90.75 -2.32 57.81 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.359 -0.838 . . . . 0.0 109.538 179.271 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 6.5 m-85 -89.09 138.87 31.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -0.77 . . . . 0.0 110.52 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 20.3 mmtt -130.83 146.92 52.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 109.586 179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.62 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 4.0 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.835 -1.165 . . . . 0.0 110.456 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.3 m-85 -125.73 150.14 47.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.926 -179.289 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 29.1 tt0 -120.32 140.2 51.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 109.243 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.3 t -77.4 116.81 18.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.06 -1.025 . . . . 0.0 110.562 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.14 -16.15 63.88 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.897 -1.127 . . . . 0.0 108.511 178.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.11 -59.48 2.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.65 -0.656 . . . . 0.0 110.539 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -109.27 -3.4 17.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.058 -1.026 . . . . 0.0 110.788 -179.113 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.747 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.06 6.82 88.75 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 121.118 -0.989 . . . . 0.0 111.571 177.602 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.695 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 51.5 t80 -58.98 144.33 45.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.83 -1.394 . . . . 0.0 109.894 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -116.05 113.07 42.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.761 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.589 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 40.7 t80 -81.55 123.23 28.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.743 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -102.21 118.01 59.96 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.47 -0.769 . . . . 0.0 110.294 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 46.5 Cg_endo -71.53 -30.67 14.73 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.902 1.475 . . . . 0.0 110.288 179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.82 -7.09 36.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.07 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 9.5 mttt -118.99 -35.73 3.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.884 . . . . 0.0 110.065 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.31 168.73 25.8 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.549 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -85.19 54.99 3.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.419 -1.047 . . . . 0.0 109.903 179.195 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -39.78 -58.13 1.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.574 -179.539 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.601 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -47.58 -34.05 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.412 -0.805 . . . . 0.0 110.537 -179.847 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -91.97 -65.3 1.02 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 110.239 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.96 52.99 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.548 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -132.49 142.59 45.46 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 0.0 109.908 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -69.97 161.95 44.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.871 1.458 . . . . 0.0 110.304 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.3 Cg_endo -71.92 162.99 40.24 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.993 1.523 . . . . 0.0 110.866 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 80.31 12.74 82.8 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 29' ' ' PRO . 2.2 m -101.71 126.19 34.88 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.147 -1.208 . . . . 0.0 110.219 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 46.9 Cg_endo -73.88 140.51 28.93 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.834 1.439 . . . . 0.0 110.613 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.589 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -52.13 -41.67 62.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.985 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -53.22 -18.71 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.445 -179.37 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 8.7 t70 -84.91 -6.66 59.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.237 -0.914 . . . . 0.0 110.118 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 41' ' ' PHE . 16.9 mt -73.67 121.94 21.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.345 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -41.34 152.74 0.05 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.413 -0.804 . . . . 0.0 110.336 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.19 -11.81 16.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 110.266 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.03 5.8 49.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.437 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.549 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.7 t80 -58.91 137.38 57.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 110.155 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.8 mtt -117.94 143.11 46.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 109.558 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 47' ' ' ARG . 43.2 t -59.62 125.71 80.63 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 110.169 -179.74 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.8 Cg_endo -71.15 -9.75 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.891 1.469 . . . . 0.0 109.899 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.695 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -93.19 -53.44 4.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -0.824 . . . . 0.0 110.193 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.489 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.8 p -117.64 8.3 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.615 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' CYS . 11.7 ttp180 61.81 15.44 7.06 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.245 -0.91 . . . . 0.0 112.097 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.454 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -68.29 168.64 12.94 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.858 -1.151 . . . . 0.0 109.895 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 48.0 Cg_endo -73.92 141.95 30.84 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.834 1.439 . . . . 0.0 110.524 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.579 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.7 tttm -50.21 -28.9 8.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -0.926 . . . . 0.0 109.956 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.78 -12.17 22.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.847 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.2 tm0? -88.67 -2.21 58.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.339 -0.851 . . . . 0.0 109.737 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 26.8 m-85 -85.24 136.78 33.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.717 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.87 137.31 54.09 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.642 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.6 t . . . . . 0 C--N 1.3 -1.545 0 O-C-N 120.76 -1.212 . . . . 0.0 110.489 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.171 0.51 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 23.9 m-85 -116.4 139.46 50.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.109 -0.994 . . . . 0.0 110.22 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -113.96 135.22 54.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 109.969 179.594 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 14' ' ' GLY . 2.5 t -72.67 117.77 14.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.543 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -68.57 -15.76 63.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.776 -1.202 . . . . 0.0 108.513 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.24 -59.02 2.45 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.501 -0.75 . . . . 0.0 110.406 179.49 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.509 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.5 p -109.69 -0.65 18.46 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.863 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 72.7 11.84 77.74 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.075 -1.015 . . . . 0.0 111.496 177.678 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.6 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 17.4 t80 -63.92 147.32 52.24 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.781 -1.423 . . . . 0.0 109.685 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 15.1 mm -112.4 115.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.027 -1.046 . . . . 0.0 110.513 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 41.7 t80 -83.09 131.44 35.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.784 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -111.48 118.19 47.69 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.779 . . . . 0.0 110.198 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.5 Cg_endo -70.25 -30.16 20.4 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.884 1.465 . . . . 0.0 110.068 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.5 -11.61 60.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.835 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 11.7 tptt -110.48 -44.01 3.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.425 -0.797 . . . . 0.0 109.944 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.52 168.59 21.87 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.64 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.2 52.46 2.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.514 -0.992 . . . . 0.0 109.748 178.974 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 1.4 ttpp -39.11 -60.4 0.89 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 110.627 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 32.0 m-85 -44.7 -31.22 1.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.798 . . . . 0.0 110.346 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -95.08 -62.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.277 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.75 51.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.64 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -128.53 143.8 49.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 109.725 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.6 Cg_endo -69.88 159.69 52.39 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.958 1.504 . . . . 0.0 110.478 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.35 161.35 44.62 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.038 1.546 . . . . 0.0 111.006 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.83 13.77 82.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 91.2 m -99.02 125.58 41.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.231 -1.158 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.76 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.7 Cg_endo -73.03 136.66 25.2 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.905 1.476 . . . . 0.0 110.481 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 50' ' ' LYS . 11.8 t80 -50.09 -42.87 50.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.76 HG22 ' HB2' ' A' ' 33' ' ' PRO . 19.1 m -53.63 -17.0 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 110.621 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 12.0 t70 -86.56 -7.84 58.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.01 -1.056 . . . . 0.0 110.281 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.472 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.3 mt -68.16 158.02 34.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 110.109 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.6 m -77.86 152.71 33.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 110.002 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -61.27 -12.19 12.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.24 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.24 2.98 35.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.898 . . . . 0.0 110.552 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CZ ' ' OD2' ' A' ' 23' ' ' ASP . 46.6 t80 -58.11 137.71 56.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.015 -1.053 . . . . 0.0 109.755 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.425 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -109.75 137.61 47.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.85 -1.156 . . . . 0.0 109.837 179.786 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 38.4 t -46.66 136.55 7.57 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.284 -0.885 . . . . 0.0 110.569 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.6 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.5 Cg_endo -81.73 34.81 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.126 1.592 . . . . 0.0 110.379 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -150.81 -48.72 0.12 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.226 -0.921 . . . . 0.0 109.526 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.509 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.6 p -120.04 9.28 11.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 110.183 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.19 14.04 5.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.406 -0.809 . . . . 0.0 112.116 178.594 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.454 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.8 m -64.98 169.0 6.09 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.498 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.4 Cg_endo -74.21 142.69 30.88 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.762 1.401 . . . . 0.0 110.151 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 11.3 tttm -50.73 -31.81 17.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.074 -1.016 . . . . 0.0 109.618 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -64.03 -11.61 30.86 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.356 -0.84 . . . . 0.0 109.316 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -85.54 -4.1 59.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.361 -0.837 . . . . 0.0 109.865 179.641 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 22.4 m-85 -79.9 133.15 36.21 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.854 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -102.92 133.3 48.25 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.221 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.642 0 O-C-N 121.029 -1.045 . . . . 0.0 110.191 -179.537 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 tptm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.193 0.521 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.9 m-85 -124.51 149.44 46.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 110.596 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -118.85 138.3 52.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.328 179.023 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 3.0 t -76.52 118.88 19.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.021 . . . . 0.0 111.042 -179.349 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.44 -16.26 63.45 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.361 178.036 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.13 -59.7 2.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.631 -0.668 . . . . 0.0 110.587 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.479 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.6 p -107.99 -1.78 20.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.962 -1.086 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 74.07 10.26 80.95 Favored Glycine 0 N--CA 1.494 2.559 0 O-C-N 121.092 -1.005 . . . . 0.0 111.458 177.471 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.685 ' C ' HD12 ' A' ' 16' ' ' ILE . 39.3 t80 -65.1 149.65 49.51 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.819 -1.4 . . . . 0.0 110.001 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.685 HD12 ' C ' ' A' ' 15' ' ' TYR . 1.8 mp -114.79 112.41 39.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.221 -0.925 . . . . 0.0 110.113 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 38.0 t80 -80.79 119.94 24.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.688 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.32 118.04 57.78 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.354 -0.841 . . . . 0.0 110.061 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 32' ' ' THR . 44.6 Cg_endo -72.19 -22.44 22.35 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.931 1.49 . . . . 0.0 110.423 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -10.49 59.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -112.63 -47.32 3.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.922 . . . . 0.0 110.199 -179.979 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.66 159.36 11.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.553 ' OD2' ' CZ ' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -85.1 57.08 4.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -1.063 . . . . 0.0 109.983 179.415 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' ASP . 57.8 mttm -40.18 -52.97 2.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.448 -0.782 . . . . 0.0 110.464 -179.658 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -50.11 -39.96 44.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.487 -0.758 . . . . 0.0 110.427 -179.918 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -88.77 -67.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.09 55.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 32' ' ' THR . 1.2 mp -129.85 144.5 53.28 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.319 -1.107 . . . . 0.0 109.925 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.564 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.3 Cg_endo -71.03 166.33 29.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.974 1.513 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.1 Cg_endo -72.0 158.81 51.74 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.873 1.459 . . . . 0.0 111.024 -179.81 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.54 14.71 82.18 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.689 HG21 HG21 ' A' ' 28' ' ' ILE . 41.2 m -92.69 119.39 67.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 110.256 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.936 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.2 Cg_endo -72.68 141.56 34.39 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.876 1.461 . . . . 0.0 110.617 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.585 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 43.7 t80 -56.84 -18.48 13.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 110.028 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.936 HG22 ' HB2' ' A' ' 33' ' ' PRO . 14.6 m -73.51 -8.36 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.938 179.693 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -95.55 -7.37 38.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.549 HD12 ' CD1' ' A' ' 34' ' ' PHE . 22.5 mt -71.69 147.55 47.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 110.212 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.81 153.49 36.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.59 -16.35 5.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 p -96.96 5.01 51.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 110.303 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.553 ' CZ ' ' OD2' ' A' ' 23' ' ' ASP . 53.8 t80 -57.95 137.01 57.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.123 -0.986 . . . . 0.0 109.893 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.5 mmt -111.79 138.98 47.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.948 -1.095 . . . . 0.0 109.526 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 39.9 t -47.46 136.55 9.5 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 0.0 110.721 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -82.76 36.39 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.017 1.535 . . . . 0.0 110.109 178.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -151.83 -49.36 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.877 . . . . 0.0 109.491 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.479 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.6 p -119.53 8.56 11.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.423 -0.798 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.74 15.38 5.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -0.805 . . . . 0.0 112.176 178.576 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.458 ' OG ' ' SG ' ' A' ' 46' ' ' CYS . 3.2 m -66.34 169.03 8.07 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.794 -1.191 . . . . 0.0 109.681 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.7 Cg_endo -73.08 140.13 30.75 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.944 1.497 . . . . 0.0 110.413 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.585 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 32.5 tttt -50.24 -31.92 15.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.123 -0.985 . . . . 0.0 109.694 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -62.14 -12.57 20.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.319 -0.863 . . . . 0.0 109.707 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -87.13 -3.35 59.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.759 179.399 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 43' ' ' CYS . 19.7 m-85 -84.99 139.21 31.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 110.592 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.61 137.45 53.85 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.73 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.4 t . . . . . 0 C--N 1.301 -1.534 0 O-C-N 120.564 -1.335 . . . . 0.0 110.653 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HD2' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.247 0.546 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 16.1 m-85 -113.85 139.91 48.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.145 -0.972 . . . . 0.0 110.04 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -118.06 137.43 52.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.104 -0.997 . . . . 0.0 109.828 179.563 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.0 t -74.82 116.64 15.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 110.359 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -67.4 -15.99 63.99 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.761 -1.212 . . . . 0.0 108.62 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.22 -59.99 2.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.618 -0.676 . . . . 0.0 110.463 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.494 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.3 p -109.03 -1.93 18.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.039 -1.038 . . . . 0.0 110.967 -179.102 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.754 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 76.4 8.61 85.81 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.374 177.762 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 31.3 t80 -59.11 144.27 46.15 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.849 -1.383 . . . . 0.0 109.578 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -113.35 113.68 44.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.221 -0.925 . . . . 0.0 110.574 -179.318 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 35.8 t80 -82.74 131.23 35.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.305 -0.872 . . . . 0.0 109.739 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 12.2 mt-10 -108.15 119.68 49.1 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.7 Cg_endo -71.73 -35.61 7.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.839 1.442 . . . . 0.0 110.055 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 31.4 tt0 -70.29 -6.23 33.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 110.037 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 5.4 mmtt -117.56 -37.13 3.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.094 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.97 172.36 28.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 1.1 t70 -85.23 58.52 5.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -1.013 . . . . 0.0 109.756 178.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -36.83 -64.6 0.34 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.542 -0.723 . . . . 0.0 110.728 -179.535 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 1.6 m-85 -42.53 -26.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.847 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -99.98 -58.03 2.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.875 . . . . 0.0 109.952 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.65 -8.07 1.54 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.318 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.583 HG23 ' HD2' ' A' ' 29' ' ' PRO . 1.8 mt -61.79 143.36 94.23 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.251 . . . . 0.0 109.927 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.6 Cg_endo -71.08 160.38 49.37 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.926 1.487 . . . . 0.0 110.659 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.4 Cg_endo -72.83 163.66 37.8 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.13 1.595 . . . . 0.0 110.801 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.72 14.12 82.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 86.4 m -105.73 127.23 28.87 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.28 -1.129 . . . . 0.0 110.134 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.746 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.9 Cg_endo -73.13 140.75 31.56 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.959 1.505 . . . . 0.0 110.492 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 2.6 t80 -50.05 -38.06 36.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.991 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.746 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.3 m -54.4 -17.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 110.363 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -85.05 -7.15 59.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.091 -1.006 . . . . 0.0 110.234 179.949 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.584 HD12 ' CD2' ' A' ' 34' ' ' PHE . 48.5 mt -69.06 155.94 39.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.0 110.089 179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.25 156.13 29.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.136 -0.977 . . . . 0.0 109.819 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -9.64 16.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.029 -1.044 . . . . 0.0 110.317 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 t -103.65 2.76 33.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.473 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.577 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.1 t80 -59.82 138.95 57.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.122 -0.987 . . . . 0.0 109.885 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 48' ' ' SER . 7.0 mtt -117.09 142.72 46.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.866 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 41.9 t -56.3 128.32 72.82 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.24 -0.913 . . . . 0.0 110.008 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.557 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.9 Cg_endo -71.45 -12.66 29.78 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.924 1.486 . . . . 0.0 109.856 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.34 -51.45 4.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 110.675 -179.703 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.494 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 7.5 p -118.83 9.39 12.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.117 -0.989 . . . . 0.0 110.939 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.44 12.68 4.52 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.285 -0.885 . . . . 0.0 112.296 178.347 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 19.0 p -65.12 166.41 13.08 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.832 -1.167 . . . . 0.0 109.765 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 44.4 Cg_endo -71.87 142.38 38.94 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.665 1.35 . . . . 0.0 110.097 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.598 ' CE ' ' CZ ' ' A' ' 34' ' ' PHE . 23.1 tttt -50.41 -28.9 9.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.772 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -62.76 -12.58 25.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.206 -0.933 . . . . 0.0 109.741 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -87.42 -3.45 59.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -0.809 . . . . 0.0 109.664 179.433 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 21.7 m-85 -84.01 136.99 33.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 110.362 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -120.27 139.6 52.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.882 . . . . 0.0 109.268 179.198 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 53.1 p . . . . . 0 C--N 1.302 -1.498 0 O-C-N 120.885 -1.134 . . . . 0.0 111.355 -179.392 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' SER . 11.7 mtmt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 10.6 m-85 -121.34 143.44 49.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.139 -0.975 . . . . 0.0 111.254 -178.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.544 ' HA ' HD13 ' A' ' 16' ' ' ILE . 3.3 tm-20 -121.39 143.69 49.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.908 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 4.7 t -78.67 116.57 19.12 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.997 -1.064 . . . . 0.0 110.531 -179.544 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -15.77 63.67 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.767 -1.208 . . . . 0.0 108.415 178.295 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.02 -61.56 1.74 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.688 -0.632 . . . . 0.0 110.445 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.482 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -106.43 -3.95 20.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.931 -1.105 . . . . 0.0 110.559 -179.221 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 80.62 2.42 89.77 Favored Glycine 0 N--CA 1.496 2.696 0 O-C-N 121.086 -1.009 . . . . 0.0 111.19 177.536 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.647 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 22.5 t80 -50.43 171.65 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.998 -1.295 . . . . 0.0 109.7 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 23.2 mm -139.48 130.48 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 110.344 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 55.8 t80 -105.12 120.6 41.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.363 -0.836 . . . . 0.0 109.927 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -108.88 119.0 50.27 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.099 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -70.72 -24.29 25.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.929 1.489 . . . . 0.0 110.316 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 8.0 tp10 -72.64 -15.53 61.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.242 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 9.9 tttt -109.84 -40.7 4.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.42 156.39 12.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 1.007 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -85.3 62.2 7.34 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.375 -1.074 . . . . 0.0 108.995 178.463 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -39.68 -48.57 2.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.467 -0.771 . . . . 0.0 111.039 -179.061 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 44' ' ' PRO . 13.4 m-85 -80.96 13.22 2.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 0.0 110.907 -179.338 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.007 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -131.55 -3.77 3.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.0 110.71 -179.83 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.86 38.53 7.97 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.954 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.751 ' CG2' HG21 ' A' ' 32' ' ' THR . 1.7 mp -133.21 136.46 27.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.838 -1.389 . . . . 0.0 110.25 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 46.6 Cg_endo -72.79 174.12 12.35 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.016 1.535 . . . . 0.0 110.486 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 43.6 Cg_endo -72.85 160.52 45.91 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.969 1.51 . . . . 0.0 111.039 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.8 11.5 84.55 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.751 HG21 ' CG2' ' A' ' 28' ' ' ILE . 54.4 m -94.54 121.38 63.4 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.232 -1.157 . . . . 0.0 110.299 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.843 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.7 Cg_endo -72.96 143.53 36.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.838 1.441 . . . . 0.0 110.456 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.668 ' CD1' HD12 ' A' ' 37' ' ' LEU . 37.9 t80 -55.97 -37.16 68.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.908 . . . . 0.0 110.05 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.843 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.9 m -55.33 -18.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.454 -0.779 . . . . 0.0 109.872 179.674 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 7.7 t70 -83.42 -6.66 59.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.819 . . . . 0.0 110.242 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.668 HD12 ' CD1' ' A' ' 34' ' ' PHE . 22.2 mt -73.67 146.15 44.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.128 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -75.62 162.32 28.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.841 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -64.16 -9.75 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.151 -0.968 . . . . 0.0 110.259 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 t -100.16 4.32 44.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.468 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.558 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 51.4 t80 -58.38 137.13 57.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 109.792 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 48' ' ' SER . 20.0 mtt -120.75 146.08 46.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.008 -1.058 . . . . 0.0 110.122 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 47.0 t -59.23 127.43 84.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 110.265 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 45.7 Cg_endo -71.47 -9.98 26.1 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.931 1.49 . . . . 0.0 109.754 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.647 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -95.09 -56.7 2.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 110.582 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.482 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.9 p -111.61 5.99 19.71 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.122 -0.986 . . . . 0.0 110.691 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.6 OUTLIER 62.54 16.56 8.85 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.337 -0.852 . . . . 0.0 112.072 178.512 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.448 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -69.05 167.69 19.29 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.835 -1.166 . . . . 0.0 109.804 179.47 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.7 Cg_endo -72.74 140.89 33.03 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.897 1.472 . . . . 0.0 110.625 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.572 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 9.6 tttm -48.25 -26.8 2.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -0.916 . . . . 0.0 109.99 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -62.82 -11.23 16.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.799 . . . . 0.0 110.156 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.64 0.3 56.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.257 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 13.0 m-85 -87.85 137.12 32.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 110.616 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -125.2 140.11 53.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 0.0 109.476 179.268 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 5.5 p . . . . . 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.162 . . . . 0.0 110.626 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt . . . . . 0 N--CA 1.505 2.291 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 5.9 m-85 -111.32 134.04 53.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 109.886 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 74.3 tt0 -119.72 141.69 49.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 0.0 110.111 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 6.5 t -77.9 114.24 16.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 0.0 110.402 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -14.9 62.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.805 -1.184 . . . . 0.0 108.524 178.593 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.18 -61.87 1.67 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.598 -0.689 . . . . 0.0 110.731 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.3 p -107.77 -4.5 18.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.015 -1.053 . . . . 0.0 110.952 -178.796 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 15' ' ' TYR . . . 83.18 3.83 90.03 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.622 177.463 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.588 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 69.3 t80 -48.39 173.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.719 -1.459 . . . . 0.0 109.023 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.588 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 11.9 mm -145.77 112.78 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.895 -1.128 . . . . 0.0 110.712 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 53.1 t80 -94.17 148.28 22.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.86 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -130.75 126.53 21.89 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -71.45 -33.58 10.73 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.852 1.448 . . . . 0.0 110.285 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -72.87 -2.32 20.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 5.3 ttmt -121.7 -43.08 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.047 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.72 168.17 20.89 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.763 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -85.19 56.44 3.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -1.015 . . . . 0.0 110.007 179.479 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' ASP . 32.2 tttt -41.19 -61.91 0.93 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.396 -0.815 . . . . 0.0 110.48 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -43.07 -30.41 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.804 . . . . 0.0 110.341 -179.981 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.09 -60.11 1.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.344 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.86 54.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.561 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -132.96 142.05 43.24 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.314 -1.11 . . . . 0.0 109.87 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.0 Cg_endo -69.69 160.72 48.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.914 1.481 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.455 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 42.9 Cg_endo -71.43 162.16 43.22 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.072 1.564 . . . . 0.0 111.027 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 82.74 14.17 76.25 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 64.7 m -107.44 125.79 31.51 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.263 -1.14 . . . . 0.0 110.039 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 45.5 Cg_endo -71.91 138.09 30.69 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.884 1.465 . . . . 0.0 110.685 -179.791 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.642 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -52.98 -41.45 64.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -55.39 -17.48 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.354 -0.841 . . . . 0.0 110.19 -179.684 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -85.26 -5.23 59.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 109.922 179.687 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 50' ' ' LYS . 22.1 mt -72.13 127.79 33.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 109.922 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 7.9 t -42.06 155.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 110.161 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 10.8 m-20 -66.72 -7.23 19.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.7 OUTLIER -100.78 3.37 42.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.568 -179.786 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.496 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 51.7 t80 -58.21 132.6 54.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.126 -0.984 . . . . 0.0 109.956 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.442 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -118.81 146.71 44.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.0 109.992 179.744 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.479 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 7.3 t -56.84 128.69 76.86 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 110.16 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.598 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.36 -11.92 29.11 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.777 1.409 . . . . 0.0 109.628 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.82 -62.57 1.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 110.675 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.542 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.9 p -100.8 3.35 41.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.217 -0.927 . . . . 0.0 111.017 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 2.8 tpp180 61.54 21.64 12.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.198 -0.939 . . . . 0.0 112.046 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 27.2 p -74.45 165.24 55.28 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.8 -1.188 . . . . 0.0 109.702 179.259 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 44.9 Cg_endo -71.38 142.45 41.03 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.722 1.38 . . . . 0.0 110.335 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 7.4 tttm -48.09 -24.84 1.22 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.012 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.87 -9.73 31.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.932 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -92.37 -2.21 56.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.262 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.584 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 3.2 m-85 -89.91 140.04 30.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.297 -0.877 . . . . 0.0 110.443 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 47.1 tttt -129.04 145.13 51.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 109.634 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.636 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 2.7 p . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.015 -1.053 . . . . 0.0 110.889 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.257 0.551 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 179.7 89.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 110.214 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.553 HD11 ' HE3' ' A' ' 7' ' ' LYS . 1.2 tt -177.72 171.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.55 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 8.4 m-20 -149.85 130.13 13.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.473 -0.767 . . . . 0.0 110.234 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 3.3 tp10 179.8 -141.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.55 27.33 21.0 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HE3' HD11 ' A' ' 3' ' ' ILE . 1.3 mttm -79.97 121.76 25.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -1.137 . . . . 0.0 109.677 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.666 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 9.3 m-85 -118.7 140.55 49.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 110.58 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.5 tm-20 -119.84 142.62 48.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.811 . . . . 0.0 109.464 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.4 t -77.8 115.58 17.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 0.0 110.299 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -15.68 63.85 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.749 -1.219 . . . . 0.0 108.522 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -60.76 1.95 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.608 -0.682 . . . . 0.0 110.699 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.2 p -108.21 -4.35 17.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.093 . . . . 0.0 110.91 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 82.74 3.53 90.46 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.648 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.715 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 65.3 t80 -49.25 173.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.429 . . . . 0.0 109.255 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.611 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 12.2 mm -144.41 110.6 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.025 -1.047 . . . . 0.0 110.525 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 54.9 t80 -83.69 128.48 34.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.916 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -110.16 121.15 42.47 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.2 Cg_endo -71.8 -34.06 9.35 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.859 1.452 . . . . 0.0 110.239 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.93 -14.78 62.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 0.0 109.902 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -113.26 -18.51 12.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 110.049 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 85.35 170.66 47.4 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.695 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.16 49.96 1.85 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -1.069 . . . . 0.0 109.855 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.97 -54.82 2.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.41 -0.806 . . . . 0.0 110.393 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -47.51 -37.02 11.16 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 110.2 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.1 -65.96 0.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.06 51.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.701 HG23 ' HD2' ' A' ' 29' ' ' PRO . 2.1 mp -133.48 147.38 64.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.277 -1.131 . . . . 0.0 109.888 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.701 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -70.3 161.07 47.33 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.955 1.503 . . . . 0.0 110.255 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.9 Cg_endo -72.03 163.78 37.72 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.01 1.531 . . . . 0.0 110.841 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.03 11.04 85.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 18.0 m -100.41 122.12 50.97 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.299 -1.119 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.903 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.2 Cg_endo -72.49 143.3 38.23 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.873 1.46 . . . . 0.0 110.71 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.666 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 30.5 t80 -54.52 -18.86 4.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.901 . . . . 0.0 109.796 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.903 HG22 ' HB2' ' A' ' 33' ' ' PRO . 15.1 m -70.5 -13.88 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.381 -0.824 . . . . 0.0 109.68 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.8 -7.16 56.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.0 110.363 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.56 HD12 ' CD1' ' A' ' 34' ' ' PHE . 19.2 mt -72.23 148.72 45.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.053 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.486 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -77.35 163.69 26.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.909 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -7.06 21.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.983 . . . . 0.0 110.174 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.06 2.68 35.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.339 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 48.0 t80 -58.72 136.31 57.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.757 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 48' ' ' SER . 30.0 mtt -119.46 145.85 45.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.019 -1.051 . . . . 0.0 110.025 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 34.6 t -58.88 128.28 84.31 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 110.194 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 45.8 Cg_endo -72.14 -10.16 25.49 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.857 1.451 . . . . 0.0 109.775 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.715 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -95.99 -58.78 2.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.467 -0.771 . . . . 0.0 110.452 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.533 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.9 p -108.29 5.38 25.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.882 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.35 17.46 9.42 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.201 -0.937 . . . . 0.0 112.049 178.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.451 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.9 m -70.46 167.93 23.09 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.91 -1.118 . . . . 0.0 109.833 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.2 Cg_endo -72.88 141.46 33.51 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.967 1.509 . . . . 0.0 110.527 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.591 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 7.9 tttm -48.4 -26.33 2.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.886 . . . . 0.0 109.832 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -63.85 -11.1 24.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 109.977 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.79 -1.41 57.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.331 -0.855 . . . . 0.0 109.6 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -88.08 138.66 31.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.519 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -129.03 144.43 51.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -0.84 . . . . 0.0 109.686 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.9 p -81.35 167.06 19.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.939 -1.101 . . . . 0.0 110.711 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.485 HG12 ' HB3' ' A' ' 7' ' ' LYS . 2.5 pt -122.2 72.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.614 -0.679 . . . . 0.0 110.096 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -106.74 65.88 0.68 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 110.237 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -142.97 152.61 42.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.271 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 59' ' ' VAL . 27.6 m -144.41 124.73 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 60' ' ' ILE . 55.6 mt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.237 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.274 0.559 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 58' ' ' LYS . 7.7 mp0 -116.53 114.09 23.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.153 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 56' ' ' ILE . 4.5 pt -144.21 136.47 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.204 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -160.2 126.15 4.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 110.183 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.518 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.3 mt-10 -178.11 64.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.049 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 43.89 26.02 0.73 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 5' ' ' GLU . 27.3 mtmt -87.12 127.38 35.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.182 -1.187 . . . . 0.0 109.845 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.647 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 31.0 m-85 -124.06 145.64 49.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.976 . . . . 0.0 110.62 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -116.78 139.58 50.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 0.0 109.703 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.0 t -76.91 115.96 17.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.085 -1.01 . . . . 0.0 110.596 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -16.2 64.04 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.955 -1.091 . . . . 0.0 108.583 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.16 -58.73 2.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.571 -0.705 . . . . 0.0 110.654 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.89 -4.02 16.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.053 -1.029 . . . . 0.0 110.932 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.755 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 80.09 7.06 88.86 Favored Glycine 0 N--CA 1.497 2.727 0 O-C-N 121.101 -0.999 . . . . 0.0 111.583 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.704 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 53.8 t80 -59.65 142.81 52.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.758 -1.436 . . . . 0.0 110.051 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -114.94 113.82 44.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.16 -0.962 . . . . 0.0 110.638 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.582 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.8 t80 -82.41 132.21 35.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.833 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.24 116.95 41.7 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 110.3 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 44.0 Cg_endo -70.38 -26.48 24.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.879 1.463 . . . . 0.0 110.343 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -72.5 -12.47 61.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.365 -0.835 . . . . 0.0 109.784 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -114.25 -39.72 3.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.525 -0.734 . . . . 0.0 109.857 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.67 167.64 22.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.632 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.13 53.75 2.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.559 -0.965 . . . . 0.0 109.819 179.255 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.82 -57.94 1.46 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 110.634 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.527 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 64.7 m-85 -47.61 -34.83 8.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.366 -0.834 . . . . 0.0 110.328 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.5 -65.88 0.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.374 -0.829 . . . . 0.0 110.083 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.22 52.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.632 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -130.76 144.98 55.68 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.213 -1.169 . . . . 0.0 109.93 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.593 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.5 Cg_endo -70.28 161.86 44.45 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.946 1.498 . . . . 0.0 110.533 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.0 Cg_endo -72.94 162.75 40.22 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.05 1.553 . . . . 0.0 110.902 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.98 11.91 85.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 92.2 m -97.02 124.76 48.59 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.223 -1.163 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.669 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.0 Cg_endo -72.77 138.8 29.59 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.799 1.421 . . . . 0.0 110.553 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.582 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 27.6 t80 -52.47 -41.91 63.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 0.0 110.066 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' A' ' 33' ' ' PRO . 15.9 m -53.66 -17.98 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 110.233 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 28.4 t0 -83.9 -7.31 59.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.965 . . . . 0.0 110.391 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.517 HD12 ' CD1' ' A' ' 34' ' ' PHE . 18.6 mt -70.03 154.37 42.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 110.028 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.54 151.42 36.35 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.18 -0.95 . . . . 0.0 109.885 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.95 -14.49 6.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.071 -1.018 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 p -97.65 5.17 49.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 110.381 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.8 t80 -59.68 137.62 57.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.142 -0.974 . . . . 0.0 109.873 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.2 mtt -117.18 143.73 45.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 47' ' ' ARG . 49.4 t -58.88 125.7 78.49 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.0 110.093 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 43.6 Cg_endo -70.61 -10.17 27.32 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.943 1.496 . . . . 0.0 109.93 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.704 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -92.82 -52.51 4.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.468 -0.77 . . . . 0.0 110.294 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.8 p -119.32 8.89 11.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.705 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' CYS . 8.7 ttm-85 62.51 13.52 6.25 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.277 -0.89 . . . . 0.0 112.243 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.495 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 16.6 p -66.0 166.96 13.26 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.886 -1.134 . . . . 0.0 109.921 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.2 Cg_endo -73.0 142.49 34.73 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.679 1.357 . . . . 0.0 110.373 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.545 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 24.2 tttm -49.04 -29.82 5.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 109.951 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -63.89 -10.8 22.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.333 -0.854 . . . . 0.0 109.806 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -87.53 -4.81 58.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.268 -0.895 . . . . 0.0 109.757 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 29.0 m-85 -79.99 132.75 36.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.584 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HB3' ' OE2' ' A' ' 9' ' ' GLU . 42.9 tttt -105.16 130.14 53.4 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.647 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -80.6 160.35 25.13 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 110.342 -179.299 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 3' ' ' ILE . 2.7 pt -147.46 68.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 0.0 110.336 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -97.84 61.46 1.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -0.89 . . . . 0.0 110.06 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -82.67 107.14 15.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 59' ' ' VAL . 47.1 t -115.03 55.24 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.878 . . . . 0.0 110.085 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.467 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 33.6 mm . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.181 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.666 ' HG2' HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.26 0.553 . . . . 0.0 110.169 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.552 ' C ' HG23 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -110.98 71.79 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.21 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.552 HG23 ' C ' ' A' ' 2' ' ' GLU . 8.3 pt -156.17 -176.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.131 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.441 ' HB3' ' HG2' ' A' ' 57' ' ' LYS . 3.8 m-20 -149.86 128.24 12.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.198 -0.939 . . . . 0.0 110.256 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -176.49 -144.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 110.153 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.478 ' CA ' ' HG3' ' A' ' 19' ' ' PRO . . . -101.13 29.44 12.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.474 ' HD2' ' HB3' ' A' ' 5' ' ' GLU . 1.6 mttt -85.78 121.34 28.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -1.126 . . . . 0.0 109.831 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.638 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 29.9 m-85 -123.06 147.14 47.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 0.0 110.647 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 27.3 tt0 -117.24 137.34 52.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.429 -0.794 . . . . 0.0 109.549 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' GLY . 3.3 t -75.87 117.87 18.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.032 -1.042 . . . . 0.0 110.775 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -16.41 63.54 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.901 -1.124 . . . . 0.0 108.46 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.22 -57.68 2.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.672 -0.643 . . . . 0.0 110.48 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.503 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -110.75 -2.98 15.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.092 -1.005 . . . . 0.0 110.927 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.709 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 77.39 8.46 87.06 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.095 -1.003 . . . . 0.0 111.467 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 42.9 t80 -61.1 144.86 52.75 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.903 -1.351 . . . . 0.0 109.838 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -114.85 113.47 43.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.133 -0.979 . . . . 0.0 110.485 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.4 t80 -81.75 127.66 33.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.747 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -106.47 117.69 56.46 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.467 -0.77 . . . . 0.0 110.27 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.9 Cg_endo -70.04 -30.64 20.68 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.937 1.493 . . . . 0.0 110.198 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.04 -11.09 60.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.97 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 6.0 mtpt -110.62 -42.05 4.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 110.051 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.17 165.77 21.28 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.577 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.22 56.39 3.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.516 -0.991 . . . . 0.0 109.893 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.12 -57.23 1.72 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.825 . . . . 0.0 110.809 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 94.8 m-85 -47.13 -33.6 5.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.587 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.67 -64.3 1.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.189 -0.944 . . . . 0.0 110.399 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.0 53.68 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.577 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.1 mp -128.76 144.97 54.39 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.34 -1.094 . . . . 0.0 109.82 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -71.35 160.31 49.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.997 1.524 . . . . 0.0 110.421 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.11 163.16 39.61 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.004 1.529 . . . . 0.0 110.777 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.78 13.01 84.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.6 m -99.98 127.42 33.61 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.205 -1.173 . . . . 0.0 110.214 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 47.8 Cg_endo -73.15 140.15 30.57 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.969 1.51 . . . . 0.0 110.717 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.577 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.5 t80 -52.03 -41.92 62.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.138 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -17.65 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 110.476 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 4.3 t0 -84.07 -7.4 59.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.989 . . . . 0.0 110.249 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 mt -69.35 155.68 40.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.055 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -76.2 148.67 37.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.96 . . . . 0.0 109.785 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -15.81 5.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.996 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.7 5.63 49.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 110.346 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.523 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 54.8 t80 -60.0 139.89 57.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.207 -0.933 . . . . 0.0 109.904 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -118.23 143.31 46.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.07 -1.019 . . . . 0.0 110.027 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 47' ' ' ARG . 48.7 t -58.7 126.23 79.42 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.898 . . . . 0.0 110.139 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.582 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 43.8 Cg_endo -70.97 -10.48 27.67 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.911 1.48 . . . . 0.0 109.898 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -92.89 -52.42 4.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.46 -0.775 . . . . 0.0 110.34 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.6 p -118.98 9.15 11.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.684 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.79 13.72 5.65 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.248 -0.908 . . . . 0.0 112.209 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.5 m -66.47 169.13 8.07 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.832 -1.168 . . . . 0.0 109.878 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 48.0 Cg_endo -74.11 141.79 29.99 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.793 1.417 . . . . 0.0 110.405 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.568 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 26.6 tttm -49.85 -30.9 10.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 109.806 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -62.9 -11.9 21.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -87.16 -3.65 59.07 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.404 -0.81 . . . . 0.0 109.77 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 15.2 m-85 -79.94 132.49 36.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 110.399 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.24 129.46 50.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.009 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.638 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -81.89 160.83 23.33 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 110.368 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.666 HD13 ' HG2' ' A' ' 1' ' ' MET . 1.2 pp -136.59 76.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.833 . . . . 0.0 110.219 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HG2' ' HB3' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -102.97 63.16 0.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.16 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.498 ' HG2' ' CD1' ' A' ' 60' ' ' ILE . 0.4 OUTLIER -132.63 157.69 44.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 110.266 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 48.7 t -125.21 61.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.0 110.167 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.498 ' CD1' ' HG2' ' A' ' 58' ' ' LYS . 3.4 mp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.208 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' O ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.235 0.541 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.643 ' O ' HG23 ' A' ' 3' ' ' ILE . 1.2 tt0 -83.0 65.19 8.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 2' ' ' GLU . 1.2 pt -158.09 135.29 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.502 ' OD2' ' CG2' ' A' ' 59' ' ' VAL . 36.5 m-20 -128.62 126.14 39.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.336 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -164.85 52.91 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.297 -0.877 . . . . 0.0 109.966 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 43.24 26.27 0.54 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 5' ' ' GLU . 10.5 tttt -86.3 130.8 34.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.031 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.663 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 37.6 m-85 -121.37 143.71 49.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.26 -0.9 . . . . 0.0 110.351 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' O ' ' CG ' ' A' ' 54' ' ' LYS . 7.4 mt-10 -117.04 139.83 50.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.366 -0.834 . . . . 0.0 110.374 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -76.31 113.01 13.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.999 -1.063 . . . . 0.0 110.412 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.6 -15.52 61.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.808 -1.183 . . . . 0.0 108.606 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.2 -61.73 1.7 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.565 -0.709 . . . . 0.0 110.634 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.508 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -107.19 -3.25 20.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 110.97 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.791 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.02 7.54 88.39 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.434 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 29.0 t80 -59.49 142.02 53.45 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.836 -1.391 . . . . 0.0 109.692 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.791 HD12 ' O ' ' A' ' 14' ' ' GLY . 1.9 mp -114.6 115.46 49.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 32.1 t80 -83.78 137.82 33.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -116.28 119.76 36.0 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 110.43 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.2 Cg_endo -69.95 -33.24 16.27 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.905 1.476 . . . . 0.0 110.115 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.32 -12.89 61.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.838 . . . . 0.0 109.788 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -14.85 11.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.913 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 79.97 172.91 44.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.656 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.15 49.56 1.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -1.048 . . . . 0.0 109.759 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ASP . 16.8 ttmt -39.7 -59.0 1.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.57 -0.706 . . . . 0.0 110.442 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.549 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 1.1 m-85 -44.51 -32.83 1.52 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.376 -0.827 . . . . 0.0 110.088 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -93.79 -61.92 1.45 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 0.0 110.263 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.28 51.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.656 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -134.01 143.75 48.64 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.286 -1.126 . . . . 0.0 109.944 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.515 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.1 Cg_endo -68.52 160.95 47.11 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.004 1.529 . . . . 0.0 110.277 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 44.2 Cg_endo -71.76 162.93 40.53 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.027 1.541 . . . . 0.0 111.034 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 81.31 13.29 80.89 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 3.7 m -102.97 121.58 48.59 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.24 -1.153 . . . . 0.0 110.136 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.772 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.1 Cg_endo -72.52 135.11 23.59 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.799 1.42 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 8.0 t80 -47.89 -39.91 20.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.281 -0.887 . . . . 0.0 110.161 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 33' ' ' PRO . 10.6 m -53.54 -22.12 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.401 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 21.2 t0 -84.31 -5.79 59.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 110.367 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.511 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 17.0 mt -72.31 123.34 22.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 110.271 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 7.2 m -41.4 151.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -0.828 . . . . 0.0 110.205 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -63.91 -10.0 18.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -100.02 5.38 45.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.579 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.504 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 55.5 t80 -59.77 138.05 57.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.791 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.0 mtm -122.46 148.06 45.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.978 -1.076 . . . . 0.0 109.936 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 2.0 t -55.75 129.95 71.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 110.5 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.549 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -72.59 -12.55 26.97 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 123.835 1.439 . . . . 0.0 109.114 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.24 -67.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.592 -0.692 . . . . 0.0 110.667 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.508 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.7 p -93.82 1.18 56.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 111.113 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 2.6 ttm180 61.06 31.12 19.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.083 -1.011 . . . . 0.0 111.764 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.4 m -85.01 168.62 19.7 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.775 -1.203 . . . . 0.0 109.883 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.1 Cg_endo -72.42 138.84 30.64 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.959 1.505 . . . . 0.0 110.457 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.614 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 20.9 tttm -51.0 -31.16 17.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.047 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -63.33 -12.11 27.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 109.73 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -85.04 -5.96 59.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.73 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.614 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 23.2 m-85 -79.99 137.96 36.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 110.553 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.508 ' CG ' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -109.71 132.75 53.86 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.384 -0.823 . . . . 0.0 108.997 178.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.663 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -81.13 161.64 24.01 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.072 -1.018 . . . . 0.0 110.443 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.88 62.71 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.394 -0.816 . . . . 0.0 110.109 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HG3' ' HB3' ' A' ' 4' ' ' ASP . 4.1 tttt -97.47 60.83 1.62 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.244 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 1' ' ' MET . 7.1 mmtt -119.52 140.86 49.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.868 . . . . 0.0 110.186 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 45.9 t -123.33 62.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 110.187 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.401 ' OXT' HG13 ' A' ' 60' ' ' ILE . 3.1 pt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.181 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 3' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.253 0.549 . . . . 0.0 110.276 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 1.5 pp20? -48.01 153.31 0.67 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 110.212 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 1' ' ' MET . 6.3 pt -146.36 135.22 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 15.9 t0 -92.45 -149.57 0.25 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.3 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.491 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 32.4 tt0 175.42 -23.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 0.0 110.615 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.36 4.58 17.75 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.55 ' HB3' HD13 ' A' ' 56' ' ' ILE . 4.0 tttt -85.68 118.21 25.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -1.195 . . . . 0.0 109.664 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.609 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 30.7 m-85 -128.92 146.69 50.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.125 -0.984 . . . . 0.0 110.808 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 4.0 mt-10 -116.95 143.2 45.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 0.0 109.578 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 4.3 t -78.13 114.38 16.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.913 -1.117 . . . . 0.0 110.709 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.32 -15.68 63.83 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.915 -1.116 . . . . 0.0 108.41 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -59.62 2.28 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.728 -0.608 . . . . 0.0 110.712 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -109.13 -4.87 16.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.976 -1.078 . . . . 0.0 110.972 -178.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.682 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 84.27 3.63 88.63 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.957 -1.089 . . . . 0.0 111.728 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.848 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 77.7 t80 -52.46 174.34 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.748 -1.443 . . . . 0.0 109.564 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.682 HD12 ' O ' ' A' ' 14' ' ' GLY . 1.2 mp -148.12 110.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.991 . . . . 0.0 110.227 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 49.0 t80 -81.21 123.47 28.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.829 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -107.87 116.91 56.49 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 110.197 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.8 Cg_endo -70.05 -27.46 25.08 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.812 1.427 . . . . 0.0 110.401 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -73.07 -15.18 61.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.342 -0.849 . . . . 0.0 109.998 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 -12.06 12.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.788 . . . . 0.0 109.973 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 80.99 165.74 34.48 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.683 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.21 50.16 1.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -1.064 . . . . 0.0 109.897 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.78 -51.62 2.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.5 -0.75 . . . . 0.0 110.374 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -49.41 -38.7 30.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.385 -0.822 . . . . 0.0 110.28 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.64 -67.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -0.881 . . . . 0.0 110.404 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.73 51.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.825 HG21 HG21 ' A' ' 32' ' ' THR . 2.1 mp -133.69 147.09 63.08 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.27 -1.135 . . . . 0.0 109.921 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.705 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.9 Cg_endo -71.42 165.49 32.31 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.987 1.519 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.9 Cg_endo -72.04 162.51 41.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.96 1.505 . . . . 0.0 110.832 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.81 12.49 82.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.825 HG21 HG21 ' A' ' 28' ' ' ILE . 21.7 m -92.32 122.97 63.67 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -1.139 . . . . 0.0 110.19 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.99 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.5 Cg_endo -72.7 139.07 30.25 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.879 1.463 . . . . 0.0 110.651 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.588 ' CE2' ' HE2' ' A' ' 50' ' ' LYS . 79.8 t80 -55.9 -17.78 7.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.887 . . . . 0.0 109.819 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.99 HG22 ' HB2' ' A' ' 33' ' ' PRO . 14.2 m -73.78 -7.47 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.67 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -95.31 -7.58 38.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 110.383 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.553 HD12 ' CD1' ' A' ' 34' ' ' PHE . 18.3 mt -70.94 147.61 48.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.97 . . . . 0.0 109.978 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.7 m -75.49 155.41 36.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.843 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -58.7 -14.19 7.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.129 -0.982 . . . . 0.0 110.268 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.23 5.43 50.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 110.55 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.527 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.6 t80 -59.01 135.74 57.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.682 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.0 mtp -118.24 146.05 44.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.057 -1.027 . . . . 0.0 110.351 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 47' ' ' ARG . 42.5 t -61.22 124.27 79.67 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.408 -0.808 . . . . 0.0 110.097 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.602 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.0 Cg_endo -70.48 -7.87 22.29 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.883 1.465 . . . . 0.0 109.823 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.848 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -94.0 -54.84 3.44 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.477 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 10.3 p -115.99 7.02 14.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.438 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 43' ' ' CYS . 6.0 ttm180 63.21 15.94 9.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.241 -0.912 . . . . 0.0 112.171 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 20.6 p -68.64 166.56 25.51 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 0.0 109.811 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.2 Cg_endo -72.29 142.01 36.66 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.733 1.386 . . . . 0.0 110.495 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.588 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 10.5 tttm -48.51 -28.47 3.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 109.961 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.99 -10.42 21.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -0.87 . . . . 0.0 109.886 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -88.66 -4.19 58.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.276 -0.89 . . . . 0.0 109.695 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 19.1 m-85 -80.18 132.34 35.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 110.589 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.48 128.83 53.77 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.609 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -79.16 160.78 26.83 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.059 -1.026 . . . . 0.0 110.02 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.55 HD13 ' HB3' ' A' ' 7' ' ' LYS . 7.4 pt -96.45 -40.81 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.473 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.503 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 9.1 ttmt 58.87 94.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.978 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.491 ' NZ ' ' OE1' ' A' ' 5' ' ' GLU . 6.9 mttp -74.58 165.1 25.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.409 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 14.8 p -125.24 138.42 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 110.184 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 1' ' ' MET . 5.3 tt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.189 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' HB3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.254 0.55 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.617 ' O ' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -101.83 82.72 2.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.153 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 2' ' ' GLU . 19.8 pt -157.83 152.62 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 110.245 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.412 ' HB2' ' HG2' ' A' ' 57' ' ' LYS . 22.9 p-10 -160.77 134.61 6.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 6' ' ' GLY . 2.2 tt0 -173.15 60.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.054 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 44.36 25.82 0.86 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 5' ' ' GLU . 22.2 mtpt -86.77 127.95 35.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 0.0 110.007 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.614 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 22.4 m-85 -120.05 146.99 45.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.295 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 70.7 tt0 -121.4 139.89 52.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.7 t -77.11 117.01 18.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.025 . . . . 0.0 110.398 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -68.07 -16.53 64.06 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.785 -1.197 . . . . 0.0 108.617 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.13 -59.14 2.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.637 -0.664 . . . . 0.0 110.574 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.37 -3.76 16.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.006 -1.059 . . . . 0.0 110.918 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.4 6.13 89.02 Favored Glycine 0 N--CA 1.496 2.696 0 O-C-N 121.081 -1.012 . . . . 0.0 111.43 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 17.7 t80 -56.79 144.2 33.9 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.927 -1.337 . . . . 0.0 109.829 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 13.3 mm -115.99 111.27 34.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.651 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.9 t80 -81.24 121.42 26.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.835 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -101.84 118.48 59.38 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.251 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -72.0 -29.25 15.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.968 1.509 . . . . 0.0 110.166 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.08 -9.23 58.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 110.224 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.5 mmmp? -111.81 -45.48 3.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.273 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.52 159.57 12.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.553 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.19 55.18 3.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -1.06 . . . . 0.0 109.882 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.54 -51.59 2.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 110.499 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 65.3 m-85 -51.25 -37.95 49.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.844 . . . . 0.0 110.294 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.54 -68.52 0.78 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 110.183 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.43 53.85 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.651 ' CG2' HG21 ' A' ' 32' ' ' THR . 1.4 mp -131.84 143.37 48.8 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.232 -1.158 . . . . 0.0 109.949 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -72.0 168.67 23.32 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.012 1.533 . . . . 0.0 110.36 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.2 Cg_endo -72.25 161.38 44.65 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.889 1.468 . . . . 0.0 110.88 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.67 15.47 80.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.651 HG21 ' CG2' ' A' ' 28' ' ' ILE . 31.4 m -95.54 122.59 58.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.263 -1.139 . . . . 0.0 110.227 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.785 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -73.26 138.72 28.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.862 1.454 . . . . 0.0 110.58 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.584 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 13.7 t80 -53.13 -40.18 64.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.115 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.785 HG22 ' HB2' ' A' ' 33' ' ' PRO . 11.4 m -53.77 -18.09 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 110.177 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.51 -7.16 59.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.107 -0.996 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.485 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.2 mt -71.86 151.87 43.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.944 . . . . 0.0 110.077 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -76.95 158.68 30.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -10.85 15.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 0.0 110.158 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 4.12 45.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.398 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.483 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 50.0 t80 -59.47 134.73 57.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -0.945 . . . . 0.0 109.845 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -118.81 146.86 44.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.048 -1.033 . . . . 0.0 109.853 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.9 t -56.89 130.01 78.48 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 110.422 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.531 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -72.05 -11.85 27.61 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.865 1.455 . . . . 0.0 109.51 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.42 -64.9 1.0 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 110.751 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.534 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.3 p -98.69 3.34 47.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 0.0 111.109 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 6.0 ttm180 62.09 21.68 12.56 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.05 -1.031 . . . . 0.0 111.994 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.7 m -74.98 168.24 29.36 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.776 -1.202 . . . . 0.0 109.931 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.5 Cg_endo -73.53 141.87 32.0 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.917 1.483 . . . . 0.0 110.561 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 41.3 tttm -50.19 -30.24 11.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.005 . . . . 0.0 109.968 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.04 -12.46 19.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.28 -0.888 . . . . 0.0 109.872 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -88.44 -2.37 58.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.279 -0.888 . . . . 0.0 109.798 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -86.15 139.1 31.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 110.688 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 138.24 54.37 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.0 t -85.4 172.79 10.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.66 -1.275 . . . . 0.0 110.787 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 56' ' ' ILE . 5.7 pt -138.33 71.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.208 0.528 . . . . 0.0 110.281 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.412 ' HG2' ' HB2' ' A' ' 4' ' ' ASP . 16.9 mttp -107.42 65.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.149 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -96.68 74.58 2.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.242 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -83.42 92.55 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.185 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.444 ' OXT' ' CG1' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.241 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 mmt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.299 0.571 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.8 OUTLIER -175.41 97.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.249 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.456 HG13 ' HB2' ' A' ' 58' ' ' LYS . 4.6 pt -151.69 126.67 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.152 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 5' ' ' GLU . 6.7 p-10 -145.71 125.56 13.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 110.301 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER 175.28 70.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.086 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 47.23 30.13 5.43 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . 9.6 mttt -77.95 119.17 21.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -1.092 . . . . 0.0 109.624 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.625 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.2 m-85 -118.37 138.41 52.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 110.701 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -116.04 140.25 49.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.436 -0.79 . . . . 0.0 109.554 179.321 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.7 t -75.93 115.55 15.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.954 . . . . 0.0 110.148 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -16.12 63.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.789 -1.194 . . . . 0.0 108.684 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.16 -60.8 1.93 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.593 -0.692 . . . . 0.0 110.552 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.2 p -108.31 -2.97 18.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.001 . . . . 0.0 111.001 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.723 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 78.65 6.95 88.33 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.013 -1.054 . . . . 0.0 111.418 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 4.8 t80 -58.16 142.76 46.32 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.968 -1.313 . . . . 0.0 109.695 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.723 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -110.53 113.62 44.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.481 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 50.9 t80 -82.89 121.29 26.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 109.882 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -100.0 118.24 61.93 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 110.318 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -71.32 -35.93 7.72 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.82 1.432 . . . . 0.0 110.114 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -71.62 -10.51 59.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.801 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 -12.83 13.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.971 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.502 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 76.54 170.84 32.29 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.57 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 1.8 t70 -85.28 59.02 5.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.455 -1.026 . . . . 0.0 109.66 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -36.92 -62.99 0.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.555 -0.716 . . . . 0.0 110.699 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.538 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 18.5 m-85 -42.46 -27.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 110.32 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -101.04 -58.2 1.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.434 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.87 -10.07 1.2 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.185 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.558 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -61.27 141.2 94.27 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.061 -1.258 . . . . 0.0 109.73 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.9 Cg_endo -69.75 160.52 49.42 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.899 1.473 . . . . 0.0 110.665 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 45.1 Cg_endo -72.43 165.42 32.73 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.075 1.566 . . . . 0.0 110.702 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.15 12.83 83.23 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 20.4 m -103.79 126.33 32.18 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -1.144 . . . . 0.0 110.128 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.764 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.3 Cg_endo -73.11 142.92 35.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.889 1.468 . . . . 0.0 110.54 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.575 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.1 t80 -51.3 -36.39 42.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.885 . . . . 0.0 110.142 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.764 HG22 ' HB2' ' A' ' 33' ' ' PRO . 12.5 m -54.32 -17.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -84.36 -7.41 59.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 110.303 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.572 HD12 ' CD2' ' A' ' 34' ' ' PHE . 38.3 mt -71.22 152.79 42.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 110.076 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.461 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 1.4 m -80.15 167.85 19.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.95 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -73.59 -0.73 16.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 110.187 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 t -109.8 -0.12 18.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.168 -0.957 . . . . 0.0 110.387 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.57 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.9 t80 -59.7 138.69 57.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 109.791 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 48' ' ' SER . 11.4 mtt -120.93 145.77 47.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.129 -0.982 . . . . 0.0 110.051 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.472 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 12.9 t -55.53 131.35 71.05 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.838 . . . . 0.0 110.114 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.538 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 47.0 Cg_endo -73.38 -13.32 25.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.923 1.486 . . . . 0.0 109.609 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.78 -59.42 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.775 . . . . 0.0 110.95 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.526 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.0 p -105.15 5.06 31.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 111.076 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER 61.79 17.8 9.13 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.195 -0.94 . . . . 0.0 112.251 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 21.4 p -70.29 165.96 39.1 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.161 . . . . 0.0 109.672 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 45.8 Cg_endo -72.23 142.71 38.18 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.692 1.364 . . . . 0.0 110.388 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.548 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 27.3 tttm -48.78 -27.72 3.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 109.927 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.96 -11.18 26.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.35 -0.844 . . . . 0.0 109.825 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.3 mm-40 -89.84 -2.96 58.32 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.379 -0.825 . . . . 0.0 109.589 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 24.3 m-85 -87.7 139.22 30.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -132.08 147.88 52.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.651 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 3.2 p -83.24 166.31 18.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.023 . . . . 0.0 110.468 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 7' ' ' LYS . 12.8 pt -118.59 -43.97 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.553 -0.717 . . . . 0.0 110.3 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' N ' HG13 ' A' ' 56' ' ' ILE . 44.3 mttm 38.44 73.1 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.575 -0.703 . . . . 0.0 110.617 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HB2' HG13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -105.07 139.58 39.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.128 -0.983 . . . . 0.0 110.27 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 2.6 p 179.9 130.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.446 ' H ' HG22 ' A' ' 60' ' ' ILE . 13.5 tt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.902 -1.046 . . . . 0.0 110.267 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.256 0.55 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . 0.4 OUTLIER -82.85 108.15 15.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.178 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.4 pt -147.19 144.17 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.176 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 4' ' ' ASP . 43.7 p-10 -160.68 136.13 7.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.261 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER 175.6 30.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.878 . . . . 0.0 110.527 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.75 30.82 12.26 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.54 125.14 33.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.196 -1.179 . . . . 0.0 109.763 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 16.6 m-85 -123.55 152.91 41.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.207 -0.933 . . . . 0.0 110.405 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -125.64 141.19 52.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.418 -0.801 . . . . 0.0 109.527 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 5.0 t -78.01 117.32 19.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.506 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -16.36 63.92 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.595 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.12 -59.56 2.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.683 -0.636 . . . . 0.0 110.595 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.28 -3.91 16.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.992 -1.067 . . . . 0.0 110.775 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.766 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.95 5.67 89.44 Favored Glycine 0 N--CA 1.497 2.707 0 O-C-N 121.136 -0.977 . . . . 0.0 111.587 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 41.7 t80 -57.13 144.47 34.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.862 -1.375 . . . . 0.0 109.937 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.766 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -115.96 111.28 34.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.23 -0.919 . . . . 0.0 110.601 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 38.3 t80 -80.83 123.17 28.03 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.264 -0.897 . . . . 0.0 109.574 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -106.95 116.73 58.1 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 110.226 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' THR . 44.3 Cg_endo -71.19 -24.97 22.76 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.792 1.417 . . . . 0.0 110.24 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 15.3 tt0 -73.14 -9.94 59.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.08 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.1 tttp -114.78 -43.26 3.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.125 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.98 159.51 13.13 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.556 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.09 55.18 3.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.445 -1.032 . . . . 0.0 109.94 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.74 -50.16 3.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.596 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 26.1 m-85 -52.12 -39.25 59.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 110.354 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.55 -69.22 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.213 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.28 54.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.69 HG21 HG21 ' A' ' 32' ' ' THR . 1.4 mp -131.0 144.22 52.68 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.236 -1.156 . . . . 0.0 110.04 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.599 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -71.39 166.63 28.72 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.015 1.534 . . . . 0.0 110.505 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.3 Cg_endo -72.34 161.9 43.07 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.915 1.481 . . . . 0.0 110.819 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 73.58 13.65 80.1 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.69 HG21 HG21 ' A' ' 28' ' ' ILE . 16.9 m -94.69 121.97 61.78 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.266 -1.138 . . . . 0.0 110.19 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.79 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.3 Cg_endo -71.89 141.4 36.96 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.81 1.426 . . . . 0.0 110.669 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.749 ' CD1' HD12 ' A' ' 37' ' ' LEU . 85.5 t80 -56.06 -18.1 8.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 33' ' ' PRO . 4.3 m -70.63 -11.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.38 -0.825 . . . . 0.0 109.47 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -89.35 -6.87 56.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.503 -0.748 . . . . 0.0 110.265 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.749 HD12 ' CD1' ' A' ' 34' ' ' PHE . 19.1 mt -73.63 144.75 45.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.143 -0.973 . . . . 0.0 110.044 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.2 t -75.46 160.38 30.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 110.096 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -62.27 -11.55 15.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.217 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.17 4.89 46.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.359 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.526 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 51.8 t80 -59.89 135.58 57.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.119 -0.988 . . . . 0.0 109.876 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -118.78 146.49 44.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.066 -1.022 . . . . 0.0 109.868 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.6 t -55.93 131.61 73.5 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.579 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 44.6 Cg_endo -72.4 -12.61 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.901 1.474 . . . . 0.0 109.585 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.88 -65.74 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.502 -0.749 . . . . 0.0 110.866 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.6 p -96.62 2.87 52.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 0.0 111.205 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HB3' ' O ' ' A' ' 46' ' ' CYS . 0.1 OUTLIER 61.88 22.37 12.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.133 -0.979 . . . . 0.0 111.997 178.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.9 m -75.73 168.16 30.22 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.786 -1.196 . . . . 0.0 109.92 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.1 Cg_endo -73.37 141.91 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.796 1.419 . . . . 0.0 110.494 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 11.9 tttm -50.17 -29.3 8.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 1.9 m-20 -62.4 -12.36 21.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.874 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -89.54 -1.58 58.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.284 -0.885 . . . . 0.0 109.727 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 3.2 m-85 -85.71 137.75 32.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.921 . . . . 0.0 110.421 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.42 137.99 54.47 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.0 t -87.14 174.19 8.78 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.761 -1.212 . . . . 0.0 110.454 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.481 HG13 ' N ' ' A' ' 57' ' ' LYS . 9.7 pt -130.47 -44.92 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.156 -0.617 . . . . 0.0 110.431 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.481 ' N ' HG13 ' A' ' 56' ' ' ILE . 10.2 mttt 41.85 71.42 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.359 -0.838 . . . . 0.0 110.195 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.424 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 2.4 tttt -84.96 148.16 26.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.11 -0.994 . . . . 0.0 110.276 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 59' ' ' VAL . 11.2 p -177.04 59.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.26 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.212 0.53 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.584 ' C ' HG23 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -112.12 86.61 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.901 . . . . 0.0 110.249 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.584 HG23 ' C ' ' A' ' 2' ' ' GLU . 1.1 pt -155.21 145.58 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 0.0 110.104 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.559 ' OD2' HG22 ' A' ' 59' ' ' VAL . 8.4 m-20 -145.08 129.21 17.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 110.307 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.2 pt-20 178.82 29.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.805 . . . . 0.0 110.383 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.57 28.12 30.63 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.735 ' HB3' HD11 ' A' ' 56' ' ' ILE . 3.3 mttt -79.69 122.84 27.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -1.051 . . . . 0.0 109.696 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 9.8 m-85 -115.57 138.46 51.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 110.44 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.769 ' HG3' HG21 ' A' ' 56' ' ' ILE . 5.0 mt-10 -117.98 140.24 50.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 109.561 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 14' ' ' GLY . 5.3 t -77.14 115.77 17.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 110.283 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -16.19 63.96 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.773 -1.205 . . . . 0.0 108.638 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.12 -60.68 1.97 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.6 -0.687 . . . . 0.0 110.689 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.21 -3.72 18.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.067 -1.02 . . . . 0.0 110.909 -179.034 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.773 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 80.14 6.02 89.38 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.059 -1.025 . . . . 0.0 111.591 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 41.9 t80 -57.53 143.2 41.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.798 -1.413 . . . . 0.0 109.872 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.773 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -114.34 112.93 42.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.231 -0.918 . . . . 0.0 110.752 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 38.2 t80 -81.49 125.16 30.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.562 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -101.12 117.58 62.02 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.468 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 43.1 Cg_endo -71.24 -36.38 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.877 1.462 . . . . 0.0 109.98 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -9.69 54.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 109.747 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE3' ' HE3' ' A' ' 24' ' ' LYS . 1.7 tmtm? -117.09 -17.55 10.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.474 -0.766 . . . . 0.0 109.724 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.486 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 83.19 172.61 48.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.744 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -85.12 49.81 1.82 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -1.04 . . . . 0.0 109.784 179.13 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.9 ttmt -39.3 -58.32 1.23 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.535 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.0 -33.08 1.89 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.55 -62.68 1.32 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.901 . . . . 0.0 110.243 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.16 51.16 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.744 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -131.22 146.82 63.69 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.238 -1.154 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.648 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.5 Cg_endo -69.78 155.44 65.86 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.891 1.469 . . . . 0.0 110.228 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.486 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 44.0 Cg_endo -71.17 165.34 32.71 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.871 1.458 . . . . 0.0 110.788 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 79.03 11.28 85.33 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 13.0 m -103.51 125.44 34.89 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.294 -1.121 . . . . 0.0 110.193 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.736 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.7 Cg_endo -73.06 142.29 34.23 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.87 1.458 . . . . 0.0 110.473 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 31.7 t80 -51.92 -39.2 58.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 110.033 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 33' ' ' PRO . 11.4 m -55.14 -17.08 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.424 -0.797 . . . . 0.0 110.119 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 8.9 t70 -84.22 -6.87 59.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 110.253 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.509 HD13 ' CD1' ' A' ' 41' ' ' PHE . 17.9 mt -72.26 155.71 39.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 109.937 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.7 t -78.74 164.23 24.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.922 . . . . 0.0 110.071 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -5.88 21.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.9 m -103.4 1.49 32.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.203 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 37' ' ' LEU . 41.2 t80 -58.53 133.7 56.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.048 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' SER . 4.6 mtm -120.84 147.54 45.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 109.965 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.5 t -56.34 128.38 73.15 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.357 -0.84 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.535 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.1 Cg_endo -70.84 -11.42 29.41 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.785 1.413 . . . . 0.0 109.267 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.23 -67.95 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.487 -0.758 . . . . 0.0 110.663 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.533 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.7 p -94.53 2.06 55.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 111.06 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.56 23.78 14.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.143 -0.973 . . . . 0.0 111.892 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 52' ' ' GLN . 2.2 t -75.79 160.72 78.26 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.755 -1.216 . . . . 0.0 109.909 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 43.2 Cg_endo -69.85 144.39 53.38 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.677 1.356 . . . . 0.0 110.323 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.567 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 18.3 tttm -49.22 -26.7 3.1 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.292 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -64.07 -11.62 31.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.896 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.523 ' CB ' ' OG ' ' A' ' 48' ' ' SER . 1.3 tm0? -91.96 -0.85 57.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.616 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 8.3 m-85 -89.54 138.77 31.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.683 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -128.1 143.6 51.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 109.522 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.67 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.7 p -81.53 167.65 19.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.885 -1.135 . . . . 0.0 110.923 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.769 HG21 ' HG3' ' A' ' 9' ' ' GLU . 3.1 pt -142.1 82.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.668 -0.645 . . . . 0.0 109.97 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.422 ' C ' ' OD1' ' A' ' 4' ' ' ASP . 41.8 mttm -105.87 65.61 0.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.5 158.0 19.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.376 -0.827 . . . . 0.0 110.123 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.559 HG22 ' OD2' ' A' ' 4' ' ' ASP . 14.4 t -136.58 56.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.162 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.622 ' O ' HG23 ' A' ' 60' ' ' ILE . 3.7 tp . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.226 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.734 ' O ' HG23 ' A' ' 59' ' ' VAL . 10.3 ttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.172 0.511 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 1' ' ' MET . 4.8 tt0 177.03 115.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.311 -0.868 . . . . 0.0 110.185 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 9.4 pt -139.57 134.58 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.228 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 1.8 p30 -163.76 128.03 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.925 . . . . 0.0 110.286 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -174.82 61.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 46.07 27.61 2.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.678 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -81.68 121.46 26.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -1.159 . . . . 0.0 109.894 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.676 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 13.8 m-85 -116.5 143.9 45.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.94 . . . . 0.0 110.424 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -121.34 139.11 53.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.942 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.8 t -76.53 116.85 17.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.95 . . . . 0.0 110.327 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.09 -16.19 63.91 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.732 -1.23 . . . . 0.0 108.566 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -59.68 2.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.602 -0.686 . . . . 0.0 110.566 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.83 -3.45 17.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.967 -1.083 . . . . 0.0 110.916 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.06 6.11 88.88 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.343 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 42.2 t80 -56.29 143.62 33.32 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.875 -1.368 . . . . 0.0 109.796 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 14.9 mm -115.39 111.56 36.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.325 -0.859 . . . . 0.0 110.639 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 44.1 t80 -81.13 122.56 27.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.828 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -101.97 117.18 62.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 110.243 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.6 Cg_endo -71.8 -31.1 13.41 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.849 1.447 . . . . 0.0 110.234 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.4 -5.06 25.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.159 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -120.38 -38.45 2.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.81 167.42 23.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -85.15 56.13 3.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.969 . . . . 0.0 109.894 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -40.14 -58.58 1.43 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.776 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.605 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 2.2 t80 -48.01 -32.94 7.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.594 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -92.25 -65.4 1.01 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.082 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.25 53.34 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.572 HG23 ' HD2' ' A' ' 29' ' ' PRO . 1.2 mp -131.02 144.71 54.67 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.286 -1.126 . . . . 0.0 109.817 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -71.11 162.4 42.74 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.929 1.489 . . . . 0.0 110.425 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.29 163.44 38.66 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.91 1.479 . . . . 0.0 110.772 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.24 14.81 82.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -100.74 124.31 42.63 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.268 -1.137 . . . . 0.0 110.197 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.699 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.0 Cg_endo -73.32 140.38 30.43 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.92 1.484 . . . . 0.0 110.551 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.676 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 18.4 t80 -53.58 -40.38 65.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.361 -0.837 . . . . 0.0 110.319 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.699 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.1 m -53.86 -18.3 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.408 -0.808 . . . . 0.0 110.368 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 1.2 t0 -85.61 -6.81 59.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.394 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.435 HD13 ' CD1' ' A' ' 41' ' ' PHE . 16.2 mt -73.15 121.95 21.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 37' ' ' LEU . 47.4 t -42.02 155.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 110.381 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -9.19 21.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 110.292 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -98.26 4.6 48.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.333 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.513 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 46.1 t80 -59.72 136.31 57.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 110.222 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.466 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.9 mtp -120.33 145.7 46.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 109.69 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.5 t -54.82 131.81 66.21 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 110.333 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.605 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 45.5 Cg_endo -72.61 -13.88 27.35 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.899 1.473 . . . . 0.0 109.534 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.99 -65.29 0.97 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.486 -0.758 . . . . 0.0 110.908 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.526 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.5 p -96.28 2.91 53.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 111.167 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 3.1 ttm180 61.59 22.49 12.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.123 -0.986 . . . . 0.0 111.963 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.4 m -74.49 167.3 37.34 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.826 -1.172 . . . . 0.0 109.923 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 47.4 Cg_endo -73.51 142.96 33.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.946 1.498 . . . . 0.0 110.433 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 21.9 tttm -49.93 -30.08 9.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.53 ' ND2' ' HB2' ' A' ' 49' ' ' PRO . 26.5 p30 -62.9 -11.74 20.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.119 -0.988 . . . . 0.0 109.968 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.2 mm-40 -89.27 -2.52 58.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.885 . . . . 0.0 109.54 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 7.3 m-85 -87.04 139.29 30.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.398 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -123.54 140.56 52.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.166 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 35.0 p -83.41 168.61 16.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.836 -1.165 . . . . 0.0 111.266 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -151.34 86.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.226 0.536 . . . . 0.0 109.875 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 4' ' ' ASP . 18.5 pttt -138.65 81.03 1.83 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 110.263 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 60' ' ' ILE . 10.8 tttp -162.16 167.57 23.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.357 -0.839 . . . . 0.0 110.213 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 1' ' ' MET . 14.5 p -70.19 126.72 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 110.258 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.485 HG22 ' OXT' ' A' ' 60' ' ' ILE . 50.7 mt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.172 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.225 0.536 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 3' ' ' ILE . 2.8 pt-20 -121.97 110.9 16.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 110.198 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 2' ' ' GLU . 19.7 pt -157.24 126.24 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -149.4 132.85 16.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.243 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.495 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -173.91 61.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.88 . . . . 0.0 110.145 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 44.08 26.34 0.86 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HG3' ' HB3' ' A' ' 5' ' ' GLU . 12.5 mttm -88.39 131.24 34.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -1.172 . . . . 0.0 109.877 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 21.2 m-85 -123.8 148.84 46.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 83.6 tt0 -122.85 142.7 50.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 109.535 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.5 t -79.39 115.74 19.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 110.645 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -15.28 63.52 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.372 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.25 -60.93 1.89 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.631 -0.668 . . . . 0.0 110.555 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -107.94 -4.74 17.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.957 -1.089 . . . . 0.0 110.717 -178.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 82.62 3.1 90.65 Favored Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.101 -0.999 . . . . 0.0 111.417 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.544 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . 89.6 t80 -49.53 172.39 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.854 -1.38 . . . . 0.0 109.421 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.501 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 10.4 mm -146.13 108.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.04 -1.038 . . . . 0.0 110.396 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.3 t80 -81.55 129.03 34.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 110.011 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -111.68 118.29 47.15 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 110.263 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -71.85 -29.29 15.57 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.885 1.466 . . . . 0.0 110.309 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -71.59 -10.61 60.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.007 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 6.2 mttt -115.68 -39.65 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.381 -0.824 . . . . 0.0 110.003 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.46 164.59 20.95 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.558 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -85.1 55.76 3.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -1.075 . . . . 0.0 109.844 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -41.1 -54.41 2.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.359 -0.838 . . . . 0.0 110.504 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 97.8 m-85 -49.63 -36.71 25.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.398 -0.814 . . . . 0.0 110.42 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.56 -67.47 0.85 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.04 54.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.558 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -133.36 141.73 41.59 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 109.98 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.7 Cg_endo -69.96 165.11 32.3 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.018 1.536 . . . . 0.0 110.432 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.0 Cg_endo -71.92 162.77 40.91 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.039 1.547 . . . . 0.0 110.841 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.11 12.04 84.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.8 m -98.87 123.2 50.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.286 -1.126 . . . . 0.0 110.232 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.644 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.89 143.48 36.87 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.924 1.486 . . . . 0.0 110.75 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.583 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 7.7 t80 -57.54 -15.86 8.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.902 . . . . 0.0 110.041 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 33' ' ' PRO . 3.9 m -69.97 -26.21 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.73 -5.51 55.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.41 -0.806 . . . . 0.0 110.409 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.434 HD13 ' CD1' ' A' ' 41' ' ' PHE . 11.1 mt -74.1 115.61 13.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.234 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 37' ' ' LEU . 63.9 m -41.68 151.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 110.378 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.64 -12.88 11.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 110.123 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 t -95.93 8.05 44.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.422 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.52 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.8 t80 -61.0 138.56 58.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.02 . . . . 0.0 109.894 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.2 mtt -121.34 147.48 45.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.031 . . . . 0.0 109.731 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.9 t -56.56 131.67 77.32 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 110.509 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 45.3 Cg_endo -72.42 -12.45 27.3 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.797 1.42 . . . . 0.0 109.561 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.5 -67.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 110.822 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.6 p -93.59 1.4 56.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.06 -1.025 . . . . 0.0 111.097 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.96 24.34 14.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.171 -0.956 . . . . 0.0 111.932 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 42' ' ' MET . 4.1 m -77.67 167.94 31.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.828 -1.17 . . . . 0.0 109.835 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.9 Cg_endo -72.64 140.92 33.44 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.801 1.422 . . . . 0.0 110.481 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.549 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 11.2 tttm -49.28 -27.21 3.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.005 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -63.14 -11.86 23.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.956 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.3 mm-40 -90.72 -0.86 57.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.292 -0.88 . . . . 0.0 109.604 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -87.12 137.88 31.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.656 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -119.79 136.34 54.49 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.6 t -84.6 172.3 11.72 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.724 -1.235 . . . . 0.0 110.81 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 pt -141.3 59.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.051 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -82.04 55.23 2.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -72.66 136.37 45.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.319 -0.863 . . . . 0.0 110.175 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.734 ' O ' HG22 ' A' ' 59' ' ' VAL . 4.6 p -163.9 56.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 110.249 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 pt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.219 179.969 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mtt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.259 0.552 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.534 ' O ' HG23 ' A' ' 3' ' ' ILE . 3.2 tm-20 -168.25 81.76 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.912 . . . . 0.0 110.143 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 2' ' ' GLU . 11.8 pt -154.49 127.23 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 110.323 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.503 ' HB3' HG23 ' A' ' 59' ' ' VAL . 2.9 p30 -134.21 136.03 43.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 110.024 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.4 tt0 176.74 69.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -0.982 . . . . 0.0 110.43 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 47.9 30.11 6.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.552 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . 0.7 OUTLIER -79.39 117.67 20.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -1.152 . . . . 0.0 109.437 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.5 m-85 -118.43 142.1 47.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.953 . . . . 0.0 110.8 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 6.6 tm-20 -119.22 140.26 50.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -0.809 . . . . 0.0 109.439 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' GLY . 5.0 t -76.57 116.75 17.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.15 -0.969 . . . . 0.0 110.233 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -16.59 64.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.767 -1.208 . . . . 0.0 108.713 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -59.8 2.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.578 -0.702 . . . . 0.0 110.599 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.95 -3.46 17.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.031 -1.043 . . . . 0.0 110.966 -179.032 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.762 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.37 6.29 88.97 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.153 -1.022 . . . . 0.0 111.458 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 40.5 t80 -57.57 143.59 40.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.918 -1.342 . . . . 0.0 109.698 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -114.17 112.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.281 -0.887 . . . . 0.0 110.647 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 33.9 t80 -82.21 128.05 33.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.651 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -109.49 117.2 53.36 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.872 . . . . 0.0 110.184 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 43.8 Cg_endo -71.28 -28.97 17.74 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.827 1.435 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.78 -5.83 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 110.053 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -119.82 -39.13 2.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 110.185 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.19 166.13 22.11 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.56 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -85.12 54.61 3.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -1.043 . . . . 0.0 109.899 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASP . 18.4 mmtt -39.74 -56.66 1.68 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.378 -0.826 . . . . 0.0 110.695 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 65.2 m-85 -47.34 -33.91 6.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.98 -64.63 1.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 110.484 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.98 52.83 0.02 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.574 HG23 ' HD2' ' A' ' 29' ' ' PRO . 1.2 mp -129.11 145.22 55.79 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.274 -1.133 . . . . 0.0 109.82 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.574 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.6 Cg_endo -70.95 160.95 47.74 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.948 1.499 . . . . 0.0 110.43 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.446 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.6 Cg_endo -71.9 163.27 39.39 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.963 1.507 . . . . 0.0 110.765 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.11 15.34 81.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 26.7 m -102.46 124.2 40.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.265 -1.138 . . . . 0.0 110.254 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 48.0 Cg_endo -73.65 140.26 29.25 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.874 1.46 . . . . 0.0 110.561 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.59 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.7 t80 -50.42 -41.04 51.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.035 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.52 -17.14 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 110.266 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -84.42 -7.06 59.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.24 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 41' ' ' PHE . 17.8 mt -71.65 155.86 40.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.952 . . . . 0.0 110.044 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 156.59 30.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.9 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -11.33 13.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.136 -0.978 . . . . 0.0 110.363 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.2 m -99.64 3.87 45.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.946 . . . . 0.0 110.418 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.56 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 44.8 t80 -59.68 136.37 57.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 109.964 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 48' ' ' SER . 6.8 mtt -120.0 146.37 45.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.077 -1.015 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.9 t -55.94 130.62 73.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 110.319 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.525 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.9 Cg_endo -71.99 -12.7 28.51 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.875 1.461 . . . . 0.0 109.526 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.35 -64.26 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.453 -0.779 . . . . 0.0 110.842 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.54 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.8 p -98.77 3.76 47.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 111.173 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.7 OUTLIER 61.69 20.53 11.42 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.111 -0.993 . . . . 0.0 112.036 178.522 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.6 m -73.05 167.31 35.42 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.769 -1.207 . . . . 0.0 109.786 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.3 Cg_endo -73.21 142.78 34.5 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.863 1.454 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 22.8 tttm -49.37 -27.67 4.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 109.834 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -63.04 -12.2 24.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.873 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -90.27 -1.8 57.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.612 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 15.5 m-85 -88.53 139.65 30.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 110.379 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -130.74 146.27 52.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.702 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 p -82.96 167.66 17.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.908 -1.12 . . . . 0.0 110.44 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.552 ' CD1' ' HB3' ' A' ' 7' ' ' LYS . 16.9 pt -114.04 -44.71 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 110.314 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' N ' HG13 ' A' ' 56' ' ' ILE . 0.3 OUTLIER 37.59 78.67 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.527 -0.733 . . . . 0.0 110.712 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 3' ' ' ILE . 1.1 tttp -113.4 99.89 8.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 59' ' ' VAL . 32.6 t -129.48 82.28 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.245 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 pt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.175 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.262 0.553 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.453 ' C ' HG22 ' A' ' 3' ' ' ILE . 3.7 pt-20 -170.23 112.15 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.271 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.647 ' N ' HG12 ' A' ' 59' ' ' VAL . 1.3 tt 177.86 171.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -0.908 . . . . 0.0 110.305 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.564 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 10.9 m-20 -125.69 128.03 47.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 110.1 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER 169.96 -71.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 0.0 110.051 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.32 42.73 0.6 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 56' ' ' ILE . 2.4 tptm -78.78 118.51 20.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.425 -1.044 . . . . 0.0 109.769 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.0 m-85 -117.78 139.5 50.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 110.661 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.585 ' HA ' HD13 ' A' ' 16' ' ' ILE . 14.3 pt-20 -116.76 139.18 50.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.308 -0.87 . . . . 0.0 109.615 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -76.55 117.03 17.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 110.426 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -16.3 64.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.868 -1.145 . . . . 0.0 108.668 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.2 -59.49 2.31 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.649 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.93 -3.49 17.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.951 -179.032 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 78.28 7.74 87.71 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 30.6 t80 -58.76 142.56 49.76 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.807 -1.408 . . . . 0.0 109.636 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.585 HD13 ' HA ' ' A' ' 9' ' ' GLU . 24.5 mm -113.8 114.75 47.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.274 -0.891 . . . . 0.0 110.777 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 24.6 t80 -83.22 133.03 35.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 109.719 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -110.89 119.43 46.05 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 110.224 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -71.31 -34.51 9.73 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.861 1.453 . . . . 0.0 110.217 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -70.06 -6.76 36.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.398 -0.814 . . . . 0.0 110.028 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 14.5 tttt -117.96 -36.45 3.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.109 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.92 171.53 28.81 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 1.7 t70 -85.31 57.98 4.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.515 -0.991 . . . . 0.0 109.767 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ASP . 1.1 tptt -37.58 -63.0 0.48 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.554 -0.716 . . . . 0.0 110.727 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.556 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 17.7 m-85 -43.27 -27.13 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.393 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.26 -58.42 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.267 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.92 -7.52 1.06 Allowed Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.495 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.549 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.8 mp -64.93 142.27 98.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.344 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.543 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.2 Cg_endo -71.61 162.49 42.01 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.997 1.524 . . . . 0.0 110.611 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -72.59 163.86 37.28 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.991 1.522 . . . . 0.0 110.775 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.53 13.37 83.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 60.5 m -105.75 126.59 30.36 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.274 -1.133 . . . . 0.0 110.168 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.786 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -72.56 142.15 35.86 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.839 1.442 . . . . 0.0 110.603 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.581 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 2.9 t80 -53.21 -38.71 63.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.133 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.786 HG22 ' HB2' ' A' ' 33' ' ' PRO . 20.3 m -54.76 -17.68 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 110.051 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -83.12 -6.17 59.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 37' ' ' LEU . 22.3 mt -70.23 156.34 39.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.58 162.63 25.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.872 . . . . 0.0 109.858 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -69.97 -3.91 18.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.252 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.0 m -106.7 0.67 24.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.542 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 44.7 t80 -59.98 136.58 58.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.978 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 48' ' ' SER . 21.7 mtp -119.62 146.06 45.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.12 -0.988 . . . . 0.0 109.908 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.4 t -54.86 129.64 65.46 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.266 -0.896 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.6 Cg_endo -71.27 -13.53 30.88 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.819 1.431 . . . . 0.0 109.47 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.98 -63.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.752 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.4 p -98.84 3.78 47.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.192 -0.942 . . . . 0.0 111.156 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.24 21.37 11.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.165 -0.96 . . . . 0.0 112.087 178.597 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.5 m -73.93 166.9 40.33 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.828 -1.17 . . . . 0.0 109.808 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.7 Cg_endo -72.91 142.68 35.43 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.818 1.431 . . . . 0.0 110.33 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.549 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 7.4 tttt -49.58 -25.64 2.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -66.26 -11.86 52.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.793 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -89.05 -3.23 58.75 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.35 -0.844 . . . . 0.0 109.492 179.279 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.522 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 4.6 m-85 -88.62 140.56 29.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.433 -0.792 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 5.1 mttt -129.89 146.35 51.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.9 p -82.76 165.67 19.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.936 -1.103 . . . . 0.0 110.705 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -139.61 -37.37 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.638 -0.664 . . . . 0.0 110.144 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 56' ' ' ILE . 2.5 tttt 40.73 83.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 110.409 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -171.81 162.98 6.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 110.357 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.647 HG12 ' N ' ' A' ' 3' ' ' ILE . 5.6 m -131.91 142.86 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.335 -0.853 . . . . 0.0 110.094 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.6 tp . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.237 0.541 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.712 ' O ' HG23 ' A' ' 3' ' ' ILE . 24.5 tt0 -163.49 69.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 2' ' ' GLU . 1.2 pt -159.56 137.49 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.081 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.527 ' CB ' ' HA ' ' A' ' 57' ' ' LYS . 5.0 p-10 -140.51 122.45 15.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.903 . . . . 0.0 110.582 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -119.05 -88.57 0.62 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.503 -0.748 . . . . 0.0 109.715 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.39 32.18 2.43 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.541 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . 9.4 mttt -75.66 111.29 10.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -1.114 . . . . 0.0 109.295 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.625 ' CE1' ' HB3' ' A' ' 55' ' ' SER . 9.3 m-85 -121.12 137.82 54.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 111.089 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.517 ' HA ' HD13 ' A' ' 16' ' ' ILE . 83.2 tt0 -118.43 145.64 45.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.0 109.393 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 6.6 t -79.05 115.21 18.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.05 -1.031 . . . . 0.0 110.442 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.76 -15.23 63.41 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.508 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -61.14 1.84 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.703 -0.623 . . . . 0.0 110.771 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -108.39 -5.04 16.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.03 -1.044 . . . . 0.0 111.102 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.424 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 83.99 3.01 89.4 Favored Glycine 0 N--CA 1.497 2.75 0 O-C-N 120.973 -1.08 . . . . 0.0 111.419 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 29.3 t80 -50.64 173.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.827 -1.396 . . . . 0.0 109.17 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 12.1 mm -144.31 132.81 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.924 -1.11 . . . . 0.0 110.684 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 40.3 t80 -106.1 132.55 52.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.349 -0.844 . . . . 0.0 109.65 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 3.3 mt-10 -113.96 119.98 39.79 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.895 . . . . 0.0 110.372 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.511 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 43.5 Cg_endo -69.95 -35.73 11.57 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.861 1.453 . . . . 0.0 110.333 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.06 -10.24 56.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 109.844 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -116.33 -30.46 5.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.859 . . . . 0.0 109.936 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.08 171.58 33.93 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.713 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.2 51.01 2.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -1.061 . . . . 0.0 109.736 179.189 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.09 -56.87 1.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.805 . . . . 0.0 110.455 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.534 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.05 -33.95 2.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.785 . . . . 0.0 110.229 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -94.3 -62.38 1.35 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.381 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.67 52.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.713 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -131.72 145.71 58.7 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.243 -1.151 . . . . 0.0 110.014 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.614 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.6 Cg_endo -70.08 160.17 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.952 1.501 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.3 163.87 37.34 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.983 1.517 . . . . 0.0 110.837 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 79.98 13.72 81.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 58.9 m -107.55 126.04 30.87 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.195 -1.18 . . . . 0.0 110.222 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.511 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.7 Cg_endo -73.22 142.71 34.33 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.837 1.441 . . . . 0.0 110.636 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.579 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 t80 -51.22 -40.09 58.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.299 -0.876 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -16.93 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 110.309 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -84.24 -6.87 59.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.517 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 18.7 mt -70.13 157.14 38.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -0.949 . . . . 0.0 109.946 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -77.81 157.54 29.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.206 -0.934 . . . . 0.0 109.811 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.37 -9.92 14.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.15 -0.969 . . . . 0.0 110.262 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 42' ' ' MET . 2.4 m -100.48 2.92 42.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 110.428 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.9 t80 -58.2 132.8 54.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 109.77 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.447 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.7 mtt -118.81 147.24 44.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 110.06 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 8.0 t -58.08 127.41 79.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.319 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.534 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.15 -10.43 27.34 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.784 1.413 . . . . 0.0 109.565 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.57 -62.74 1.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.588 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.8 p -102.02 3.73 39.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.153 -0.967 . . . . 0.0 110.911 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER 62.26 20.85 12.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.196 -0.94 . . . . 0.0 112.063 178.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 25.5 p -73.83 165.52 52.47 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.864 -1.148 . . . . 0.0 109.781 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.1 Cg_endo -71.95 142.78 39.43 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.816 1.429 . . . . 0.0 110.377 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.543 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 43.2 tttm -48.29 -23.94 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 109.931 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.63 -10.8 39.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.852 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.7 -1.93 57.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.245 -0.909 . . . . 0.0 109.614 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 20.1 m-85 -88.57 138.12 31.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 110.506 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 2.5 tptp -130.7 146.52 52.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.339 -0.851 . . . . 0.0 109.662 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.625 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.2 p -80.55 164.95 22.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.901 -1.124 . . . . 0.0 110.435 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 7' ' ' LYS . 8.9 pt -106.72 -44.29 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.687 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 4.5 ttpt 52.4 93.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 110.087 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -77.79 58.15 1.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.158 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 74.8 t -114.03 126.07 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.158 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.22 0.533 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.563 ' HG3' HG23 ' A' ' 60' ' ' ILE . 17.7 mt-10 54.63 55.44 7.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pt -137.62 153.3 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.21 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.531 ' CB ' ' HG3' ' A' ' 57' ' ' LYS . 12.7 p30 -170.68 142.88 2.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.954 . . . . 0.0 110.332 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.82 -153.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 110.076 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.41 33.14 5.85 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 56' ' ' ILE . 1.5 ttpt -87.19 129.25 35.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -1.114 . . . . 0.0 110.0 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 29.8 m-85 -125.67 145.09 50.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.572 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HG2' ' CD1' ' A' ' 16' ' ' ILE . 14.5 mt-10 -117.67 142.63 47.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.399 -0.813 . . . . 0.0 109.901 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.4 t -77.56 113.61 15.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.975 -1.078 . . . . 0.0 110.584 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -15.1 63.31 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.912 -1.118 . . . . 0.0 108.441 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.06 -60.96 1.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.577 -0.702 . . . . 0.0 110.59 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.62 -4.4 17.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.972 -1.08 . . . . 0.0 110.887 -178.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 82.0 3.43 90.58 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.33 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.577 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 29.3 t80 -49.96 172.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.032 -1.275 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.577 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 24.5 mm -141.12 130.01 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.005 -1.059 . . . . 0.0 110.455 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 66.7 t80 -103.06 124.38 48.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.689 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -109.34 116.33 55.06 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.33 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.5 Cg_endo -69.34 -31.41 22.46 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.969 1.51 . . . . 0.0 110.075 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.08 -12.31 61.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 109.826 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.89 -12.69 10.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.89 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 81.3 167.41 38.26 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.624 ' CB ' HD13 ' A' ' 28' ' ' ILE . 1.2 t0 -85.18 50.6 1.98 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -1.032 . . . . 0.0 109.774 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.3 mmtt -39.31 -53.84 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.347 -0.845 . . . . 0.0 110.534 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.528 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -47.13 -36.5 8.49 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.428 -0.795 . . . . 0.0 110.225 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -92.27 -64.34 1.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 0.0 110.377 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.22 52.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.624 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.88 145.7 58.6 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -1.097 . . . . 0.0 109.939 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.616 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.7 Cg_endo -70.49 161.85 44.55 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.962 1.507 . . . . 0.0 110.198 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.2 Cg_endo -71.64 162.78 41.09 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.973 1.512 . . . . 0.0 110.853 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.12 12.59 84.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 21.9 m -97.73 125.1 45.8 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.239 -1.153 . . . . 0.0 110.179 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.736 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.89 139.29 30.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.867 1.456 . . . . 0.0 110.605 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.574 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 62.5 t80 -52.11 -41.46 62.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.074 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.1 m -53.52 -17.59 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.432 -0.793 . . . . 0.0 110.384 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 36' ' ' ASP . 59.2 t0 -83.96 -7.6 59.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.127 -0.983 . . . . 0.0 110.4 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.498 HD12 ' CD1' ' A' ' 34' ' ' PHE . 17.9 mt -69.43 153.21 43.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 109.9 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.0 155.36 32.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.716 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -11.22 12.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 110.212 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.47 4.1 43.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 110.509 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.54 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 50.1 t80 -59.7 134.86 57.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.016 -1.052 . . . . 0.0 109.576 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.3 mtp -119.23 148.42 43.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.986 -1.071 . . . . 0.0 110.458 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.473 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 6.2 t -58.63 126.93 81.32 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.45 -0.781 . . . . 0.0 110.38 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.528 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.0 Cg_endo -70.69 -9.65 26.21 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.814 1.428 . . . . 0.0 109.486 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.36 -64.86 1.0 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.512 -0.743 . . . . 0.0 110.464 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.538 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.2 p -99.37 2.64 45.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.954 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.0 OUTLIER 63.04 22.34 13.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.153 -0.967 . . . . 0.0 112.094 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 29.9 p -76.31 166.11 47.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.735 -1.228 . . . . 0.0 109.859 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 45.2 Cg_endo -71.72 142.13 39.04 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.766 1.403 . . . . 0.0 110.437 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.567 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 10.1 tttm -48.64 -27.65 2.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.901 . . . . 0.0 110.0 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.06 -10.15 27.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.817 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -87.64 -5.57 58.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.306 -0.871 . . . . 0.0 109.628 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 23.7 m-85 -79.96 133.62 36.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 110.566 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.08 131.25 54.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.467 -0.771 . . . . 0.0 108.93 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.596 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -79.77 159.29 26.62 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 110.194 -179.442 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.511 ' O ' ' CB ' ' A' ' 57' ' ' LYS . 1.7 pt -101.45 -107.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.337 -0.852 . . . . 0.0 110.34 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HG3' ' CB ' ' A' ' 4' ' ' ASP . 6.8 ttpt 70.26 94.54 0.07 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.885 -1.134 . . . . 0.0 110.202 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -138.21 171.12 14.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.215 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.521 HG22 ' H ' ' A' ' 60' ' ' ILE . 9.5 p -164.42 175.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.95 . . . . 0.0 110.204 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.563 HG23 ' HG3' ' A' ' 2' ' ' GLU . 1.1 pt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.136 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.437 ' CE ' ' OE1' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.265 0.555 . . . . 0.0 110.168 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.713 ' O ' HG23 ' A' ' 3' ' ' ILE . 5.6 mt-10 -141.49 72.02 1.37 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.161 -0.962 . . . . 0.0 110.182 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.713 HG23 ' O ' ' A' ' 2' ' ' GLU . 9.4 pt -159.4 131.28 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.287 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 5' ' ' GLU . 5.1 m-20 -105.54 132.3 51.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 110.138 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.2 mt-10 169.7 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.269 -0.894 . . . . 0.0 110.251 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 51.02 31.95 26.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.448 ' HE2' ' CG2' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -83.4 118.77 23.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.12 . . . . 0.0 109.918 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 18.0 m-85 -120.03 146.65 45.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.176 -0.953 . . . . 0.0 110.372 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 4.6 mt-10 -121.07 140.08 52.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 109.565 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.3 t -76.42 118.44 19.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.117 -0.99 . . . . 0.0 110.399 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.84 -16.74 63.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.852 -1.155 . . . . 0.0 108.644 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -58.93 2.49 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.681 -0.637 . . . . 0.0 110.547 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.498 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -109.61 -3.09 17.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 110.931 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.748 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 78.27 6.73 87.84 Favored Glycine 0 N--CA 1.495 2.622 0 O-C-N 120.999 -1.063 . . . . 0.0 111.414 177.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 43.2 t80 -57.87 144.59 38.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.943 -1.328 . . . . 0.0 109.78 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.748 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -114.44 111.6 36.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.294 -0.879 . . . . 0.0 110.584 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 49.3 t80 -82.07 122.38 27.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.905 . . . . 0.0 109.984 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -107.0 119.65 50.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.832 . . . . 0.0 110.088 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 44.3 Cg_endo -71.47 -24.45 22.42 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.902 1.475 . . . . 0.0 110.299 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.407 ' OE2' ' HB3' ' A' ' 5' ' ' GLU . 6.1 mp0 -72.05 -16.0 62.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 109.948 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -109.95 -37.75 5.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.05 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.54 166.05 24.5 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.608 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.21 50.41 1.94 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -1.051 . . . . 0.0 109.644 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 4.4 tttm -38.91 -53.02 1.76 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.492 -0.755 . . . . 0.0 110.618 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.536 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 13.9 m-85 -48.88 -36.46 17.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.378 -0.826 . . . . 0.0 110.295 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -91.58 -66.25 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.329 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.95 51.46 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.608 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.16 144.7 53.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.238 -1.154 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.573 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.6 Cg_endo -70.89 163.03 40.62 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.956 1.503 . . . . 0.0 110.31 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -71.89 161.82 43.79 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.949 1.5 . . . . 0.0 110.905 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.34 13.13 83.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.464 HG21 ' CG2' ' A' ' 28' ' ' ILE . 37.4 m -93.89 123.11 60.51 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.3 -1.118 . . . . 0.0 110.174 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.773 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.4 Cg_endo -73.45 141.5 31.7 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.821 1.432 . . . . 0.0 110.641 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.576 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 30.3 t80 -55.53 -18.02 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.948 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.773 HG22 ' HB2' ' A' ' 33' ' ' PRO . 3.8 m -72.84 -10.6 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 109.687 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -91.84 -7.62 48.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.29 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.465 HD12 ' CD2' ' A' ' 34' ' ' PHE . 20.9 mt -72.22 146.23 47.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.056 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.81 158.75 31.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.068 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -60.96 -12.93 12.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 0.0 110.158 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 97.2 p -99.27 4.84 46.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.449 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 52.3 t80 -58.96 139.57 56.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.101 -0.999 . . . . 0.0 109.984 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.7 mmm -119.79 143.8 47.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.985 -1.072 . . . . 0.0 110.049 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 45' ' ' ALA . 49.5 t -59.91 125.17 79.9 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 110.14 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.536 ' HB2' ' CB ' ' A' ' 25' ' ' PHE . 43.9 Cg_endo -70.67 -8.87 24.59 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.858 1.452 . . . . 0.0 109.871 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -93.34 -53.66 4.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.482 -0.761 . . . . 0.0 110.167 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 48' ' ' SER . 9.5 p -118.15 8.47 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 110.707 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.81 14.18 7.13 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.255 -0.903 . . . . 0.0 112.162 178.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 52' ' ' GLN . 2.2 t -66.8 161.39 61.71 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.834 -1.166 . . . . 0.0 110.044 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 42.9 Cg_endo -69.29 143.38 52.91 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.608 1.32 . . . . 0.0 110.25 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.559 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 17.4 tttm -50.21 -28.86 8.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.129 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -63.01 -11.94 22.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.118 -0.989 . . . . 0.0 109.786 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.523 ' CB ' ' OG ' ' A' ' 48' ' ' SER . 0.8 OUTLIER -88.67 -2.52 58.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.879 . . . . 0.0 109.85 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.422 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 25.4 m-85 -83.93 135.38 34.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.583 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' NZ ' ' O ' ' A' ' 55' ' ' SER . 0.5 OUTLIER -120.67 138.14 54.09 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.734 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.3 t -88.59 174.26 8.17 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.819 -1.176 . . . . 0.0 110.535 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 57' ' ' LYS . 1.4 tp -158.2 -45.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.388 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' H ' HG23 ' A' ' 56' ' ' ILE . 32.0 mtmt 40.49 80.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.401 -0.812 . . . . 0.0 110.314 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 3' ' ' ILE . 35.6 ttmt -113.29 147.7 37.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.0 110.381 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.755 ' O ' HG13 ' A' ' 59' ' ' VAL . 8.9 p -153.36 55.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 110.188 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 tp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.203 -179.951 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.26 0.552 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.428 ' OE1' ' HE3' ' A' ' 57' ' ' LYS . 1.8 pt-20 -112.14 157.39 20.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.185 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.606 HG22 ' H ' ' A' ' 4' ' ' ASP . 13.4 mt -147.31 179.05 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.606 ' H ' HG22 ' A' ' 3' ' ' ILE . 2.6 p30 -137.75 -168.2 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 110.338 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -179.47 -27.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.231 -0.918 . . . . 0.0 110.433 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.49 7.18 11.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.542 ' O ' HG23 ' A' ' 56' ' ' ILE . 2.7 mtpp -82.21 110.79 17.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -1.128 . . . . 0.0 109.569 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 12.1 m-85 -120.7 144.14 48.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.937 . . . . 0.0 110.949 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.6 pp20? -118.85 140.24 50.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 0.0 109.513 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.4 t -77.31 117.99 19.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.056 -1.028 . . . . 0.0 110.534 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.439 ' OE1' ' CA ' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -69.11 -16.57 63.7 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.833 -1.167 . . . . 0.0 108.525 178.46 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -59.21 2.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.594 -0.691 . . . . 0.0 110.547 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.03 -3.21 17.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.98 -1.075 . . . . 0.0 110.815 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 78.24 6.14 87.62 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.081 -1.012 . . . . 0.0 111.404 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 47.6 t80 -56.83 144.89 31.4 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.957 -1.32 . . . . 0.0 109.744 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.505 HD13 ' CB ' ' A' ' 9' ' ' GLU . 22.2 mm -115.71 110.58 32.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.234 -0.917 . . . . 0.0 110.5 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 45.8 t80 -81.26 121.47 26.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.81 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.03 121.13 50.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.386 -0.821 . . . . 0.0 110.213 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.5 Cg_endo -70.78 -27.68 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.935 1.492 . . . . 0.0 110.277 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.91 -18.87 62.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 110.234 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -39.61 6.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.151 -0.968 . . . . 0.0 110.175 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.81 164.67 24.18 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.622 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -85.18 51.38 2.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.449 -1.03 . . . . 0.0 109.83 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -40.12 -51.54 2.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.345 -0.847 . . . . 0.0 110.67 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 26.1 m-85 -48.98 -36.63 18.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.352 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.97 -66.13 0.95 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.246 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.76 53.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.622 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -131.86 143.93 51.11 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.378 -1.072 . . . . 0.0 110.038 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.1 Cg_endo -72.04 165.43 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.108 1.583 . . . . 0.0 110.311 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.24 163.06 39.83 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.932 1.491 . . . . 0.0 110.833 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.47 12.07 82.38 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 25.1 m -94.38 123.61 58.06 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.238 -1.154 . . . . 0.0 110.2 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.733 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.9 Cg_endo -73.18 141.3 32.23 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.811 1.427 . . . . 0.0 110.585 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.573 ' CE1' ' HE2' ' A' ' 50' ' ' LYS . 47.6 t80 -55.38 -38.97 69.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.29 -0.881 . . . . 0.0 110.186 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.733 HG22 ' HB2' ' A' ' 33' ' ' PRO . 17.0 m -54.1 -18.47 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -6.72 59.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.408 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.501 HD12 ' CD2' ' A' ' 34' ' ' PHE . 19.3 mt -73.05 150.65 42.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.114 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.472 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -76.71 159.52 30.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 109.996 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -10.23 18.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.211 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 p -100.28 4.33 44.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.264 -0.897 . . . . 0.0 110.327 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.9 t80 -60.42 137.77 58.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 110.038 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' SER . 18.3 mtm -119.84 146.14 46.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.178 -0.951 . . . . 0.0 110.093 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 10.9 t -56.91 130.26 78.77 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.793 . . . . 0.0 110.443 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 45.6 Cg_endo -72.25 -12.1 27.41 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.921 1.485 . . . . 0.0 109.698 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.6 -61.95 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 110.708 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.5 p -102.51 4.37 38.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 111.128 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.1 tpt180 62.12 18.96 10.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.136 -0.977 . . . . 0.0 112.102 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.7 m -71.83 168.1 25.42 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.831 -1.168 . . . . 0.0 109.759 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.9 Cg_endo -73.8 142.75 32.38 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.817 1.43 . . . . 0.0 110.406 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.9 tttm -49.37 -28.38 4.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 109.784 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -63.13 -11.94 23.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 109.856 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -89.5 -2.39 58.35 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.595 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -87.56 139.18 30.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 110.43 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.16 139.13 54.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.458 -0.776 . . . . 0.0 108.94 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 40.8 p -82.16 168.94 17.18 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.854 -1.154 . . . . 0.0 110.632 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 7' ' ' LYS . 2.3 pp -96.65 -26.57 4.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.326 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.605 ' O ' HG23 ' A' ' 59' ' ' VAL . 14.7 tttt 49.32 89.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.96 . . . . 0.0 110.233 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -54.54 124.77 17.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 0.0 110.15 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 57' ' ' LYS . 47.7 t -115.49 110.75 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.143 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.24 0.543 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' C ' HD12 ' A' ' 3' ' ' ILE . 1.4 mp0 -53.17 159.22 1.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.192 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.514 HD12 ' C ' ' A' ' 2' ' ' GLU . 1.5 mp 63.36 167.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.137 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.527 ' N ' ' HA ' ' A' ' 57' ' ' LYS . 20.0 p-10 -78.66 126.13 30.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 110.285 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 5' ' ' GLU . 35.3 tt0 -90.23 15.47 10.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.853 . . . . 0.0 110.036 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.418 ' C ' ' HG3' ' A' ' 19' ' ' PRO . . . 114.67 8.55 15.87 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -85.14 117.82 24.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -1.149 . . . . 0.0 109.733 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.4 m-85 -125.56 148.68 48.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.95 . . . . 0.0 110.859 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 32.6 tt0 -119.04 140.27 50.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.839 . . . . 0.0 109.424 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.6 t -77.33 117.45 18.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.047 -1.033 . . . . 0.0 110.421 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -16.42 63.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.822 -1.174 . . . . 0.0 108.585 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.18 -59.12 2.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.579 -0.701 . . . . 0.0 110.551 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.39 -3.8 16.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.009 -1.057 . . . . 0.0 110.906 -179.041 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.471 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.41 6.25 88.99 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.537 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 34.0 t80 -57.01 143.58 37.63 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.797 -1.413 . . . . 0.0 109.807 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.505 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 17.8 mm -115.19 111.86 37.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.342 -0.848 . . . . 0.0 110.65 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.0 t80 -81.38 122.21 27.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.773 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -102.28 117.78 60.41 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 0.0 110.226 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.8 Cg_endo -71.16 -30.37 16.16 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.87 1.458 . . . . 0.0 110.307 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -72.48 -7.91 52.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.304 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -114.4 -43.56 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.285 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.1 163.34 18.08 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.547 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.16 56.17 3.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.453 -1.027 . . . . 0.0 109.983 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' ASP . 9.5 mtpt -40.92 -55.5 2.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 110.502 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 27.1 m-85 -48.45 -34.86 11.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.375 -0.828 . . . . 0.0 110.506 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -92.8 -65.75 0.98 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 110.3 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.46 54.34 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.605 HG21 HG21 ' A' ' 32' ' ' THR . 1.3 mp -132.1 144.07 51.6 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.296 -1.12 . . . . 0.0 109.993 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.563 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.2 Cg_endo -71.59 165.05 33.71 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.956 1.503 . . . . 0.0 110.391 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.06 162.9 40.41 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.017 1.535 . . . . 0.0 110.804 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.11 15.02 81.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.605 HG21 HG21 ' A' ' 28' ' ' ILE . 15.8 m -97.65 123.29 52.51 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.283 -1.127 . . . . 0.0 110.198 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.782 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -73.75 139.9 28.44 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.873 1.46 . . . . 0.0 110.586 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.577 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 12.4 t80 -53.42 -40.61 65.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.273 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 33' ' ' PRO . 27.3 m -53.17 -18.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 110.467 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 3.8 t70 -85.52 -7.1 59.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 0.0 110.386 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.556 HD13 ' CD1' ' A' ' 41' ' ' PHE . 13.7 mt -73.99 120.06 19.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 37' ' ' LEU . 18.5 t -42.21 159.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.457 -0.777 . . . . 0.0 110.335 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.45 -7.7 27.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 0.0 110.161 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 p -99.03 4.19 47.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' A' ' 37' ' ' LEU . 49.1 t80 -58.61 134.76 57.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.193 -0.942 . . . . 0.0 110.157 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -120.13 146.15 46.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.139 -0.975 . . . . 0.0 109.718 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.9 t -56.46 130.06 75.91 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 110.493 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -71.93 -12.4 28.36 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.845 1.445 . . . . 0.0 109.477 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.04 -65.81 0.94 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.576 -0.703 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.1 p -96.66 2.39 52.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.162 -0.961 . . . . 0.0 111.126 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.04 23.33 13.74 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.101 -0.999 . . . . 0.0 111.878 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.462 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -76.29 167.46 36.5 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.866 -1.146 . . . . 0.0 109.907 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.0 Cg_endo -73.75 142.77 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.972 1.512 . . . . 0.0 110.525 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 9.4 tttm -49.85 -29.53 8.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.105 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -63.16 -11.99 24.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.856 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -88.73 -2.65 58.7 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 109.673 179.342 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.82 138.69 31.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.943 . . . . 0.0 110.658 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.54 138.57 54.25 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.8 t -85.1 172.04 11.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.622 -1.299 . . . . 0.0 110.51 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.536 HG13 ' N ' ' A' ' 57' ' ' LYS . 17.6 pt -103.92 -42.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.488 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.536 ' N ' HG13 ' A' ' 56' ' ' ILE . 10.9 mttt 63.96 97.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -80.27 152.58 28.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.271 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 59' ' ' VAL . 7.0 m -143.53 93.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.968 . . . . 0.0 110.224 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 60' ' ' ILE . 2.7 tt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 2' ' ' GLU . 23.8 mtt . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.281 0.562 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 3' ' ' ILE . 4.6 mt-10 61.35 123.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.146 -0.971 . . . . 0.0 110.166 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 2' ' ' GLU . 0.9 OUTLIER -156.58 144.93 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.841 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 10.9 t0 -135.26 -153.78 0.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.62 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 19' ' ' PRO . 9.1 tp10 -178.21 58.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.375 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' A' ' 19' ' ' PRO . . . 45.72 22.52 0.75 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -87.11 118.5 26.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.045 -1.268 . . . . 0.0 109.67 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.4 m-85 -126.68 151.24 48.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.945 . . . . 0.0 110.766 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -121.95 141.38 51.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.398 -0.814 . . . . 0.0 109.424 179.113 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -78.11 117.73 19.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -0.996 . . . . 0.0 110.521 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.85 -16.34 63.74 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.831 -1.168 . . . . 0.0 108.515 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -59.2 2.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.603 -0.685 . . . . 0.0 110.411 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.491 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.33 -3.43 17.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.961 -1.087 . . . . 0.0 110.774 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.729 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 78.66 5.79 88.28 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.155 -0.965 . . . . 0.0 111.474 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.579 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 52.9 t80 -58.12 146.04 34.72 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.855 -1.38 . . . . 0.0 109.92 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.4 mp -116.42 110.44 31.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.214 -0.929 . . . . 0.0 110.443 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.515 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 36.8 t80 -80.94 121.63 26.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -106.33 120.12 49.71 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.437 -0.789 . . . . 0.0 110.027 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 45.5 Cg_endo -72.09 -23.14 21.83 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.99 1.521 . . . . 0.0 110.524 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -72.35 -16.22 61.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.113 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.69 -39.71 5.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 110.112 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.5 163.05 20.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.603 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.19 51.86 2.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -1.048 . . . . 0.0 109.866 179.016 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 3.5 mmtt -39.8 -50.01 2.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.441 -0.787 . . . . 0.0 110.65 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.558 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 41.1 m-85 -51.05 -39.5 56.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.269 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.77 -68.93 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.191 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.44 52.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.603 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.05 144.15 52.38 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.298 -1.119 . . . . 0.0 109.997 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.587 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.9 Cg_endo -72.01 166.54 29.3 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.875 1.461 . . . . 0.0 110.407 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.48 160.86 45.73 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.91 1.479 . . . . 0.0 110.861 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.65 12.45 84.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.523 HG21 ' CG2' ' A' ' 28' ' ' ILE . 25.9 m -92.92 121.04 66.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.18 -1.188 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.955 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.4 Cg_endo -73.18 142.48 34.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.859 1.452 . . . . 0.0 110.553 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.56 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 31.0 t80 -56.01 -21.39 21.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.294 -0.879 . . . . 0.0 110.024 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.955 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.3 m -72.11 -9.02 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -0.874 . . . . 0.0 109.784 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.54 -7.17 44.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.984 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 50' ' ' LYS . 23.7 mt -72.91 146.16 46.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.013 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -73.58 151.38 40.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.879 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.0 -17.15 3.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.55 7.83 45.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 0.0 110.427 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.503 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 55.0 t80 -60.8 139.84 57.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 109.81 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 48' ' ' SER . 32.9 mtm -118.4 144.47 45.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.024 -1.048 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 42.5 t -59.31 127.56 84.46 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.402 -0.811 . . . . 0.0 110.284 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HB2' ' CB ' ' A' ' 25' ' ' PHE . 44.1 Cg_endo -71.46 -10.0 26.15 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.002 1.528 . . . . 0.0 110.0 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.579 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -94.33 -54.87 3.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.461 -0.774 . . . . 0.0 110.327 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.491 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 10.0 p -115.3 7.47 15.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 110.773 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 63.01 14.39 7.53 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.28 -0.887 . . . . 0.0 112.171 178.488 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.46 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 3.6 m -67.56 169.3 9.42 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.857 -1.152 . . . . 0.0 109.894 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.3 Cg_endo -74.19 141.36 29.13 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.788 1.415 . . . . 0.0 110.461 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 10.5 tttm -50.05 -29.55 9.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 109.892 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -61.88 -12.52 18.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.866 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -88.64 -1.92 58.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.788 179.475 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 24.5 m-85 -84.6 137.32 33.36 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.725 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -120.5 137.23 54.47 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.1 t -84.74 172.64 11.33 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.621 -1.299 . . . . 0.0 110.537 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.501 HG13 ' N ' ' A' ' 57' ' ' LYS . 11.9 pt -110.35 -44.42 5.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.826 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.501 ' N ' HG13 ' A' ' 56' ' ' ILE . 7.4 ttmt 50.97 92.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.135 -0.978 . . . . 0.0 109.886 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -64.75 171.96 3.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 110.378 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 59' ' ' VAL . 16.4 m -141.19 93.92 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 0.0 110.156 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.23 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.198 0.523 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.841 ' OE1' HG12 ' A' ' 59' ' ' VAL . 5.0 mt-10 57.07 177.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.337 -0.852 . . . . 0.0 110.254 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 2' ' ' GLU . 5.1 pt -158.28 140.54 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 2.1 p30 -86.18 -162.29 0.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 2.4 tt0 178.7 -26.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.895 . . . . 0.0 110.513 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.507 ' CA ' ' HG3' ' A' ' 19' ' ' PRO . . . 119.2 7.42 10.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.66 111.67 19.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -1.17 . . . . 0.0 109.653 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 18.8 m-85 -123.18 148.5 45.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 110.897 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.578 ' CG ' ' CD1' ' A' ' 16' ' ' ILE . 14.4 mt-10 -120.46 139.71 52.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.426 -0.796 . . . . 0.0 109.608 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.461 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.6 t -76.57 117.21 17.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.127 -0.983 . . . . 0.0 110.417 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -16.54 63.97 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.857 -1.152 . . . . 0.0 108.597 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.1 -58.82 2.53 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.647 -0.658 . . . . 0.0 110.683 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.63 -3.56 16.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.884 -1.135 . . . . 0.0 110.984 -179.096 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.461 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.34 6.47 88.91 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.058 -1.026 . . . . 0.0 111.392 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 26.9 t80 -56.59 143.1 37.04 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.942 -1.328 . . . . 0.0 109.687 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.578 ' CD1' ' CG ' ' A' ' 9' ' ' GLU . 16.4 mm -115.66 112.05 38.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.259 -0.9 . . . . 0.0 110.704 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.588 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.0 t80 -81.82 130.06 34.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.741 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -110.14 119.34 47.4 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 110.288 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -70.65 -30.2 18.5 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.892 1.469 . . . . 0.0 110.09 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.71 -13.82 61.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.833 . . . . 0.0 110.043 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -111.79 -38.23 4.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.381 -0.825 . . . . 0.0 110.049 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.36 168.94 25.76 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.665 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.09 53.09 2.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.454 -1.027 . . . . 0.0 109.944 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -40.3 -57.4 1.75 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.375 -0.828 . . . . 0.0 110.533 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.526 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 27.0 m-85 -47.73 -34.35 8.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.47 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.99 -65.83 0.98 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.032 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.15 52.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.665 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.13 145.19 56.68 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.225 -1.162 . . . . 0.0 109.889 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -70.3 160.94 47.83 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.038 1.546 . . . . 0.0 110.47 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -71.93 163.14 39.77 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.049 1.552 . . . . 0.0 110.848 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.4 12.37 84.32 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 94.1 m -98.64 125.93 40.88 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.248 -1.148 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.749 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -73.74 139.76 28.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.016 1.535 . . . . 0.0 110.593 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.588 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 3.0 t80 -52.66 -40.0 62.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.017 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.3 m -53.76 -17.87 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -0.823 . . . . 0.0 110.282 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 63.3 t0 -83.53 -7.12 59.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 110.404 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.544 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.0 mt -71.42 153.86 41.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.086 -1.009 . . . . 0.0 109.98 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.22 157.99 30.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.979 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -11.52 15.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.267 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -99.52 4.01 45.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 110.435 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.568 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 48.7 t80 -59.65 132.81 55.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 109.832 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 48' ' ' SER . 10.4 mtp -117.08 147.01 42.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.052 -1.03 . . . . 0.0 109.966 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.6 t -56.59 129.97 76.66 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.321 -0.862 . . . . 0.0 110.458 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -72.22 -11.7 27.13 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.892 1.469 . . . . 0.0 109.4 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.64 -65.02 0.99 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.518 -0.739 . . . . 0.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.7 p -98.3 3.21 48.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.92 . . . . 0.0 111.151 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER 62.06 22.39 13.06 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.079 -1.013 . . . . 0.0 112.06 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.7 m -75.78 168.37 28.35 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.806 -1.184 . . . . 0.0 109.994 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.4 Cg_endo -74.08 142.57 31.19 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.907 1.478 . . . . 0.0 110.431 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 42.0 tttm -50.48 -29.41 10.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 109.944 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -62.95 -12.34 24.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.743 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -87.54 -3.08 59.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.786 179.515 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -86.45 139.63 30.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.748 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -122.55 139.86 53.43 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.2 t -85.41 172.08 11.32 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.677 -1.265 . . . . 0.0 110.566 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 57' ' ' LYS . 40.0 pt -106.02 -31.13 2.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.236 0.541 . . . . 0.0 110.465 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.508 ' N ' HG13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER 61.26 95.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.103 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 2' ' ' GLU . 3.1 mttt -63.97 149.78 46.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.841 HG12 ' OE1' ' A' ' 2' ' ' GLU . 34.4 m -111.13 164.8 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 110.229 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.734 ' C ' HD12 ' A' ' 60' ' ' ILE . 1.7 pp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.204 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 2' ' ' GLU . 1.5 mtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.221 0.534 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 1' ' ' MET . 26.3 tp10 57.94 109.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.279 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -146.5 151.45 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.196 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.541 ' N ' ' HA ' ' A' ' 57' ' ' LYS . 7.1 p-10 -91.4 127.83 36.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 2.0 tt0 -84.43 13.34 5.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.041 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA3' ' HG3' ' A' ' 19' ' ' PRO . . . 116.25 7.44 14.42 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.526 ' CB ' HG12 ' A' ' 56' ' ' ILE . 20.9 mmtt -79.43 110.2 14.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.122 . . . . 0.0 109.145 179.201 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 10.0 m-85 -119.77 145.8 46.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.051 -1.03 . . . . 0.0 111.2 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 16' ' ' ILE . 6.5 pt-20 -121.16 139.64 53.08 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.552 -0.717 . . . . 0.0 109.145 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.9 t -76.94 116.79 17.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.025 -1.047 . . . . 0.0 110.314 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.43 -16.52 64.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.84 -1.162 . . . . 0.0 108.601 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -59.53 2.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.662 -0.649 . . . . 0.0 110.563 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.44 -3.46 17.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.057 . . . . 0.0 110.986 -179.074 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.46 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.82 5.98 89.25 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.138 -1.029 . . . . 0.0 111.385 177.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 45.8 t80 -56.93 143.56 37.22 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.901 -1.353 . . . . 0.0 109.767 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.55 HD13 ' HA ' ' A' ' 9' ' ' GLU . 21.7 mm -115.14 111.84 37.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 121.294 -0.879 . . . . 0.0 110.718 -179.323 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.1 t80 -82.17 129.34 34.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.867 . . . . 0.0 109.739 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -109.25 121.43 42.68 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.875 . . . . 0.0 110.202 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -71.66 -30.97 13.97 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.189 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.42 -14.81 62.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.082 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -108.88 -38.58 5.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 110.157 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.32 169.04 25.81 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.679 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.671 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.07 54.73 3.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.462 -1.022 . . . . 0.0 109.886 179.212 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -40.37 -58.03 1.63 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.396 -0.815 . . . . 0.0 110.756 -179.528 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.527 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 47.5 m-85 -46.31 -33.34 3.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.07 -63.75 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.003 . . . . 0.0 110.292 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.59 53.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.671 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.92 144.96 55.14 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.279 -1.13 . . . . 0.0 109.819 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.3 Cg_endo -70.65 161.13 47.14 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.966 1.508 . . . . 0.0 110.366 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.19 162.87 40.42 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.999 1.526 . . . . 0.0 110.787 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.41 13.33 83.67 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 83.7 m -99.85 124.06 45.22 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.269 -1.136 . . . . 0.0 110.15 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 46.4 Cg_endo -73.25 139.95 30.01 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.915 1.482 . . . . 0.0 110.644 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.583 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 t80 -50.96 -41.61 59.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.897 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -53.98 -17.55 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.418 -0.801 . . . . 0.0 110.423 -179.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 9.6 t0 -84.29 -7.44 59.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -0.992 . . . . 0.0 110.178 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 37' ' ' LEU . 19.8 mt -71.14 154.99 41.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.018 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.68 149.63 38.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 109.823 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -55.67 -16.48 4.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.152 -0.967 . . . . 0.0 110.294 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -95.57 6.3 49.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.6 t80 -60.13 136.98 58.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.142 -0.974 . . . . 0.0 109.913 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' SER . 4.7 mtm -119.77 146.55 45.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 110.01 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 8.2 t -56.07 131.05 74.28 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 110.448 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.7 Cg_endo -72.21 -12.67 27.96 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.872 1.459 . . . . 0.0 109.583 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.34 -64.31 1.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.463 -0.773 . . . . 0.0 110.82 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.538 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.2 p -98.84 3.83 47.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.899 . . . . 0.0 111.206 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 14.2 mtm180 61.6 20.77 11.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.134 -0.979 . . . . 0.0 112.103 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.7 m -73.71 168.36 26.51 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.72 -1.238 . . . . 0.0 109.767 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.6 Cg_endo -73.57 142.27 32.46 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.951 1.5 . . . . 0.0 110.383 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 28.0 tttm -50.01 -29.22 8.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 109.807 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -61.23 -13.24 16.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.0 110.013 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.59 -1.08 57.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.328 -0.857 . . . . 0.0 109.681 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 13.3 m-85 -87.98 139.32 30.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 110.477 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 3.3 mttt -127.36 143.18 51.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.455 -0.778 . . . . 0.0 109.449 179.246 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 12.0 p -82.06 168.84 17.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.76 -1.213 . . . . 0.0 110.709 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.526 HG12 ' CB ' ' A' ' 7' ' ' LYS . 14.8 pt -105.22 -26.07 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.666 -0.646 . . . . 0.0 110.454 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HA ' ' N ' ' A' ' 4' ' ' ASP . 2.4 tptt 66.99 98.39 0.05 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.0 110.158 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -90.94 154.0 19.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.915 . . . . 0.0 110.153 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 11.9 p -75.19 164.2 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.947 . . . . 0.0 110.22 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.438 ' N ' HG22 ' A' ' 59' ' ' VAL . 1.5 tt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.175 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mtt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.229 0.537 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 3' ' ' ILE . 3.1 pt-20 -131.69 64.62 1.59 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.237 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 2' ' ' GLU . 20.1 pt -156.61 177.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 110.073 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -152.6 126.25 8.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.43 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -174.23 60.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.715 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 43.62 25.98 0.63 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.529 ' HB2' ' CG1' ' A' ' 56' ' ' ILE . 37.0 mttt -80.74 120.91 25.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -1.194 . . . . 0.0 109.744 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.688 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 11.4 m-85 -114.25 140.36 48.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 110.469 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 9.9 pt-20 -117.63 136.75 53.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 109.562 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 3.6 t -74.87 120.0 19.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.7 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -16.67 63.27 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.751 -1.218 . . . . 0.0 108.481 178.249 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -58.78 2.55 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.561 -0.712 . . . . 0.0 110.564 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.488 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.5 p -109.52 -1.2 18.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.953 -1.092 . . . . 0.0 110.814 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.685 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 73.52 10.38 79.32 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 120.176 -1.012 . . . . 0.0 111.505 177.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 41.0 t80 -62.19 147.69 46.99 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.775 -1.427 . . . . 0.0 109.331 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -116.08 114.32 45.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.539 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 34' ' ' PHE . 18.5 t80 -83.16 134.68 34.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -111.23 119.18 46.15 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.432 -0.792 . . . . 0.0 110.07 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.2 Cg_endo -71.26 -31.71 13.91 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.955 1.503 . . . . 0.0 110.265 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.76 -8.52 56.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.371 -0.83 . . . . 0.0 109.972 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.3 tttt -110.06 -47.03 3.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.9 . . . . 0.0 110.16 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.21 162.84 14.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.554 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.17 56.68 4.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.509 -0.995 . . . . 0.0 109.927 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 23' ' ' ASP . 10.1 mmtt -40.14 -57.22 1.73 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.432 -0.793 . . . . 0.0 110.703 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -45.45 -34.01 2.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.398 -0.814 . . . . 0.0 110.604 -179.809 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -95.38 -61.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 110.405 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.24 55.77 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.554 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.1 mp -129.94 143.67 50.0 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.269 -1.136 . . . . 0.0 109.953 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.0 Cg_endo -70.5 162.9 40.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.943 1.496 . . . . 0.0 110.533 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.4 Cg_endo -72.41 161.68 43.62 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.983 1.517 . . . . 0.0 110.92 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.85 14.98 82.02 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 97.7 m -102.04 125.87 35.42 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.177 . . . . 0.0 110.187 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.811 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.6 Cg_endo -72.95 136.94 25.89 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.855 1.45 . . . . 0.0 110.528 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.606 ' CD2' HD12 ' A' ' 37' ' ' LEU . 15.1 t80 -53.06 -39.17 63.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.179 -0.951 . . . . 0.0 110.174 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.8 m -53.32 -18.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.119 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 15.2 t0 -82.41 -5.88 58.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 110.416 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 41' ' ' PHE . 22.2 mt -70.06 157.35 37.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.917 . . . . 0.0 110.067 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.05 155.95 30.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.2 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -60.48 -13.67 15.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.211 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.2 m -98.25 2.21 48.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 110.077 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.628 ' CD1' HD13 ' A' ' 37' ' ' LEU . 44.7 t80 -56.06 133.13 51.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.865 . . . . 0.0 110.139 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 35.4 mtt -111.03 138.29 47.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.006 -1.059 . . . . 0.0 109.307 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . 43.9 t -47.08 136.42 8.42 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 110.73 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.7 Cg_endo -82.8 36.18 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.124 1.592 . . . . 0.0 110.08 179.061 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.522 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -151.92 -50.31 0.11 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.247 -0.908 . . . . 0.0 109.588 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.488 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.5 p -118.17 8.41 12.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.389 -0.819 . . . . 0.0 110.128 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 27.3 mtp180 61.1 15.02 5.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.486 -0.759 . . . . 0.0 112.084 178.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.452 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.6 m -64.81 166.76 10.97 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.874 -1.141 . . . . 0.0 109.815 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.3 Cg_endo -73.25 142.32 33.62 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.932 1.49 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.2 tttm -49.85 -31.54 12.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.777 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -62.42 -12.26 20.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 109.808 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -89.56 -2.14 58.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.835 . . . . 0.0 109.745 179.505 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 13.7 m-85 -88.11 139.82 30.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 110.508 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 20.1 tttt -126.12 142.45 51.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 109.371 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.688 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 9.3 p -83.29 169.44 15.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.936 -1.103 . . . . 0.0 111.023 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 7' ' ' LYS . 1.1 pt -131.98 53.37 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.797 -0.565 . . . . 0.0 110.055 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.438 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 5.2 tttm -91.8 58.52 3.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.893 . . . . 0.0 110.239 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -116.4 63.76 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 110.258 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.44 137.12 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.222 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.3 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.226 -179.97 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ttp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.215 0.531 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.603 ' C ' HG22 ' A' ' 3' ' ' ILE . 1.8 pt-20 -143.6 128.47 18.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 110.23 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.603 HG22 ' C ' ' A' ' 2' ' ' GLU . 1.0 OUTLIER 171.29 171.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 109.973 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.553 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 3.7 p30 -144.6 121.18 11.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.757 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -117.5 -88.68 0.6 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 109.807 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.3 32.41 2.25 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.539 ' HD2' HD11 ' A' ' 56' ' ' ILE . 30.9 mtmt -76.9 113.5 14.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 109.278 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.62 ' CE1' ' HB3' ' A' ' 55' ' ' SER . 8.6 m-85 -120.6 140.22 51.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 0.0 111.144 -178.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 45.6 tt0 -117.03 141.54 48.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.538 -0.726 . . . . 0.0 109.358 179.198 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.462 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.9 t -77.13 116.54 17.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.072 -1.017 . . . . 0.0 110.309 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -16.25 64.19 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.787 -1.195 . . . . 0.0 108.663 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -60.1 2.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.575 -0.703 . . . . 0.0 110.605 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.55 -3.61 17.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.061 -1.024 . . . . 0.0 110.945 -178.984 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.749 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.27 6.87 88.79 Favored Glycine 0 N--CA 1.496 2.685 0 O-C-N 121.09 -1.006 . . . . 0.0 111.611 177.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 28.0 t80 -59.17 143.01 50.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.736 -1.45 . . . . 0.0 109.723 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.4 mp -113.99 113.87 45.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.215 -0.928 . . . . 0.0 110.746 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 25.6 t80 -84.64 137.43 33.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -0.852 . . . . 0.0 109.593 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -114.73 122.6 33.53 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.788 . . . . 0.0 110.222 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.6 Cg_endo -71.08 -34.07 10.82 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.811 1.427 . . . . 0.0 110.089 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.31 -11.27 60.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 110.053 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -111.68 -38.2 4.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.28 170.98 28.28 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.624 ' OD1' HG21 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -85.19 57.15 4.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.493 -1.004 . . . . 0.0 109.702 179.099 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' ASP . 14.6 tptm -38.94 -61.33 0.75 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.454 -0.779 . . . . 0.0 110.532 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 27.2 m-85 -45.88 -30.38 1.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.835 . . . . 0.0 110.459 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -95.11 -63.5 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 0.0 110.276 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.43 54.24 0.02 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.624 HG21 ' OD1' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -129.95 144.17 51.99 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.212 -1.169 . . . . 0.0 109.662 179.798 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -70.44 159.0 54.38 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.982 1.517 . . . . 0.0 110.522 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.33 164.3 36.04 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.996 1.524 . . . . 0.0 110.741 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 80.22 13.98 81.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.8 m -105.19 126.69 30.34 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.176 -1.191 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.679 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.1 Cg_endo -72.97 141.73 33.63 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.897 1.472 . . . . 0.0 110.533 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.572 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 51.9 t80 -52.62 -41.37 63.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 110.177 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 33' ' ' PRO . 5.8 m -54.76 -17.17 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.337 -0.852 . . . . 0.0 110.305 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 29.6 t70 -86.7 -6.78 58.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 110.272 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.606 HD13 ' CD1' ' A' ' 41' ' ' PHE . 17.7 mt -72.81 124.76 26.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.195 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' LEU . 16.0 m -43.01 164.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.172 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -72.77 -2.01 18.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.0 110.182 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' ' SD ' ' A' ' 42' ' ' MET . 7.9 p -103.11 1.49 33.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.416 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.606 ' CD1' HD13 ' A' ' 37' ' ' LEU . 47.5 t80 -56.79 130.21 44.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 110.225 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -119.21 146.09 45.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.681 179.594 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.4 t -55.36 129.53 68.84 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 110.494 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.583 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.49 -13.34 30.2 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.895 1.471 . . . . 0.0 109.461 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.69 -65.16 0.98 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.558 -0.714 . . . . 0.0 110.917 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.523 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.2 p -97.0 2.85 52.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.191 -0.943 . . . . 0.0 111.159 -179.121 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.2 tpp180 61.65 22.99 13.38 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.137 -0.977 . . . . 0.0 111.945 178.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.459 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.2 m -74.38 165.48 53.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.839 -1.163 . . . . 0.0 109.94 179.438 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.9 Cg_endo -73.36 143.86 35.74 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.947 1.498 . . . . 0.0 110.44 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 12.5 tttt -49.16 -25.33 2.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 110.032 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -66.74 -11.2 53.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.88 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.2 mm-40 -90.75 -2.32 57.81 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.359 -0.838 . . . . 0.0 109.538 179.271 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 6.5 m-85 -89.09 138.87 31.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -0.77 . . . . 0.0 110.52 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 20.3 mmtt -130.83 146.92 52.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 109.586 179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.62 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 4.0 p -82.55 166.17 19.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.835 -1.165 . . . . 0.0 110.456 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.544 ' CG1' ' N ' ' A' ' 57' ' ' LYS . 9.1 pt -111.51 -44.14 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.545 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.544 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 2.6 mtpt 55.15 94.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -92.77 70.53 4.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 0.0 110.191 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.5 t -106.35 89.32 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.192 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.534 HG22 ' OXT' ' A' ' 60' ' ' ILE . 84.8 mt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.202 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.217 0.532 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.68 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -175.54 174.06 2.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.22 179.923 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.525 HG13 ' CB ' ' A' ' 58' ' ' LYS . 1.4 pt -146.34 -179.41 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 110.128 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 1.0 OUTLIER -116.09 -167.68 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 110.398 -179.858 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 0.4 OUTLIER 175.26 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.822 . . . . 0.0 110.418 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.474 ' CA ' ' HG3' ' A' ' 19' ' ' PRO . . . 119.45 7.61 9.79 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.413 ' NZ ' HD11 ' A' ' 56' ' ' ILE . 1.4 mmmp? -84.26 112.12 20.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -1.112 . . . . 0.0 109.506 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.3 m-85 -125.73 150.14 47.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.926 -179.289 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 29.1 tt0 -120.32 140.2 51.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 109.243 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.3 t -77.4 116.81 18.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.06 -1.025 . . . . 0.0 110.562 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.14 -16.15 63.88 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.897 -1.127 . . . . 0.0 108.511 178.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.11 -59.48 2.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.65 -0.656 . . . . 0.0 110.539 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -109.27 -3.4 17.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.058 -1.026 . . . . 0.0 110.788 -179.113 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.747 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.06 6.82 88.75 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 121.118 -0.989 . . . . 0.0 111.571 177.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.695 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 51.5 t80 -58.98 144.33 45.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.83 -1.394 . . . . 0.0 109.894 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -116.05 113.07 42.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.761 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.589 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 40.7 t80 -81.55 123.23 28.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.743 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -102.21 118.01 59.96 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.47 -0.769 . . . . 0.0 110.294 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 46.5 Cg_endo -71.53 -30.67 14.73 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.902 1.475 . . . . 0.0 110.288 179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.82 -7.09 36.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.07 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 9.5 mttt -118.99 -35.73 3.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.884 . . . . 0.0 110.065 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.31 168.73 25.8 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -85.19 54.99 3.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.419 -1.047 . . . . 0.0 109.903 179.195 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -39.78 -58.13 1.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.574 -179.539 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.601 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -47.58 -34.05 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.412 -0.805 . . . . 0.0 110.537 -179.847 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -91.97 -65.3 1.02 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 110.239 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.96 52.99 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.548 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -132.49 142.59 45.46 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 0.0 109.908 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -69.97 161.95 44.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.871 1.458 . . . . 0.0 110.304 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.3 Cg_endo -71.92 162.99 40.24 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.993 1.523 . . . . 0.0 110.866 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 80.31 12.74 82.8 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 29' ' ' PRO . 2.2 m -101.71 126.19 34.88 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.147 -1.208 . . . . 0.0 110.219 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 46.9 Cg_endo -73.88 140.51 28.93 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.834 1.439 . . . . 0.0 110.613 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.589 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -52.13 -41.67 62.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.985 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -53.22 -18.71 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.445 -179.37 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 8.7 t70 -84.91 -6.66 59.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.237 -0.914 . . . . 0.0 110.118 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 41' ' ' PHE . 16.9 mt -73.67 121.94 21.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.345 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -41.34 152.74 0.05 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.413 -0.804 . . . . 0.0 110.336 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.19 -11.81 16.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 110.266 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.03 5.8 49.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.437 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.549 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.7 t80 -58.91 137.38 57.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 110.155 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.8 mtt -117.94 143.11 46.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 109.558 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 47' ' ' ARG . 43.2 t -59.62 125.71 80.63 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 110.169 -179.74 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.8 Cg_endo -71.15 -9.75 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.891 1.469 . . . . 0.0 109.899 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.695 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -93.19 -53.44 4.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -0.824 . . . . 0.0 110.193 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.489 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.8 p -117.64 8.3 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.615 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' CYS . 11.7 ttp180 61.81 15.44 7.06 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.245 -0.91 . . . . 0.0 112.097 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.454 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -68.29 168.64 12.94 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.858 -1.151 . . . . 0.0 109.895 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 48.0 Cg_endo -73.92 141.95 30.84 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.834 1.439 . . . . 0.0 110.524 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.579 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.7 tttm -50.21 -28.9 8.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -0.926 . . . . 0.0 109.956 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.78 -12.17 22.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.847 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.2 tm0? -88.67 -2.21 58.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.339 -0.851 . . . . 0.0 109.737 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 26.8 m-85 -85.24 136.78 33.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.717 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.87 137.31 54.09 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.642 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.6 t -85.32 172.24 11.25 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.76 -1.212 . . . . 0.0 110.489 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.413 HD11 ' NZ ' ' A' ' 7' ' ' LYS . 5.9 pt -113.16 -20.54 6.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.259 0.552 . . . . 0.0 110.379 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER 60.15 95.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.006 -179.904 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.525 ' CB ' HG13 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -49.32 116.1 1.58 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.186 -179.89 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.68 HG22 ' HB3' ' A' ' 2' ' ' GLU . 94.6 t -102.45 129.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.293 -0.879 . . . . 0.0 110.282 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 tt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.164 179.935 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' CG ' ' A' ' 2' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.222 0.534 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.789 ' HG2' HG13 ' A' ' 59' ' ' VAL . 1.6 mt-10 174.67 104.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.25 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.858 HG21 HG23 ' A' ' 56' ' ' ILE . 32.2 mm -134.79 170.6 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.936 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER 165.68 -20.51 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.381 -0.824 . . . . 0.0 110.584 179.969 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.8 pm0 -73.49 59.1 0.59 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 110.366 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.32 31.7 13.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.557 ' HD2' HD12 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -80.43 119.95 23.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -1.127 . . . . 0.0 109.928 179.662 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 23.9 m-85 -116.4 139.46 50.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.109 -0.994 . . . . 0.0 110.22 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -113.96 135.22 54.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 109.969 179.594 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 14' ' ' GLY . 2.5 t -72.67 117.77 14.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.543 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -68.57 -15.76 63.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.776 -1.202 . . . . 0.0 108.513 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.24 -59.02 2.45 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.501 -0.75 . . . . 0.0 110.406 179.49 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.509 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.5 p -109.69 -0.65 18.46 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.863 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 72.7 11.84 77.74 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.075 -1.015 . . . . 0.0 111.496 177.678 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.6 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 17.4 t80 -63.92 147.32 52.24 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.781 -1.423 . . . . 0.0 109.685 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 15.1 mm -112.4 115.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.027 -1.046 . . . . 0.0 110.513 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 41.7 t80 -83.09 131.44 35.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.784 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -111.48 118.19 47.69 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.779 . . . . 0.0 110.198 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 43.5 Cg_endo -70.25 -30.16 20.4 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.884 1.465 . . . . 0.0 110.068 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.5 -11.61 60.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.835 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 11.7 tptt -110.48 -44.01 3.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.425 -0.797 . . . . 0.0 109.944 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.52 168.59 21.87 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.64 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.2 52.46 2.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.514 -0.992 . . . . 0.0 109.748 178.974 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 1.4 ttpp -39.11 -60.4 0.89 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 110.627 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 32.0 m-85 -44.7 -31.22 1.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.798 . . . . 0.0 110.346 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -95.08 -62.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.277 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.75 51.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.64 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -128.53 143.8 49.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 109.725 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.6 Cg_endo -69.88 159.69 52.39 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.958 1.504 . . . . 0.0 110.478 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.35 161.35 44.62 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.038 1.546 . . . . 0.0 111.006 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.83 13.77 82.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 91.2 m -99.02 125.58 41.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.231 -1.158 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.76 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.7 Cg_endo -73.03 136.66 25.2 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.905 1.476 . . . . 0.0 110.481 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 50' ' ' LYS . 11.8 t80 -50.09 -42.87 50.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.76 HG22 ' HB2' ' A' ' 33' ' ' PRO . 19.1 m -53.63 -17.0 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 110.621 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 12.0 t70 -86.56 -7.84 58.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.01 -1.056 . . . . 0.0 110.281 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.472 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.3 mt -68.16 158.02 34.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 110.109 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.6 m -77.86 152.71 33.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 110.002 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -61.27 -12.19 12.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.24 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.24 2.98 35.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.898 . . . . 0.0 110.552 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CZ ' ' OD2' ' A' ' 23' ' ' ASP . 46.6 t80 -58.11 137.71 56.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.015 -1.053 . . . . 0.0 109.755 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.425 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -109.75 137.61 47.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.85 -1.156 . . . . 0.0 109.837 179.786 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 38.4 t -46.66 136.55 7.57 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.284 -0.885 . . . . 0.0 110.569 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.6 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.5 Cg_endo -81.73 34.81 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.126 1.592 . . . . 0.0 110.379 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -150.81 -48.72 0.12 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.226 -0.921 . . . . 0.0 109.526 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.509 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.6 p -120.04 9.28 11.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 110.183 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.19 14.04 5.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.406 -0.809 . . . . 0.0 112.116 178.594 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.454 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.8 m -64.98 169.0 6.09 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.498 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.4 Cg_endo -74.21 142.69 30.88 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.762 1.401 . . . . 0.0 110.151 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 11.3 tttm -50.73 -31.81 17.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.074 -1.016 . . . . 0.0 109.618 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -64.03 -11.61 30.86 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.356 -0.84 . . . . 0.0 109.316 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -85.54 -4.1 59.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.361 -0.837 . . . . 0.0 109.865 179.641 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 22.4 m-85 -79.9 133.15 36.21 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.854 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -102.92 133.3 48.25 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.221 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -86.05 159.61 19.53 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.029 -1.045 . . . . 0.0 110.191 -179.537 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.858 HG23 HG21 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -153.57 89.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 110.028 -179.936 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HB3' ' OD1' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -113.66 64.18 0.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 110.245 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.438 ' C ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -118.8 162.62 18.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 179.866 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.789 HG13 ' HG2' ' A' ' 2' ' ' GLU . 95.4 t -148.77 116.7 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 110.248 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.637 HG22 ' OXT' ' A' ' 60' ' ' ILE . 21.6 mm . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.202 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' O ' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.214 0.531 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.704 ' O ' HG23 ' A' ' 3' ' ' ILE . 4.7 mm-40 46.28 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 2' ' ' GLU . 10.7 pt -159.09 -170.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 110.204 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 4' ' ' ASP . 24.3 p30 -142.37 158.52 43.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 110.275 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.511 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.2 tt0 -145.39 38.3 1.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.487 ' CA ' ' HG3' ' A' ' 19' ' ' PRO . . . 45.45 23.92 0.94 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.746 ' HG2' HD13 ' A' ' 56' ' ' ILE . 1.6 tptm -87.47 119.93 28.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -1.21 . . . . 0.0 109.854 179.907 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.9 m-85 -124.51 149.44 46.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 110.596 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -118.85 138.3 52.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.328 179.023 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 3.0 t -76.52 118.88 19.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.021 . . . . 0.0 111.042 -179.349 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.44 -16.26 63.45 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.361 178.036 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.13 -59.7 2.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.631 -0.668 . . . . 0.0 110.587 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.479 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.6 p -107.99 -1.78 20.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.962 -1.086 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 74.07 10.26 80.95 Favored Glycine 0 N--CA 1.494 2.559 0 O-C-N 121.092 -1.005 . . . . 0.0 111.458 177.471 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.685 ' C ' HD12 ' A' ' 16' ' ' ILE . 39.3 t80 -65.1 149.65 49.51 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.819 -1.4 . . . . 0.0 110.001 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.685 HD12 ' C ' ' A' ' 15' ' ' TYR . 1.8 mp -114.79 112.41 39.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.221 -0.925 . . . . 0.0 110.113 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 38.0 t80 -80.79 119.94 24.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.688 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.32 118.04 57.78 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.354 -0.841 . . . . 0.0 110.061 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 32' ' ' THR . 44.6 Cg_endo -72.19 -22.44 22.35 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.931 1.49 . . . . 0.0 110.423 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -10.49 59.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -112.63 -47.32 3.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.922 . . . . 0.0 110.199 -179.979 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.66 159.36 11.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.553 ' OD2' ' CZ ' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -85.1 57.08 4.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -1.063 . . . . 0.0 109.983 179.415 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' ASP . 57.8 mttm -40.18 -52.97 2.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.448 -0.782 . . . . 0.0 110.464 -179.658 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -50.11 -39.96 44.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.487 -0.758 . . . . 0.0 110.427 -179.918 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -88.77 -67.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.09 55.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 32' ' ' THR . 1.2 mp -129.85 144.5 53.28 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.319 -1.107 . . . . 0.0 109.925 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.564 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.3 Cg_endo -71.03 166.33 29.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.974 1.513 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.1 Cg_endo -72.0 158.81 51.74 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.873 1.459 . . . . 0.0 111.024 -179.81 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.54 14.71 82.18 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.689 HG21 HG21 ' A' ' 28' ' ' ILE . 41.2 m -92.69 119.39 67.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 110.256 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.936 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.2 Cg_endo -72.68 141.56 34.39 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.876 1.461 . . . . 0.0 110.617 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.585 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 43.7 t80 -56.84 -18.48 13.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 110.028 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.936 HG22 ' HB2' ' A' ' 33' ' ' PRO . 14.6 m -73.51 -8.36 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.938 179.693 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -95.55 -7.37 38.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.549 HD12 ' CD1' ' A' ' 34' ' ' PHE . 22.5 mt -71.69 147.55 47.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 110.212 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.81 153.49 36.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.59 -16.35 5.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 p -96.96 5.01 51.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 110.303 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.553 ' CZ ' ' OD2' ' A' ' 23' ' ' ASP . 53.8 t80 -57.95 137.01 57.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.123 -0.986 . . . . 0.0 109.893 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.5 mmt -111.79 138.98 47.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.948 -1.095 . . . . 0.0 109.526 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 39.9 t -47.46 136.55 9.5 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 0.0 110.721 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -82.76 36.39 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.017 1.535 . . . . 0.0 110.109 178.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -151.83 -49.36 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.877 . . . . 0.0 109.491 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.479 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.6 p -119.53 8.56 11.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.423 -0.798 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.74 15.38 5.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -0.805 . . . . 0.0 112.176 178.576 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.451 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.2 m -66.34 169.03 8.07 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.794 -1.191 . . . . 0.0 109.681 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.7 Cg_endo -73.08 140.13 30.75 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.944 1.497 . . . . 0.0 110.413 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.585 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 32.5 tttt -50.24 -31.92 15.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.123 -0.985 . . . . 0.0 109.694 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -62.14 -12.57 20.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.319 -0.863 . . . . 0.0 109.707 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -87.13 -3.35 59.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.759 179.399 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 43' ' ' CYS . 19.7 m-85 -84.99 139.21 31.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 110.592 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.61 137.45 53.85 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.73 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.4 t -85.24 172.26 11.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.564 -1.335 . . . . 0.0 110.653 -179.467 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.746 HD13 ' HG2' ' A' ' 7' ' ' LYS . 9.1 pt -108.74 -43.82 6.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.564 -179.829 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.543 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 0.2 OUTLIER 58.84 97.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -62.42 74.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 -179.767 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.718 ' O ' HG13 ' A' ' 59' ' ' VAL . 12.6 p -96.79 73.77 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 110.296 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.8 tt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.137 -179.959 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.281 0.563 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.9 OUTLIER 51.52 88.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 110.256 179.974 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 1.036 HD12 HD13 ' A' ' 56' ' ' ILE . 8.1 pt -145.13 124.6 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 110.156 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 58' ' ' LYS . 2.6 m-20 -150.92 11.48 0.65 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.461 -0.774 . . . . 0.0 110.692 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 4.6 pt-20 -75.57 59.24 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -0.86 . . . . 0.0 110.799 -179.377 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.07 31.74 11.44 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.723 ' CB ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -80.74 124.32 28.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -1.119 . . . . 0.0 110.148 179.836 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 16.1 m-85 -113.85 139.91 48.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.145 -0.972 . . . . 0.0 110.04 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -118.06 137.43 52.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.104 -0.997 . . . . 0.0 109.828 179.563 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.0 t -74.82 116.64 15.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 110.359 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -67.4 -15.99 63.99 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.761 -1.212 . . . . 0.0 108.62 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.22 -59.99 2.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.618 -0.676 . . . . 0.0 110.463 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.494 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.3 p -109.03 -1.93 18.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.039 -1.038 . . . . 0.0 110.967 -179.102 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.754 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 76.4 8.61 85.81 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.374 177.762 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 31.3 t80 -59.11 144.27 46.15 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.849 -1.383 . . . . 0.0 109.578 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -113.35 113.68 44.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.221 -0.925 . . . . 0.0 110.574 -179.318 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 35.8 t80 -82.74 131.23 35.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.305 -0.872 . . . . 0.0 109.739 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 12.2 mt-10 -108.15 119.68 49.1 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.521 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 43.7 Cg_endo -71.73 -35.61 7.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.839 1.442 . . . . 0.0 110.055 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 31.4 tt0 -70.29 -6.23 33.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 110.037 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 5.4 mmtt -117.56 -37.13 3.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.094 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.97 172.36 28.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 1.1 t70 -85.23 58.52 5.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -1.013 . . . . 0.0 109.756 178.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -36.83 -64.6 0.34 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.542 -0.723 . . . . 0.0 110.728 -179.535 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 1.6 m-85 -42.53 -26.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.847 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -99.98 -58.03 2.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.875 . . . . 0.0 109.952 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.65 -8.07 1.54 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.318 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.583 HG23 ' HD2' ' A' ' 29' ' ' PRO . 1.8 mt -61.79 143.36 94.23 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.251 . . . . 0.0 109.927 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.6 Cg_endo -71.08 160.38 49.37 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.926 1.487 . . . . 0.0 110.659 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.4 Cg_endo -72.83 163.66 37.8 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.13 1.595 . . . . 0.0 110.801 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.72 14.12 82.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 86.4 m -105.73 127.23 28.87 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.28 -1.129 . . . . 0.0 110.134 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.746 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.9 Cg_endo -73.13 140.75 31.56 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.959 1.505 . . . . 0.0 110.492 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 2.6 t80 -50.05 -38.06 36.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.991 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.746 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.3 m -54.4 -17.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 110.363 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -85.05 -7.15 59.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.091 -1.006 . . . . 0.0 110.234 179.949 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.584 HD12 ' CD2' ' A' ' 34' ' ' PHE . 48.5 mt -69.06 155.94 39.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.0 110.089 179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.25 156.13 29.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.136 -0.977 . . . . 0.0 109.819 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -9.64 16.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.029 -1.044 . . . . 0.0 110.317 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 t -103.65 2.76 33.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.473 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.577 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.1 t80 -59.82 138.95 57.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.122 -0.987 . . . . 0.0 109.885 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 48' ' ' SER . 7.0 mtt -117.09 142.72 46.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.866 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 41.9 t -56.3 128.32 72.82 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.24 -0.913 . . . . 0.0 110.008 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.9 Cg_endo -71.45 -12.66 29.78 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.924 1.486 . . . . 0.0 109.856 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.34 -51.45 4.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 110.675 -179.703 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.494 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 7.5 p -118.83 9.39 12.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.117 -0.989 . . . . 0.0 110.939 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.44 12.68 4.52 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.285 -0.885 . . . . 0.0 112.296 178.347 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 19.0 p -65.12 166.41 13.08 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.832 -1.167 . . . . 0.0 109.765 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 44.4 Cg_endo -71.87 142.38 38.94 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.665 1.35 . . . . 0.0 110.097 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.598 ' CE ' ' CZ ' ' A' ' 34' ' ' PHE . 23.1 tttt -50.41 -28.9 9.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.772 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -62.76 -12.58 25.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.206 -0.933 . . . . 0.0 109.741 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -87.42 -3.45 59.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -0.809 . . . . 0.0 109.664 179.433 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 21.7 m-85 -84.01 136.99 33.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 110.362 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -120.27 139.6 52.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.882 . . . . 0.0 109.268 179.198 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 53.1 p -85.55 168.38 14.55 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.885 -1.134 . . . . 0.0 111.355 -179.392 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.036 HD13 HD12 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -139.21 83.04 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.381 0.61 . . . . 0.0 109.826 179.709 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER -106.31 68.62 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.46 -0.775 . . . . 0.0 109.881 -179.887 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.524 ' N ' ' OD2' ' A' ' 4' ' ' ASP . 6.9 mmtt -126.01 170.49 11.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 110.355 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 4.1 p -166.42 130.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 0.0 110.211 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 mm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.064 -0.969 . . . . 0.0 110.205 -179.959 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 19.6 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.215 0.531 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.566 ' C ' HG23 ' A' ' 3' ' ' ILE . 3.8 mt-10 54.4 -176.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.781 ' O ' HD12 ' A' ' 3' ' ' ILE . 2.6 pp -153.26 126.35 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' A' ' 57' ' ' LYS . 15.2 p-10 -96.2 133.38 40.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 110.147 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.31 13.95 4.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.13 -0.981 . . . . 0.0 110.118 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.438 ' HA3' ' HG3' ' A' ' 19' ' ' PRO . . . 113.0 10.97 14.7 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.537 ' O ' HG23 ' A' ' 56' ' ' ILE . 11.7 mtmt -79.11 111.47 15.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -1.173 . . . . 0.0 109.131 179.333 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 10.6 m-85 -121.34 143.44 49.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.139 -0.975 . . . . 0.0 111.254 -178.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.544 ' HA ' HD13 ' A' ' 16' ' ' ILE . 3.3 tm-20 -121.39 143.69 49.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.908 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 4.7 t -78.67 116.57 19.12 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.997 -1.064 . . . . 0.0 110.531 -179.544 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -15.77 63.67 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.767 -1.208 . . . . 0.0 108.415 178.295 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.02 -61.56 1.74 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.688 -0.632 . . . . 0.0 110.445 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.482 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -106.43 -3.95 20.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.931 -1.105 . . . . 0.0 110.559 -179.221 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 80.62 2.42 89.77 Favored Glycine 0 N--CA 1.496 2.696 0 O-C-N 121.086 -1.009 . . . . 0.0 111.19 177.536 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.647 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 22.5 t80 -50.43 171.65 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.998 -1.295 . . . . 0.0 109.7 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 23.2 mm -139.48 130.48 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 110.344 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 55.8 t80 -105.12 120.6 41.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.363 -0.836 . . . . 0.0 109.927 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -108.88 119.0 50.27 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.099 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -70.72 -24.29 25.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.929 1.489 . . . . 0.0 110.316 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 8.0 tp10 -72.64 -15.53 61.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.242 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 9.9 tttt -109.84 -40.7 4.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.42 156.39 12.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 1.007 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -85.3 62.2 7.34 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.375 -1.074 . . . . 0.0 108.995 178.463 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -39.68 -48.57 2.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.467 -0.771 . . . . 0.0 111.039 -179.061 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 44' ' ' PRO . 13.4 m-85 -80.96 13.22 2.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 0.0 110.907 -179.338 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.007 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -131.55 -3.77 3.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.0 110.71 -179.83 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.86 38.53 7.97 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.954 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.751 ' CG2' HG21 ' A' ' 32' ' ' THR . 1.7 mp -133.21 136.46 27.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.838 -1.389 . . . . 0.0 110.25 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 46.6 Cg_endo -72.79 174.12 12.35 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.016 1.535 . . . . 0.0 110.486 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 43.6 Cg_endo -72.85 160.52 45.91 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.969 1.51 . . . . 0.0 111.039 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.8 11.5 84.55 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.751 HG21 ' CG2' ' A' ' 28' ' ' ILE . 54.4 m -94.54 121.38 63.4 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.232 -1.157 . . . . 0.0 110.299 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.843 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.7 Cg_endo -72.96 143.53 36.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.838 1.441 . . . . 0.0 110.456 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.668 ' CD1' HD12 ' A' ' 37' ' ' LEU . 37.9 t80 -55.97 -37.16 68.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.908 . . . . 0.0 110.05 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.843 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.9 m -55.33 -18.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.454 -0.779 . . . . 0.0 109.872 179.674 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 7.7 t70 -83.42 -6.66 59.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.819 . . . . 0.0 110.242 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.668 HD12 ' CD1' ' A' ' 34' ' ' PHE . 22.2 mt -73.67 146.15 44.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.128 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -75.62 162.32 28.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.841 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -64.16 -9.75 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.151 -0.968 . . . . 0.0 110.259 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 t -100.16 4.32 44.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.468 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.558 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 51.4 t80 -58.38 137.13 57.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 109.792 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 48' ' ' SER . 20.0 mtt -120.75 146.08 46.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.008 -1.058 . . . . 0.0 110.122 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 47.0 t -59.23 127.43 84.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 110.265 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 45.7 Cg_endo -71.47 -9.98 26.1 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.931 1.49 . . . . 0.0 109.754 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.647 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -95.09 -56.7 2.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 110.582 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.482 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.9 p -111.61 5.99 19.71 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.122 -0.986 . . . . 0.0 110.691 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.6 OUTLIER 62.54 16.56 8.85 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.337 -0.852 . . . . 0.0 112.072 178.512 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.448 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -69.05 167.69 19.29 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.835 -1.166 . . . . 0.0 109.804 179.47 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.7 Cg_endo -72.74 140.89 33.03 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.897 1.472 . . . . 0.0 110.625 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.572 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 9.6 tttm -48.25 -26.8 2.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -0.916 . . . . 0.0 109.99 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -62.82 -11.23 16.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.799 . . . . 0.0 110.156 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.64 0.3 56.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.257 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 13.0 m-85 -87.85 137.12 32.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 110.616 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -125.2 140.11 53.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 0.0 109.476 179.268 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 5.5 p -79.88 168.02 19.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.162 . . . . 0.0 110.626 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' A' ' 58' ' ' LYS . 2.0 pp -97.07 -27.06 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.661 -0.649 . . . . 0.0 110.49 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.46 ' C ' HD12 ' A' ' 56' ' ' ILE . 21.9 mtpp 52.18 87.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 110.2 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.631 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.6 tttt -92.69 128.0 38.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.471 ' HB ' ' HG2' ' A' ' 2' ' ' GLU . 14.9 p -61.15 152.4 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.175 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.199 179.964 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.286 0.565 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -100.47 79.96 2.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.555 ' CG1' ' N ' ' A' ' 4' ' ' ASP . 0.9 OUTLIER -174.3 171.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 110.193 -179.917 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.555 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 18.0 p-10 -166.22 125.46 1.58 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.542 -0.724 . . . . 0.0 110.349 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 19.9 tt0 -179.03 36.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 109.806 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . 92.92 -50.44 2.53 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.559 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.74 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.9 mmmt 8.51 108.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 5.9 m-85 -111.32 134.04 53.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 109.886 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 74.3 tt0 -119.72 141.69 49.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 0.0 110.111 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 6.5 t -77.9 114.24 16.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 0.0 110.402 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -14.9 62.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.805 -1.184 . . . . 0.0 108.524 178.593 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.18 -61.87 1.67 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.598 -0.689 . . . . 0.0 110.731 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.3 p -107.77 -4.5 18.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.015 -1.053 . . . . 0.0 110.952 -178.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 15' ' ' TYR . . . 83.18 3.83 90.03 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.622 177.463 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.588 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 69.3 t80 -48.39 173.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.719 -1.459 . . . . 0.0 109.023 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.588 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 11.9 mm -145.77 112.78 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.895 -1.128 . . . . 0.0 110.712 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 53.1 t80 -94.17 148.28 22.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.86 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -130.75 126.53 21.89 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 44.1 Cg_endo -71.45 -33.58 10.73 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.852 1.448 . . . . 0.0 110.285 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -72.87 -2.32 20.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 5.3 ttmt -121.7 -43.08 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.047 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.72 168.17 20.89 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.763 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -85.19 56.44 3.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -1.015 . . . . 0.0 110.007 179.479 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' ASP . 32.2 tttt -41.19 -61.91 0.93 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.396 -0.815 . . . . 0.0 110.48 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -43.07 -30.41 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.804 . . . . 0.0 110.341 -179.981 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.09 -60.11 1.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.344 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.86 54.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.561 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -132.96 142.05 43.24 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.314 -1.11 . . . . 0.0 109.87 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.0 Cg_endo -69.69 160.72 48.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.914 1.481 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.455 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 42.9 Cg_endo -71.43 162.16 43.22 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.072 1.564 . . . . 0.0 111.027 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 82.74 14.17 76.25 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 64.7 m -107.44 125.79 31.51 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.263 -1.14 . . . . 0.0 110.039 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 45.5 Cg_endo -71.91 138.09 30.69 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.884 1.465 . . . . 0.0 110.685 -179.791 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.642 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -52.98 -41.45 64.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -55.39 -17.48 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.354 -0.841 . . . . 0.0 110.19 -179.684 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -85.26 -5.23 59.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 109.922 179.687 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 50' ' ' LYS . 22.1 mt -72.13 127.79 33.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 109.922 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 7.9 t -42.06 155.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 110.161 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 10.8 m-20 -66.72 -7.23 19.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.7 OUTLIER -100.78 3.37 42.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.568 -179.786 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.496 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 51.7 t80 -58.21 132.6 54.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.126 -0.984 . . . . 0.0 109.956 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.442 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -118.81 146.71 44.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.0 109.992 179.744 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.479 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 7.3 t -56.84 128.69 76.86 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 110.16 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.598 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.36 -11.92 29.11 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.777 1.409 . . . . 0.0 109.628 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.82 -62.57 1.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 110.675 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.542 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.9 p -100.8 3.35 41.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.217 -0.927 . . . . 0.0 111.017 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 2.8 tpp180 61.54 21.64 12.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.198 -0.939 . . . . 0.0 112.046 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 27.2 p -74.45 165.24 55.28 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.8 -1.188 . . . . 0.0 109.702 179.259 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 44.9 Cg_endo -71.38 142.45 41.03 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.722 1.38 . . . . 0.0 110.335 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 7.4 tttm -48.09 -24.84 1.22 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.012 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.87 -9.73 31.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.932 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -92.37 -2.21 56.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.262 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.584 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 3.2 m-85 -89.91 140.04 30.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.297 -0.877 . . . . 0.0 110.443 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 47.1 tttt -129.04 145.13 51.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 109.634 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.636 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 2.7 p -81.48 165.75 20.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.015 -1.053 . . . . 0.0 110.889 -179.638 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.74 HG22 ' O ' ' A' ' 7' ' ' LYS . 3.1 tt -158.6 90.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.759 -0.588 . . . . 0.0 110.024 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -134.54 78.99 1.78 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 110.134 -179.897 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.61 161.89 27.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -0.85 . . . . 0.0 110.21 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.83 80.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 110.2 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 pt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.203 -179.925 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mttm . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.179 0.514 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.666 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 9.3 m-85 -118.7 140.55 49.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 110.58 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.5 tm-20 -119.84 142.62 48.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.811 . . . . 0.0 109.464 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.4 t -77.8 115.58 17.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 0.0 110.299 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -15.68 63.85 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.749 -1.219 . . . . 0.0 108.522 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -60.76 1.95 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.608 -0.682 . . . . 0.0 110.699 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.2 p -108.21 -4.35 17.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.093 . . . . 0.0 110.91 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 82.74 3.53 90.46 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.648 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.715 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 65.3 t80 -49.25 173.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.429 . . . . 0.0 109.255 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.611 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 12.2 mm -144.41 110.6 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.025 -1.047 . . . . 0.0 110.525 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 54.9 t80 -83.69 128.48 34.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.916 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -110.16 121.15 42.47 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.2 Cg_endo -71.8 -34.06 9.35 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.859 1.452 . . . . 0.0 110.239 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.93 -14.78 62.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 0.0 109.902 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -113.26 -18.51 12.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 110.049 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 85.35 170.66 47.4 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.695 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.16 49.96 1.85 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -1.069 . . . . 0.0 109.855 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.97 -54.82 2.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.41 -0.806 . . . . 0.0 110.393 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -47.51 -37.02 11.16 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 110.2 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.1 -65.96 0.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.06 51.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.701 HG23 ' HD2' ' A' ' 29' ' ' PRO . 2.1 mp -133.48 147.38 64.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.277 -1.131 . . . . 0.0 109.888 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.701 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -70.3 161.07 47.33 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.955 1.503 . . . . 0.0 110.255 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.9 Cg_endo -72.03 163.78 37.72 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.01 1.531 . . . . 0.0 110.841 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.03 11.04 85.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 18.0 m -100.41 122.12 50.97 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.299 -1.119 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.903 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.2 Cg_endo -72.49 143.3 38.23 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.873 1.46 . . . . 0.0 110.71 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.666 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 30.5 t80 -54.52 -18.86 4.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.901 . . . . 0.0 109.796 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.903 HG22 ' HB2' ' A' ' 33' ' ' PRO . 15.1 m -70.5 -13.88 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.381 -0.824 . . . . 0.0 109.68 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.8 -7.16 56.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.0 110.363 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.56 HD12 ' CD1' ' A' ' 34' ' ' PHE . 19.2 mt -72.23 148.72 45.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.053 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.486 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -77.35 163.69 26.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.909 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -7.06 21.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.983 . . . . 0.0 110.174 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.06 2.68 35.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.339 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 48.0 t80 -58.72 136.31 57.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.757 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 48' ' ' SER . 30.0 mtt -119.46 145.85 45.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.019 -1.051 . . . . 0.0 110.025 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 34.6 t -58.88 128.28 84.31 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 110.194 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 45.8 Cg_endo -72.14 -10.16 25.49 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.857 1.451 . . . . 0.0 109.775 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.715 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -95.99 -58.78 2.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.467 -0.771 . . . . 0.0 110.452 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.533 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.9 p -108.29 5.38 25.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.882 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.35 17.46 9.42 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.201 -0.937 . . . . 0.0 112.049 178.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.451 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.9 m -70.46 167.93 23.09 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.91 -1.118 . . . . 0.0 109.833 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.2 Cg_endo -72.88 141.46 33.51 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.967 1.509 . . . . 0.0 110.527 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.591 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 7.9 tttm -48.4 -26.33 2.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.886 . . . . 0.0 109.832 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -63.85 -11.1 24.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 109.977 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.473 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -91.79 -1.41 57.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.331 -0.855 . . . . 0.0 109.6 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -88.08 138.66 31.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.519 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -129.03 144.43 51.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -0.84 . . . . 0.0 109.686 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.939 -1.101 . . . . 0.0 110.711 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.205 0.526 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.647 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 31.0 m-85 -124.06 145.64 49.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.976 . . . . 0.0 110.62 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -116.78 139.58 50.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 0.0 109.703 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.0 t -76.91 115.96 17.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.085 -1.01 . . . . 0.0 110.596 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -16.2 64.04 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.955 -1.091 . . . . 0.0 108.583 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.16 -58.73 2.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.571 -0.705 . . . . 0.0 110.654 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.89 -4.02 16.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.053 -1.029 . . . . 0.0 110.932 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.755 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 80.09 7.06 88.86 Favored Glycine 0 N--CA 1.497 2.727 0 O-C-N 121.101 -0.999 . . . . 0.0 111.583 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.704 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 53.8 t80 -59.65 142.81 52.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.758 -1.436 . . . . 0.0 110.051 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -114.94 113.82 44.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.16 -0.962 . . . . 0.0 110.638 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.582 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.8 t80 -82.41 132.21 35.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.833 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.24 116.95 41.7 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 110.3 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -70.38 -26.48 24.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.879 1.463 . . . . 0.0 110.343 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -72.5 -12.47 61.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.365 -0.835 . . . . 0.0 109.784 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -114.25 -39.72 3.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.525 -0.734 . . . . 0.0 109.857 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.67 167.64 22.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.632 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.13 53.75 2.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.559 -0.965 . . . . 0.0 109.819 179.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.82 -57.94 1.46 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 110.634 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.527 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 64.7 m-85 -47.61 -34.83 8.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.366 -0.834 . . . . 0.0 110.328 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.5 -65.88 0.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.374 -0.829 . . . . 0.0 110.083 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.22 52.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.632 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -130.76 144.98 55.68 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.213 -1.169 . . . . 0.0 109.93 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.593 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.5 Cg_endo -70.28 161.86 44.45 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.946 1.498 . . . . 0.0 110.533 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.0 Cg_endo -72.94 162.75 40.22 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.05 1.553 . . . . 0.0 110.902 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.98 11.91 85.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 92.2 m -97.02 124.76 48.59 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.223 -1.163 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.669 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.0 Cg_endo -72.77 138.8 29.59 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.799 1.421 . . . . 0.0 110.553 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.582 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 27.6 t80 -52.47 -41.91 63.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 0.0 110.066 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' A' ' 33' ' ' PRO . 15.9 m -53.66 -17.98 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 110.233 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 28.4 t0 -83.9 -7.31 59.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.965 . . . . 0.0 110.391 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.517 HD12 ' CD1' ' A' ' 34' ' ' PHE . 18.6 mt -70.03 154.37 42.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 110.028 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.54 151.42 36.35 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.18 -0.95 . . . . 0.0 109.885 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.95 -14.49 6.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.071 -1.018 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 p -97.65 5.17 49.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 110.381 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.8 t80 -59.68 137.62 57.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.142 -0.974 . . . . 0.0 109.873 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.2 mtt -117.18 143.73 45.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 47' ' ' ARG . 49.4 t -58.88 125.7 78.49 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.0 110.093 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 43.6 Cg_endo -70.61 -10.17 27.32 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.943 1.496 . . . . 0.0 109.93 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.704 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -92.82 -52.51 4.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.468 -0.77 . . . . 0.0 110.294 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.8 p -119.32 8.89 11.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.705 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' CYS . 8.7 ttm-85 62.51 13.52 6.25 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.277 -0.89 . . . . 0.0 112.243 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.495 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 16.6 p -66.0 166.96 13.26 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.886 -1.134 . . . . 0.0 109.921 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.2 Cg_endo -73.0 142.49 34.73 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.679 1.357 . . . . 0.0 110.373 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.545 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 24.2 tttm -49.04 -29.82 5.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 109.951 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -63.89 -10.8 22.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.333 -0.854 . . . . 0.0 109.806 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.53 -4.81 58.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.268 -0.895 . . . . 0.0 109.757 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 29.0 m-85 -79.99 132.75 36.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.584 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HB3' ' OE2' ' A' ' 9' ' ' GLU . 42.9 tttt -105.16 130.14 53.4 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.647 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 110.342 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 mttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.234 0.54 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.638 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 29.9 m-85 -123.06 147.14 47.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 0.0 110.647 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 27.3 tt0 -117.24 137.34 52.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.429 -0.794 . . . . 0.0 109.549 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' GLY . 3.3 t -75.87 117.87 18.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.032 -1.042 . . . . 0.0 110.775 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -16.41 63.54 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.901 -1.124 . . . . 0.0 108.46 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.22 -57.68 2.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.672 -0.643 . . . . 0.0 110.48 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.503 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -110.75 -2.98 15.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.092 -1.005 . . . . 0.0 110.927 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.709 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 77.39 8.46 87.06 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.095 -1.003 . . . . 0.0 111.467 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 42.9 t80 -61.1 144.86 52.75 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.903 -1.351 . . . . 0.0 109.838 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -114.85 113.47 43.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.133 -0.979 . . . . 0.0 110.485 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.4 t80 -81.75 127.66 33.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.747 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -106.47 117.69 56.46 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.467 -0.77 . . . . 0.0 110.27 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.9 Cg_endo -70.04 -30.64 20.68 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.937 1.493 . . . . 0.0 110.198 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.04 -11.09 60.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.97 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 6.0 mtpt -110.62 -42.05 4.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 110.051 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.17 165.77 21.28 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.577 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.22 56.39 3.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.516 -0.991 . . . . 0.0 109.893 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.12 -57.23 1.72 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.825 . . . . 0.0 110.809 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 94.8 m-85 -47.13 -33.6 5.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.587 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.67 -64.3 1.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.189 -0.944 . . . . 0.0 110.399 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.0 53.68 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.577 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.1 mp -128.76 144.97 54.39 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.34 -1.094 . . . . 0.0 109.82 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -71.35 160.31 49.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.997 1.524 . . . . 0.0 110.421 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.11 163.16 39.61 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.004 1.529 . . . . 0.0 110.777 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.78 13.01 84.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.6 m -99.98 127.42 33.61 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.205 -1.173 . . . . 0.0 110.214 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 47.8 Cg_endo -73.15 140.15 30.57 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.969 1.51 . . . . 0.0 110.717 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.577 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.5 t80 -52.03 -41.92 62.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.138 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -17.65 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 110.476 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 4.3 t0 -84.07 -7.4 59.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.989 . . . . 0.0 110.249 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 mt -69.35 155.68 40.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.055 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -76.2 148.67 37.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.96 . . . . 0.0 109.785 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -15.81 5.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.996 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.7 5.63 49.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 110.346 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.523 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 54.8 t80 -60.0 139.89 57.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.207 -0.933 . . . . 0.0 109.904 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -118.23 143.31 46.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.07 -1.019 . . . . 0.0 110.027 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 47' ' ' ARG . 48.7 t -58.7 126.23 79.42 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.898 . . . . 0.0 110.139 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.582 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 43.8 Cg_endo -70.97 -10.48 27.67 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.911 1.48 . . . . 0.0 109.898 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -92.89 -52.42 4.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.46 -0.775 . . . . 0.0 110.34 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.6 p -118.98 9.15 11.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.684 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.79 13.72 5.65 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.248 -0.908 . . . . 0.0 112.209 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.5 m -66.47 169.13 8.07 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.832 -1.168 . . . . 0.0 109.878 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 48.0 Cg_endo -74.11 141.79 29.99 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.793 1.417 . . . . 0.0 110.405 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.568 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 26.6 tttm -49.85 -30.9 10.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 109.806 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -62.9 -11.9 21.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.16 -3.65 59.07 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.404 -0.81 . . . . 0.0 109.77 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 15.2 m-85 -79.94 132.49 36.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 110.399 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.24 129.46 50.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.009 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.638 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 110.368 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 tttt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.243 0.544 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.663 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 37.6 m-85 -121.37 143.71 49.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.26 -0.9 . . . . 0.0 110.351 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' O ' ' CG ' ' A' ' 54' ' ' LYS . 7.4 mt-10 -117.04 139.83 50.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.366 -0.834 . . . . 0.0 110.374 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -76.31 113.01 13.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.999 -1.063 . . . . 0.0 110.412 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.6 -15.52 61.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.808 -1.183 . . . . 0.0 108.606 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.2 -61.73 1.7 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.565 -0.709 . . . . 0.0 110.634 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.508 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -107.19 -3.25 20.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 110.97 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.791 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.02 7.54 88.39 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.434 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 29.0 t80 -59.49 142.02 53.45 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.836 -1.391 . . . . 0.0 109.692 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.791 HD12 ' O ' ' A' ' 14' ' ' GLY . 1.9 mp -114.6 115.46 49.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 32.1 t80 -83.78 137.82 33.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -116.28 119.76 36.0 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 110.43 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.2 Cg_endo -69.95 -33.24 16.27 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.905 1.476 . . . . 0.0 110.115 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.32 -12.89 61.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.838 . . . . 0.0 109.788 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -14.85 11.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.913 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 79.97 172.91 44.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.656 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.15 49.56 1.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -1.048 . . . . 0.0 109.759 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ASP . 16.8 ttmt -39.7 -59.0 1.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.57 -0.706 . . . . 0.0 110.442 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.549 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 1.1 m-85 -44.51 -32.83 1.52 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.376 -0.827 . . . . 0.0 110.088 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -93.79 -61.92 1.45 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 0.0 110.263 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.28 51.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.656 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -134.01 143.75 48.64 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.286 -1.126 . . . . 0.0 109.944 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.515 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.1 Cg_endo -68.52 160.95 47.11 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.004 1.529 . . . . 0.0 110.277 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 44.2 Cg_endo -71.76 162.93 40.53 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.027 1.541 . . . . 0.0 111.034 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 81.31 13.29 80.89 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 3.7 m -102.97 121.58 48.59 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.24 -1.153 . . . . 0.0 110.136 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.772 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.1 Cg_endo -72.52 135.11 23.59 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.799 1.42 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 8.0 t80 -47.89 -39.91 20.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.281 -0.887 . . . . 0.0 110.161 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 33' ' ' PRO . 10.6 m -53.54 -22.12 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.401 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 21.2 t0 -84.31 -5.79 59.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 110.367 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.511 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 17.0 mt -72.31 123.34 22.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 110.271 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 7.2 m -41.4 151.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -0.828 . . . . 0.0 110.205 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -63.91 -10.0 18.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -100.02 5.38 45.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.579 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.504 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 55.5 t80 -59.77 138.05 57.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.791 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.0 mtm -122.46 148.06 45.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.978 -1.076 . . . . 0.0 109.936 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 2.0 t -55.75 129.95 71.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 110.5 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.549 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -72.59 -12.55 26.97 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 123.835 1.439 . . . . 0.0 109.114 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.24 -67.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.592 -0.692 . . . . 0.0 110.667 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.508 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.7 p -93.82 1.18 56.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 111.113 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 2.6 ttm180 61.06 31.12 19.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.083 -1.011 . . . . 0.0 111.764 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.4 m -85.01 168.62 19.7 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.775 -1.203 . . . . 0.0 109.883 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.1 Cg_endo -72.42 138.84 30.64 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.959 1.505 . . . . 0.0 110.457 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.614 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 20.9 tttm -51.0 -31.16 17.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.047 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -63.33 -12.11 27.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 109.73 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -85.04 -5.96 59.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.73 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.614 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 23.2 m-85 -79.99 137.96 36.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 110.553 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.508 ' CG ' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -109.71 132.75 53.86 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.384 -0.823 . . . . 0.0 108.997 178.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.663 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.6 0 O-C-N 121.072 -1.018 . . . . 0.0 110.443 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 tttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.609 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 30.7 m-85 -128.92 146.69 50.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.125 -0.984 . . . . 0.0 110.808 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 4.0 mt-10 -116.95 143.2 45.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 0.0 109.578 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 4.3 t -78.13 114.38 16.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.913 -1.117 . . . . 0.0 110.709 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.32 -15.68 63.83 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.915 -1.116 . . . . 0.0 108.41 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -59.62 2.28 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.728 -0.608 . . . . 0.0 110.712 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -109.13 -4.87 16.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.976 -1.078 . . . . 0.0 110.972 -178.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.682 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 84.27 3.63 88.63 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.957 -1.089 . . . . 0.0 111.728 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.848 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 77.7 t80 -52.46 174.34 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.748 -1.443 . . . . 0.0 109.564 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.682 HD12 ' O ' ' A' ' 14' ' ' GLY . 1.2 mp -148.12 110.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.991 . . . . 0.0 110.227 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 49.0 t80 -81.21 123.47 28.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.829 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -107.87 116.91 56.49 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 110.197 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.8 Cg_endo -70.05 -27.46 25.08 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.812 1.427 . . . . 0.0 110.401 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -73.07 -15.18 61.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.342 -0.849 . . . . 0.0 109.998 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 -12.06 12.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.788 . . . . 0.0 109.973 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 80.99 165.74 34.48 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.683 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.21 50.16 1.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -1.064 . . . . 0.0 109.897 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.78 -51.62 2.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.5 -0.75 . . . . 0.0 110.374 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -49.41 -38.7 30.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.385 -0.822 . . . . 0.0 110.28 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.64 -67.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -0.881 . . . . 0.0 110.404 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.73 51.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.825 HG21 HG21 ' A' ' 32' ' ' THR . 2.1 mp -133.69 147.09 63.08 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.27 -1.135 . . . . 0.0 109.921 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.705 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.9 Cg_endo -71.42 165.49 32.31 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.987 1.519 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.9 Cg_endo -72.04 162.51 41.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.96 1.505 . . . . 0.0 110.832 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.81 12.49 82.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.825 HG21 HG21 ' A' ' 28' ' ' ILE . 21.7 m -92.32 122.97 63.67 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -1.139 . . . . 0.0 110.19 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.99 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.5 Cg_endo -72.7 139.07 30.25 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.879 1.463 . . . . 0.0 110.651 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.588 ' CE2' ' HE2' ' A' ' 50' ' ' LYS . 79.8 t80 -55.9 -17.78 7.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.887 . . . . 0.0 109.819 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.99 HG22 ' HB2' ' A' ' 33' ' ' PRO . 14.2 m -73.78 -7.47 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.67 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -95.31 -7.58 38.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 110.383 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.553 HD12 ' CD1' ' A' ' 34' ' ' PHE . 18.3 mt -70.94 147.61 48.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.97 . . . . 0.0 109.978 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.7 m -75.49 155.41 36.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.843 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -58.7 -14.19 7.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.129 -0.982 . . . . 0.0 110.268 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.23 5.43 50.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 110.55 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.527 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.6 t80 -59.01 135.74 57.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.682 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.0 mtp -118.24 146.05 44.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.057 -1.027 . . . . 0.0 110.351 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 47' ' ' ARG . 42.5 t -61.22 124.27 79.67 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.408 -0.808 . . . . 0.0 110.097 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.602 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.0 Cg_endo -70.48 -7.87 22.29 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.883 1.465 . . . . 0.0 109.823 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.848 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -94.0 -54.84 3.44 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.477 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 10.3 p -115.99 7.02 14.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.438 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 43' ' ' CYS . 6.0 ttm180 63.21 15.94 9.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.241 -0.912 . . . . 0.0 112.171 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 20.6 p -68.64 166.56 25.51 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 0.0 109.811 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.2 Cg_endo -72.29 142.01 36.66 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.733 1.386 . . . . 0.0 110.495 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.588 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 10.5 tttm -48.51 -28.47 3.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 109.961 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.99 -10.42 21.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -0.87 . . . . 0.0 109.886 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.66 -4.19 58.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.276 -0.89 . . . . 0.0 109.695 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 19.1 m-85 -80.18 132.34 35.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 110.589 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.48 128.83 53.77 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.609 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.567 0 O-C-N 121.059 -1.026 . . . . 0.0 110.02 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.199 0.523 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.614 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 22.4 m-85 -120.05 146.99 45.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.295 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 70.7 tt0 -121.4 139.89 52.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.7 t -77.11 117.01 18.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.025 . . . . 0.0 110.398 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -68.07 -16.53 64.06 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.785 -1.197 . . . . 0.0 108.617 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.13 -59.14 2.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.637 -0.664 . . . . 0.0 110.574 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.37 -3.76 16.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.006 -1.059 . . . . 0.0 110.918 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.4 6.13 89.02 Favored Glycine 0 N--CA 1.496 2.696 0 O-C-N 121.081 -1.012 . . . . 0.0 111.43 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 17.7 t80 -56.79 144.2 33.9 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.927 -1.337 . . . . 0.0 109.829 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 13.3 mm -115.99 111.27 34.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.651 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.9 t80 -81.24 121.42 26.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.835 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -101.84 118.48 59.38 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.251 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -72.0 -29.25 15.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.968 1.509 . . . . 0.0 110.166 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.08 -9.23 58.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 110.224 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.5 mmmp? -111.81 -45.48 3.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.273 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.52 159.57 12.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.553 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.19 55.18 3.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -1.06 . . . . 0.0 109.882 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.54 -51.59 2.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 110.499 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 65.3 m-85 -51.25 -37.95 49.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.844 . . . . 0.0 110.294 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.54 -68.52 0.78 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 110.183 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.43 53.85 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.651 ' CG2' HG21 ' A' ' 32' ' ' THR . 1.4 mp -131.84 143.37 48.8 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.232 -1.158 . . . . 0.0 109.949 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -72.0 168.67 23.32 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.012 1.533 . . . . 0.0 110.36 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.2 Cg_endo -72.25 161.38 44.65 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.889 1.468 . . . . 0.0 110.88 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.67 15.47 80.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.651 HG21 ' CG2' ' A' ' 28' ' ' ILE . 31.4 m -95.54 122.59 58.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.263 -1.139 . . . . 0.0 110.227 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.785 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -73.26 138.72 28.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.862 1.454 . . . . 0.0 110.58 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.584 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 13.7 t80 -53.13 -40.18 64.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.115 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.785 HG22 ' HB2' ' A' ' 33' ' ' PRO . 11.4 m -53.77 -18.09 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 110.177 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.51 -7.16 59.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.107 -0.996 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.485 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.2 mt -71.86 151.87 43.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.944 . . . . 0.0 110.077 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -76.95 158.68 30.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -10.85 15.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 0.0 110.158 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 4.12 45.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.398 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.483 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 50.0 t80 -59.47 134.73 57.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -0.945 . . . . 0.0 109.845 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -118.81 146.86 44.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.048 -1.033 . . . . 0.0 109.853 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.9 t -56.89 130.01 78.48 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 110.422 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.531 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -72.05 -11.85 27.61 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.865 1.455 . . . . 0.0 109.51 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.42 -64.9 1.0 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 110.751 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.534 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.3 p -98.69 3.34 47.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 0.0 111.109 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 6.0 ttm180 62.09 21.68 12.56 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.05 -1.031 . . . . 0.0 111.994 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.7 m -74.98 168.24 29.36 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.776 -1.202 . . . . 0.0 109.931 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.5 Cg_endo -73.53 141.87 32.0 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.917 1.483 . . . . 0.0 110.561 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 41.3 tttm -50.19 -30.24 11.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.005 . . . . 0.0 109.968 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.04 -12.46 19.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.28 -0.888 . . . . 0.0 109.872 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.44 -2.37 58.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.279 -0.888 . . . . 0.0 109.798 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -86.15 139.1 31.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 110.688 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 138.24 54.37 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.0 t . . . . . 0 C--N 1.301 -1.525 0 O-C-N 120.66 -1.275 . . . . 0.0 110.787 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.6 mttt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.195 0.521 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.625 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.2 m-85 -118.37 138.41 52.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 110.701 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -116.04 140.25 49.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.436 -0.79 . . . . 0.0 109.554 179.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.7 t -75.93 115.55 15.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.954 . . . . 0.0 110.148 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -16.12 63.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.789 -1.194 . . . . 0.0 108.684 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.16 -60.8 1.93 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.593 -0.692 . . . . 0.0 110.552 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.2 p -108.31 -2.97 18.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.001 . . . . 0.0 111.001 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.723 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 78.65 6.95 88.33 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.013 -1.054 . . . . 0.0 111.418 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 4.8 t80 -58.16 142.76 46.32 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.968 -1.313 . . . . 0.0 109.695 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.723 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -110.53 113.62 44.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.481 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 50.9 t80 -82.89 121.29 26.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 109.882 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -100.0 118.24 61.93 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 110.318 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -71.32 -35.93 7.72 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.82 1.432 . . . . 0.0 110.114 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -71.62 -10.51 59.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.801 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 -12.83 13.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.971 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.502 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 76.54 170.84 32.29 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.57 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 1.8 t70 -85.28 59.02 5.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.455 -1.026 . . . . 0.0 109.66 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -36.92 -62.99 0.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.555 -0.716 . . . . 0.0 110.699 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.538 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 18.5 m-85 -42.46 -27.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 110.32 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -101.04 -58.2 1.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.434 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.87 -10.07 1.2 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.185 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.558 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -61.27 141.2 94.27 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.061 -1.258 . . . . 0.0 109.73 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.9 Cg_endo -69.75 160.52 49.42 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.899 1.473 . . . . 0.0 110.665 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 45.1 Cg_endo -72.43 165.42 32.73 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.075 1.566 . . . . 0.0 110.702 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.15 12.83 83.23 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 20.4 m -103.79 126.33 32.18 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -1.144 . . . . 0.0 110.128 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.764 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.3 Cg_endo -73.11 142.92 35.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.889 1.468 . . . . 0.0 110.54 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.575 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.1 t80 -51.3 -36.39 42.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.885 . . . . 0.0 110.142 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.764 HG22 ' HB2' ' A' ' 33' ' ' PRO . 12.5 m -54.32 -17.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -84.36 -7.41 59.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 110.303 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.572 HD12 ' CD2' ' A' ' 34' ' ' PHE . 38.3 mt -71.22 152.79 42.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 110.076 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.461 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 1.4 m -80.15 167.85 19.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.95 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -73.59 -0.73 16.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 110.187 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 t -109.8 -0.12 18.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.168 -0.957 . . . . 0.0 110.387 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.57 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.9 t80 -59.7 138.69 57.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 109.791 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 48' ' ' SER . 11.4 mtt -120.93 145.77 47.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.129 -0.982 . . . . 0.0 110.051 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.472 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 12.9 t -55.53 131.35 71.05 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.838 . . . . 0.0 110.114 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.538 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 47.0 Cg_endo -73.38 -13.32 25.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.923 1.486 . . . . 0.0 109.609 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.78 -59.42 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.775 . . . . 0.0 110.95 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.526 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.0 p -105.15 5.06 31.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 111.076 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER 61.79 17.8 9.13 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.195 -0.94 . . . . 0.0 112.251 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 21.4 p -70.29 165.96 39.1 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.161 . . . . 0.0 109.672 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 45.8 Cg_endo -72.23 142.71 38.18 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.692 1.364 . . . . 0.0 110.388 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.548 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 27.3 tttm -48.78 -27.72 3.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 109.927 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.96 -11.18 26.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.35 -0.844 . . . . 0.0 109.825 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.84 -2.96 58.32 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.379 -0.825 . . . . 0.0 109.589 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 24.3 m-85 -87.7 139.22 30.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -132.08 147.88 52.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.651 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 3.2 p . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.023 . . . . 0.0 110.468 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.143 0.497 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 16.6 m-85 -123.55 152.91 41.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.207 -0.933 . . . . 0.0 110.405 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -125.64 141.19 52.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.418 -0.801 . . . . 0.0 109.527 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 5.0 t -78.01 117.32 19.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.506 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -16.36 63.92 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.595 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.12 -59.56 2.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.683 -0.636 . . . . 0.0 110.595 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.28 -3.91 16.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.992 -1.067 . . . . 0.0 110.775 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.766 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.95 5.67 89.44 Favored Glycine 0 N--CA 1.497 2.707 0 O-C-N 121.136 -0.977 . . . . 0.0 111.587 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 41.7 t80 -57.13 144.47 34.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.862 -1.375 . . . . 0.0 109.937 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.766 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -115.96 111.28 34.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.23 -0.919 . . . . 0.0 110.601 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 38.3 t80 -80.83 123.17 28.03 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.264 -0.897 . . . . 0.0 109.574 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -106.95 116.73 58.1 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 110.226 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' THR . 44.3 Cg_endo -71.19 -24.97 22.76 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.792 1.417 . . . . 0.0 110.24 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -73.14 -9.94 59.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.08 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.1 tttp -114.78 -43.26 3.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.125 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.98 159.51 13.13 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.556 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.09 55.18 3.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.445 -1.032 . . . . 0.0 109.94 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.74 -50.16 3.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.596 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 26.1 m-85 -52.12 -39.25 59.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 110.354 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.55 -69.22 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.213 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.28 54.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.69 HG21 HG21 ' A' ' 32' ' ' THR . 1.4 mp -131.0 144.22 52.68 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.236 -1.156 . . . . 0.0 110.04 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.599 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -71.39 166.63 28.72 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.015 1.534 . . . . 0.0 110.505 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.3 Cg_endo -72.34 161.9 43.07 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.915 1.481 . . . . 0.0 110.819 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 73.58 13.65 80.1 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.69 HG21 HG21 ' A' ' 28' ' ' ILE . 16.9 m -94.69 121.97 61.78 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.266 -1.138 . . . . 0.0 110.19 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.79 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.3 Cg_endo -71.89 141.4 36.96 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.81 1.426 . . . . 0.0 110.669 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.749 ' CD1' HD12 ' A' ' 37' ' ' LEU . 85.5 t80 -56.06 -18.1 8.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 33' ' ' PRO . 4.3 m -70.63 -11.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.38 -0.825 . . . . 0.0 109.47 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -89.35 -6.87 56.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.503 -0.748 . . . . 0.0 110.265 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.749 HD12 ' CD1' ' A' ' 34' ' ' PHE . 19.1 mt -73.63 144.75 45.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.143 -0.973 . . . . 0.0 110.044 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.2 t -75.46 160.38 30.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 110.096 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -62.27 -11.55 15.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.217 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.17 4.89 46.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.359 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.526 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 51.8 t80 -59.89 135.58 57.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.119 -0.988 . . . . 0.0 109.876 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -118.78 146.49 44.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.066 -1.022 . . . . 0.0 109.868 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.6 t -55.93 131.61 73.5 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.579 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 44.6 Cg_endo -72.4 -12.61 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.901 1.474 . . . . 0.0 109.585 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.88 -65.74 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.502 -0.749 . . . . 0.0 110.866 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.6 p -96.62 2.87 52.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 0.0 111.205 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HB3' ' O ' ' A' ' 46' ' ' CYS . 0.1 OUTLIER 61.88 22.37 12.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.133 -0.979 . . . . 0.0 111.997 178.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.9 m -75.73 168.16 30.22 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.786 -1.196 . . . . 0.0 109.92 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.1 Cg_endo -73.37 141.91 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.796 1.419 . . . . 0.0 110.494 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 11.9 tttm -50.17 -29.3 8.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 1.9 m-20 -62.4 -12.36 21.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.874 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.54 -1.58 58.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.284 -0.885 . . . . 0.0 109.727 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 3.2 m-85 -85.71 137.75 32.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.921 . . . . 0.0 110.421 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.42 137.99 54.47 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.0 t . . . . . 0 C--N 1.3 -1.565 0 O-C-N 120.761 -1.212 . . . . 0.0 110.454 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.228 0.537 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 9.8 m-85 -115.57 138.46 51.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 110.44 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.0 mt-10 -117.98 140.24 50.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 109.561 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 14' ' ' GLY . 5.3 t -77.14 115.77 17.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 110.283 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -16.19 63.96 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.773 -1.205 . . . . 0.0 108.638 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.12 -60.68 1.97 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.6 -0.687 . . . . 0.0 110.689 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.21 -3.72 18.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.067 -1.02 . . . . 0.0 110.909 -179.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.773 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 80.14 6.02 89.38 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.059 -1.025 . . . . 0.0 111.591 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 41.9 t80 -57.53 143.2 41.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.798 -1.413 . . . . 0.0 109.872 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.773 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -114.34 112.93 42.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.231 -0.918 . . . . 0.0 110.752 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 38.2 t80 -81.49 125.16 30.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.562 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -101.12 117.58 62.02 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.468 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.466 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 43.1 Cg_endo -71.24 -36.38 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.877 1.462 . . . . 0.0 109.98 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -9.69 54.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 109.747 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE3' ' HE3' ' A' ' 24' ' ' LYS . 1.7 tmtm? -117.09 -17.55 10.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.474 -0.766 . . . . 0.0 109.724 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.486 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 83.19 172.61 48.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.744 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -85.12 49.81 1.82 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -1.04 . . . . 0.0 109.784 179.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.9 ttmt -39.3 -58.32 1.23 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.535 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.0 -33.08 1.89 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.55 -62.68 1.32 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.901 . . . . 0.0 110.243 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.16 51.16 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.744 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -131.22 146.82 63.69 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.238 -1.154 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.648 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.5 Cg_endo -69.78 155.44 65.86 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.891 1.469 . . . . 0.0 110.228 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.486 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 44.0 Cg_endo -71.17 165.34 32.71 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.871 1.458 . . . . 0.0 110.788 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 79.03 11.28 85.33 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 13.0 m -103.51 125.44 34.89 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.294 -1.121 . . . . 0.0 110.193 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.736 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.7 Cg_endo -73.06 142.29 34.23 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.87 1.458 . . . . 0.0 110.473 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 31.7 t80 -51.92 -39.2 58.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 110.033 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 33' ' ' PRO . 11.4 m -55.14 -17.08 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.424 -0.797 . . . . 0.0 110.119 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 8.9 t70 -84.22 -6.87 59.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 110.253 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.509 HD13 ' CD1' ' A' ' 41' ' ' PHE . 17.9 mt -72.26 155.71 39.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 109.937 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.7 t -78.74 164.23 24.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.922 . . . . 0.0 110.071 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -5.88 21.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.9 m -103.4 1.49 32.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.203 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 37' ' ' LEU . 41.2 t80 -58.53 133.7 56.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.048 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' SER . 4.6 mtm -120.84 147.54 45.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 109.965 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.5 t -56.34 128.38 73.15 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.357 -0.84 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.535 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.1 Cg_endo -70.84 -11.42 29.41 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.785 1.413 . . . . 0.0 109.267 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.23 -67.95 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.487 -0.758 . . . . 0.0 110.663 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.533 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.7 p -94.53 2.06 55.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 111.06 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.56 23.78 14.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.143 -0.973 . . . . 0.0 111.892 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 52' ' ' GLN . 2.2 t -75.79 160.72 78.26 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.755 -1.216 . . . . 0.0 109.909 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 43.2 Cg_endo -69.85 144.39 53.38 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.677 1.356 . . . . 0.0 110.323 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.567 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 18.3 tttm -49.22 -26.7 3.1 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.292 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -64.07 -11.62 31.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.896 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.523 ' CB ' ' OG ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -91.96 -0.85 57.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.616 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 8.3 m-85 -89.54 138.77 31.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.683 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -128.1 143.6 51.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 109.522 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.67 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.7 p . . . . . 0 N--CA 1.492 1.651 0 O-C-N 120.885 -1.135 . . . . 0.0 110.923 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.211 0.529 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.676 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 13.8 m-85 -116.5 143.9 45.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.94 . . . . 0.0 110.424 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -121.34 139.11 53.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.942 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.8 t -76.53 116.85 17.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.95 . . . . 0.0 110.327 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.09 -16.19 63.91 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.732 -1.23 . . . . 0.0 108.566 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -59.68 2.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.602 -0.686 . . . . 0.0 110.566 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.83 -3.45 17.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.967 -1.083 . . . . 0.0 110.916 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.06 6.11 88.88 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.343 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 42.2 t80 -56.29 143.62 33.32 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.875 -1.368 . . . . 0.0 109.796 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 14.9 mm -115.39 111.56 36.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.325 -0.859 . . . . 0.0 110.639 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 44.1 t80 -81.13 122.56 27.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.828 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -101.97 117.18 62.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 110.243 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.6 Cg_endo -71.8 -31.1 13.41 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.849 1.447 . . . . 0.0 110.234 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.4 -5.06 25.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.159 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -120.38 -38.45 2.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.81 167.42 23.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -85.15 56.13 3.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.969 . . . . 0.0 109.894 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -40.14 -58.58 1.43 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.776 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.605 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 2.2 t80 -48.01 -32.94 7.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.594 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -92.25 -65.4 1.01 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.082 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.25 53.34 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.572 HG23 ' HD2' ' A' ' 29' ' ' PRO . 1.2 mp -131.02 144.71 54.67 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.286 -1.126 . . . . 0.0 109.817 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -71.11 162.4 42.74 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.929 1.489 . . . . 0.0 110.425 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.29 163.44 38.66 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.91 1.479 . . . . 0.0 110.772 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.24 14.81 82.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -100.74 124.31 42.63 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.268 -1.137 . . . . 0.0 110.197 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.699 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.0 Cg_endo -73.32 140.38 30.43 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.92 1.484 . . . . 0.0 110.551 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.676 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 18.4 t80 -53.58 -40.38 65.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.361 -0.837 . . . . 0.0 110.319 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.699 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.1 m -53.86 -18.3 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.408 -0.808 . . . . 0.0 110.368 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 1.2 t0 -85.61 -6.81 59.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.394 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.435 HD13 ' CD1' ' A' ' 41' ' ' PHE . 16.2 mt -73.15 121.95 21.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 37' ' ' LEU . 47.4 t -42.02 155.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 110.381 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -9.19 21.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 110.292 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -98.26 4.6 48.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.333 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.513 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 46.1 t80 -59.72 136.31 57.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 110.222 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.466 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.9 mtp -120.33 145.7 46.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 109.69 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.5 t -54.82 131.81 66.21 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 110.333 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.605 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 45.5 Cg_endo -72.61 -13.88 27.35 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.899 1.473 . . . . 0.0 109.534 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.99 -65.29 0.97 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.486 -0.758 . . . . 0.0 110.908 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.526 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.5 p -96.28 2.91 53.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 111.167 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 3.1 ttm180 61.59 22.49 12.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.123 -0.986 . . . . 0.0 111.963 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.4 m -74.49 167.3 37.34 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.826 -1.172 . . . . 0.0 109.923 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 47.4 Cg_endo -73.51 142.96 33.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.946 1.498 . . . . 0.0 110.433 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 21.9 tttm -49.93 -30.08 9.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.53 ' ND2' ' HB2' ' A' ' 49' ' ' PRO . 26.5 p30 -62.9 -11.74 20.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.119 -0.988 . . . . 0.0 109.968 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.488 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -89.27 -2.52 58.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.885 . . . . 0.0 109.54 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 7.3 m-85 -87.04 139.29 30.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.398 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -123.54 140.56 52.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.166 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 35.0 p . . . . . 0 N--CA 1.489 1.52 0 O-C-N 120.836 -1.165 . . . . 0.0 111.266 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HG2' ' HD2' ' A' ' 19' ' ' PRO . 12.5 mttm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.244 0.545 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 21.2 m-85 -123.8 148.84 46.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 83.6 tt0 -122.85 142.7 50.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 109.535 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.5 t -79.39 115.74 19.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 110.645 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -15.28 63.52 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.372 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.25 -60.93 1.89 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.631 -0.668 . . . . 0.0 110.555 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -107.94 -4.74 17.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.957 -1.089 . . . . 0.0 110.717 -178.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 82.62 3.1 90.65 Favored Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.101 -0.999 . . . . 0.0 111.417 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.544 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . 89.6 t80 -49.53 172.39 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.854 -1.38 . . . . 0.0 109.421 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.501 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 10.4 mm -146.13 108.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.04 -1.038 . . . . 0.0 110.396 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.3 t80 -81.55 129.03 34.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 110.011 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -111.68 118.29 47.15 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 110.263 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -71.85 -29.29 15.57 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.885 1.466 . . . . 0.0 110.309 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -71.59 -10.61 60.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.007 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 6.2 mttt -115.68 -39.65 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.381 -0.824 . . . . 0.0 110.003 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.46 164.59 20.95 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.558 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -85.1 55.76 3.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -1.075 . . . . 0.0 109.844 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -41.1 -54.41 2.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.359 -0.838 . . . . 0.0 110.504 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 97.8 m-85 -49.63 -36.71 25.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.398 -0.814 . . . . 0.0 110.42 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.56 -67.47 0.85 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.04 54.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.558 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -133.36 141.73 41.59 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 109.98 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.7 Cg_endo -69.96 165.11 32.3 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.018 1.536 . . . . 0.0 110.432 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.0 Cg_endo -71.92 162.77 40.91 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.039 1.547 . . . . 0.0 110.841 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.11 12.04 84.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.8 m -98.87 123.2 50.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.286 -1.126 . . . . 0.0 110.232 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.644 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.89 143.48 36.87 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.924 1.486 . . . . 0.0 110.75 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.583 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 7.7 t80 -57.54 -15.86 8.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.902 . . . . 0.0 110.041 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 33' ' ' PRO . 3.9 m -69.97 -26.21 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.73 -5.51 55.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.41 -0.806 . . . . 0.0 110.409 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.434 HD13 ' CD1' ' A' ' 41' ' ' PHE . 11.1 mt -74.1 115.61 13.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.234 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 37' ' ' LEU . 63.9 m -41.68 151.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 110.378 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.64 -12.88 11.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 110.123 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 t -95.93 8.05 44.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.422 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.52 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.8 t80 -61.0 138.56 58.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.02 . . . . 0.0 109.894 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.2 mtt -121.34 147.48 45.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.031 . . . . 0.0 109.731 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.9 t -56.56 131.67 77.32 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 110.509 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 45.3 Cg_endo -72.42 -12.45 27.3 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.797 1.42 . . . . 0.0 109.561 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.5 -67.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 110.822 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.6 p -93.59 1.4 56.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.06 -1.025 . . . . 0.0 111.097 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.96 24.34 14.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.171 -0.956 . . . . 0.0 111.932 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 42' ' ' MET . 4.1 m -77.67 167.94 31.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.828 -1.17 . . . . 0.0 109.835 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.9 Cg_endo -72.64 140.92 33.44 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.801 1.422 . . . . 0.0 110.481 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.549 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 11.2 tttm -49.28 -27.21 3.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.005 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 0.7 OUTLIER -63.14 -11.86 23.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.956 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.479 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -90.72 -0.86 57.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.292 -0.88 . . . . 0.0 109.604 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -87.12 137.88 31.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.656 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -119.79 136.34 54.49 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.6 t . . . . . 0 C--N 1.3 -1.586 0 O-C-N 120.724 -1.235 . . . . 0.0 110.81 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.5 m-85 -118.43 142.1 47.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.953 . . . . 0.0 110.8 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 6.6 tm-20 -119.22 140.26 50.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -0.809 . . . . 0.0 109.439 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' GLY . 5.0 t -76.57 116.75 17.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.15 -0.969 . . . . 0.0 110.233 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -16.59 64.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.767 -1.208 . . . . 0.0 108.713 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -59.8 2.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.578 -0.702 . . . . 0.0 110.599 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.95 -3.46 17.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.031 -1.043 . . . . 0.0 110.966 -179.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.762 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.37 6.29 88.97 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.153 -1.022 . . . . 0.0 111.458 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 40.5 t80 -57.57 143.59 40.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.918 -1.342 . . . . 0.0 109.698 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -114.17 112.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.281 -0.887 . . . . 0.0 110.647 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 33.9 t80 -82.21 128.05 33.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.651 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -109.49 117.2 53.36 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.872 . . . . 0.0 110.184 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 43.8 Cg_endo -71.28 -28.97 17.74 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.827 1.435 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.78 -5.83 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 110.053 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -119.82 -39.13 2.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 110.185 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.19 166.13 22.11 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.56 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -85.12 54.61 3.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -1.043 . . . . 0.0 109.899 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASP . 18.4 mmtt -39.74 -56.66 1.68 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.378 -0.826 . . . . 0.0 110.695 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 65.2 m-85 -47.34 -33.91 6.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.98 -64.63 1.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 110.484 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.98 52.83 0.02 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.574 HG23 ' HD2' ' A' ' 29' ' ' PRO . 1.2 mp -129.11 145.22 55.79 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.274 -1.133 . . . . 0.0 109.82 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.574 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.6 Cg_endo -70.95 160.95 47.74 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.948 1.499 . . . . 0.0 110.43 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.446 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.6 Cg_endo -71.9 163.27 39.39 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.963 1.507 . . . . 0.0 110.765 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.11 15.34 81.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 26.7 m -102.46 124.2 40.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.265 -1.138 . . . . 0.0 110.254 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 48.0 Cg_endo -73.65 140.26 29.25 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.874 1.46 . . . . 0.0 110.561 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.59 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.7 t80 -50.42 -41.04 51.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.035 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.52 -17.14 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 110.266 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -84.42 -7.06 59.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.24 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 41' ' ' PHE . 17.8 mt -71.65 155.86 40.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.952 . . . . 0.0 110.044 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 156.59 30.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.9 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -11.33 13.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.136 -0.978 . . . . 0.0 110.363 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.2 m -99.64 3.87 45.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.946 . . . . 0.0 110.418 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.56 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 44.8 t80 -59.68 136.37 57.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 109.964 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 48' ' ' SER . 6.8 mtt -120.0 146.37 45.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.077 -1.015 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.9 t -55.94 130.62 73.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 110.319 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.525 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.9 Cg_endo -71.99 -12.7 28.51 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.875 1.461 . . . . 0.0 109.526 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.35 -64.26 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.453 -0.779 . . . . 0.0 110.842 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.54 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.8 p -98.77 3.76 47.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 111.173 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.7 OUTLIER 61.69 20.53 11.42 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.111 -0.993 . . . . 0.0 112.036 178.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.6 m -73.05 167.31 35.42 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.769 -1.207 . . . . 0.0 109.786 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.3 Cg_endo -73.21 142.78 34.5 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.863 1.454 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 22.8 tttm -49.37 -27.67 4.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 109.834 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -63.04 -12.2 24.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.873 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -90.27 -1.8 57.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.612 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 15.5 m-85 -88.53 139.65 30.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 110.379 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -130.74 146.27 52.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.702 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 p . . . . . 0 N--CA 1.491 1.596 0 O-C-N 120.908 -1.12 . . . . 0.0 110.44 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 tptm . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.137 0.494 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.0 m-85 -117.78 139.5 50.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 110.661 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.585 ' HA ' HD13 ' A' ' 16' ' ' ILE . 14.3 pt-20 -116.76 139.18 50.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.308 -0.87 . . . . 0.0 109.615 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -76.55 117.03 17.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 110.426 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -16.3 64.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.868 -1.145 . . . . 0.0 108.668 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.2 -59.49 2.31 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.649 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.93 -3.49 17.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.951 -179.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 78.28 7.74 87.71 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 30.6 t80 -58.76 142.56 49.76 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.807 -1.408 . . . . 0.0 109.636 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.585 HD13 ' HA ' ' A' ' 9' ' ' GLU . 24.5 mm -113.8 114.75 47.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.274 -0.891 . . . . 0.0 110.777 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 24.6 t80 -83.22 133.03 35.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 109.719 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -110.89 119.43 46.05 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 110.224 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -71.31 -34.51 9.73 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.861 1.453 . . . . 0.0 110.217 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -70.06 -6.76 36.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.398 -0.814 . . . . 0.0 110.028 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 14.5 tttt -117.96 -36.45 3.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.109 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.92 171.53 28.81 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.549 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 1.7 t70 -85.31 57.98 4.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.515 -0.991 . . . . 0.0 109.767 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ASP . 1.1 tptt -37.58 -63.0 0.48 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.554 -0.716 . . . . 0.0 110.727 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.556 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 17.7 m-85 -43.27 -27.13 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.393 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.26 -58.42 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.267 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.92 -7.52 1.06 Allowed Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.495 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.549 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.8 mp -64.93 142.27 98.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.344 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.543 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.2 Cg_endo -71.61 162.49 42.01 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.997 1.524 . . . . 0.0 110.611 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -72.59 163.86 37.28 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.991 1.522 . . . . 0.0 110.775 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.53 13.37 83.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 60.5 m -105.75 126.59 30.36 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.274 -1.133 . . . . 0.0 110.168 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.786 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -72.56 142.15 35.86 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.839 1.442 . . . . 0.0 110.603 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.581 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 2.9 t80 -53.21 -38.71 63.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.133 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.786 HG22 ' HB2' ' A' ' 33' ' ' PRO . 20.3 m -54.76 -17.68 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 110.051 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -83.12 -6.17 59.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 37' ' ' LEU . 22.3 mt -70.23 156.34 39.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.58 162.63 25.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.872 . . . . 0.0 109.858 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -69.97 -3.91 18.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.252 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.0 m -106.7 0.67 24.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.542 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 44.7 t80 -59.98 136.58 58.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.978 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 48' ' ' SER . 21.7 mtp -119.62 146.06 45.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.12 -0.988 . . . . 0.0 109.908 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.4 t -54.86 129.64 65.46 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.266 -0.896 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.6 Cg_endo -71.27 -13.53 30.88 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.819 1.431 . . . . 0.0 109.47 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.98 -63.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.752 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.4 p -98.84 3.78 47.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.192 -0.942 . . . . 0.0 111.156 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.24 21.37 11.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.165 -0.96 . . . . 0.0 112.087 178.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.5 m -73.93 166.9 40.33 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.828 -1.17 . . . . 0.0 109.808 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.7 Cg_endo -72.91 142.68 35.43 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.818 1.431 . . . . 0.0 110.33 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.549 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 7.4 tttt -49.58 -25.64 2.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -66.26 -11.86 52.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.793 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.05 -3.23 58.75 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.35 -0.844 . . . . 0.0 109.492 179.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.522 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 4.6 m-85 -88.62 140.56 29.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.433 -0.792 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 5.1 mttt -129.89 146.35 51.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.491 1.584 0 O-C-N 120.936 -1.103 . . . . 0.0 110.705 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 55' ' ' SER . 9.4 mttt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.625 ' CE1' ' HB3' ' A' ' 55' ' ' SER . 9.3 m-85 -121.12 137.82 54.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 111.089 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.517 ' HA ' HD13 ' A' ' 16' ' ' ILE . 83.2 tt0 -118.43 145.64 45.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.0 109.393 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 6.6 t -79.05 115.21 18.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.05 -1.031 . . . . 0.0 110.442 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.76 -15.23 63.41 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.508 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -61.14 1.84 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.703 -0.623 . . . . 0.0 110.771 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -108.39 -5.04 16.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.03 -1.044 . . . . 0.0 111.102 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.424 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 83.99 3.01 89.4 Favored Glycine 0 N--CA 1.497 2.75 0 O-C-N 120.973 -1.08 . . . . 0.0 111.419 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 29.3 t80 -50.64 173.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.827 -1.396 . . . . 0.0 109.17 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 12.1 mm -144.31 132.81 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.924 -1.11 . . . . 0.0 110.684 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 40.3 t80 -106.1 132.55 52.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.349 -0.844 . . . . 0.0 109.65 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 3.3 mt-10 -113.96 119.98 39.79 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.895 . . . . 0.0 110.372 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.511 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 43.5 Cg_endo -69.95 -35.73 11.57 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.861 1.453 . . . . 0.0 110.333 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.06 -10.24 56.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 109.844 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -116.33 -30.46 5.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.859 . . . . 0.0 109.936 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.08 171.58 33.93 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.713 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.2 51.01 2.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -1.061 . . . . 0.0 109.736 179.189 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.09 -56.87 1.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.805 . . . . 0.0 110.455 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.534 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.05 -33.95 2.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.785 . . . . 0.0 110.229 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -94.3 -62.38 1.35 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.381 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.67 52.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.713 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -131.72 145.71 58.7 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.243 -1.151 . . . . 0.0 110.014 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.614 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.6 Cg_endo -70.08 160.17 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.952 1.501 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.3 163.87 37.34 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.983 1.517 . . . . 0.0 110.837 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 79.98 13.72 81.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 58.9 m -107.55 126.04 30.87 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.195 -1.18 . . . . 0.0 110.222 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.511 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.7 Cg_endo -73.22 142.71 34.33 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.837 1.441 . . . . 0.0 110.636 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.579 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 t80 -51.22 -40.09 58.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.299 -0.876 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -16.93 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 110.309 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -84.24 -6.87 59.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.517 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 18.7 mt -70.13 157.14 38.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -0.949 . . . . 0.0 109.946 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -77.81 157.54 29.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.206 -0.934 . . . . 0.0 109.811 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.37 -9.92 14.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.15 -0.969 . . . . 0.0 110.262 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 42' ' ' MET . 2.4 m -100.48 2.92 42.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 110.428 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.9 t80 -58.2 132.8 54.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 109.77 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.447 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.7 mtt -118.81 147.24 44.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 110.06 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 8.0 t -58.08 127.41 79.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.319 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.534 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.15 -10.43 27.34 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.784 1.413 . . . . 0.0 109.565 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.57 -62.74 1.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.588 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.8 p -102.02 3.73 39.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.153 -0.967 . . . . 0.0 110.911 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER 62.26 20.85 12.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.196 -0.94 . . . . 0.0 112.063 178.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 25.5 p -73.83 165.52 52.47 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.864 -1.148 . . . . 0.0 109.781 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.1 Cg_endo -71.95 142.78 39.43 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.816 1.429 . . . . 0.0 110.377 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.543 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 43.2 tttm -48.29 -23.94 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 109.931 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.63 -10.8 39.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.852 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.503 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -91.7 -1.93 57.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.245 -0.909 . . . . 0.0 109.614 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 20.1 m-85 -88.57 138.12 31.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 110.506 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 2.5 tptp -130.7 146.52 52.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.339 -0.851 . . . . 0.0 109.662 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.625 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.2 p . . . . . 0 N--CA 1.492 1.626 0 O-C-N 120.901 -1.124 . . . . 0.0 110.435 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.169 0.509 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 29.8 m-85 -125.67 145.09 50.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.572 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HG2' ' CD1' ' A' ' 16' ' ' ILE . 14.5 mt-10 -117.67 142.63 47.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.399 -0.813 . . . . 0.0 109.901 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.4 t -77.56 113.61 15.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.975 -1.078 . . . . 0.0 110.584 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -15.1 63.31 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.912 -1.118 . . . . 0.0 108.441 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.06 -60.96 1.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.577 -0.702 . . . . 0.0 110.59 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.62 -4.4 17.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.972 -1.08 . . . . 0.0 110.887 -178.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 82.0 3.43 90.58 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.33 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.577 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 29.3 t80 -49.96 172.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.032 -1.275 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.577 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 24.5 mm -141.12 130.01 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.005 -1.059 . . . . 0.0 110.455 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 66.7 t80 -103.06 124.38 48.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.689 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -109.34 116.33 55.06 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.33 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.5 Cg_endo -69.34 -31.41 22.46 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.969 1.51 . . . . 0.0 110.075 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.08 -12.31 61.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 109.826 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.89 -12.69 10.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.89 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 81.3 167.41 38.26 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.624 ' CB ' HD13 ' A' ' 28' ' ' ILE . 1.2 t0 -85.18 50.6 1.98 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -1.032 . . . . 0.0 109.774 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.3 mmtt -39.31 -53.84 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.347 -0.845 . . . . 0.0 110.534 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.528 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -47.13 -36.5 8.49 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.428 -0.795 . . . . 0.0 110.225 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -92.27 -64.34 1.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 0.0 110.377 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.22 52.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.624 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.88 145.7 58.6 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -1.097 . . . . 0.0 109.939 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.616 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.7 Cg_endo -70.49 161.85 44.55 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.962 1.507 . . . . 0.0 110.198 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.2 Cg_endo -71.64 162.78 41.09 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.973 1.512 . . . . 0.0 110.853 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.12 12.59 84.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 21.9 m -97.73 125.1 45.8 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.239 -1.153 . . . . 0.0 110.179 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.736 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.89 139.29 30.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.867 1.456 . . . . 0.0 110.605 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.574 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 62.5 t80 -52.11 -41.46 62.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.074 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.1 m -53.52 -17.59 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.432 -0.793 . . . . 0.0 110.384 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 36' ' ' ASP . 59.2 t0 -83.96 -7.6 59.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.127 -0.983 . . . . 0.0 110.4 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.498 HD12 ' CD1' ' A' ' 34' ' ' PHE . 17.9 mt -69.43 153.21 43.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 109.9 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.0 155.36 32.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.716 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -11.22 12.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 110.212 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.47 4.1 43.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 110.509 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.54 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 50.1 t80 -59.7 134.86 57.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.016 -1.052 . . . . 0.0 109.576 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.3 mtp -119.23 148.42 43.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.986 -1.071 . . . . 0.0 110.458 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.473 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 6.2 t -58.63 126.93 81.32 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.45 -0.781 . . . . 0.0 110.38 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.528 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.0 Cg_endo -70.69 -9.65 26.21 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.814 1.428 . . . . 0.0 109.486 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.36 -64.86 1.0 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.512 -0.743 . . . . 0.0 110.464 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.538 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.2 p -99.37 2.64 45.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.954 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.0 OUTLIER 63.04 22.34 13.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.153 -0.967 . . . . 0.0 112.094 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 29.9 p -76.31 166.11 47.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.735 -1.228 . . . . 0.0 109.859 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 45.2 Cg_endo -71.72 142.13 39.04 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.766 1.403 . . . . 0.0 110.437 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.567 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 10.1 tttm -48.64 -27.65 2.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.901 . . . . 0.0 110.0 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.06 -10.15 27.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.817 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.504 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -87.64 -5.57 58.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.306 -0.871 . . . . 0.0 109.628 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 23.7 m-85 -79.96 133.62 36.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 110.566 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.08 131.25 54.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.467 -0.771 . . . . 0.0 108.93 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.596 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 110.194 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.448 ' HE2' ' CG2' ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.182 0.515 . . . . 0.0 109.918 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 18.0 m-85 -120.03 146.65 45.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.176 -0.953 . . . . 0.0 110.372 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 4.6 mt-10 -121.07 140.08 52.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 109.565 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.3 t -76.42 118.44 19.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.117 -0.99 . . . . 0.0 110.399 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.84 -16.74 63.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.852 -1.155 . . . . 0.0 108.644 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -58.93 2.49 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.681 -0.637 . . . . 0.0 110.547 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.498 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -109.61 -3.09 17.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 110.931 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.748 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 78.27 6.73 87.84 Favored Glycine 0 N--CA 1.495 2.622 0 O-C-N 120.999 -1.063 . . . . 0.0 111.414 177.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 43.2 t80 -57.87 144.59 38.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.943 -1.328 . . . . 0.0 109.78 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.748 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -114.44 111.6 36.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.294 -0.879 . . . . 0.0 110.584 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 49.3 t80 -82.07 122.38 27.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.905 . . . . 0.0 109.984 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -107.0 119.65 50.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.832 . . . . 0.0 110.088 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.3 Cg_endo -71.47 -24.45 22.42 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.902 1.475 . . . . 0.0 110.299 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -72.05 -16.0 62.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 109.948 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -109.95 -37.75 5.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.05 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.54 166.05 24.5 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.608 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.21 50.41 1.94 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -1.051 . . . . 0.0 109.644 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 4.4 tttm -38.91 -53.02 1.76 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.492 -0.755 . . . . 0.0 110.618 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.536 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 13.9 m-85 -48.88 -36.46 17.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.378 -0.826 . . . . 0.0 110.295 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -91.58 -66.25 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.329 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.95 51.46 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.608 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.16 144.7 53.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.238 -1.154 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.573 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.6 Cg_endo -70.89 163.03 40.62 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.956 1.503 . . . . 0.0 110.31 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -71.89 161.82 43.79 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.949 1.5 . . . . 0.0 110.905 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.34 13.13 83.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.464 HG21 ' CG2' ' A' ' 28' ' ' ILE . 37.4 m -93.89 123.11 60.51 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.3 -1.118 . . . . 0.0 110.174 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.773 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.4 Cg_endo -73.45 141.5 31.7 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.821 1.432 . . . . 0.0 110.641 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.576 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 30.3 t80 -55.53 -18.02 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.948 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.773 HG22 ' HB2' ' A' ' 33' ' ' PRO . 3.8 m -72.84 -10.6 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 109.687 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -91.84 -7.62 48.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.29 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.465 HD12 ' CD2' ' A' ' 34' ' ' PHE . 20.9 mt -72.22 146.23 47.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.056 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.81 158.75 31.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.068 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -60.96 -12.93 12.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 0.0 110.158 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 97.2 p -99.27 4.84 46.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.449 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 52.3 t80 -58.96 139.57 56.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.101 -0.999 . . . . 0.0 109.984 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.7 mmm -119.79 143.8 47.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.985 -1.072 . . . . 0.0 110.049 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 45' ' ' ALA . 49.5 t -59.91 125.17 79.9 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 110.14 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.536 ' HB2' ' CB ' ' A' ' 25' ' ' PHE . 43.9 Cg_endo -70.67 -8.87 24.59 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.858 1.452 . . . . 0.0 109.871 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -93.34 -53.66 4.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.482 -0.761 . . . . 0.0 110.167 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 48' ' ' SER . 9.5 p -118.15 8.47 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 110.707 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.81 14.18 7.13 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.255 -0.903 . . . . 0.0 112.162 178.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 52' ' ' GLN . 2.2 t -66.8 161.39 61.71 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.834 -1.166 . . . . 0.0 110.044 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 42.9 Cg_endo -69.29 143.38 52.91 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.608 1.32 . . . . 0.0 110.25 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.559 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 17.4 tttm -50.21 -28.86 8.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.129 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -63.01 -11.94 22.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.118 -0.989 . . . . 0.0 109.786 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.523 ' CB ' ' OG ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -88.67 -2.52 58.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.879 . . . . 0.0 109.85 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.422 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 25.4 m-85 -83.93 135.38 34.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.583 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' NZ ' ' O ' ' A' ' 55' ' ' SER . 0.5 OUTLIER -120.67 138.14 54.09 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.3 t . . . . . 0 C--N 1.3 -1.564 0 O-C-N 120.819 -1.176 . . . . 0.0 110.535 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 12.1 m-85 -120.7 144.14 48.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.937 . . . . 0.0 110.949 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.6 pp20? -118.85 140.24 50.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 0.0 109.513 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.4 t -77.31 117.99 19.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.056 -1.028 . . . . 0.0 110.534 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.439 ' OE1' ' CA ' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -69.11 -16.57 63.7 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.833 -1.167 . . . . 0.0 108.525 178.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -59.21 2.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.594 -0.691 . . . . 0.0 110.547 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.03 -3.21 17.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.98 -1.075 . . . . 0.0 110.815 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 78.24 6.14 87.62 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.081 -1.012 . . . . 0.0 111.404 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 47.6 t80 -56.83 144.89 31.4 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.957 -1.32 . . . . 0.0 109.744 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.505 HD13 ' CB ' ' A' ' 9' ' ' GLU . 22.2 mm -115.71 110.58 32.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.234 -0.917 . . . . 0.0 110.5 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 45.8 t80 -81.26 121.47 26.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.81 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.03 121.13 50.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.386 -0.821 . . . . 0.0 110.213 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.5 Cg_endo -70.78 -27.68 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.935 1.492 . . . . 0.0 110.277 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.91 -18.87 62.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 110.234 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -39.61 6.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.151 -0.968 . . . . 0.0 110.175 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.81 164.67 24.18 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.622 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -85.18 51.38 2.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.449 -1.03 . . . . 0.0 109.83 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -40.12 -51.54 2.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.345 -0.847 . . . . 0.0 110.67 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 26.1 m-85 -48.98 -36.63 18.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.352 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.97 -66.13 0.95 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.246 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.76 53.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.622 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -131.86 143.93 51.11 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.378 -1.072 . . . . 0.0 110.038 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.1 Cg_endo -72.04 165.43 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.108 1.583 . . . . 0.0 110.311 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.24 163.06 39.83 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.932 1.491 . . . . 0.0 110.833 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.47 12.07 82.38 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 25.1 m -94.38 123.61 58.06 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.238 -1.154 . . . . 0.0 110.2 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.733 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.9 Cg_endo -73.18 141.3 32.23 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.811 1.427 . . . . 0.0 110.585 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.573 ' CE1' ' HE2' ' A' ' 50' ' ' LYS . 47.6 t80 -55.38 -38.97 69.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.29 -0.881 . . . . 0.0 110.186 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.733 HG22 ' HB2' ' A' ' 33' ' ' PRO . 17.0 m -54.1 -18.47 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -6.72 59.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.408 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.501 HD12 ' CD2' ' A' ' 34' ' ' PHE . 19.3 mt -73.05 150.65 42.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.114 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.472 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -76.71 159.52 30.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 109.996 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -10.23 18.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.211 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 p -100.28 4.33 44.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.264 -0.897 . . . . 0.0 110.327 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.9 t80 -60.42 137.77 58.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 110.038 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' SER . 18.3 mtm -119.84 146.14 46.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.178 -0.951 . . . . 0.0 110.093 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 10.9 t -56.91 130.26 78.77 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.793 . . . . 0.0 110.443 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 45.6 Cg_endo -72.25 -12.1 27.41 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.921 1.485 . . . . 0.0 109.698 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.6 -61.95 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 110.708 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.5 p -102.51 4.37 38.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 111.128 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.1 tpt180 62.12 18.96 10.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.136 -0.977 . . . . 0.0 112.102 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.7 m -71.83 168.1 25.42 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.831 -1.168 . . . . 0.0 109.759 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.9 Cg_endo -73.8 142.75 32.38 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.817 1.43 . . . . 0.0 110.406 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.9 tttm -49.37 -28.38 4.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 109.784 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -63.13 -11.94 23.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 109.856 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.439 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -89.5 -2.39 58.35 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.595 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -87.56 139.18 30.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 110.43 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.16 139.13 54.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.458 -0.776 . . . . 0.0 108.94 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 40.8 p . . . . . 0 C--N 1.302 -1.457 0 O-C-N 120.854 -1.154 . . . . 0.0 110.632 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.8 mttp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.129 0.49 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.4 m-85 -125.56 148.68 48.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.95 . . . . 0.0 110.859 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 32.6 tt0 -119.04 140.27 50.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.839 . . . . 0.0 109.424 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.6 t -77.33 117.45 18.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.047 -1.033 . . . . 0.0 110.421 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -16.42 63.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.822 -1.174 . . . . 0.0 108.585 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.18 -59.12 2.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.579 -0.701 . . . . 0.0 110.551 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.39 -3.8 16.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.009 -1.057 . . . . 0.0 110.906 -179.041 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.471 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.41 6.25 88.99 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.537 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 34.0 t80 -57.01 143.58 37.63 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.797 -1.413 . . . . 0.0 109.807 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.505 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 17.8 mm -115.19 111.86 37.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.342 -0.848 . . . . 0.0 110.65 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.0 t80 -81.38 122.21 27.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.773 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -102.28 117.78 60.41 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 0.0 110.226 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.8 Cg_endo -71.16 -30.37 16.16 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.87 1.458 . . . . 0.0 110.307 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -72.48 -7.91 52.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.304 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -114.4 -43.56 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.285 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.1 163.34 18.08 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.547 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.16 56.17 3.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.453 -1.027 . . . . 0.0 109.983 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' ASP . 9.5 mtpt -40.92 -55.5 2.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 110.502 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 27.1 m-85 -48.45 -34.86 11.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.375 -0.828 . . . . 0.0 110.506 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -92.8 -65.75 0.98 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 110.3 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.46 54.34 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.605 HG21 HG21 ' A' ' 32' ' ' THR . 1.3 mp -132.1 144.07 51.6 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.296 -1.12 . . . . 0.0 109.993 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.563 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.2 Cg_endo -71.59 165.05 33.71 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.956 1.503 . . . . 0.0 110.391 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.06 162.9 40.41 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.017 1.535 . . . . 0.0 110.804 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.11 15.02 81.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.605 HG21 HG21 ' A' ' 28' ' ' ILE . 15.8 m -97.65 123.29 52.51 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.283 -1.127 . . . . 0.0 110.198 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.782 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -73.75 139.9 28.44 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.873 1.46 . . . . 0.0 110.586 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.577 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 12.4 t80 -53.42 -40.61 65.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.273 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 33' ' ' PRO . 27.3 m -53.17 -18.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 110.467 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 3.8 t70 -85.52 -7.1 59.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 0.0 110.386 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.556 HD13 ' CD1' ' A' ' 41' ' ' PHE . 13.7 mt -73.99 120.06 19.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 37' ' ' LEU . 18.5 t -42.21 159.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.457 -0.777 . . . . 0.0 110.335 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.45 -7.7 27.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 0.0 110.161 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 p -99.03 4.19 47.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' A' ' 37' ' ' LEU . 49.1 t80 -58.61 134.76 57.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.193 -0.942 . . . . 0.0 110.157 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -120.13 146.15 46.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.139 -0.975 . . . . 0.0 109.718 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.9 t -56.46 130.06 75.91 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 110.493 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -71.93 -12.4 28.36 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.845 1.445 . . . . 0.0 109.477 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.04 -65.81 0.94 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.576 -0.703 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.1 p -96.66 2.39 52.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.162 -0.961 . . . . 0.0 111.126 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.04 23.33 13.74 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.101 -0.999 . . . . 0.0 111.878 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.462 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -76.29 167.46 36.5 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.866 -1.146 . . . . 0.0 109.907 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.0 Cg_endo -73.75 142.77 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.972 1.512 . . . . 0.0 110.525 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 9.4 tttm -49.85 -29.53 8.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.105 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -63.16 -11.99 24.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.856 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.444 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -88.73 -2.65 58.7 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 109.673 179.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.82 138.69 31.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.943 . . . . 0.0 110.658 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.54 138.57 54.25 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.8 t . . . . . 0 C--N 1.301 -1.528 0 O-C-N 120.622 -1.299 . . . . 0.0 110.51 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.4 m-85 -126.68 151.24 48.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.945 . . . . 0.0 110.766 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -121.95 141.38 51.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.398 -0.814 . . . . 0.0 109.424 179.113 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -78.11 117.73 19.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -0.996 . . . . 0.0 110.521 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.85 -16.34 63.74 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.831 -1.168 . . . . 0.0 108.515 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -59.2 2.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.603 -0.685 . . . . 0.0 110.411 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.491 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.33 -3.43 17.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.961 -1.087 . . . . 0.0 110.774 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.729 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 78.66 5.79 88.28 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.155 -0.965 . . . . 0.0 111.474 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.579 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 52.9 t80 -58.12 146.04 34.72 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.855 -1.38 . . . . 0.0 109.92 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.4 mp -116.42 110.44 31.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.214 -0.929 . . . . 0.0 110.443 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.515 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 36.8 t80 -80.94 121.63 26.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -106.33 120.12 49.71 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.437 -0.789 . . . . 0.0 110.027 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 45.5 Cg_endo -72.09 -23.14 21.83 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.99 1.521 . . . . 0.0 110.524 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -72.35 -16.22 61.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.113 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.69 -39.71 5.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 110.112 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.5 163.05 20.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.603 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.19 51.86 2.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -1.048 . . . . 0.0 109.866 179.016 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 3.5 mmtt -39.8 -50.01 2.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.441 -0.787 . . . . 0.0 110.65 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.558 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 41.1 m-85 -51.05 -39.5 56.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.269 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.77 -68.93 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.191 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.44 52.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.603 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.05 144.15 52.38 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.298 -1.119 . . . . 0.0 109.997 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.587 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.9 Cg_endo -72.01 166.54 29.3 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.875 1.461 . . . . 0.0 110.407 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.48 160.86 45.73 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.91 1.479 . . . . 0.0 110.861 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.65 12.45 84.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.523 HG21 ' CG2' ' A' ' 28' ' ' ILE . 25.9 m -92.92 121.04 66.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.18 -1.188 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.955 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.4 Cg_endo -73.18 142.48 34.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.859 1.452 . . . . 0.0 110.553 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.56 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 31.0 t80 -56.01 -21.39 21.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.294 -0.879 . . . . 0.0 110.024 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.955 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.3 m -72.11 -9.02 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -0.874 . . . . 0.0 109.784 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.54 -7.17 44.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.984 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 50' ' ' LYS . 23.7 mt -72.91 146.16 46.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.013 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -73.58 151.38 40.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.879 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.0 -17.15 3.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.55 7.83 45.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 0.0 110.427 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.503 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 55.0 t80 -60.8 139.84 57.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 109.81 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 48' ' ' SER . 32.9 mtm -118.4 144.47 45.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.024 -1.048 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 42.5 t -59.31 127.56 84.46 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.402 -0.811 . . . . 0.0 110.284 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HB2' ' CB ' ' A' ' 25' ' ' PHE . 44.1 Cg_endo -71.46 -10.0 26.15 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.002 1.528 . . . . 0.0 110.0 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.579 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -94.33 -54.87 3.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.461 -0.774 . . . . 0.0 110.327 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.491 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 10.0 p -115.3 7.47 15.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 110.773 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 63.01 14.39 7.53 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.28 -0.887 . . . . 0.0 112.171 178.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.46 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 3.6 m -67.56 169.3 9.42 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.857 -1.152 . . . . 0.0 109.894 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.3 Cg_endo -74.19 141.36 29.13 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.788 1.415 . . . . 0.0 110.461 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 10.5 tttm -50.05 -29.55 9.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 109.892 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -61.88 -12.52 18.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.866 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.64 -1.92 58.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.788 179.475 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 24.5 m-85 -84.6 137.32 33.36 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.725 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -120.5 137.23 54.47 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.1 t . . . . . 0 C--N 1.3 -1.552 0 O-C-N 120.621 -1.299 . . . . 0.0 110.537 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.162 0.506 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 18.8 m-85 -123.18 148.5 45.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 110.897 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.578 ' CG ' ' CD1' ' A' ' 16' ' ' ILE . 14.4 mt-10 -120.46 139.71 52.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.426 -0.796 . . . . 0.0 109.608 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.461 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.6 t -76.57 117.21 17.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.127 -0.983 . . . . 0.0 110.417 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -16.54 63.97 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.857 -1.152 . . . . 0.0 108.597 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.1 -58.82 2.53 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.647 -0.658 . . . . 0.0 110.683 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.63 -3.56 16.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.884 -1.135 . . . . 0.0 110.984 -179.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.461 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.34 6.47 88.91 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.058 -1.026 . . . . 0.0 111.392 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 26.9 t80 -56.59 143.1 37.04 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.942 -1.328 . . . . 0.0 109.687 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.578 ' CD1' ' CG ' ' A' ' 9' ' ' GLU . 16.4 mm -115.66 112.05 38.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.259 -0.9 . . . . 0.0 110.704 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.588 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.0 t80 -81.82 130.06 34.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.741 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -110.14 119.34 47.4 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 110.288 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -70.65 -30.2 18.5 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.892 1.469 . . . . 0.0 110.09 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.71 -13.82 61.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.833 . . . . 0.0 110.043 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -111.79 -38.23 4.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.381 -0.825 . . . . 0.0 110.049 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.36 168.94 25.76 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.665 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.09 53.09 2.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.454 -1.027 . . . . 0.0 109.944 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -40.3 -57.4 1.75 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.375 -0.828 . . . . 0.0 110.533 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.526 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 27.0 m-85 -47.73 -34.35 8.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.47 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.99 -65.83 0.98 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.032 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.15 52.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.665 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.13 145.19 56.68 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.225 -1.162 . . . . 0.0 109.889 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -70.3 160.94 47.83 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.038 1.546 . . . . 0.0 110.47 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -71.93 163.14 39.77 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.049 1.552 . . . . 0.0 110.848 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.4 12.37 84.32 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 94.1 m -98.64 125.93 40.88 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.248 -1.148 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.749 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -73.74 139.76 28.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.016 1.535 . . . . 0.0 110.593 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.588 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 3.0 t80 -52.66 -40.0 62.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.017 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.3 m -53.76 -17.87 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -0.823 . . . . 0.0 110.282 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 63.3 t0 -83.53 -7.12 59.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 110.404 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.544 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.0 mt -71.42 153.86 41.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.086 -1.009 . . . . 0.0 109.98 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.22 157.99 30.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.979 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -11.52 15.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.267 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -99.52 4.01 45.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 110.435 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.568 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 48.7 t80 -59.65 132.81 55.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 109.832 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 48' ' ' SER . 10.4 mtp -117.08 147.01 42.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.052 -1.03 . . . . 0.0 109.966 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.6 t -56.59 129.97 76.66 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.321 -0.862 . . . . 0.0 110.458 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -72.22 -11.7 27.13 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.892 1.469 . . . . 0.0 109.4 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.64 -65.02 0.99 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.518 -0.739 . . . . 0.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.7 p -98.3 3.21 48.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.92 . . . . 0.0 111.151 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER 62.06 22.39 13.06 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.079 -1.013 . . . . 0.0 112.06 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.7 m -75.78 168.37 28.35 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.806 -1.184 . . . . 0.0 109.994 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.4 Cg_endo -74.08 142.57 31.19 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.907 1.478 . . . . 0.0 110.431 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 42.0 tttm -50.48 -29.41 10.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 109.944 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -62.95 -12.34 24.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.743 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.482 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -87.54 -3.08 59.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.786 179.515 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -86.45 139.63 30.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.748 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -122.55 139.86 53.43 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.2 t . . . . . 0 C--N 1.3 -1.575 0 O-C-N 120.677 -1.265 . . . . 0.0 110.566 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 10.0 m-85 -119.77 145.8 46.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.051 -1.03 . . . . 0.0 111.2 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 16' ' ' ILE . 6.5 pt-20 -121.16 139.64 53.08 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.552 -0.717 . . . . 0.0 109.145 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.9 t -76.94 116.79 17.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.025 -1.047 . . . . 0.0 110.314 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.43 -16.52 64.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.84 -1.162 . . . . 0.0 108.601 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -59.53 2.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.662 -0.649 . . . . 0.0 110.563 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.44 -3.46 17.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.057 . . . . 0.0 110.986 -179.074 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.46 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.82 5.98 89.25 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.138 -1.029 . . . . 0.0 111.385 177.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 45.8 t80 -56.93 143.56 37.22 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.901 -1.353 . . . . 0.0 109.767 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.55 HD13 ' HA ' ' A' ' 9' ' ' GLU . 21.7 mm -115.14 111.84 37.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 121.294 -0.879 . . . . 0.0 110.718 -179.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.1 t80 -82.17 129.34 34.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.867 . . . . 0.0 109.739 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -109.25 121.43 42.68 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.875 . . . . 0.0 110.202 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -71.66 -30.97 13.97 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.189 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.42 -14.81 62.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.082 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -108.88 -38.58 5.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 110.157 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.32 169.04 25.81 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.671 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.07 54.73 3.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.462 -1.022 . . . . 0.0 109.886 179.212 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -40.37 -58.03 1.63 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.396 -0.815 . . . . 0.0 110.756 -179.528 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.527 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 47.5 m-85 -46.31 -33.34 3.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.07 -63.75 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.003 . . . . 0.0 110.292 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.59 53.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.671 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.92 144.96 55.14 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.279 -1.13 . . . . 0.0 109.819 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.3 Cg_endo -70.65 161.13 47.14 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.966 1.508 . . . . 0.0 110.366 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.19 162.87 40.42 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.999 1.526 . . . . 0.0 110.787 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.41 13.33 83.67 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 83.7 m -99.85 124.06 45.22 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.269 -1.136 . . . . 0.0 110.15 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 46.4 Cg_endo -73.25 139.95 30.01 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.915 1.482 . . . . 0.0 110.644 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.583 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 t80 -50.96 -41.61 59.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.897 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -53.98 -17.55 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.418 -0.801 . . . . 0.0 110.423 -179.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 9.6 t0 -84.29 -7.44 59.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -0.992 . . . . 0.0 110.178 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 37' ' ' LEU . 19.8 mt -71.14 154.99 41.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.018 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.68 149.63 38.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 109.823 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -55.67 -16.48 4.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.152 -0.967 . . . . 0.0 110.294 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -95.57 6.3 49.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.6 t80 -60.13 136.98 58.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.142 -0.974 . . . . 0.0 109.913 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' SER . 4.7 mtm -119.77 146.55 45.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 110.01 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 8.2 t -56.07 131.05 74.28 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 110.448 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.7 Cg_endo -72.21 -12.67 27.96 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.872 1.459 . . . . 0.0 109.583 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.34 -64.31 1.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.463 -0.773 . . . . 0.0 110.82 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.538 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.2 p -98.84 3.83 47.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.899 . . . . 0.0 111.206 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 14.2 mtm180 61.6 20.77 11.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.134 -0.979 . . . . 0.0 112.103 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.7 m -73.71 168.36 26.51 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.72 -1.238 . . . . 0.0 109.767 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.6 Cg_endo -73.57 142.27 32.46 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.951 1.5 . . . . 0.0 110.383 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 28.0 tttm -50.01 -29.22 8.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 109.807 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -61.23 -13.24 16.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.0 110.013 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.59 -1.08 57.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.328 -0.857 . . . . 0.0 109.681 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 13.3 m-85 -87.98 139.32 30.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 110.477 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 3.3 mttt -127.36 143.18 51.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.455 -0.778 . . . . 0.0 109.449 179.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 12.0 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.76 -1.213 . . . . 0.0 110.709 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 mttt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.167 0.508 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.688 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 11.4 m-85 -114.25 140.36 48.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 110.469 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 9.9 pt-20 -117.63 136.75 53.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 109.562 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 3.6 t -74.87 120.0 19.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.7 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -16.67 63.27 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.751 -1.218 . . . . 0.0 108.481 178.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -58.78 2.55 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.561 -0.712 . . . . 0.0 110.564 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.488 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.5 p -109.52 -1.2 18.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.953 -1.092 . . . . 0.0 110.814 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.685 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 73.52 10.38 79.32 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 120.176 -1.012 . . . . 0.0 111.505 177.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 41.0 t80 -62.19 147.69 46.99 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.775 -1.427 . . . . 0.0 109.331 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -116.08 114.32 45.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.539 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 34' ' ' PHE . 18.5 t80 -83.16 134.68 34.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -111.23 119.18 46.15 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.432 -0.792 . . . . 0.0 110.07 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.2 Cg_endo -71.26 -31.71 13.91 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.955 1.503 . . . . 0.0 110.265 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.76 -8.52 56.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.371 -0.83 . . . . 0.0 109.972 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.3 tttt -110.06 -47.03 3.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.9 . . . . 0.0 110.16 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.21 162.84 14.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.554 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.17 56.68 4.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.509 -0.995 . . . . 0.0 109.927 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 23' ' ' ASP . 10.1 mmtt -40.14 -57.22 1.73 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.432 -0.793 . . . . 0.0 110.703 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -45.45 -34.01 2.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.398 -0.814 . . . . 0.0 110.604 -179.809 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -95.38 -61.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 110.405 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.24 55.77 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.554 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.1 mp -129.94 143.67 50.0 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.269 -1.136 . . . . 0.0 109.953 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.0 Cg_endo -70.5 162.9 40.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.943 1.496 . . . . 0.0 110.533 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.4 Cg_endo -72.41 161.68 43.62 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.983 1.517 . . . . 0.0 110.92 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.85 14.98 82.02 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 97.7 m -102.04 125.87 35.42 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.177 . . . . 0.0 110.187 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.811 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.6 Cg_endo -72.95 136.94 25.89 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.855 1.45 . . . . 0.0 110.528 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.606 ' CD2' HD12 ' A' ' 37' ' ' LEU . 15.1 t80 -53.06 -39.17 63.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.179 -0.951 . . . . 0.0 110.174 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.8 m -53.32 -18.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.119 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.46 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 15.2 t0 -82.41 -5.88 58.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 110.416 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 41' ' ' PHE . 22.2 mt -70.06 157.35 37.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.917 . . . . 0.0 110.067 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.05 155.95 30.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.2 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -60.48 -13.67 15.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.211 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.2 m -98.25 2.21 48.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 110.077 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.628 ' CD1' HD13 ' A' ' 37' ' ' LEU . 44.7 t80 -56.06 133.13 51.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.865 . . . . 0.0 110.139 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 35.4 mtt -111.03 138.29 47.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.006 -1.059 . . . . 0.0 109.307 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . 43.9 t -47.08 136.42 8.42 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 110.73 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.7 Cg_endo -82.8 36.18 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.124 1.592 . . . . 0.0 110.08 179.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.522 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -151.92 -50.31 0.11 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.247 -0.908 . . . . 0.0 109.588 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.488 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.5 p -118.17 8.41 12.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.389 -0.819 . . . . 0.0 110.128 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 27.3 mtp180 61.1 15.02 5.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.486 -0.759 . . . . 0.0 112.084 178.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.452 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.6 m -64.81 166.76 10.97 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.874 -1.141 . . . . 0.0 109.815 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.3 Cg_endo -73.25 142.32 33.62 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.932 1.49 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.2 tttm -49.85 -31.54 12.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.777 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -62.42 -12.26 20.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 109.808 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.56 -2.14 58.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.835 . . . . 0.0 109.745 179.505 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 13.7 m-85 -88.11 139.82 30.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 110.508 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 20.1 tttt -126.12 142.45 51.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 109.371 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.688 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 9.3 p . . . . . 0 N--CA 1.491 1.616 0 O-C-N 120.936 -1.103 . . . . 0.0 111.023 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.62 ' CE1' ' HB3' ' A' ' 55' ' ' SER . 8.6 m-85 -120.6 140.22 51.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 0.0 111.144 -178.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 45.6 tt0 -117.03 141.54 48.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.538 -0.726 . . . . 0.0 109.358 179.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.462 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.9 t -77.13 116.54 17.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.072 -1.017 . . . . 0.0 110.309 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -16.25 64.19 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.787 -1.195 . . . . 0.0 108.663 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -60.1 2.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.575 -0.703 . . . . 0.0 110.605 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.55 -3.61 17.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.061 -1.024 . . . . 0.0 110.945 -178.984 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.749 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.27 6.87 88.79 Favored Glycine 0 N--CA 1.496 2.685 0 O-C-N 121.09 -1.006 . . . . 0.0 111.611 177.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 28.0 t80 -59.17 143.01 50.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.736 -1.45 . . . . 0.0 109.723 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.4 mp -113.99 113.87 45.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.215 -0.928 . . . . 0.0 110.746 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 25.6 t80 -84.64 137.43 33.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -0.852 . . . . 0.0 109.593 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -114.73 122.6 33.53 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.788 . . . . 0.0 110.222 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.6 Cg_endo -71.08 -34.07 10.82 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.811 1.427 . . . . 0.0 110.089 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.31 -11.27 60.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 110.053 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -111.68 -38.2 4.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.28 170.98 28.28 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.624 ' OD1' HG21 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -85.19 57.15 4.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.493 -1.004 . . . . 0.0 109.702 179.099 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' ASP . 14.6 tptm -38.94 -61.33 0.75 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.454 -0.779 . . . . 0.0 110.532 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 27.2 m-85 -45.88 -30.38 1.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.835 . . . . 0.0 110.459 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -95.11 -63.5 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 0.0 110.276 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.43 54.24 0.02 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.624 HG21 ' OD1' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -129.95 144.17 51.99 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.212 -1.169 . . . . 0.0 109.662 179.798 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -70.44 159.0 54.38 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.982 1.517 . . . . 0.0 110.522 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.33 164.3 36.04 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.996 1.524 . . . . 0.0 110.741 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 80.22 13.98 81.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.8 m -105.19 126.69 30.34 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.176 -1.191 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.679 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.1 Cg_endo -72.97 141.73 33.63 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.897 1.472 . . . . 0.0 110.533 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.572 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 51.9 t80 -52.62 -41.37 63.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 110.177 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 33' ' ' PRO . 5.8 m -54.76 -17.17 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.337 -0.852 . . . . 0.0 110.305 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 29.6 t70 -86.7 -6.78 58.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 110.272 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.606 HD13 ' CD1' ' A' ' 41' ' ' PHE . 17.7 mt -72.81 124.76 26.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.195 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' LEU . 16.0 m -43.01 164.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.172 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -72.77 -2.01 18.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.0 110.182 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' ' SD ' ' A' ' 42' ' ' MET . 7.9 p -103.11 1.49 33.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.416 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.606 ' CD1' HD13 ' A' ' 37' ' ' LEU . 47.5 t80 -56.79 130.21 44.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 110.225 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -119.21 146.09 45.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.681 179.594 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.4 t -55.36 129.53 68.84 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 110.494 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.583 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.49 -13.34 30.2 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.895 1.471 . . . . 0.0 109.461 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.69 -65.16 0.98 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.558 -0.714 . . . . 0.0 110.917 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.523 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.2 p -97.0 2.85 52.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.191 -0.943 . . . . 0.0 111.159 -179.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.2 tpp180 61.65 22.99 13.38 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.137 -0.977 . . . . 0.0 111.945 178.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.459 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.2 m -74.38 165.48 53.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.839 -1.163 . . . . 0.0 109.94 179.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.9 Cg_endo -73.36 143.86 35.74 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.947 1.498 . . . . 0.0 110.44 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 12.5 tttt -49.16 -25.33 2.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 110.032 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -66.74 -11.2 53.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.88 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.496 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -90.75 -2.32 57.81 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.359 -0.838 . . . . 0.0 109.538 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 6.5 m-85 -89.09 138.87 31.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -0.77 . . . . 0.0 110.52 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 20.3 mmtt -130.83 146.92 52.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 109.586 179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.62 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 4.0 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.835 -1.165 . . . . 0.0 110.456 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.3 m-85 -125.73 150.14 47.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.926 -179.289 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 29.1 tt0 -120.32 140.2 51.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 109.243 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.3 t -77.4 116.81 18.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.06 -1.025 . . . . 0.0 110.562 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.14 -16.15 63.88 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.897 -1.127 . . . . 0.0 108.511 178.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.11 -59.48 2.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.65 -0.656 . . . . 0.0 110.539 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -109.27 -3.4 17.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.058 -1.026 . . . . 0.0 110.788 -179.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.747 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.06 6.82 88.75 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 121.118 -0.989 . . . . 0.0 111.571 177.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.695 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 51.5 t80 -58.98 144.33 45.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.83 -1.394 . . . . 0.0 109.894 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -116.05 113.07 42.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.761 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.589 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 40.7 t80 -81.55 123.23 28.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.743 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -102.21 118.01 59.96 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.47 -0.769 . . . . 0.0 110.294 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 46.5 Cg_endo -71.53 -30.67 14.73 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.902 1.475 . . . . 0.0 110.288 179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.82 -7.09 36.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.07 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 9.5 mttt -118.99 -35.73 3.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.884 . . . . 0.0 110.065 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.31 168.73 25.8 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.549 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -85.19 54.99 3.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.419 -1.047 . . . . 0.0 109.903 179.195 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -39.78 -58.13 1.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.574 -179.539 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.601 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -47.58 -34.05 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.412 -0.805 . . . . 0.0 110.537 -179.847 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -91.97 -65.3 1.02 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 110.239 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.96 52.99 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.548 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -132.49 142.59 45.46 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 0.0 109.908 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -69.97 161.95 44.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.871 1.458 . . . . 0.0 110.304 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.3 Cg_endo -71.92 162.99 40.24 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.993 1.523 . . . . 0.0 110.866 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 80.31 12.74 82.8 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 29' ' ' PRO . 2.2 m -101.71 126.19 34.88 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.147 -1.208 . . . . 0.0 110.219 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 46.9 Cg_endo -73.88 140.51 28.93 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.834 1.439 . . . . 0.0 110.613 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.589 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -52.13 -41.67 62.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.985 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -53.22 -18.71 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.445 -179.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 8.7 t70 -84.91 -6.66 59.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.237 -0.914 . . . . 0.0 110.118 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 41' ' ' PHE . 16.9 mt -73.67 121.94 21.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.345 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -41.34 152.74 0.05 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.413 -0.804 . . . . 0.0 110.336 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.19 -11.81 16.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 110.266 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.03 5.8 49.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.437 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.549 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.7 t80 -58.91 137.38 57.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 110.155 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.8 mtt -117.94 143.11 46.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 109.558 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 47' ' ' ARG . 43.2 t -59.62 125.71 80.63 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 110.169 -179.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.8 Cg_endo -71.15 -9.75 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.891 1.469 . . . . 0.0 109.899 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.695 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -93.19 -53.44 4.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -0.824 . . . . 0.0 110.193 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.489 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.8 p -117.64 8.3 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.615 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' CYS . 11.7 ttp180 61.81 15.44 7.06 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.245 -0.91 . . . . 0.0 112.097 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.454 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -68.29 168.64 12.94 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.858 -1.151 . . . . 0.0 109.895 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 48.0 Cg_endo -73.92 141.95 30.84 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.834 1.439 . . . . 0.0 110.524 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.579 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.7 tttm -50.21 -28.9 8.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -0.926 . . . . 0.0 109.956 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.78 -12.17 22.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.847 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.67 -2.21 58.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.339 -0.851 . . . . 0.0 109.737 179.41 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 26.8 m-85 -85.24 136.78 33.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.717 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.87 137.31 54.09 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.6 t . . . . . 0 C--N 1.3 -1.545 0 O-C-N 120.76 -1.212 . . . . 0.0 110.489 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.171 0.51 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 23.9 m-85 -116.4 139.46 50.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.109 -0.994 . . . . 0.0 110.22 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -113.96 135.22 54.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 109.969 179.594 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 14' ' ' GLY . 2.5 t -72.67 117.77 14.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.543 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -68.57 -15.76 63.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.776 -1.202 . . . . 0.0 108.513 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.24 -59.02 2.45 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.501 -0.75 . . . . 0.0 110.406 179.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.509 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.5 p -109.69 -0.65 18.46 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.863 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 72.7 11.84 77.74 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.075 -1.015 . . . . 0.0 111.496 177.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.6 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 17.4 t80 -63.92 147.32 52.24 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.781 -1.423 . . . . 0.0 109.685 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 15.1 mm -112.4 115.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.027 -1.046 . . . . 0.0 110.513 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 41.7 t80 -83.09 131.44 35.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.784 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -111.48 118.19 47.69 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.779 . . . . 0.0 110.198 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.5 Cg_endo -70.25 -30.16 20.4 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.884 1.465 . . . . 0.0 110.068 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.5 -11.61 60.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.835 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 11.7 tptt -110.48 -44.01 3.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.425 -0.797 . . . . 0.0 109.944 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.52 168.59 21.87 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.64 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.2 52.46 2.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.514 -0.992 . . . . 0.0 109.748 178.974 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 1.4 ttpp -39.11 -60.4 0.89 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 110.627 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 32.0 m-85 -44.7 -31.22 1.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.798 . . . . 0.0 110.346 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -95.08 -62.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.277 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.75 51.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.64 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -128.53 143.8 49.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 109.725 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.6 Cg_endo -69.88 159.69 52.39 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.958 1.504 . . . . 0.0 110.478 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.35 161.35 44.62 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.038 1.546 . . . . 0.0 111.006 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.83 13.77 82.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 91.2 m -99.02 125.58 41.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.231 -1.158 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.76 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.7 Cg_endo -73.03 136.66 25.2 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.905 1.476 . . . . 0.0 110.481 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 50' ' ' LYS . 11.8 t80 -50.09 -42.87 50.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.76 HG22 ' HB2' ' A' ' 33' ' ' PRO . 19.1 m -53.63 -17.0 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 110.621 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 12.0 t70 -86.56 -7.84 58.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.01 -1.056 . . . . 0.0 110.281 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.472 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.3 mt -68.16 158.02 34.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 110.109 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.6 m -77.86 152.71 33.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 110.002 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -61.27 -12.19 12.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.24 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.24 2.98 35.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.898 . . . . 0.0 110.552 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CZ ' ' OD2' ' A' ' 23' ' ' ASP . 46.6 t80 -58.11 137.71 56.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.015 -1.053 . . . . 0.0 109.755 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.425 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -109.75 137.61 47.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.85 -1.156 . . . . 0.0 109.837 179.786 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 38.4 t -46.66 136.55 7.57 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.284 -0.885 . . . . 0.0 110.569 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.6 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.5 Cg_endo -81.73 34.81 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.126 1.592 . . . . 0.0 110.379 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -150.81 -48.72 0.12 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.226 -0.921 . . . . 0.0 109.526 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.509 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.6 p -120.04 9.28 11.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 110.183 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.19 14.04 5.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.406 -0.809 . . . . 0.0 112.116 178.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.454 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.8 m -64.98 169.0 6.09 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.498 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.4 Cg_endo -74.21 142.69 30.88 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.762 1.401 . . . . 0.0 110.151 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 11.3 tttm -50.73 -31.81 17.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.074 -1.016 . . . . 0.0 109.618 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -64.03 -11.61 30.86 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.356 -0.84 . . . . 0.0 109.316 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.518 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -85.54 -4.1 59.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.361 -0.837 . . . . 0.0 109.865 179.641 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 22.4 m-85 -79.9 133.15 36.21 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.854 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -102.92 133.3 48.25 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.221 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.642 0 O-C-N 121.029 -1.045 . . . . 0.0 110.191 -179.537 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 tptm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.193 0.521 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.9 m-85 -124.51 149.44 46.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 110.596 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -118.85 138.3 52.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.328 179.023 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 3.0 t -76.52 118.88 19.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.021 . . . . 0.0 111.042 -179.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.44 -16.26 63.45 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.361 178.036 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.13 -59.7 2.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.631 -0.668 . . . . 0.0 110.587 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.479 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.6 p -107.99 -1.78 20.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.962 -1.086 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 74.07 10.26 80.95 Favored Glycine 0 N--CA 1.494 2.559 0 O-C-N 121.092 -1.005 . . . . 0.0 111.458 177.471 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.685 ' C ' HD12 ' A' ' 16' ' ' ILE . 39.3 t80 -65.1 149.65 49.51 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.819 -1.4 . . . . 0.0 110.001 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.685 HD12 ' C ' ' A' ' 15' ' ' TYR . 1.8 mp -114.79 112.41 39.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.221 -0.925 . . . . 0.0 110.113 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 38.0 t80 -80.79 119.94 24.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.688 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.32 118.04 57.78 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.354 -0.841 . . . . 0.0 110.061 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 32' ' ' THR . 44.6 Cg_endo -72.19 -22.44 22.35 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.931 1.49 . . . . 0.0 110.423 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -10.49 59.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -112.63 -47.32 3.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.922 . . . . 0.0 110.199 -179.979 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.66 159.36 11.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.553 ' OD2' ' CZ ' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -85.1 57.08 4.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -1.063 . . . . 0.0 109.983 179.415 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' ASP . 57.8 mttm -40.18 -52.97 2.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.448 -0.782 . . . . 0.0 110.464 -179.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -50.11 -39.96 44.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.487 -0.758 . . . . 0.0 110.427 -179.918 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -88.77 -67.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.09 55.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 32' ' ' THR . 1.2 mp -129.85 144.5 53.28 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.319 -1.107 . . . . 0.0 109.925 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.564 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.3 Cg_endo -71.03 166.33 29.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.974 1.513 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.1 Cg_endo -72.0 158.81 51.74 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.873 1.459 . . . . 0.0 111.024 -179.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.54 14.71 82.18 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.689 HG21 HG21 ' A' ' 28' ' ' ILE . 41.2 m -92.69 119.39 67.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 110.256 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.936 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.2 Cg_endo -72.68 141.56 34.39 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.876 1.461 . . . . 0.0 110.617 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.585 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 43.7 t80 -56.84 -18.48 13.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 110.028 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.936 HG22 ' HB2' ' A' ' 33' ' ' PRO . 14.6 m -73.51 -8.36 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.938 179.693 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -95.55 -7.37 38.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.549 HD12 ' CD1' ' A' ' 34' ' ' PHE . 22.5 mt -71.69 147.55 47.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 110.212 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.81 153.49 36.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.59 -16.35 5.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 p -96.96 5.01 51.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 110.303 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.553 ' CZ ' ' OD2' ' A' ' 23' ' ' ASP . 53.8 t80 -57.95 137.01 57.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.123 -0.986 . . . . 0.0 109.893 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.5 mmt -111.79 138.98 47.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.948 -1.095 . . . . 0.0 109.526 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 39.9 t -47.46 136.55 9.5 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 0.0 110.721 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -82.76 36.39 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.017 1.535 . . . . 0.0 110.109 178.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -151.83 -49.36 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.877 . . . . 0.0 109.491 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.479 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.6 p -119.53 8.56 11.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.423 -0.798 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.74 15.38 5.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -0.805 . . . . 0.0 112.176 178.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.458 ' OG ' ' SG ' ' A' ' 46' ' ' CYS . 3.2 m -66.34 169.03 8.07 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.794 -1.191 . . . . 0.0 109.681 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.7 Cg_endo -73.08 140.13 30.75 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.944 1.497 . . . . 0.0 110.413 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.585 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 32.5 tttt -50.24 -31.92 15.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.123 -0.985 . . . . 0.0 109.694 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -62.14 -12.57 20.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.319 -0.863 . . . . 0.0 109.707 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.13 -3.35 59.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.759 179.399 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 43' ' ' CYS . 19.7 m-85 -84.99 139.21 31.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 110.592 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.61 137.45 53.85 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.4 t . . . . . 0 C--N 1.301 -1.534 0 O-C-N 120.564 -1.335 . . . . 0.0 110.653 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HD2' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.247 0.546 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 16.1 m-85 -113.85 139.91 48.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.145 -0.972 . . . . 0.0 110.04 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -118.06 137.43 52.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.104 -0.997 . . . . 0.0 109.828 179.563 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.0 t -74.82 116.64 15.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 110.359 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -67.4 -15.99 63.99 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.761 -1.212 . . . . 0.0 108.62 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.22 -59.99 2.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.618 -0.676 . . . . 0.0 110.463 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.494 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.3 p -109.03 -1.93 18.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.039 -1.038 . . . . 0.0 110.967 -179.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.754 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 76.4 8.61 85.81 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.374 177.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 31.3 t80 -59.11 144.27 46.15 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.849 -1.383 . . . . 0.0 109.578 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -113.35 113.68 44.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.221 -0.925 . . . . 0.0 110.574 -179.318 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 35.8 t80 -82.74 131.23 35.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.305 -0.872 . . . . 0.0 109.739 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 12.2 mt-10 -108.15 119.68 49.1 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.7 Cg_endo -71.73 -35.61 7.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.839 1.442 . . . . 0.0 110.055 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 31.4 tt0 -70.29 -6.23 33.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 110.037 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 5.4 mmtt -117.56 -37.13 3.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.094 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.97 172.36 28.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 1.1 t70 -85.23 58.52 5.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -1.013 . . . . 0.0 109.756 178.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -36.83 -64.6 0.34 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.542 -0.723 . . . . 0.0 110.728 -179.535 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 1.6 m-85 -42.53 -26.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.847 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -99.98 -58.03 2.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.875 . . . . 0.0 109.952 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.65 -8.07 1.54 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.318 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.583 HG23 ' HD2' ' A' ' 29' ' ' PRO . 1.8 mt -61.79 143.36 94.23 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.251 . . . . 0.0 109.927 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.6 Cg_endo -71.08 160.38 49.37 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.926 1.487 . . . . 0.0 110.659 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.4 Cg_endo -72.83 163.66 37.8 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.13 1.595 . . . . 0.0 110.801 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.72 14.12 82.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 86.4 m -105.73 127.23 28.87 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.28 -1.129 . . . . 0.0 110.134 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.746 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.9 Cg_endo -73.13 140.75 31.56 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.959 1.505 . . . . 0.0 110.492 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 2.6 t80 -50.05 -38.06 36.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.991 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.746 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.3 m -54.4 -17.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 110.363 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -85.05 -7.15 59.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.091 -1.006 . . . . 0.0 110.234 179.949 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.584 HD12 ' CD2' ' A' ' 34' ' ' PHE . 48.5 mt -69.06 155.94 39.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.0 110.089 179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.25 156.13 29.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.136 -0.977 . . . . 0.0 109.819 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -9.64 16.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.029 -1.044 . . . . 0.0 110.317 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 t -103.65 2.76 33.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.473 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.577 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.1 t80 -59.82 138.95 57.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.122 -0.987 . . . . 0.0 109.885 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 48' ' ' SER . 7.0 mtt -117.09 142.72 46.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.866 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 41.9 t -56.3 128.32 72.82 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.24 -0.913 . . . . 0.0 110.008 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.557 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.9 Cg_endo -71.45 -12.66 29.78 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.924 1.486 . . . . 0.0 109.856 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.34 -51.45 4.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 110.675 -179.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.494 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 7.5 p -118.83 9.39 12.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.117 -0.989 . . . . 0.0 110.939 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.44 12.68 4.52 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.285 -0.885 . . . . 0.0 112.296 178.347 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 19.0 p -65.12 166.41 13.08 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.832 -1.167 . . . . 0.0 109.765 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 44.4 Cg_endo -71.87 142.38 38.94 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.665 1.35 . . . . 0.0 110.097 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.598 ' CE ' ' CZ ' ' A' ' 34' ' ' PHE . 23.1 tttt -50.41 -28.9 9.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.772 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -62.76 -12.58 25.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.206 -0.933 . . . . 0.0 109.741 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.42 -3.45 59.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -0.809 . . . . 0.0 109.664 179.433 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 21.7 m-85 -84.01 136.99 33.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 110.362 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -120.27 139.6 52.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.882 . . . . 0.0 109.268 179.198 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 53.1 p . . . . . 0 C--N 1.302 -1.498 0 O-C-N 120.885 -1.134 . . . . 0.0 111.355 -179.392 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' SER . 11.7 mtmt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 10.6 m-85 -121.34 143.44 49.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.139 -0.975 . . . . 0.0 111.254 -178.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.544 ' HA ' HD13 ' A' ' 16' ' ' ILE . 3.3 tm-20 -121.39 143.69 49.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 4.7 t -78.67 116.57 19.12 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.997 -1.064 . . . . 0.0 110.531 -179.544 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -15.77 63.67 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.767 -1.208 . . . . 0.0 108.415 178.295 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.02 -61.56 1.74 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.688 -0.632 . . . . 0.0 110.445 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.482 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -106.43 -3.95 20.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.931 -1.105 . . . . 0.0 110.559 -179.221 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 80.62 2.42 89.77 Favored Glycine 0 N--CA 1.496 2.696 0 O-C-N 121.086 -1.009 . . . . 0.0 111.19 177.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.647 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 22.5 t80 -50.43 171.65 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.998 -1.295 . . . . 0.0 109.7 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 23.2 mm -139.48 130.48 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 110.344 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 55.8 t80 -105.12 120.6 41.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.363 -0.836 . . . . 0.0 109.927 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -108.88 119.0 50.27 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.099 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -70.72 -24.29 25.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.929 1.489 . . . . 0.0 110.316 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 8.0 tp10 -72.64 -15.53 61.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.242 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 9.9 tttt -109.84 -40.7 4.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.42 156.39 12.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 1.007 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -85.3 62.2 7.34 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.375 -1.074 . . . . 0.0 108.995 178.463 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -39.68 -48.57 2.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.467 -0.771 . . . . 0.0 111.039 -179.061 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 44' ' ' PRO . 13.4 m-85 -80.96 13.22 2.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 0.0 110.907 -179.338 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.007 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -131.55 -3.77 3.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.0 110.71 -179.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.86 38.53 7.97 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.954 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.751 ' CG2' HG21 ' A' ' 32' ' ' THR . 1.7 mp -133.21 136.46 27.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.838 -1.389 . . . . 0.0 110.25 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 46.6 Cg_endo -72.79 174.12 12.35 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.016 1.535 . . . . 0.0 110.486 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 43.6 Cg_endo -72.85 160.52 45.91 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.969 1.51 . . . . 0.0 111.039 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.8 11.5 84.55 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.751 HG21 ' CG2' ' A' ' 28' ' ' ILE . 54.4 m -94.54 121.38 63.4 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.232 -1.157 . . . . 0.0 110.299 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.843 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.7 Cg_endo -72.96 143.53 36.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.838 1.441 . . . . 0.0 110.456 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.668 ' CD1' HD12 ' A' ' 37' ' ' LEU . 37.9 t80 -55.97 -37.16 68.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.908 . . . . 0.0 110.05 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.843 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.9 m -55.33 -18.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.454 -0.779 . . . . 0.0 109.872 179.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 7.7 t70 -83.42 -6.66 59.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.819 . . . . 0.0 110.242 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.668 HD12 ' CD1' ' A' ' 34' ' ' PHE . 22.2 mt -73.67 146.15 44.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.128 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -75.62 162.32 28.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.841 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -64.16 -9.75 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.151 -0.968 . . . . 0.0 110.259 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 t -100.16 4.32 44.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.468 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.558 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 51.4 t80 -58.38 137.13 57.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 109.792 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 48' ' ' SER . 20.0 mtt -120.75 146.08 46.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.008 -1.058 . . . . 0.0 110.122 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 47.0 t -59.23 127.43 84.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 110.265 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 45.7 Cg_endo -71.47 -9.98 26.1 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.931 1.49 . . . . 0.0 109.754 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.647 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -95.09 -56.7 2.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 110.582 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.482 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.9 p -111.61 5.99 19.71 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.122 -0.986 . . . . 0.0 110.691 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.6 OUTLIER 62.54 16.56 8.85 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.337 -0.852 . . . . 0.0 112.072 178.512 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.448 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -69.05 167.69 19.29 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.835 -1.166 . . . . 0.0 109.804 179.47 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.7 Cg_endo -72.74 140.89 33.03 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.897 1.472 . . . . 0.0 110.625 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.572 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 9.6 tttm -48.25 -26.8 2.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -0.916 . . . . 0.0 109.99 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 -11.23 16.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.799 . . . . 0.0 110.156 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.401 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -93.64 0.3 56.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.257 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 13.0 m-85 -87.85 137.12 32.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 110.616 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -125.2 140.11 53.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 0.0 109.476 179.268 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 5.5 p . . . . . 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.162 . . . . 0.0 110.626 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt . . . . . 0 N--CA 1.505 2.291 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 5.9 m-85 -111.32 134.04 53.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 109.886 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 74.3 tt0 -119.72 141.69 49.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 0.0 110.111 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 6.5 t -77.9 114.24 16.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 0.0 110.402 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -14.9 62.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.805 -1.184 . . . . 0.0 108.524 178.593 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.18 -61.87 1.67 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.598 -0.689 . . . . 0.0 110.731 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.3 p -107.77 -4.5 18.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.015 -1.053 . . . . 0.0 110.952 -178.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 15' ' ' TYR . . . 83.18 3.83 90.03 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.622 177.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.588 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 69.3 t80 -48.39 173.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.719 -1.459 . . . . 0.0 109.023 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.588 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 11.9 mm -145.77 112.78 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.895 -1.128 . . . . 0.0 110.712 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 53.1 t80 -94.17 148.28 22.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.86 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -130.75 126.53 21.89 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -71.45 -33.58 10.73 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.852 1.448 . . . . 0.0 110.285 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -72.87 -2.32 20.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 5.3 ttmt -121.7 -43.08 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.047 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.72 168.17 20.89 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.763 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -85.19 56.44 3.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -1.015 . . . . 0.0 110.007 179.479 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' ASP . 32.2 tttt -41.19 -61.91 0.93 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.396 -0.815 . . . . 0.0 110.48 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -43.07 -30.41 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.804 . . . . 0.0 110.341 -179.981 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.09 -60.11 1.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.344 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.86 54.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.561 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -132.96 142.05 43.24 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.314 -1.11 . . . . 0.0 109.87 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.0 Cg_endo -69.69 160.72 48.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.914 1.481 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.455 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 42.9 Cg_endo -71.43 162.16 43.22 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.072 1.564 . . . . 0.0 111.027 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 82.74 14.17 76.25 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 64.7 m -107.44 125.79 31.51 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.263 -1.14 . . . . 0.0 110.039 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 45.5 Cg_endo -71.91 138.09 30.69 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.884 1.465 . . . . 0.0 110.685 -179.791 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.642 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -52.98 -41.45 64.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -55.39 -17.48 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.354 -0.841 . . . . 0.0 110.19 -179.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -85.26 -5.23 59.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 109.922 179.687 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 50' ' ' LYS . 22.1 mt -72.13 127.79 33.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 109.922 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 7.9 t -42.06 155.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 110.161 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 10.8 m-20 -66.72 -7.23 19.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.7 OUTLIER -100.78 3.37 42.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.568 -179.786 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.496 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 51.7 t80 -58.21 132.6 54.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.126 -0.984 . . . . 0.0 109.956 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.442 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -118.81 146.71 44.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.0 109.992 179.744 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.479 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 7.3 t -56.84 128.69 76.86 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 110.16 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.598 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.36 -11.92 29.11 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.777 1.409 . . . . 0.0 109.628 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.82 -62.57 1.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 110.675 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.542 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.9 p -100.8 3.35 41.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.217 -0.927 . . . . 0.0 111.017 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 2.8 tpp180 61.54 21.64 12.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.198 -0.939 . . . . 0.0 112.046 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 27.2 p -74.45 165.24 55.28 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.8 -1.188 . . . . 0.0 109.702 179.259 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 44.9 Cg_endo -71.38 142.45 41.03 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.722 1.38 . . . . 0.0 110.335 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 7.4 tttm -48.09 -24.84 1.22 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.012 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.87 -9.73 31.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.932 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.498 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -92.37 -2.21 56.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.262 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.584 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 3.2 m-85 -89.91 140.04 30.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.297 -0.877 . . . . 0.0 110.443 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 47.1 tttt -129.04 145.13 51.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 109.634 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.636 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 2.7 p . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.015 -1.053 . . . . 0.0 110.889 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.257 0.551 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 179.7 89.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 110.214 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.553 HD11 ' HE3' ' A' ' 7' ' ' LYS . 1.2 tt -177.72 171.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.55 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 8.4 m-20 -149.85 130.13 13.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.473 -0.767 . . . . 0.0 110.234 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 3.3 tp10 179.8 -141.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.55 27.33 21.0 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HE3' HD11 ' A' ' 3' ' ' ILE . 1.3 mttm -79.97 121.76 25.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -1.137 . . . . 0.0 109.677 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.666 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 9.3 m-85 -118.7 140.55 49.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 110.58 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.5 tm-20 -119.84 142.62 48.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.811 . . . . 0.0 109.464 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.4 t -77.8 115.58 17.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 0.0 110.299 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -15.68 63.85 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.749 -1.219 . . . . 0.0 108.522 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -60.76 1.95 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.608 -0.682 . . . . 0.0 110.699 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.2 p -108.21 -4.35 17.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.093 . . . . 0.0 110.91 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 82.74 3.53 90.46 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.648 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.715 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 65.3 t80 -49.25 173.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.429 . . . . 0.0 109.255 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.611 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 12.2 mm -144.41 110.6 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.025 -1.047 . . . . 0.0 110.525 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 54.9 t80 -83.69 128.48 34.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.916 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -110.16 121.15 42.47 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.2 Cg_endo -71.8 -34.06 9.35 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.859 1.452 . . . . 0.0 110.239 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.93 -14.78 62.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 0.0 109.902 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -113.26 -18.51 12.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 110.049 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 85.35 170.66 47.4 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.695 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.16 49.96 1.85 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -1.069 . . . . 0.0 109.855 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.97 -54.82 2.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.41 -0.806 . . . . 0.0 110.393 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -47.51 -37.02 11.16 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 110.2 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.1 -65.96 0.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.06 51.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.701 HG23 ' HD2' ' A' ' 29' ' ' PRO . 2.1 mp -133.48 147.38 64.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.277 -1.131 . . . . 0.0 109.888 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.701 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -70.3 161.07 47.33 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.955 1.503 . . . . 0.0 110.255 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.9 Cg_endo -72.03 163.78 37.72 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.01 1.531 . . . . 0.0 110.841 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.03 11.04 85.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 18.0 m -100.41 122.12 50.97 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.299 -1.119 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.903 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.2 Cg_endo -72.49 143.3 38.23 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.873 1.46 . . . . 0.0 110.71 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.666 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 30.5 t80 -54.52 -18.86 4.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.901 . . . . 0.0 109.796 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.903 HG22 ' HB2' ' A' ' 33' ' ' PRO . 15.1 m -70.5 -13.88 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.381 -0.824 . . . . 0.0 109.68 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.8 -7.16 56.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.0 110.363 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.56 HD12 ' CD1' ' A' ' 34' ' ' PHE . 19.2 mt -72.23 148.72 45.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.053 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.486 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -77.35 163.69 26.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.909 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -7.06 21.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.983 . . . . 0.0 110.174 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.06 2.68 35.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.339 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 48.0 t80 -58.72 136.31 57.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.757 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 48' ' ' SER . 30.0 mtt -119.46 145.85 45.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.019 -1.051 . . . . 0.0 110.025 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 34.6 t -58.88 128.28 84.31 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 110.194 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 45.8 Cg_endo -72.14 -10.16 25.49 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.857 1.451 . . . . 0.0 109.775 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.715 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -95.99 -58.78 2.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.467 -0.771 . . . . 0.0 110.452 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.533 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.9 p -108.29 5.38 25.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.882 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.35 17.46 9.42 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.201 -0.937 . . . . 0.0 112.049 178.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.451 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.9 m -70.46 167.93 23.09 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.91 -1.118 . . . . 0.0 109.833 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.2 Cg_endo -72.88 141.46 33.51 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.967 1.509 . . . . 0.0 110.527 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.591 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 7.9 tttm -48.4 -26.33 2.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.886 . . . . 0.0 109.832 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -63.85 -11.1 24.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 109.977 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.473 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -91.79 -1.41 57.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.331 -0.855 . . . . 0.0 109.6 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -88.08 138.66 31.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.519 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -129.03 144.43 51.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -0.84 . . . . 0.0 109.686 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.9 p -81.35 167.06 19.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.939 -1.101 . . . . 0.0 110.711 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.485 HG12 ' HB3' ' A' ' 7' ' ' LYS . 2.5 pt -122.2 72.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.614 -0.679 . . . . 0.0 110.096 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -106.74 65.88 0.68 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 110.237 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -142.97 152.61 42.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.271 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 59' ' ' VAL . 27.6 m -144.41 124.73 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 60' ' ' ILE . 55.6 mt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.237 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.274 0.559 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 58' ' ' LYS . 7.7 mp0 -116.53 114.09 23.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.153 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 56' ' ' ILE . 4.5 pt -144.21 136.47 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.204 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -160.2 126.15 4.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 110.183 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.518 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.3 mt-10 -178.11 64.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.049 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 43.89 26.02 0.73 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 5' ' ' GLU . 27.3 mtmt -87.12 127.38 35.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.182 -1.187 . . . . 0.0 109.845 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.647 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 31.0 m-85 -124.06 145.64 49.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.976 . . . . 0.0 110.62 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -116.78 139.58 50.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 0.0 109.703 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.0 t -76.91 115.96 17.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.085 -1.01 . . . . 0.0 110.596 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -16.2 64.04 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.955 -1.091 . . . . 0.0 108.583 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.16 -58.73 2.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.571 -0.705 . . . . 0.0 110.654 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.89 -4.02 16.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.053 -1.029 . . . . 0.0 110.932 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.755 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 80.09 7.06 88.86 Favored Glycine 0 N--CA 1.497 2.727 0 O-C-N 121.101 -0.999 . . . . 0.0 111.583 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.704 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 53.8 t80 -59.65 142.81 52.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.758 -1.436 . . . . 0.0 110.051 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -114.94 113.82 44.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.16 -0.962 . . . . 0.0 110.638 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.582 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.8 t80 -82.41 132.21 35.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.833 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.24 116.95 41.7 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 110.3 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 44.0 Cg_endo -70.38 -26.48 24.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.879 1.463 . . . . 0.0 110.343 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -72.5 -12.47 61.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.365 -0.835 . . . . 0.0 109.784 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -114.25 -39.72 3.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.525 -0.734 . . . . 0.0 109.857 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.67 167.64 22.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.632 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.13 53.75 2.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.559 -0.965 . . . . 0.0 109.819 179.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.82 -57.94 1.46 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 110.634 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.527 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 64.7 m-85 -47.61 -34.83 8.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.366 -0.834 . . . . 0.0 110.328 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.5 -65.88 0.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.374 -0.829 . . . . 0.0 110.083 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.22 52.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.632 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -130.76 144.98 55.68 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.213 -1.169 . . . . 0.0 109.93 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.593 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.5 Cg_endo -70.28 161.86 44.45 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.946 1.498 . . . . 0.0 110.533 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.0 Cg_endo -72.94 162.75 40.22 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.05 1.553 . . . . 0.0 110.902 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.98 11.91 85.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 92.2 m -97.02 124.76 48.59 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.223 -1.163 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.669 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.0 Cg_endo -72.77 138.8 29.59 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.799 1.421 . . . . 0.0 110.553 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.582 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 27.6 t80 -52.47 -41.91 63.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 0.0 110.066 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' A' ' 33' ' ' PRO . 15.9 m -53.66 -17.98 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 110.233 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 28.4 t0 -83.9 -7.31 59.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.965 . . . . 0.0 110.391 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.517 HD12 ' CD1' ' A' ' 34' ' ' PHE . 18.6 mt -70.03 154.37 42.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 110.028 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.54 151.42 36.35 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.18 -0.95 . . . . 0.0 109.885 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.95 -14.49 6.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.071 -1.018 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 p -97.65 5.17 49.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 110.381 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.8 t80 -59.68 137.62 57.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.142 -0.974 . . . . 0.0 109.873 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.2 mtt -117.18 143.73 45.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 47' ' ' ARG . 49.4 t -58.88 125.7 78.49 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.0 110.093 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 43.6 Cg_endo -70.61 -10.17 27.32 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.943 1.496 . . . . 0.0 109.93 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.704 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -92.82 -52.51 4.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.468 -0.77 . . . . 0.0 110.294 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.8 p -119.32 8.89 11.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.705 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' CYS . 8.7 ttm-85 62.51 13.52 6.25 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.277 -0.89 . . . . 0.0 112.243 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.495 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 16.6 p -66.0 166.96 13.26 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.886 -1.134 . . . . 0.0 109.921 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.2 Cg_endo -73.0 142.49 34.73 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.679 1.357 . . . . 0.0 110.373 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.545 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 24.2 tttm -49.04 -29.82 5.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 109.951 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -63.89 -10.8 22.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.333 -0.854 . . . . 0.0 109.806 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.53 -4.81 58.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.268 -0.895 . . . . 0.0 109.757 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 29.0 m-85 -79.99 132.75 36.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.584 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HB3' ' OE2' ' A' ' 9' ' ' GLU . 42.9 tttt -105.16 130.14 53.4 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.647 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -80.6 160.35 25.13 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 110.342 -179.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 3' ' ' ILE . 2.7 pt -147.46 68.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 0.0 110.336 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -97.84 61.46 1.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -0.89 . . . . 0.0 110.06 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -82.67 107.14 15.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 59' ' ' VAL . 47.1 t -115.03 55.24 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.878 . . . . 0.0 110.085 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.467 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 33.6 mm . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.181 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.666 ' HG2' HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.26 0.553 . . . . 0.0 110.169 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.552 ' C ' HG23 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -110.98 71.79 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.21 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.552 HG23 ' C ' ' A' ' 2' ' ' GLU . 8.3 pt -156.17 -176.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.131 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.441 ' HB3' ' HG2' ' A' ' 57' ' ' LYS . 3.8 m-20 -149.86 128.24 12.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.198 -0.939 . . . . 0.0 110.256 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -176.49 -144.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 110.153 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.478 ' CA ' ' HG3' ' A' ' 19' ' ' PRO . . . -101.13 29.44 12.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.474 ' HD2' ' HB3' ' A' ' 5' ' ' GLU . 1.6 mttt -85.78 121.34 28.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -1.126 . . . . 0.0 109.831 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.638 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 29.9 m-85 -123.06 147.14 47.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 0.0 110.647 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 27.3 tt0 -117.24 137.34 52.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.429 -0.794 . . . . 0.0 109.549 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' GLY . 3.3 t -75.87 117.87 18.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.032 -1.042 . . . . 0.0 110.775 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -16.41 63.54 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.901 -1.124 . . . . 0.0 108.46 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.22 -57.68 2.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.672 -0.643 . . . . 0.0 110.48 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.503 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -110.75 -2.98 15.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.092 -1.005 . . . . 0.0 110.927 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.709 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 77.39 8.46 87.06 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.095 -1.003 . . . . 0.0 111.467 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 42.9 t80 -61.1 144.86 52.75 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.903 -1.351 . . . . 0.0 109.838 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -114.85 113.47 43.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.133 -0.979 . . . . 0.0 110.485 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.4 t80 -81.75 127.66 33.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.747 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -106.47 117.69 56.46 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.467 -0.77 . . . . 0.0 110.27 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.9 Cg_endo -70.04 -30.64 20.68 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.937 1.493 . . . . 0.0 110.198 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.04 -11.09 60.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 109.97 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 6.0 mtpt -110.62 -42.05 4.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 110.051 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.17 165.77 21.28 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.577 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.22 56.39 3.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.516 -0.991 . . . . 0.0 109.893 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.12 -57.23 1.72 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.825 . . . . 0.0 110.809 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 94.8 m-85 -47.13 -33.6 5.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.587 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.67 -64.3 1.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.189 -0.944 . . . . 0.0 110.399 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.0 53.68 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.577 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.1 mp -128.76 144.97 54.39 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.34 -1.094 . . . . 0.0 109.82 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -71.35 160.31 49.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.997 1.524 . . . . 0.0 110.421 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.11 163.16 39.61 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.004 1.529 . . . . 0.0 110.777 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.78 13.01 84.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.6 m -99.98 127.42 33.61 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.205 -1.173 . . . . 0.0 110.214 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 47.8 Cg_endo -73.15 140.15 30.57 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.969 1.51 . . . . 0.0 110.717 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.577 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.5 t80 -52.03 -41.92 62.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.138 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -17.65 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 110.476 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 4.3 t0 -84.07 -7.4 59.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.989 . . . . 0.0 110.249 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 mt -69.35 155.68 40.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.055 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -76.2 148.67 37.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.96 . . . . 0.0 109.785 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -15.81 5.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.996 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.7 5.63 49.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 110.346 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.523 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 54.8 t80 -60.0 139.89 57.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.207 -0.933 . . . . 0.0 109.904 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -118.23 143.31 46.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.07 -1.019 . . . . 0.0 110.027 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 47' ' ' ARG . 48.7 t -58.7 126.23 79.42 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.898 . . . . 0.0 110.139 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.582 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 43.8 Cg_endo -70.97 -10.48 27.67 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.911 1.48 . . . . 0.0 109.898 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -92.89 -52.42 4.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.46 -0.775 . . . . 0.0 110.34 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 8.6 p -118.98 9.15 11.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.684 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.79 13.72 5.65 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.248 -0.908 . . . . 0.0 112.209 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.5 m -66.47 169.13 8.07 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.832 -1.168 . . . . 0.0 109.878 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 48.0 Cg_endo -74.11 141.79 29.99 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.793 1.417 . . . . 0.0 110.405 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.568 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 26.6 tttm -49.85 -30.9 10.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 109.806 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -62.9 -11.9 21.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.16 -3.65 59.07 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.404 -0.81 . . . . 0.0 109.77 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 15.2 m-85 -79.94 132.49 36.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 110.399 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.24 129.46 50.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.009 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.638 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -81.89 160.83 23.33 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 110.368 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.666 HD13 ' HG2' ' A' ' 1' ' ' MET . 1.2 pp -136.59 76.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.833 . . . . 0.0 110.219 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HG2' ' HB3' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -102.97 63.16 0.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.16 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.498 ' HG2' ' CD1' ' A' ' 60' ' ' ILE . 0.4 OUTLIER -132.63 157.69 44.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 110.266 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 48.7 t -125.21 61.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.0 110.167 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.498 ' CD1' ' HG2' ' A' ' 58' ' ' LYS . 3.4 mp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.208 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' O ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.235 0.541 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.643 ' O ' HG23 ' A' ' 3' ' ' ILE . 1.2 tt0 -83.0 65.19 8.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 2' ' ' GLU . 1.2 pt -158.09 135.29 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.502 ' OD2' ' CG2' ' A' ' 59' ' ' VAL . 36.5 m-20 -128.62 126.14 39.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.336 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -164.85 52.91 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.297 -0.877 . . . . 0.0 109.966 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 43.24 26.27 0.54 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 5' ' ' GLU . 10.5 tttt -86.3 130.8 34.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.031 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.663 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 37.6 m-85 -121.37 143.71 49.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.26 -0.9 . . . . 0.0 110.351 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' O ' ' CG ' ' A' ' 54' ' ' LYS . 7.4 mt-10 -117.04 139.83 50.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.366 -0.834 . . . . 0.0 110.374 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -76.31 113.01 13.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.999 -1.063 . . . . 0.0 110.412 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.6 -15.52 61.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.808 -1.183 . . . . 0.0 108.606 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.2 -61.73 1.7 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.565 -0.709 . . . . 0.0 110.634 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.508 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -107.19 -3.25 20.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 110.97 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.791 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.02 7.54 88.39 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.434 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 29.0 t80 -59.49 142.02 53.45 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.836 -1.391 . . . . 0.0 109.692 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.791 HD12 ' O ' ' A' ' 14' ' ' GLY . 1.9 mp -114.6 115.46 49.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 32.1 t80 -83.78 137.82 33.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -116.28 119.76 36.0 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 110.43 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.2 Cg_endo -69.95 -33.24 16.27 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.905 1.476 . . . . 0.0 110.115 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.32 -12.89 61.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.838 . . . . 0.0 109.788 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -14.85 11.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.913 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 79.97 172.91 44.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.656 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.15 49.56 1.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -1.048 . . . . 0.0 109.759 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ASP . 16.8 ttmt -39.7 -59.0 1.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.57 -0.706 . . . . 0.0 110.442 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.549 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 1.1 m-85 -44.51 -32.83 1.52 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.376 -0.827 . . . . 0.0 110.088 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -93.79 -61.92 1.45 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 0.0 110.263 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.28 51.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.656 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -134.01 143.75 48.64 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.286 -1.126 . . . . 0.0 109.944 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.515 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.1 Cg_endo -68.52 160.95 47.11 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.004 1.529 . . . . 0.0 110.277 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 44.2 Cg_endo -71.76 162.93 40.53 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.027 1.541 . . . . 0.0 111.034 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 81.31 13.29 80.89 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 3.7 m -102.97 121.58 48.59 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.24 -1.153 . . . . 0.0 110.136 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.772 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.1 Cg_endo -72.52 135.11 23.59 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.799 1.42 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 8.0 t80 -47.89 -39.91 20.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.281 -0.887 . . . . 0.0 110.161 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 33' ' ' PRO . 10.6 m -53.54 -22.12 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.401 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 21.2 t0 -84.31 -5.79 59.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 110.367 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.511 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 17.0 mt -72.31 123.34 22.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 110.271 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 7.2 m -41.4 151.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -0.828 . . . . 0.0 110.205 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -63.91 -10.0 18.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -100.02 5.38 45.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.579 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.504 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 55.5 t80 -59.77 138.05 57.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.791 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.0 mtm -122.46 148.06 45.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.978 -1.076 . . . . 0.0 109.936 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 2.0 t -55.75 129.95 71.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 110.5 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.549 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -72.59 -12.55 26.97 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 123.835 1.439 . . . . 0.0 109.114 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.24 -67.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.592 -0.692 . . . . 0.0 110.667 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.508 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.7 p -93.82 1.18 56.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 111.113 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 2.6 ttm180 61.06 31.12 19.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.083 -1.011 . . . . 0.0 111.764 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.4 m -85.01 168.62 19.7 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.775 -1.203 . . . . 0.0 109.883 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.1 Cg_endo -72.42 138.84 30.64 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.959 1.505 . . . . 0.0 110.457 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.614 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 20.9 tttm -51.0 -31.16 17.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.047 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -63.33 -12.11 27.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 109.73 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -85.04 -5.96 59.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.73 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.614 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 23.2 m-85 -79.99 137.96 36.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 110.553 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.508 ' CG ' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -109.71 132.75 53.86 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.384 -0.823 . . . . 0.0 108.997 178.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.663 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -81.13 161.64 24.01 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.072 -1.018 . . . . 0.0 110.443 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.88 62.71 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.394 -0.816 . . . . 0.0 110.109 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HG3' ' HB3' ' A' ' 4' ' ' ASP . 4.1 tttt -97.47 60.83 1.62 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.244 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 1' ' ' MET . 7.1 mmtt -119.52 140.86 49.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.868 . . . . 0.0 110.186 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 45.9 t -123.33 62.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 110.187 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.401 ' OXT' HG13 ' A' ' 60' ' ' ILE . 3.1 pt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.181 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 3' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.253 0.549 . . . . 0.0 110.276 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 1.5 pp20? -48.01 153.31 0.67 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 110.212 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 1' ' ' MET . 6.3 pt -146.36 135.22 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 15.9 t0 -92.45 -149.57 0.25 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.3 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.491 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 32.4 tt0 175.42 -23.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 0.0 110.615 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.36 4.58 17.75 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.55 ' HB3' HD13 ' A' ' 56' ' ' ILE . 4.0 tttt -85.68 118.21 25.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -1.195 . . . . 0.0 109.664 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.609 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 30.7 m-85 -128.92 146.69 50.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.125 -0.984 . . . . 0.0 110.808 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 4.0 mt-10 -116.95 143.2 45.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 0.0 109.578 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 4.3 t -78.13 114.38 16.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.913 -1.117 . . . . 0.0 110.709 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.32 -15.68 63.83 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.915 -1.116 . . . . 0.0 108.41 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -59.62 2.28 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.728 -0.608 . . . . 0.0 110.712 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -109.13 -4.87 16.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.976 -1.078 . . . . 0.0 110.972 -178.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.682 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 84.27 3.63 88.63 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.957 -1.089 . . . . 0.0 111.728 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.848 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 77.7 t80 -52.46 174.34 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.748 -1.443 . . . . 0.0 109.564 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.682 HD12 ' O ' ' A' ' 14' ' ' GLY . 1.2 mp -148.12 110.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.991 . . . . 0.0 110.227 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 49.0 t80 -81.21 123.47 28.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.829 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -107.87 116.91 56.49 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 110.197 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.8 Cg_endo -70.05 -27.46 25.08 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.812 1.427 . . . . 0.0 110.401 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -73.07 -15.18 61.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.342 -0.849 . . . . 0.0 109.998 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 -12.06 12.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.788 . . . . 0.0 109.973 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 80.99 165.74 34.48 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.683 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.21 50.16 1.89 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -1.064 . . . . 0.0 109.897 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -39.78 -51.62 2.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.5 -0.75 . . . . 0.0 110.374 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -49.41 -38.7 30.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.385 -0.822 . . . . 0.0 110.28 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.64 -67.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -0.881 . . . . 0.0 110.404 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.73 51.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.825 HG21 HG21 ' A' ' 32' ' ' THR . 2.1 mp -133.69 147.09 63.08 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.27 -1.135 . . . . 0.0 109.921 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.705 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.9 Cg_endo -71.42 165.49 32.31 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.987 1.519 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.9 Cg_endo -72.04 162.51 41.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.96 1.505 . . . . 0.0 110.832 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.81 12.49 82.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.825 HG21 HG21 ' A' ' 28' ' ' ILE . 21.7 m -92.32 122.97 63.67 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -1.139 . . . . 0.0 110.19 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.99 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.5 Cg_endo -72.7 139.07 30.25 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.879 1.463 . . . . 0.0 110.651 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.588 ' CE2' ' HE2' ' A' ' 50' ' ' LYS . 79.8 t80 -55.9 -17.78 7.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.887 . . . . 0.0 109.819 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.99 HG22 ' HB2' ' A' ' 33' ' ' PRO . 14.2 m -73.78 -7.47 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.67 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -95.31 -7.58 38.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 110.383 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.553 HD12 ' CD1' ' A' ' 34' ' ' PHE . 18.3 mt -70.94 147.61 48.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.97 . . . . 0.0 109.978 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.7 m -75.49 155.41 36.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.843 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -58.7 -14.19 7.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.129 -0.982 . . . . 0.0 110.268 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.23 5.43 50.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 110.55 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.527 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.6 t80 -59.01 135.74 57.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.682 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.0 mtp -118.24 146.05 44.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.057 -1.027 . . . . 0.0 110.351 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 47' ' ' ARG . 42.5 t -61.22 124.27 79.67 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.408 -0.808 . . . . 0.0 110.097 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.602 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.0 Cg_endo -70.48 -7.87 22.29 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.883 1.465 . . . . 0.0 109.823 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.848 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -94.0 -54.84 3.44 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.477 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 10.3 p -115.99 7.02 14.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.438 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 43' ' ' CYS . 6.0 ttm180 63.21 15.94 9.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.241 -0.912 . . . . 0.0 112.171 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 20.6 p -68.64 166.56 25.51 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 0.0 109.811 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.2 Cg_endo -72.29 142.01 36.66 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.733 1.386 . . . . 0.0 110.495 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.588 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 10.5 tttm -48.51 -28.47 3.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 109.961 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.99 -10.42 21.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -0.87 . . . . 0.0 109.886 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.66 -4.19 58.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.276 -0.89 . . . . 0.0 109.695 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CZ ' ' HE2' ' A' ' 41' ' ' PHE . 19.1 m-85 -80.18 132.34 35.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 110.589 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.48 128.83 53.77 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.609 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -79.16 160.78 26.83 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.059 -1.026 . . . . 0.0 110.02 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.55 HD13 ' HB3' ' A' ' 7' ' ' LYS . 7.4 pt -96.45 -40.81 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.473 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.503 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 9.1 ttmt 58.87 94.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.978 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.491 ' NZ ' ' OE1' ' A' ' 5' ' ' GLU . 6.9 mttp -74.58 165.1 25.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.409 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 14.8 p -125.24 138.42 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 110.184 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 1' ' ' MET . 5.3 tt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.189 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' HB3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.254 0.55 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.617 ' O ' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -101.83 82.72 2.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.153 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 2' ' ' GLU . 19.8 pt -157.83 152.62 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 110.245 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.412 ' HB2' ' HG2' ' A' ' 57' ' ' LYS . 22.9 p-10 -160.77 134.61 6.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 6' ' ' GLY . 2.2 tt0 -173.15 60.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.054 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 44.36 25.82 0.86 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 5' ' ' GLU . 22.2 mtpt -86.77 127.95 35.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 0.0 110.007 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.614 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 22.4 m-85 -120.05 146.99 45.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.295 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 70.7 tt0 -121.4 139.89 52.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.7 t -77.11 117.01 18.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.025 . . . . 0.0 110.398 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -68.07 -16.53 64.06 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.785 -1.197 . . . . 0.0 108.617 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.13 -59.14 2.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.637 -0.664 . . . . 0.0 110.574 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.37 -3.76 16.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.006 -1.059 . . . . 0.0 110.918 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.4 6.13 89.02 Favored Glycine 0 N--CA 1.496 2.696 0 O-C-N 121.081 -1.012 . . . . 0.0 111.43 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 17.7 t80 -56.79 144.2 33.9 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.927 -1.337 . . . . 0.0 109.829 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 13.3 mm -115.99 111.27 34.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.651 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.9 t80 -81.24 121.42 26.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.835 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -101.84 118.48 59.38 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.251 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -72.0 -29.25 15.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.968 1.509 . . . . 0.0 110.166 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.08 -9.23 58.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 110.224 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.5 mmmp? -111.81 -45.48 3.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.273 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.52 159.57 12.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.553 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.19 55.18 3.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -1.06 . . . . 0.0 109.882 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.54 -51.59 2.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 110.499 -179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 65.3 m-85 -51.25 -37.95 49.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.844 . . . . 0.0 110.294 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.54 -68.52 0.78 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 110.183 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.43 53.85 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.651 ' CG2' HG21 ' A' ' 32' ' ' THR . 1.4 mp -131.84 143.37 48.8 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.232 -1.158 . . . . 0.0 109.949 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -72.0 168.67 23.32 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.012 1.533 . . . . 0.0 110.36 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.2 Cg_endo -72.25 161.38 44.65 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.889 1.468 . . . . 0.0 110.88 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.67 15.47 80.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.651 HG21 ' CG2' ' A' ' 28' ' ' ILE . 31.4 m -95.54 122.59 58.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.263 -1.139 . . . . 0.0 110.227 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.785 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -73.26 138.72 28.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.862 1.454 . . . . 0.0 110.58 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.584 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 13.7 t80 -53.13 -40.18 64.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.115 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.785 HG22 ' HB2' ' A' ' 33' ' ' PRO . 11.4 m -53.77 -18.09 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 110.177 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.51 -7.16 59.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.107 -0.996 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.485 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.2 mt -71.86 151.87 43.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.944 . . . . 0.0 110.077 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -76.95 158.68 30.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -10.85 15.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 0.0 110.158 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 4.12 45.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.398 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.483 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 50.0 t80 -59.47 134.73 57.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -0.945 . . . . 0.0 109.845 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -118.81 146.86 44.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.048 -1.033 . . . . 0.0 109.853 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.9 t -56.89 130.01 78.48 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 110.422 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.531 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -72.05 -11.85 27.61 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.865 1.455 . . . . 0.0 109.51 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.42 -64.9 1.0 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 110.751 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.534 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.3 p -98.69 3.34 47.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 0.0 111.109 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 6.0 ttm180 62.09 21.68 12.56 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.05 -1.031 . . . . 0.0 111.994 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.7 m -74.98 168.24 29.36 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.776 -1.202 . . . . 0.0 109.931 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.5 Cg_endo -73.53 141.87 32.0 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.917 1.483 . . . . 0.0 110.561 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 41.3 tttm -50.19 -30.24 11.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.005 . . . . 0.0 109.968 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.04 -12.46 19.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.28 -0.888 . . . . 0.0 109.872 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.44 -2.37 58.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.279 -0.888 . . . . 0.0 109.798 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -86.15 139.1 31.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 110.688 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 138.24 54.37 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.0 t -85.4 172.79 10.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.66 -1.275 . . . . 0.0 110.787 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 56' ' ' ILE . 5.7 pt -138.33 71.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.208 0.528 . . . . 0.0 110.281 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.412 ' HG2' ' HB2' ' A' ' 4' ' ' ASP . 16.9 mttp -107.42 65.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.149 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -96.68 74.58 2.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.242 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -83.42 92.55 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.185 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.444 ' OXT' ' CG1' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.241 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 mmt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.299 0.571 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.8 OUTLIER -175.41 97.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.249 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.456 HG13 ' HB2' ' A' ' 58' ' ' LYS . 4.6 pt -151.69 126.67 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.152 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 5' ' ' GLU . 6.7 p-10 -145.71 125.56 13.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 110.301 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER 175.28 70.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.086 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 47.23 30.13 5.43 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . 9.6 mttt -77.95 119.17 21.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -1.092 . . . . 0.0 109.624 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.625 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.2 m-85 -118.37 138.41 52.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 110.701 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -116.04 140.25 49.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.436 -0.79 . . . . 0.0 109.554 179.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.7 t -75.93 115.55 15.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.954 . . . . 0.0 110.148 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -16.12 63.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.789 -1.194 . . . . 0.0 108.684 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.16 -60.8 1.93 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.593 -0.692 . . . . 0.0 110.552 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.2 p -108.31 -2.97 18.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.001 . . . . 0.0 111.001 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.723 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 78.65 6.95 88.33 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.013 -1.054 . . . . 0.0 111.418 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 4.8 t80 -58.16 142.76 46.32 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.968 -1.313 . . . . 0.0 109.695 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.723 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -110.53 113.62 44.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.481 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 50.9 t80 -82.89 121.29 26.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 109.882 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -100.0 118.24 61.93 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 110.318 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -71.32 -35.93 7.72 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.82 1.432 . . . . 0.0 110.114 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -71.62 -10.51 59.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.801 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 -12.83 13.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.971 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.502 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 76.54 170.84 32.29 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.57 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 1.8 t70 -85.28 59.02 5.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.455 -1.026 . . . . 0.0 109.66 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -36.92 -62.99 0.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.555 -0.716 . . . . 0.0 110.699 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.538 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 18.5 m-85 -42.46 -27.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 110.32 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -101.04 -58.2 1.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.434 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.87 -10.07 1.2 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.185 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.558 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -61.27 141.2 94.27 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.061 -1.258 . . . . 0.0 109.73 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.9 Cg_endo -69.75 160.52 49.42 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.899 1.473 . . . . 0.0 110.665 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 45.1 Cg_endo -72.43 165.42 32.73 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.075 1.566 . . . . 0.0 110.702 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.15 12.83 83.23 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 20.4 m -103.79 126.33 32.18 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.255 -1.144 . . . . 0.0 110.128 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.764 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.3 Cg_endo -73.11 142.92 35.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.889 1.468 . . . . 0.0 110.54 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.575 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.1 t80 -51.3 -36.39 42.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.885 . . . . 0.0 110.142 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.764 HG22 ' HB2' ' A' ' 33' ' ' PRO . 12.5 m -54.32 -17.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -84.36 -7.41 59.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 110.303 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.572 HD12 ' CD2' ' A' ' 34' ' ' PHE . 38.3 mt -71.22 152.79 42.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 110.076 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.461 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 1.4 m -80.15 167.85 19.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.95 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -73.59 -0.73 16.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 110.187 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 t -109.8 -0.12 18.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.168 -0.957 . . . . 0.0 110.387 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.57 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.9 t80 -59.7 138.69 57.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 109.791 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 48' ' ' SER . 11.4 mtt -120.93 145.77 47.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.129 -0.982 . . . . 0.0 110.051 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.472 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 12.9 t -55.53 131.35 71.05 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.838 . . . . 0.0 110.114 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.538 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 47.0 Cg_endo -73.38 -13.32 25.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.923 1.486 . . . . 0.0 109.609 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.78 -59.42 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.459 -0.775 . . . . 0.0 110.95 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.526 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.0 p -105.15 5.06 31.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 111.076 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER 61.79 17.8 9.13 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.195 -0.94 . . . . 0.0 112.251 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 21.4 p -70.29 165.96 39.1 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.161 . . . . 0.0 109.672 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 45.8 Cg_endo -72.23 142.71 38.18 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.692 1.364 . . . . 0.0 110.388 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.548 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 27.3 tttm -48.78 -27.72 3.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 109.927 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.96 -11.18 26.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.35 -0.844 . . . . 0.0 109.825 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.84 -2.96 58.32 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.379 -0.825 . . . . 0.0 109.589 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 24.3 m-85 -87.7 139.22 30.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -132.08 147.88 52.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.651 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 3.2 p -83.24 166.31 18.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.023 . . . . 0.0 110.468 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 7' ' ' LYS . 12.8 pt -118.59 -43.97 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.553 -0.717 . . . . 0.0 110.3 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' N ' HG13 ' A' ' 56' ' ' ILE . 44.3 mttm 38.44 73.1 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.575 -0.703 . . . . 0.0 110.617 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HB2' HG13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -105.07 139.58 39.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.128 -0.983 . . . . 0.0 110.27 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 2.6 p 179.9 130.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.446 ' H ' HG22 ' A' ' 60' ' ' ILE . 13.5 tt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.902 -1.046 . . . . 0.0 110.267 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.256 0.55 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . 0.4 OUTLIER -82.85 108.15 15.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.178 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.4 pt -147.19 144.17 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.176 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 4' ' ' ASP . 43.7 p-10 -160.68 136.13 7.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.261 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER 175.6 30.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.878 . . . . 0.0 110.527 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.75 30.82 12.26 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.54 125.14 33.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.196 -1.179 . . . . 0.0 109.763 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 16.6 m-85 -123.55 152.91 41.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.207 -0.933 . . . . 0.0 110.405 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -125.64 141.19 52.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.418 -0.801 . . . . 0.0 109.527 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 5.0 t -78.01 117.32 19.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.506 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -16.36 63.92 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.595 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.12 -59.56 2.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.683 -0.636 . . . . 0.0 110.595 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.28 -3.91 16.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.992 -1.067 . . . . 0.0 110.775 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.766 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.95 5.67 89.44 Favored Glycine 0 N--CA 1.497 2.707 0 O-C-N 121.136 -0.977 . . . . 0.0 111.587 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 41.7 t80 -57.13 144.47 34.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.862 -1.375 . . . . 0.0 109.937 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.766 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -115.96 111.28 34.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.23 -0.919 . . . . 0.0 110.601 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 38.3 t80 -80.83 123.17 28.03 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.264 -0.897 . . . . 0.0 109.574 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -106.95 116.73 58.1 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 110.226 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' THR . 44.3 Cg_endo -71.19 -24.97 22.76 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.792 1.417 . . . . 0.0 110.24 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 15.3 tt0 -73.14 -9.94 59.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.08 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.1 tttp -114.78 -43.26 3.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.125 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.98 159.51 13.13 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.556 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.09 55.18 3.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.445 -1.032 . . . . 0.0 109.94 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.74 -50.16 3.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.871 . . . . 0.0 110.596 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 26.1 m-85 -52.12 -39.25 59.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 110.354 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.55 -69.22 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.213 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.28 54.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.69 HG21 HG21 ' A' ' 32' ' ' THR . 1.4 mp -131.0 144.22 52.68 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.236 -1.156 . . . . 0.0 110.04 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.599 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.5 Cg_endo -71.39 166.63 28.72 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.015 1.534 . . . . 0.0 110.505 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.3 Cg_endo -72.34 161.9 43.07 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.915 1.481 . . . . 0.0 110.819 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 73.58 13.65 80.1 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.69 HG21 HG21 ' A' ' 28' ' ' ILE . 16.9 m -94.69 121.97 61.78 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.266 -1.138 . . . . 0.0 110.19 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.79 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.3 Cg_endo -71.89 141.4 36.96 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.81 1.426 . . . . 0.0 110.669 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.749 ' CD1' HD12 ' A' ' 37' ' ' LEU . 85.5 t80 -56.06 -18.1 8.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 33' ' ' PRO . 4.3 m -70.63 -11.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.38 -0.825 . . . . 0.0 109.47 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -89.35 -6.87 56.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.503 -0.748 . . . . 0.0 110.265 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.749 HD12 ' CD1' ' A' ' 34' ' ' PHE . 19.1 mt -73.63 144.75 45.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.143 -0.973 . . . . 0.0 110.044 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.2 t -75.46 160.38 30.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 110.096 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -62.27 -11.55 15.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.217 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.17 4.89 46.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.359 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.526 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 51.8 t80 -59.89 135.58 57.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.119 -0.988 . . . . 0.0 109.876 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -118.78 146.49 44.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.066 -1.022 . . . . 0.0 109.868 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.6 t -55.93 131.61 73.5 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.579 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 44.6 Cg_endo -72.4 -12.61 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.901 1.474 . . . . 0.0 109.585 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.88 -65.74 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.502 -0.749 . . . . 0.0 110.866 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.6 p -96.62 2.87 52.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 0.0 111.205 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HB3' ' O ' ' A' ' 46' ' ' CYS . 0.1 OUTLIER 61.88 22.37 12.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.133 -0.979 . . . . 0.0 111.997 178.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.9 m -75.73 168.16 30.22 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.786 -1.196 . . . . 0.0 109.92 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.1 Cg_endo -73.37 141.91 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.796 1.419 . . . . 0.0 110.494 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 11.9 tttm -50.17 -29.3 8.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 1.9 m-20 -62.4 -12.36 21.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.874 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.54 -1.58 58.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.284 -0.885 . . . . 0.0 109.727 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 3.2 m-85 -85.71 137.75 32.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.921 . . . . 0.0 110.421 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.42 137.99 54.47 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.0 t -87.14 174.19 8.78 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.761 -1.212 . . . . 0.0 110.454 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.481 HG13 ' N ' ' A' ' 57' ' ' LYS . 9.7 pt -130.47 -44.92 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.156 -0.617 . . . . 0.0 110.431 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.481 ' N ' HG13 ' A' ' 56' ' ' ILE . 10.2 mttt 41.85 71.42 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.359 -0.838 . . . . 0.0 110.195 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.424 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 2.4 tttt -84.96 148.16 26.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.11 -0.994 . . . . 0.0 110.276 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 59' ' ' VAL . 11.2 p -177.04 59.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.26 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.212 0.53 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.584 ' C ' HG23 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -112.12 86.61 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.901 . . . . 0.0 110.249 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.584 HG23 ' C ' ' A' ' 2' ' ' GLU . 1.1 pt -155.21 145.58 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 0.0 110.104 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.559 ' OD2' HG22 ' A' ' 59' ' ' VAL . 8.4 m-20 -145.08 129.21 17.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 110.307 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.2 pt-20 178.82 29.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.805 . . . . 0.0 110.383 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.57 28.12 30.63 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.735 ' HB3' HD11 ' A' ' 56' ' ' ILE . 3.3 mttt -79.69 122.84 27.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -1.051 . . . . 0.0 109.696 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 9.8 m-85 -115.57 138.46 51.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 110.44 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.769 ' HG3' HG21 ' A' ' 56' ' ' ILE . 5.0 mt-10 -117.98 140.24 50.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 109.561 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 14' ' ' GLY . 5.3 t -77.14 115.77 17.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 110.283 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -16.19 63.96 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.773 -1.205 . . . . 0.0 108.638 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.12 -60.68 1.97 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.6 -0.687 . . . . 0.0 110.689 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.21 -3.72 18.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.067 -1.02 . . . . 0.0 110.909 -179.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.773 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 80.14 6.02 89.38 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 121.059 -1.025 . . . . 0.0 111.591 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 41.9 t80 -57.53 143.2 41.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.798 -1.413 . . . . 0.0 109.872 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.773 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -114.34 112.93 42.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.231 -0.918 . . . . 0.0 110.752 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 38.2 t80 -81.49 125.16 30.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.562 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -101.12 117.58 62.02 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.468 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 43.1 Cg_endo -71.24 -36.38 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.877 1.462 . . . . 0.0 109.98 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -9.69 54.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 109.747 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE3' ' HE3' ' A' ' 24' ' ' LYS . 1.7 tmtm? -117.09 -17.55 10.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.474 -0.766 . . . . 0.0 109.724 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.486 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 83.19 172.61 48.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.744 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -85.12 49.81 1.82 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -1.04 . . . . 0.0 109.784 179.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.9 ttmt -39.3 -58.32 1.23 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.535 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.0 -33.08 1.89 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.55 -62.68 1.32 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.901 . . . . 0.0 110.243 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.16 51.16 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.744 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -131.22 146.82 63.69 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.238 -1.154 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.648 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.5 Cg_endo -69.78 155.44 65.86 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.891 1.469 . . . . 0.0 110.228 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.486 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 44.0 Cg_endo -71.17 165.34 32.71 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.871 1.458 . . . . 0.0 110.788 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 79.03 11.28 85.33 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 13.0 m -103.51 125.44 34.89 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.294 -1.121 . . . . 0.0 110.193 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.736 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.7 Cg_endo -73.06 142.29 34.23 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.87 1.458 . . . . 0.0 110.473 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 31.7 t80 -51.92 -39.2 58.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 110.033 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 33' ' ' PRO . 11.4 m -55.14 -17.08 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.424 -0.797 . . . . 0.0 110.119 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 8.9 t70 -84.22 -6.87 59.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 110.253 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.509 HD13 ' CD1' ' A' ' 41' ' ' PHE . 17.9 mt -72.26 155.71 39.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 109.937 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.7 t -78.74 164.23 24.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.922 . . . . 0.0 110.071 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -5.88 21.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.9 m -103.4 1.49 32.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.203 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 37' ' ' LEU . 41.2 t80 -58.53 133.7 56.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.048 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' SER . 4.6 mtm -120.84 147.54 45.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 109.965 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.5 t -56.34 128.38 73.15 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.357 -0.84 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.535 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.1 Cg_endo -70.84 -11.42 29.41 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.785 1.413 . . . . 0.0 109.267 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.23 -67.95 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.487 -0.758 . . . . 0.0 110.663 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.533 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.7 p -94.53 2.06 55.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 111.06 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.56 23.78 14.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.143 -0.973 . . . . 0.0 111.892 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 52' ' ' GLN . 2.2 t -75.79 160.72 78.26 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.755 -1.216 . . . . 0.0 109.909 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 43.2 Cg_endo -69.85 144.39 53.38 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.677 1.356 . . . . 0.0 110.323 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.567 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 18.3 tttm -49.22 -26.7 3.1 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.292 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -64.07 -11.62 31.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.896 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.523 ' CB ' ' OG ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -91.96 -0.85 57.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.616 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 8.3 m-85 -89.54 138.77 31.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.683 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -128.1 143.6 51.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 109.522 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.67 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.7 p -81.53 167.65 19.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.885 -1.135 . . . . 0.0 110.923 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.769 HG21 ' HG3' ' A' ' 9' ' ' GLU . 3.1 pt -142.1 82.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.668 -0.645 . . . . 0.0 109.97 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.422 ' C ' ' OD1' ' A' ' 4' ' ' ASP . 41.8 mttm -105.87 65.61 0.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.5 158.0 19.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.376 -0.827 . . . . 0.0 110.123 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.559 HG22 ' OD2' ' A' ' 4' ' ' ASP . 14.4 t -136.58 56.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.162 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.622 ' O ' HG23 ' A' ' 60' ' ' ILE . 3.7 tp . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.226 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.734 ' O ' HG23 ' A' ' 59' ' ' VAL . 10.3 ttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.172 0.511 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 1' ' ' MET . 4.8 tt0 177.03 115.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.311 -0.868 . . . . 0.0 110.185 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 9.4 pt -139.57 134.58 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.228 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 1.8 p30 -163.76 128.03 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.925 . . . . 0.0 110.286 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -174.82 61.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 46.07 27.61 2.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.678 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -81.68 121.46 26.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -1.159 . . . . 0.0 109.894 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.676 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 13.8 m-85 -116.5 143.9 45.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.94 . . . . 0.0 110.424 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -121.34 139.11 53.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.942 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.8 t -76.53 116.85 17.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.95 . . . . 0.0 110.327 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.09 -16.19 63.91 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.732 -1.23 . . . . 0.0 108.566 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -59.68 2.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.602 -0.686 . . . . 0.0 110.566 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.83 -3.45 17.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.967 -1.083 . . . . 0.0 110.916 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.06 6.11 88.88 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.343 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 42.2 t80 -56.29 143.62 33.32 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.875 -1.368 . . . . 0.0 109.796 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 14.9 mm -115.39 111.56 36.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.325 -0.859 . . . . 0.0 110.639 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 44.1 t80 -81.13 122.56 27.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.828 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -101.97 117.18 62.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 110.243 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.6 Cg_endo -71.8 -31.1 13.41 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.849 1.447 . . . . 0.0 110.234 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.4 -5.06 25.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.159 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -120.38 -38.45 2.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.81 167.42 23.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -85.15 56.13 3.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.969 . . . . 0.0 109.894 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -40.14 -58.58 1.43 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.776 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.605 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 2.2 t80 -48.01 -32.94 7.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.594 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -92.25 -65.4 1.01 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.082 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.25 53.34 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.572 HG23 ' HD2' ' A' ' 29' ' ' PRO . 1.2 mp -131.02 144.71 54.67 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.286 -1.126 . . . . 0.0 109.817 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -71.11 162.4 42.74 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.929 1.489 . . . . 0.0 110.425 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.29 163.44 38.66 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.91 1.479 . . . . 0.0 110.772 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.24 14.81 82.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -100.74 124.31 42.63 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.268 -1.137 . . . . 0.0 110.197 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.699 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.0 Cg_endo -73.32 140.38 30.43 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.92 1.484 . . . . 0.0 110.551 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.676 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 18.4 t80 -53.58 -40.38 65.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.361 -0.837 . . . . 0.0 110.319 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.699 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.1 m -53.86 -18.3 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.408 -0.808 . . . . 0.0 110.368 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 1.2 t0 -85.61 -6.81 59.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 110.394 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.435 HD13 ' CD1' ' A' ' 41' ' ' PHE . 16.2 mt -73.15 121.95 21.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 37' ' ' LEU . 47.4 t -42.02 155.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 110.381 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -9.19 21.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 110.292 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -98.26 4.6 48.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.333 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.513 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 46.1 t80 -59.72 136.31 57.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 110.222 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.466 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.9 mtp -120.33 145.7 46.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 109.69 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.5 t -54.82 131.81 66.21 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 110.333 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.605 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 45.5 Cg_endo -72.61 -13.88 27.35 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.899 1.473 . . . . 0.0 109.534 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.99 -65.29 0.97 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.486 -0.758 . . . . 0.0 110.908 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.526 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.5 p -96.28 2.91 53.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 111.167 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 3.1 ttm180 61.59 22.49 12.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.123 -0.986 . . . . 0.0 111.963 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.4 m -74.49 167.3 37.34 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.826 -1.172 . . . . 0.0 109.923 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 47.4 Cg_endo -73.51 142.96 33.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.946 1.498 . . . . 0.0 110.433 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 21.9 tttm -49.93 -30.08 9.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.53 ' ND2' ' HB2' ' A' ' 49' ' ' PRO . 26.5 p30 -62.9 -11.74 20.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.119 -0.988 . . . . 0.0 109.968 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.488 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -89.27 -2.52 58.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.885 . . . . 0.0 109.54 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 7.3 m-85 -87.04 139.29 30.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.398 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -123.54 140.56 52.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.166 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 35.0 p -83.41 168.61 16.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.836 -1.165 . . . . 0.0 111.266 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -151.34 86.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.226 0.536 . . . . 0.0 109.875 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 4' ' ' ASP . 18.5 pttt -138.65 81.03 1.83 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 110.263 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 60' ' ' ILE . 10.8 tttp -162.16 167.57 23.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.357 -0.839 . . . . 0.0 110.213 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 1' ' ' MET . 14.5 p -70.19 126.72 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 110.258 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.485 HG22 ' OXT' ' A' ' 60' ' ' ILE . 50.7 mt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.172 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.225 0.536 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 3' ' ' ILE . 2.8 pt-20 -121.97 110.9 16.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 110.198 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 2' ' ' GLU . 19.7 pt -157.24 126.24 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -149.4 132.85 16.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.243 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.495 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -173.91 61.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.88 . . . . 0.0 110.145 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 44.08 26.34 0.86 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HG3' ' HB3' ' A' ' 5' ' ' GLU . 12.5 mttm -88.39 131.24 34.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.207 -1.172 . . . . 0.0 109.877 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 21.2 m-85 -123.8 148.84 46.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 16' ' ' ILE . 83.6 tt0 -122.85 142.7 50.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 109.535 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.5 t -79.39 115.74 19.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 110.645 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -15.28 63.52 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.372 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.25 -60.93 1.89 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.631 -0.668 . . . . 0.0 110.555 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -107.94 -4.74 17.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.957 -1.089 . . . . 0.0 110.717 -178.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 82.62 3.1 90.65 Favored Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.101 -0.999 . . . . 0.0 111.417 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.544 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . 89.6 t80 -49.53 172.39 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.854 -1.38 . . . . 0.0 109.421 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.501 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 10.4 mm -146.13 108.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.04 -1.038 . . . . 0.0 110.396 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.3 t80 -81.55 129.03 34.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 110.011 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -111.68 118.29 47.15 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 110.263 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -71.85 -29.29 15.57 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.885 1.466 . . . . 0.0 110.309 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -71.59 -10.61 60.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.007 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 6.2 mttt -115.68 -39.65 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.381 -0.824 . . . . 0.0 110.003 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.46 164.59 20.95 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.558 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -85.1 55.76 3.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -1.075 . . . . 0.0 109.844 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -41.1 -54.41 2.85 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.359 -0.838 . . . . 0.0 110.504 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 97.8 m-85 -49.63 -36.71 25.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.398 -0.814 . . . . 0.0 110.42 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.56 -67.47 0.85 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.04 54.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.558 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -133.36 141.73 41.59 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 109.98 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.7 Cg_endo -69.96 165.11 32.3 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.018 1.536 . . . . 0.0 110.432 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.0 Cg_endo -71.92 162.77 40.91 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.039 1.547 . . . . 0.0 110.841 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.11 12.04 84.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.8 m -98.87 123.2 50.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.286 -1.126 . . . . 0.0 110.232 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.644 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.89 143.48 36.87 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.924 1.486 . . . . 0.0 110.75 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.583 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 7.7 t80 -57.54 -15.86 8.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.902 . . . . 0.0 110.041 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 33' ' ' PRO . 3.9 m -69.97 -26.21 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.73 -5.51 55.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.41 -0.806 . . . . 0.0 110.409 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.434 HD13 ' CD1' ' A' ' 41' ' ' PHE . 11.1 mt -74.1 115.61 13.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.234 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 37' ' ' LEU . 63.9 m -41.68 151.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 110.378 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.64 -12.88 11.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 110.123 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 t -95.93 8.05 44.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.422 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.52 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.8 t80 -61.0 138.56 58.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.02 . . . . 0.0 109.894 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' SER . 3.2 mtt -121.34 147.48 45.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.031 . . . . 0.0 109.731 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.9 t -56.56 131.67 77.32 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 110.509 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 45.3 Cg_endo -72.42 -12.45 27.3 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.797 1.42 . . . . 0.0 109.561 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.5 -67.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 110.822 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.6 p -93.59 1.4 56.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.06 -1.025 . . . . 0.0 111.097 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.96 24.34 14.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.171 -0.956 . . . . 0.0 111.932 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 42' ' ' MET . 4.1 m -77.67 167.94 31.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.828 -1.17 . . . . 0.0 109.835 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.9 Cg_endo -72.64 140.92 33.44 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.801 1.422 . . . . 0.0 110.481 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.549 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 11.2 tttm -49.28 -27.21 3.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.005 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 0.7 OUTLIER -63.14 -11.86 23.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.956 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.479 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -90.72 -0.86 57.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.292 -0.88 . . . . 0.0 109.604 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -87.12 137.88 31.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.656 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -119.79 136.34 54.49 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.6 t -84.6 172.3 11.72 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.724 -1.235 . . . . 0.0 110.81 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 pt -141.3 59.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.051 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -82.04 55.23 2.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -72.66 136.37 45.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.319 -0.863 . . . . 0.0 110.175 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.734 ' O ' HG22 ' A' ' 59' ' ' VAL . 4.6 p -163.9 56.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 110.249 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 pt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.219 179.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mtt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.259 0.552 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.534 ' O ' HG23 ' A' ' 3' ' ' ILE . 3.2 tm-20 -168.25 81.76 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.912 . . . . 0.0 110.143 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 2' ' ' GLU . 11.8 pt -154.49 127.23 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 110.323 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.503 ' HB3' HG23 ' A' ' 59' ' ' VAL . 2.9 p30 -134.21 136.03 43.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 110.024 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.4 tt0 176.74 69.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -0.982 . . . . 0.0 110.43 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 47.9 30.11 6.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.552 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . 0.7 OUTLIER -79.39 117.67 20.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -1.152 . . . . 0.0 109.437 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.5 m-85 -118.43 142.1 47.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.953 . . . . 0.0 110.8 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 6.6 tm-20 -119.22 140.26 50.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -0.809 . . . . 0.0 109.439 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' GLY . 5.0 t -76.57 116.75 17.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.15 -0.969 . . . . 0.0 110.233 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -16.59 64.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.767 -1.208 . . . . 0.0 108.713 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -59.8 2.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.578 -0.702 . . . . 0.0 110.599 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.95 -3.46 17.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.031 -1.043 . . . . 0.0 110.966 -179.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.762 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.37 6.29 88.97 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.153 -1.022 . . . . 0.0 111.458 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 40.5 t80 -57.57 143.59 40.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.918 -1.342 . . . . 0.0 109.698 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -114.17 112.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.281 -0.887 . . . . 0.0 110.647 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 33.9 t80 -82.21 128.05 33.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.651 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -109.49 117.2 53.36 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.872 . . . . 0.0 110.184 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 43.8 Cg_endo -71.28 -28.97 17.74 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.827 1.435 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.78 -5.83 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 110.053 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -119.82 -39.13 2.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 110.185 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.19 166.13 22.11 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.56 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -85.12 54.61 3.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -1.043 . . . . 0.0 109.899 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASP . 18.4 mmtt -39.74 -56.66 1.68 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.378 -0.826 . . . . 0.0 110.695 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 65.2 m-85 -47.34 -33.91 6.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.98 -64.63 1.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 110.484 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.98 52.83 0.02 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.574 HG23 ' HD2' ' A' ' 29' ' ' PRO . 1.2 mp -129.11 145.22 55.79 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.274 -1.133 . . . . 0.0 109.82 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.574 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.6 Cg_endo -70.95 160.95 47.74 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.948 1.499 . . . . 0.0 110.43 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.446 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.6 Cg_endo -71.9 163.27 39.39 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.963 1.507 . . . . 0.0 110.765 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.11 15.34 81.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 26.7 m -102.46 124.2 40.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.265 -1.138 . . . . 0.0 110.254 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 48.0 Cg_endo -73.65 140.26 29.25 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.874 1.46 . . . . 0.0 110.561 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.59 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.7 t80 -50.42 -41.04 51.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.035 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.52 -17.14 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 110.266 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -84.42 -7.06 59.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.24 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 41' ' ' PHE . 17.8 mt -71.65 155.86 40.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.952 . . . . 0.0 110.044 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 156.59 30.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.9 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -11.33 13.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.136 -0.978 . . . . 0.0 110.363 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.2 m -99.64 3.87 45.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.946 . . . . 0.0 110.418 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.56 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 44.8 t80 -59.68 136.37 57.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 109.964 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 48' ' ' SER . 6.8 mtt -120.0 146.37 45.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.077 -1.015 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 7.9 t -55.94 130.62 73.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 110.319 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.525 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.9 Cg_endo -71.99 -12.7 28.51 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.875 1.461 . . . . 0.0 109.526 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.35 -64.26 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.453 -0.779 . . . . 0.0 110.842 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.54 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.8 p -98.77 3.76 47.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 111.173 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.7 OUTLIER 61.69 20.53 11.42 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.111 -0.993 . . . . 0.0 112.036 178.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.6 m -73.05 167.31 35.42 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.769 -1.207 . . . . 0.0 109.786 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.3 Cg_endo -73.21 142.78 34.5 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.863 1.454 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 22.8 tttm -49.37 -27.67 4.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 109.834 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -63.04 -12.2 24.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.873 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -90.27 -1.8 57.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.612 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 15.5 m-85 -88.53 139.65 30.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 110.379 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -130.74 146.27 52.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.702 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 p -82.96 167.66 17.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.908 -1.12 . . . . 0.0 110.44 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.552 ' CD1' ' HB3' ' A' ' 7' ' ' LYS . 16.9 pt -114.04 -44.71 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 110.314 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' N ' HG13 ' A' ' 56' ' ' ILE . 0.3 OUTLIER 37.59 78.67 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.527 -0.733 . . . . 0.0 110.712 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 3' ' ' ILE . 1.1 tttp -113.4 99.89 8.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 59' ' ' VAL . 32.6 t -129.48 82.28 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.245 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 pt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.175 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.262 0.553 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.453 ' C ' HG22 ' A' ' 3' ' ' ILE . 3.7 pt-20 -170.23 112.15 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.271 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.647 ' N ' HG12 ' A' ' 59' ' ' VAL . 1.3 tt 177.86 171.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -0.908 . . . . 0.0 110.305 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.564 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 10.9 m-20 -125.69 128.03 47.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 110.1 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER 169.96 -71.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 0.0 110.051 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.32 42.73 0.6 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 56' ' ' ILE . 2.4 tptm -78.78 118.51 20.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.425 -1.044 . . . . 0.0 109.769 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 8.0 m-85 -117.78 139.5 50.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 110.661 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.585 ' HA ' HD13 ' A' ' 16' ' ' ILE . 14.3 pt-20 -116.76 139.18 50.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.308 -0.87 . . . . 0.0 109.615 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -76.55 117.03 17.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 110.426 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -16.3 64.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.868 -1.145 . . . . 0.0 108.668 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.2 -59.49 2.31 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.59 -0.694 . . . . 0.0 110.649 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -108.93 -3.49 17.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.951 -179.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 78.28 7.74 87.71 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 30.6 t80 -58.76 142.56 49.76 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.807 -1.408 . . . . 0.0 109.636 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.585 HD13 ' HA ' ' A' ' 9' ' ' GLU . 24.5 mm -113.8 114.75 47.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.274 -0.891 . . . . 0.0 110.777 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 24.6 t80 -83.22 133.03 35.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 109.719 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -110.89 119.43 46.05 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 110.224 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.0 Cg_endo -71.31 -34.51 9.73 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.861 1.453 . . . . 0.0 110.217 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -70.06 -6.76 36.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.398 -0.814 . . . . 0.0 110.028 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 14.5 tttt -117.96 -36.45 3.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.109 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.92 171.53 28.81 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 1.7 t70 -85.31 57.98 4.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.515 -0.991 . . . . 0.0 109.767 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ASP . 1.1 tptt -37.58 -63.0 0.48 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.554 -0.716 . . . . 0.0 110.727 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.556 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 17.7 m-85 -43.27 -27.13 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.393 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.26 -58.42 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.267 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.92 -7.52 1.06 Allowed Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.495 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.549 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.8 mp -64.93 142.27 98.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.916 -1.344 . . . . 0.0 109.853 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.543 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.2 Cg_endo -71.61 162.49 42.01 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.997 1.524 . . . . 0.0 110.611 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -72.59 163.86 37.28 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.991 1.522 . . . . 0.0 110.775 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.53 13.37 83.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 60.5 m -105.75 126.59 30.36 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.274 -1.133 . . . . 0.0 110.168 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.786 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -72.56 142.15 35.86 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.839 1.442 . . . . 0.0 110.603 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.581 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 2.9 t80 -53.21 -38.71 63.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.133 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.786 HG22 ' HB2' ' A' ' 33' ' ' PRO . 20.3 m -54.76 -17.68 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 110.051 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -83.12 -6.17 59.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 37' ' ' LEU . 22.3 mt -70.23 156.34 39.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.58 162.63 25.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.872 . . . . 0.0 109.858 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -69.97 -3.91 18.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.252 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.0 m -106.7 0.67 24.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.542 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 44.7 t80 -59.98 136.58 58.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.978 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 48' ' ' SER . 21.7 mtp -119.62 146.06 45.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.12 -0.988 . . . . 0.0 109.908 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.4 t -54.86 129.64 65.46 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.266 -0.896 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.6 Cg_endo -71.27 -13.53 30.88 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.819 1.431 . . . . 0.0 109.47 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.98 -63.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.752 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.4 p -98.84 3.78 47.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.192 -0.942 . . . . 0.0 111.156 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.24 21.37 11.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.165 -0.96 . . . . 0.0 112.087 178.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.5 m -73.93 166.9 40.33 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.828 -1.17 . . . . 0.0 109.808 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.7 Cg_endo -72.91 142.68 35.43 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.818 1.431 . . . . 0.0 110.33 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.549 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 7.4 tttt -49.58 -25.64 2.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -66.26 -11.86 52.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.793 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.05 -3.23 58.75 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.35 -0.844 . . . . 0.0 109.492 179.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.522 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 4.6 m-85 -88.62 140.56 29.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.433 -0.792 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 5.1 mttt -129.89 146.35 51.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 2.9 p -82.76 165.67 19.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.936 -1.103 . . . . 0.0 110.705 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -139.61 -37.37 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.638 -0.664 . . . . 0.0 110.144 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 56' ' ' ILE . 2.5 tttt 40.73 83.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 110.409 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -171.81 162.98 6.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 110.357 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.647 HG12 ' N ' ' A' ' 3' ' ' ILE . 5.6 m -131.91 142.86 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.335 -0.853 . . . . 0.0 110.094 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.6 tp . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.237 0.541 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.712 ' O ' HG23 ' A' ' 3' ' ' ILE . 24.5 tt0 -163.49 69.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 2' ' ' GLU . 1.2 pt -159.56 137.49 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.081 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.527 ' CB ' ' HA ' ' A' ' 57' ' ' LYS . 5.0 p-10 -140.51 122.45 15.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.903 . . . . 0.0 110.582 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -119.05 -88.57 0.62 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.503 -0.748 . . . . 0.0 109.715 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.39 32.18 2.43 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.541 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . 9.4 mttt -75.66 111.29 10.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -1.114 . . . . 0.0 109.295 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.625 ' CE1' ' HB3' ' A' ' 55' ' ' SER . 9.3 m-85 -121.12 137.82 54.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 111.089 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.517 ' HA ' HD13 ' A' ' 16' ' ' ILE . 83.2 tt0 -118.43 145.64 45.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.0 109.393 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 6.6 t -79.05 115.21 18.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.05 -1.031 . . . . 0.0 110.442 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.76 -15.23 63.41 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.508 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -61.14 1.84 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.703 -0.623 . . . . 0.0 110.771 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -108.39 -5.04 16.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.03 -1.044 . . . . 0.0 111.102 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.424 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 83.99 3.01 89.4 Favored Glycine 0 N--CA 1.497 2.75 0 O-C-N 120.973 -1.08 . . . . 0.0 111.419 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 29.3 t80 -50.64 173.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.827 -1.396 . . . . 0.0 109.17 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 12.1 mm -144.31 132.81 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.924 -1.11 . . . . 0.0 110.684 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 40.3 t80 -106.1 132.55 52.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.349 -0.844 . . . . 0.0 109.65 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 3.3 mt-10 -113.96 119.98 39.79 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.895 . . . . 0.0 110.372 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.511 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 43.5 Cg_endo -69.95 -35.73 11.57 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.861 1.453 . . . . 0.0 110.333 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -69.06 -10.24 56.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 109.844 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -116.33 -30.46 5.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.859 . . . . 0.0 109.936 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.08 171.58 33.93 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.713 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.2 51.01 2.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -1.061 . . . . 0.0 109.736 179.189 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -40.09 -56.87 1.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.805 . . . . 0.0 110.455 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.534 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.05 -33.95 2.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.785 . . . . 0.0 110.229 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -94.3 -62.38 1.35 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.381 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.67 52.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.713 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.5 mp -131.72 145.71 58.7 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.243 -1.151 . . . . 0.0 110.014 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.614 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.6 Cg_endo -70.08 160.17 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.952 1.501 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.3 163.87 37.34 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.983 1.517 . . . . 0.0 110.837 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 79.98 13.72 81.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 58.9 m -107.55 126.04 30.87 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.195 -1.18 . . . . 0.0 110.222 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.511 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.7 Cg_endo -73.22 142.71 34.33 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.837 1.441 . . . . 0.0 110.636 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.579 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 t80 -51.22 -40.09 58.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.299 -0.876 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -16.93 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 110.309 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -84.24 -6.87 59.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.517 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 18.7 mt -70.13 157.14 38.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -0.949 . . . . 0.0 109.946 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -77.81 157.54 29.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.206 -0.934 . . . . 0.0 109.811 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.37 -9.92 14.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.15 -0.969 . . . . 0.0 110.262 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 42' ' ' MET . 2.4 m -100.48 2.92 42.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 110.428 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.9 t80 -58.2 132.8 54.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 109.77 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.447 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.7 mtt -118.81 147.24 44.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 110.06 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 8.0 t -58.08 127.41 79.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.319 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.534 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.15 -10.43 27.34 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.784 1.413 . . . . 0.0 109.565 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.57 -62.74 1.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.588 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.8 p -102.02 3.73 39.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.153 -0.967 . . . . 0.0 110.911 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER 62.26 20.85 12.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.196 -0.94 . . . . 0.0 112.063 178.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 25.5 p -73.83 165.52 52.47 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.864 -1.148 . . . . 0.0 109.781 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 46.1 Cg_endo -71.95 142.78 39.43 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.816 1.429 . . . . 0.0 110.377 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.543 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 43.2 tttm -48.29 -23.94 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 109.931 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.63 -10.8 39.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.852 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.503 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -91.7 -1.93 57.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.245 -0.909 . . . . 0.0 109.614 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 20.1 m-85 -88.57 138.12 31.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 110.506 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 2.5 tptp -130.7 146.52 52.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.339 -0.851 . . . . 0.0 109.662 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.625 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.2 p -80.55 164.95 22.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.901 -1.124 . . . . 0.0 110.435 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 7' ' ' LYS . 8.9 pt -106.72 -44.29 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.687 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 4.5 ttpt 52.4 93.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 110.087 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -77.79 58.15 1.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.158 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 74.8 t -114.03 126.07 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.158 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.22 0.533 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.563 ' HG3' HG23 ' A' ' 60' ' ' ILE . 17.7 mt-10 54.63 55.44 7.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pt -137.62 153.3 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.21 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.531 ' CB ' ' HG3' ' A' ' 57' ' ' LYS . 12.7 p30 -170.68 142.88 2.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.954 . . . . 0.0 110.332 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.82 -153.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 110.076 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.41 33.14 5.85 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 56' ' ' ILE . 1.5 ttpt -87.19 129.25 35.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -1.114 . . . . 0.0 110.0 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 29.8 m-85 -125.67 145.09 50.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.572 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HG2' ' CD1' ' A' ' 16' ' ' ILE . 14.5 mt-10 -117.67 142.63 47.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.399 -0.813 . . . . 0.0 109.901 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 5.4 t -77.56 113.61 15.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.975 -1.078 . . . . 0.0 110.584 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -15.1 63.31 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.912 -1.118 . . . . 0.0 108.441 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.06 -60.96 1.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.577 -0.702 . . . . 0.0 110.59 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.62 -4.4 17.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.972 -1.08 . . . . 0.0 110.887 -178.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 82.0 3.43 90.58 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.33 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.577 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 29.3 t80 -49.96 172.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.032 -1.275 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.577 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 24.5 mm -141.12 130.01 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.005 -1.059 . . . . 0.0 110.455 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 66.7 t80 -103.06 124.38 48.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.689 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -109.34 116.33 55.06 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.33 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 43.5 Cg_endo -69.34 -31.41 22.46 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.969 1.51 . . . . 0.0 110.075 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.08 -12.31 61.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 109.826 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.89 -12.69 10.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.89 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 30' ' ' PRO . . . 81.3 167.41 38.26 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.624 ' CB ' HD13 ' A' ' 28' ' ' ILE . 1.2 t0 -85.18 50.6 1.98 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -1.032 . . . . 0.0 109.774 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 3.3 mmtt -39.31 -53.84 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.347 -0.845 . . . . 0.0 110.534 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.528 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -47.13 -36.5 8.49 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.428 -0.795 . . . . 0.0 110.225 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -92.27 -64.34 1.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 0.0 110.377 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.22 52.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.624 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.88 145.7 58.6 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -1.097 . . . . 0.0 109.939 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.616 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.7 Cg_endo -70.49 161.85 44.55 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.962 1.507 . . . . 0.0 110.198 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HA ' ' N ' ' A' ' 22' ' ' GLY . 43.2 Cg_endo -71.64 162.78 41.09 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.973 1.512 . . . . 0.0 110.853 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.12 12.59 84.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 21.9 m -97.73 125.1 45.8 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.239 -1.153 . . . . 0.0 110.179 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.736 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.89 139.29 30.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.867 1.456 . . . . 0.0 110.605 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.574 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 62.5 t80 -52.11 -41.46 62.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.074 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.1 m -53.52 -17.59 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.432 -0.793 . . . . 0.0 110.384 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 36' ' ' ASP . 59.2 t0 -83.96 -7.6 59.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.127 -0.983 . . . . 0.0 110.4 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.498 HD12 ' CD1' ' A' ' 34' ' ' PHE . 17.9 mt -69.43 153.21 43.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 109.9 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.0 155.36 32.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.716 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -11.22 12.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 110.212 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.47 4.1 43.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 110.509 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.54 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 50.1 t80 -59.7 134.86 57.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.016 -1.052 . . . . 0.0 109.576 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.3 mtp -119.23 148.42 43.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.986 -1.071 . . . . 0.0 110.458 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.473 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 6.2 t -58.63 126.93 81.32 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.45 -0.781 . . . . 0.0 110.38 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.528 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.0 Cg_endo -70.69 -9.65 26.21 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.814 1.428 . . . . 0.0 109.486 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.36 -64.86 1.0 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.512 -0.743 . . . . 0.0 110.464 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.538 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.2 p -99.37 2.64 45.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.954 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.0 OUTLIER 63.04 22.34 13.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.153 -0.967 . . . . 0.0 112.094 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 29.9 p -76.31 166.11 47.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.735 -1.228 . . . . 0.0 109.859 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 45.2 Cg_endo -71.72 142.13 39.04 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.766 1.403 . . . . 0.0 110.437 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.567 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 10.1 tttm -48.64 -27.65 2.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.901 . . . . 0.0 110.0 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.06 -10.15 27.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.817 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.504 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -87.64 -5.57 58.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.306 -0.871 . . . . 0.0 109.628 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 23.7 m-85 -79.96 133.62 36.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 110.566 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.08 131.25 54.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.467 -0.771 . . . . 0.0 108.93 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.596 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -79.77 159.29 26.62 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 110.194 -179.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.511 ' O ' ' CB ' ' A' ' 57' ' ' LYS . 1.7 pt -101.45 -107.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.337 -0.852 . . . . 0.0 110.34 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HG3' ' CB ' ' A' ' 4' ' ' ASP . 6.8 ttpt 70.26 94.54 0.07 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.885 -1.134 . . . . 0.0 110.202 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -138.21 171.12 14.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.215 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.521 HG22 ' H ' ' A' ' 60' ' ' ILE . 9.5 p -164.42 175.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.95 . . . . 0.0 110.204 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.563 HG23 ' HG3' ' A' ' 2' ' ' GLU . 1.1 pt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.136 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.437 ' CE ' ' OE1' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.265 0.555 . . . . 0.0 110.168 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.713 ' O ' HG23 ' A' ' 3' ' ' ILE . 5.6 mt-10 -141.49 72.02 1.37 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.161 -0.962 . . . . 0.0 110.182 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.713 HG23 ' O ' ' A' ' 2' ' ' GLU . 9.4 pt -159.4 131.28 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.287 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 5' ' ' GLU . 5.1 m-20 -105.54 132.3 51.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 110.138 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.2 mt-10 169.7 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.269 -0.894 . . . . 0.0 110.251 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 51.02 31.95 26.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.448 ' HE2' ' CG2' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -83.4 118.77 23.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.12 . . . . 0.0 109.918 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 18.0 m-85 -120.03 146.65 45.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.176 -0.953 . . . . 0.0 110.372 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 4.6 mt-10 -121.07 140.08 52.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 109.565 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.3 t -76.42 118.44 19.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.117 -0.99 . . . . 0.0 110.399 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.84 -16.74 63.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.852 -1.155 . . . . 0.0 108.644 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -58.93 2.49 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.681 -0.637 . . . . 0.0 110.547 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.498 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -109.61 -3.09 17.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 110.931 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.748 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 78.27 6.73 87.84 Favored Glycine 0 N--CA 1.495 2.622 0 O-C-N 120.999 -1.063 . . . . 0.0 111.414 177.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 43.2 t80 -57.87 144.59 38.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.943 -1.328 . . . . 0.0 109.78 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.748 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.2 mp -114.44 111.6 36.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.294 -0.879 . . . . 0.0 110.584 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 49.3 t80 -82.07 122.38 27.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.905 . . . . 0.0 109.984 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -107.0 119.65 50.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.832 . . . . 0.0 110.088 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 44.3 Cg_endo -71.47 -24.45 22.42 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.902 1.475 . . . . 0.0 110.299 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.407 ' OE2' ' HB3' ' A' ' 5' ' ' GLU . 6.1 mp0 -72.05 -16.0 62.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 109.948 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' C ' ' HA ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -109.95 -37.75 5.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.05 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.54 166.05 24.5 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.608 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.21 50.41 1.94 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -1.051 . . . . 0.0 109.644 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASP . 4.4 tttm -38.91 -53.02 1.76 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.492 -0.755 . . . . 0.0 110.618 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.536 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 13.9 m-85 -48.88 -36.46 17.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.378 -0.826 . . . . 0.0 110.295 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -91.58 -66.25 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.329 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.95 51.46 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.608 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.16 144.7 53.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.238 -1.154 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.573 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.6 Cg_endo -70.89 163.03 40.62 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.956 1.503 . . . . 0.0 110.31 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HA ' ' C ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -71.89 161.82 43.79 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.949 1.5 . . . . 0.0 110.905 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.34 13.13 83.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.464 HG21 ' CG2' ' A' ' 28' ' ' ILE . 37.4 m -93.89 123.11 60.51 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.3 -1.118 . . . . 0.0 110.174 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.773 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.4 Cg_endo -73.45 141.5 31.7 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.821 1.432 . . . . 0.0 110.641 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.576 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 30.3 t80 -55.53 -18.02 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.948 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.773 HG22 ' HB2' ' A' ' 33' ' ' PRO . 3.8 m -72.84 -10.6 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 109.687 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -91.84 -7.62 48.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 110.29 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.465 HD12 ' CD2' ' A' ' 34' ' ' PHE . 20.9 mt -72.22 146.23 47.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.056 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.81 158.75 31.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.068 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -60.96 -12.93 12.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 0.0 110.158 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 97.2 p -99.27 4.84 46.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.449 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 52.3 t80 -58.96 139.57 56.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.101 -0.999 . . . . 0.0 109.984 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.7 mmm -119.79 143.8 47.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.985 -1.072 . . . . 0.0 110.049 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 45' ' ' ALA . 49.5 t -59.91 125.17 79.9 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 110.14 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.536 ' HB2' ' CB ' ' A' ' 25' ' ' PHE . 43.9 Cg_endo -70.67 -8.87 24.59 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.858 1.452 . . . . 0.0 109.871 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -93.34 -53.66 4.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.482 -0.761 . . . . 0.0 110.167 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 48' ' ' SER . 9.5 p -118.15 8.47 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 110.707 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.81 14.18 7.13 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.255 -0.903 . . . . 0.0 112.162 178.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 52' ' ' GLN . 2.2 t -66.8 161.39 61.71 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.834 -1.166 . . . . 0.0 110.044 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 42.9 Cg_endo -69.29 143.38 52.91 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.608 1.32 . . . . 0.0 110.25 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.559 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 17.4 tttm -50.21 -28.86 8.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.129 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -63.01 -11.94 22.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.118 -0.989 . . . . 0.0 109.786 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.523 ' CB ' ' OG ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -88.67 -2.52 58.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.879 . . . . 0.0 109.85 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.422 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 25.4 m-85 -83.93 135.38 34.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.583 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' NZ ' ' O ' ' A' ' 55' ' ' SER . 0.5 OUTLIER -120.67 138.14 54.09 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.3 t -88.59 174.26 8.17 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.819 -1.176 . . . . 0.0 110.535 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 57' ' ' LYS . 1.4 tp -158.2 -45.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.388 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' H ' HG23 ' A' ' 56' ' ' ILE . 32.0 mtmt 40.49 80.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.401 -0.812 . . . . 0.0 110.314 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 3' ' ' ILE . 35.6 ttmt -113.29 147.7 37.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.0 110.381 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.755 ' O ' HG13 ' A' ' 59' ' ' VAL . 8.9 p -153.36 55.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 110.188 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 tp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.203 -179.951 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.26 0.552 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.428 ' OE1' ' HE3' ' A' ' 57' ' ' LYS . 1.8 pt-20 -112.14 157.39 20.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.185 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.606 HG22 ' H ' ' A' ' 4' ' ' ASP . 13.4 mt -147.31 179.05 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.606 ' H ' HG22 ' A' ' 3' ' ' ILE . 2.6 p30 -137.75 -168.2 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 110.338 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -179.47 -27.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.231 -0.918 . . . . 0.0 110.433 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.49 7.18 11.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.542 ' O ' HG23 ' A' ' 56' ' ' ILE . 2.7 mtpp -82.21 110.79 17.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -1.128 . . . . 0.0 109.569 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 12.1 m-85 -120.7 144.14 48.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.937 . . . . 0.0 110.949 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.6 pp20? -118.85 140.24 50.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 0.0 109.513 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.4 t -77.31 117.99 19.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.056 -1.028 . . . . 0.0 110.534 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.439 ' OE1' ' CA ' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -69.11 -16.57 63.7 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.833 -1.167 . . . . 0.0 108.525 178.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -59.21 2.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.594 -0.691 . . . . 0.0 110.547 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.03 -3.21 17.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.98 -1.075 . . . . 0.0 110.815 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 78.24 6.14 87.62 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.081 -1.012 . . . . 0.0 111.404 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 47.6 t80 -56.83 144.89 31.4 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.957 -1.32 . . . . 0.0 109.744 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.505 HD13 ' CB ' ' A' ' 9' ' ' GLU . 22.2 mm -115.71 110.58 32.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.234 -0.917 . . . . 0.0 110.5 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 45.8 t80 -81.26 121.47 26.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.81 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.03 121.13 50.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.386 -0.821 . . . . 0.0 110.213 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.5 Cg_endo -70.78 -27.68 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.935 1.492 . . . . 0.0 110.277 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.91 -18.87 62.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 110.234 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -39.61 6.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.151 -0.968 . . . . 0.0 110.175 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.81 164.67 24.18 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.622 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -85.18 51.38 2.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.449 -1.03 . . . . 0.0 109.83 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -40.12 -51.54 2.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.345 -0.847 . . . . 0.0 110.67 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 26.1 m-85 -48.98 -36.63 18.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.352 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.97 -66.13 0.95 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.246 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.76 53.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.622 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -131.86 143.93 51.11 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.378 -1.072 . . . . 0.0 110.038 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.1 Cg_endo -72.04 165.43 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.108 1.583 . . . . 0.0 110.311 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.24 163.06 39.83 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.932 1.491 . . . . 0.0 110.833 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 74.47 12.07 82.38 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 25.1 m -94.38 123.61 58.06 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.238 -1.154 . . . . 0.0 110.2 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.733 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.9 Cg_endo -73.18 141.3 32.23 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.811 1.427 . . . . 0.0 110.585 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.573 ' CE1' ' HE2' ' A' ' 50' ' ' LYS . 47.6 t80 -55.38 -38.97 69.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.29 -0.881 . . . . 0.0 110.186 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.733 HG22 ' HB2' ' A' ' 33' ' ' PRO . 17.0 m -54.1 -18.47 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -6.72 59.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.408 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.501 HD12 ' CD2' ' A' ' 34' ' ' PHE . 19.3 mt -73.05 150.65 42.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.114 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.472 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -76.71 159.52 30.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 109.996 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -10.23 18.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.211 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 p -100.28 4.33 44.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.264 -0.897 . . . . 0.0 110.327 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.9 t80 -60.42 137.77 58.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 110.038 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' SER . 18.3 mtm -119.84 146.14 46.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.178 -0.951 . . . . 0.0 110.093 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 10.9 t -56.91 130.26 78.77 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.793 . . . . 0.0 110.443 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 45.6 Cg_endo -72.25 -12.1 27.41 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.921 1.485 . . . . 0.0 109.698 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.6 -61.95 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 110.708 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.5 p -102.51 4.37 38.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 111.128 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.1 tpt180 62.12 18.96 10.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.136 -0.977 . . . . 0.0 112.102 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.7 m -71.83 168.1 25.42 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.831 -1.168 . . . . 0.0 109.759 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.9 Cg_endo -73.8 142.75 32.38 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.817 1.43 . . . . 0.0 110.406 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.9 tttm -49.37 -28.38 4.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 109.784 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -63.13 -11.94 23.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 109.856 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.439 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -89.5 -2.39 58.35 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.595 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -87.56 139.18 30.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 110.43 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.16 139.13 54.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.458 -0.776 . . . . 0.0 108.94 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 40.8 p -82.16 168.94 17.18 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.854 -1.154 . . . . 0.0 110.632 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 7' ' ' LYS . 2.3 pp -96.65 -26.57 4.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.326 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.605 ' O ' HG23 ' A' ' 59' ' ' VAL . 14.7 tttt 49.32 89.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.96 . . . . 0.0 110.233 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -54.54 124.77 17.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 0.0 110.15 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 57' ' ' LYS . 47.7 t -115.49 110.75 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.143 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.24 0.543 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' C ' HD12 ' A' ' 3' ' ' ILE . 1.4 mp0 -53.17 159.22 1.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.192 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.514 HD12 ' C ' ' A' ' 2' ' ' GLU . 1.5 mp 63.36 167.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.137 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.527 ' N ' ' HA ' ' A' ' 57' ' ' LYS . 20.0 p-10 -78.66 126.13 30.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 110.285 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 5' ' ' GLU . 35.3 tt0 -90.23 15.47 10.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.853 . . . . 0.0 110.036 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.418 ' C ' ' HG3' ' A' ' 19' ' ' PRO . . . 114.67 8.55 15.87 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -85.14 117.82 24.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -1.149 . . . . 0.0 109.733 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.4 m-85 -125.56 148.68 48.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.95 . . . . 0.0 110.859 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 32.6 tt0 -119.04 140.27 50.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.839 . . . . 0.0 109.424 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.6 t -77.33 117.45 18.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.047 -1.033 . . . . 0.0 110.421 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -16.42 63.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.822 -1.174 . . . . 0.0 108.585 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.18 -59.12 2.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.579 -0.701 . . . . 0.0 110.551 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.39 -3.8 16.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.009 -1.057 . . . . 0.0 110.906 -179.041 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.471 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.41 6.25 88.99 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.537 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 34.0 t80 -57.01 143.58 37.63 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.797 -1.413 . . . . 0.0 109.807 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.505 ' CD1' ' HB2' ' A' ' 9' ' ' GLU . 17.8 mm -115.19 111.86 37.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.342 -0.848 . . . . 0.0 110.65 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.0 t80 -81.38 122.21 27.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.773 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -102.28 117.78 60.41 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 0.0 110.226 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.8 Cg_endo -71.16 -30.37 16.16 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.87 1.458 . . . . 0.0 110.307 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -72.48 -7.91 52.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.304 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -114.4 -43.56 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.285 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.1 163.34 18.08 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.547 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.16 56.17 3.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.453 -1.027 . . . . 0.0 109.983 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' ASP . 9.5 mtpt -40.92 -55.5 2.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 110.502 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 27.1 m-85 -48.45 -34.86 11.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.375 -0.828 . . . . 0.0 110.506 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -92.8 -65.75 0.98 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 110.3 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.46 54.34 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.605 HG21 HG21 ' A' ' 32' ' ' THR . 1.3 mp -132.1 144.07 51.6 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.296 -1.12 . . . . 0.0 109.993 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.563 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.2 Cg_endo -71.59 165.05 33.71 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.956 1.503 . . . . 0.0 110.391 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.06 162.9 40.41 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.017 1.535 . . . . 0.0 110.804 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.11 15.02 81.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.605 HG21 HG21 ' A' ' 28' ' ' ILE . 15.8 m -97.65 123.29 52.51 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.283 -1.127 . . . . 0.0 110.198 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.782 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -73.75 139.9 28.44 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.873 1.46 . . . . 0.0 110.586 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.577 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 12.4 t80 -53.42 -40.61 65.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.273 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' ' 33' ' ' PRO . 27.3 m -53.17 -18.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 110.467 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 3.8 t70 -85.52 -7.1 59.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 0.0 110.386 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.556 HD13 ' CD1' ' A' ' 41' ' ' PHE . 13.7 mt -73.99 120.06 19.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 37' ' ' LEU . 18.5 t -42.21 159.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.457 -0.777 . . . . 0.0 110.335 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.45 -7.7 27.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 0.0 110.161 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 p -99.03 4.19 47.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' A' ' 37' ' ' LEU . 49.1 t80 -58.61 134.76 57.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.193 -0.942 . . . . 0.0 110.157 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -120.13 146.15 46.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.139 -0.975 . . . . 0.0 109.718 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.9 t -56.46 130.06 75.91 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 110.493 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 45.1 Cg_endo -71.93 -12.4 28.36 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.845 1.445 . . . . 0.0 109.477 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.04 -65.81 0.94 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.576 -0.703 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.1 p -96.66 2.39 52.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.162 -0.961 . . . . 0.0 111.126 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 62.04 23.33 13.74 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.101 -0.999 . . . . 0.0 111.878 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.462 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -76.29 167.46 36.5 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.866 -1.146 . . . . 0.0 109.907 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.0 Cg_endo -73.75 142.77 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.972 1.512 . . . . 0.0 110.525 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 9.4 tttm -49.85 -29.53 8.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.105 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -63.16 -11.99 24.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.856 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.444 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -88.73 -2.65 58.7 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 109.673 179.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.82 138.69 31.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.943 . . . . 0.0 110.658 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.54 138.57 54.25 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.8 t -85.1 172.04 11.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.622 -1.299 . . . . 0.0 110.51 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.536 HG13 ' N ' ' A' ' 57' ' ' LYS . 17.6 pt -103.92 -42.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.488 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.536 ' N ' HG13 ' A' ' 56' ' ' ILE . 10.9 mttt 63.96 97.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -80.27 152.58 28.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.271 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 59' ' ' VAL . 7.0 m -143.53 93.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.968 . . . . 0.0 110.224 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 60' ' ' ILE . 2.7 tt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 2' ' ' GLU . 23.8 mtt . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.281 0.562 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 3' ' ' ILE . 4.6 mt-10 61.35 123.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.146 -0.971 . . . . 0.0 110.166 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 2' ' ' GLU . 0.9 OUTLIER -156.58 144.93 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.841 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 10.9 t0 -135.26 -153.78 0.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.62 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 19' ' ' PRO . 9.1 tp10 -178.21 58.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.375 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' A' ' 19' ' ' PRO . . . 45.72 22.52 0.75 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -87.11 118.5 26.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.045 -1.268 . . . . 0.0 109.67 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.4 m-85 -126.68 151.24 48.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.945 . . . . 0.0 110.766 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -121.95 141.38 51.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.398 -0.814 . . . . 0.0 109.424 179.113 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.5 t -78.11 117.73 19.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -0.996 . . . . 0.0 110.521 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.85 -16.34 63.74 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.831 -1.168 . . . . 0.0 108.515 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -59.2 2.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.603 -0.685 . . . . 0.0 110.411 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.491 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.33 -3.43 17.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.961 -1.087 . . . . 0.0 110.774 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.729 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 78.66 5.79 88.28 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.155 -0.965 . . . . 0.0 111.474 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.579 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 52.9 t80 -58.12 146.04 34.72 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.855 -1.38 . . . . 0.0 109.92 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.4 mp -116.42 110.44 31.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.214 -0.929 . . . . 0.0 110.443 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.515 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 36.8 t80 -80.94 121.63 26.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -106.33 120.12 49.71 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.437 -0.789 . . . . 0.0 110.027 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 45.5 Cg_endo -72.09 -23.14 21.83 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.99 1.521 . . . . 0.0 110.524 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -72.35 -16.22 61.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.113 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.69 -39.71 5.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 110.112 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.5 163.05 20.73 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.603 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.19 51.86 2.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -1.048 . . . . 0.0 109.866 179.016 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 3.5 mmtt -39.8 -50.01 2.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.441 -0.787 . . . . 0.0 110.65 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.558 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 41.1 m-85 -51.05 -39.5 56.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.269 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.77 -68.93 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.191 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.44 52.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.603 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.05 144.15 52.38 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.298 -1.119 . . . . 0.0 109.997 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.587 ' HD2' HG23 ' A' ' 28' ' ' ILE . 45.9 Cg_endo -72.01 166.54 29.3 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.875 1.461 . . . . 0.0 110.407 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.48 160.86 45.73 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.91 1.479 . . . . 0.0 110.861 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.65 12.45 84.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.523 HG21 ' CG2' ' A' ' 28' ' ' ILE . 25.9 m -92.92 121.04 66.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.18 -1.188 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.955 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.4 Cg_endo -73.18 142.48 34.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.859 1.452 . . . . 0.0 110.553 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.56 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 31.0 t80 -56.01 -21.39 21.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.294 -0.879 . . . . 0.0 110.024 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.955 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.3 m -72.11 -9.02 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -0.874 . . . . 0.0 109.784 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.54 -7.17 44.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.984 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 50' ' ' LYS . 23.7 mt -72.91 146.16 46.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.013 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -73.58 151.38 40.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.879 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.0 -17.15 3.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.55 7.83 45.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 0.0 110.427 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.503 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 55.0 t80 -60.8 139.84 57.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 109.81 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 48' ' ' SER . 32.9 mtm -118.4 144.47 45.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.024 -1.048 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 42.5 t -59.31 127.56 84.46 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.402 -0.811 . . . . 0.0 110.284 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HB2' ' CB ' ' A' ' 25' ' ' PHE . 44.1 Cg_endo -71.46 -10.0 26.15 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.002 1.528 . . . . 0.0 110.0 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.579 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -94.33 -54.87 3.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.461 -0.774 . . . . 0.0 110.327 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.491 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 10.0 p -115.3 7.47 15.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 110.773 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 63.01 14.39 7.53 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.28 -0.887 . . . . 0.0 112.171 178.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.46 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 3.6 m -67.56 169.3 9.42 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.857 -1.152 . . . . 0.0 109.894 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 47.3 Cg_endo -74.19 141.36 29.13 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.788 1.415 . . . . 0.0 110.461 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 10.5 tttm -50.05 -29.55 9.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 109.892 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -61.88 -12.52 18.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.866 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.64 -1.92 58.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.788 179.475 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 24.5 m-85 -84.6 137.32 33.36 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.725 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -120.5 137.23 54.47 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 8.1 t -84.74 172.64 11.33 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.621 -1.299 . . . . 0.0 110.537 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.501 HG13 ' N ' ' A' ' 57' ' ' LYS . 11.9 pt -110.35 -44.42 5.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.826 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.501 ' N ' HG13 ' A' ' 56' ' ' ILE . 7.4 ttmt 50.97 92.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.135 -0.978 . . . . 0.0 109.886 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -64.75 171.96 3.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 110.378 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 59' ' ' VAL . 16.4 m -141.19 93.92 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 0.0 110.156 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.23 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.198 0.523 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.841 ' OE1' HG12 ' A' ' 59' ' ' VAL . 5.0 mt-10 57.07 177.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.337 -0.852 . . . . 0.0 110.254 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 2' ' ' GLU . 5.1 pt -158.28 140.54 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 2.1 p30 -86.18 -162.29 0.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 2.4 tt0 178.7 -26.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.895 . . . . 0.0 110.513 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.507 ' CA ' ' HG3' ' A' ' 19' ' ' PRO . . . 119.2 7.42 10.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.66 111.67 19.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -1.17 . . . . 0.0 109.653 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 18.8 m-85 -123.18 148.5 45.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 110.897 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.578 ' CG ' ' CD1' ' A' ' 16' ' ' ILE . 14.4 mt-10 -120.46 139.71 52.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.426 -0.796 . . . . 0.0 109.608 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.461 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.6 t -76.57 117.21 17.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.127 -0.983 . . . . 0.0 110.417 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -16.54 63.97 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.857 -1.152 . . . . 0.0 108.597 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.1 -58.82 2.53 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.647 -0.658 . . . . 0.0 110.683 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -109.63 -3.56 16.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.884 -1.135 . . . . 0.0 110.984 -179.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.461 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.34 6.47 88.91 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.058 -1.026 . . . . 0.0 111.392 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 26.9 t80 -56.59 143.1 37.04 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.942 -1.328 . . . . 0.0 109.687 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.578 ' CD1' ' CG ' ' A' ' 9' ' ' GLU . 16.4 mm -115.66 112.05 38.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.259 -0.9 . . . . 0.0 110.704 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.588 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 43.0 t80 -81.82 130.06 34.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.741 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -110.14 119.34 47.4 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 110.288 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -70.65 -30.2 18.5 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.892 1.469 . . . . 0.0 110.09 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.71 -13.82 61.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.833 . . . . 0.0 110.043 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -111.79 -38.23 4.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.381 -0.825 . . . . 0.0 110.049 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.36 168.94 25.76 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.665 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.09 53.09 2.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.454 -1.027 . . . . 0.0 109.944 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -40.3 -57.4 1.75 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.375 -0.828 . . . . 0.0 110.533 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.526 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 27.0 m-85 -47.73 -34.35 8.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.47 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -90.99 -65.83 0.98 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.032 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.15 52.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.665 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.4 mp -131.13 145.19 56.68 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.225 -1.162 . . . . 0.0 109.889 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -70.3 160.94 47.83 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.038 1.546 . . . . 0.0 110.47 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.9 Cg_endo -71.93 163.14 39.77 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.049 1.552 . . . . 0.0 110.848 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.4 12.37 84.32 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 94.1 m -98.64 125.93 40.88 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.248 -1.148 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.749 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -73.74 139.76 28.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.016 1.535 . . . . 0.0 110.593 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.588 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 3.0 t80 -52.66 -40.0 62.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.017 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.3 m -53.76 -17.87 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -0.823 . . . . 0.0 110.282 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 63.3 t0 -83.53 -7.12 59.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 110.404 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.544 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.0 mt -71.42 153.86 41.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.086 -1.009 . . . . 0.0 109.98 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.22 157.99 30.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.979 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -11.52 15.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.267 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -99.52 4.01 45.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 110.435 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.568 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 48.7 t80 -59.65 132.81 55.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 109.832 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 48' ' ' SER . 10.4 mtp -117.08 147.01 42.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.052 -1.03 . . . . 0.0 109.966 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 5.6 t -56.59 129.97 76.66 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.321 -0.862 . . . . 0.0 110.458 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -72.22 -11.7 27.13 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.892 1.469 . . . . 0.0 109.4 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.64 -65.02 0.99 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.518 -0.739 . . . . 0.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 3.7 p -98.3 3.21 48.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.92 . . . . 0.0 111.151 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER 62.06 22.39 13.06 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.079 -1.013 . . . . 0.0 112.06 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.7 m -75.78 168.37 28.35 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.806 -1.184 . . . . 0.0 109.994 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.4 Cg_endo -74.08 142.57 31.19 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.907 1.478 . . . . 0.0 110.431 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 42.0 tttm -50.48 -29.41 10.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 109.944 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -62.95 -12.34 24.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.743 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.482 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -87.54 -3.08 59.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.786 179.515 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -86.45 139.63 30.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.748 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -122.55 139.86 53.43 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.2 t -85.41 172.08 11.32 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.677 -1.265 . . . . 0.0 110.566 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 57' ' ' LYS . 40.0 pt -106.02 -31.13 2.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.236 0.541 . . . . 0.0 110.465 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.508 ' N ' HG13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER 61.26 95.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.103 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 2' ' ' GLU . 3.1 mttt -63.97 149.78 46.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.841 HG12 ' OE1' ' A' ' 2' ' ' GLU . 34.4 m -111.13 164.8 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 110.229 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.734 ' C ' HD12 ' A' ' 60' ' ' ILE . 1.7 pp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.204 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 2' ' ' GLU . 1.5 mtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.221 0.534 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 1' ' ' MET . 26.3 tp10 57.94 109.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.279 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -146.5 151.45 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.196 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.541 ' N ' ' HA ' ' A' ' 57' ' ' LYS . 7.1 p-10 -91.4 127.83 36.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 2.0 tt0 -84.43 13.34 5.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.041 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA3' ' HG3' ' A' ' 19' ' ' PRO . . . 116.25 7.44 14.42 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.526 ' CB ' HG12 ' A' ' 56' ' ' ILE . 20.9 mmtt -79.43 110.2 14.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.122 . . . . 0.0 109.145 179.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 10.0 m-85 -119.77 145.8 46.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.051 -1.03 . . . . 0.0 111.2 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 16' ' ' ILE . 6.5 pt-20 -121.16 139.64 53.08 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.552 -0.717 . . . . 0.0 109.145 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.9 t -76.94 116.79 17.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.025 -1.047 . . . . 0.0 110.314 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.43 -16.52 64.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.84 -1.162 . . . . 0.0 108.601 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -59.53 2.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.662 -0.649 . . . . 0.0 110.563 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -109.44 -3.46 17.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.057 . . . . 0.0 110.986 -179.074 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.46 ' N ' ' HB3' ' A' ' 10' ' ' CYS . . . 79.82 5.98 89.25 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.138 -1.029 . . . . 0.0 111.385 177.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 45.8 t80 -56.93 143.56 37.22 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.901 -1.353 . . . . 0.0 109.767 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.55 HD13 ' HA ' ' A' ' 9' ' ' GLU . 21.7 mm -115.14 111.84 37.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 121.294 -0.879 . . . . 0.0 110.718 -179.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 37.1 t80 -82.17 129.34 34.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.867 . . . . 0.0 109.739 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -109.25 121.43 42.68 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.875 . . . . 0.0 110.202 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 31' ' ' GLY . 45.2 Cg_endo -71.66 -30.97 13.97 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.189 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.42 -14.81 62.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.082 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -108.88 -38.58 5.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 110.157 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.32 169.04 25.81 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.671 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.07 54.73 3.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.462 -1.022 . . . . 0.0 109.886 179.212 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -40.37 -58.03 1.63 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.396 -0.815 . . . . 0.0 110.756 -179.528 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.527 ' HB3' ' HB2' ' A' ' 44' ' ' PRO . 47.5 m-85 -46.31 -33.34 3.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -93.07 -63.75 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.003 . . . . 0.0 110.292 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.59 53.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.671 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -129.92 144.96 55.14 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.279 -1.13 . . . . 0.0 109.819 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.3 Cg_endo -70.65 161.13 47.14 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.966 1.508 . . . . 0.0 110.366 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.19 162.87 40.42 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.999 1.526 . . . . 0.0 110.787 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 77.41 13.33 83.67 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 83.7 m -99.85 124.06 45.22 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.269 -1.136 . . . . 0.0 110.15 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 46.4 Cg_endo -73.25 139.95 30.01 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.915 1.482 . . . . 0.0 110.644 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.583 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.3 t80 -50.96 -41.61 59.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.897 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -53.98 -17.55 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.418 -0.801 . . . . 0.0 110.423 -179.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 9.6 t0 -84.29 -7.44 59.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.113 -0.992 . . . . 0.0 110.178 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 37' ' ' LEU . 19.8 mt -71.14 154.99 41.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.018 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.68 149.63 38.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 109.823 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -55.67 -16.48 4.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.152 -0.967 . . . . 0.0 110.294 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -95.57 6.3 49.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 47.6 t80 -60.13 136.98 58.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.142 -0.974 . . . . 0.0 109.913 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' SER . 4.7 mtm -119.77 146.55 45.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 110.01 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 8.2 t -56.07 131.05 74.28 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 110.448 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 44.7 Cg_endo -72.21 -12.67 27.96 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.872 1.459 . . . . 0.0 109.583 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.34 -64.31 1.05 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.463 -0.773 . . . . 0.0 110.82 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.538 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.2 p -98.84 3.83 47.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.899 . . . . 0.0 111.206 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 14.2 mtm180 61.6 20.77 11.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.134 -0.979 . . . . 0.0 112.103 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.7 m -73.71 168.36 26.51 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.72 -1.238 . . . . 0.0 109.767 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.6 Cg_endo -73.57 142.27 32.46 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.951 1.5 . . . . 0.0 110.383 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 28.0 tttm -50.01 -29.22 8.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 109.807 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -61.23 -13.24 16.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.0 110.013 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.59 -1.08 57.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.328 -0.857 . . . . 0.0 109.681 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 13.3 m-85 -87.98 139.32 30.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 110.477 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 3.3 mttt -127.36 143.18 51.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.455 -0.778 . . . . 0.0 109.449 179.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 12.0 p -82.06 168.84 17.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.76 -1.213 . . . . 0.0 110.709 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.526 HG12 ' CB ' ' A' ' 7' ' ' LYS . 14.8 pt -105.22 -26.07 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.666 -0.646 . . . . 0.0 110.454 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HA ' ' N ' ' A' ' 4' ' ' ASP . 2.4 tptt 66.99 98.39 0.05 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.0 110.158 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -90.94 154.0 19.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.915 . . . . 0.0 110.153 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 11.9 p -75.19 164.2 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.947 . . . . 0.0 110.22 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.438 ' N ' HG22 ' A' ' 59' ' ' VAL . 1.5 tt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.175 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mtt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.229 0.537 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 3' ' ' ILE . 3.1 pt-20 -131.69 64.62 1.59 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.237 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 2' ' ' GLU . 20.1 pt -156.61 177.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 110.073 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -152.6 126.25 8.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.43 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -174.23 60.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.715 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' GLU . . . 43.62 25.98 0.63 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.529 ' HB2' ' CG1' ' A' ' 56' ' ' ILE . 37.0 mttt -80.74 120.91 25.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -1.194 . . . . 0.0 109.744 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.688 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 11.4 m-85 -114.25 140.36 48.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 110.469 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 9.9 pt-20 -117.63 136.75 53.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 109.562 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 3.6 t -74.87 120.0 19.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.7 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -16.67 63.27 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.751 -1.218 . . . . 0.0 108.481 178.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -58.78 2.55 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.561 -0.712 . . . . 0.0 110.564 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.488 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.5 p -109.52 -1.2 18.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.953 -1.092 . . . . 0.0 110.814 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.685 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 73.52 10.38 79.32 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 120.176 -1.012 . . . . 0.0 111.505 177.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 41.0 t80 -62.19 147.69 46.99 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.775 -1.427 . . . . 0.0 109.331 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -116.08 114.32 45.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.539 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 34' ' ' PHE . 18.5 t80 -83.16 134.68 34.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -111.23 119.18 46.15 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.432 -0.792 . . . . 0.0 110.07 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.2 Cg_endo -71.26 -31.71 13.91 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.955 1.503 . . . . 0.0 110.265 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.76 -8.52 56.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.371 -0.83 . . . . 0.0 109.972 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 2.3 tttt -110.06 -47.03 3.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.9 . . . . 0.0 110.16 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.21 162.84 14.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.554 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -85.17 56.68 4.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.509 -0.995 . . . . 0.0 109.927 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 23' ' ' ASP . 10.1 mmtt -40.14 -57.22 1.73 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.432 -0.793 . . . . 0.0 110.703 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -45.45 -34.01 2.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.398 -0.814 . . . . 0.0 110.604 -179.809 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -95.38 -61.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 110.405 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.24 55.77 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.554 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.1 mp -129.94 143.67 50.0 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.269 -1.136 . . . . 0.0 109.953 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.0 Cg_endo -70.5 162.9 40.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.943 1.496 . . . . 0.0 110.533 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.4 Cg_endo -72.41 161.68 43.62 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.983 1.517 . . . . 0.0 110.92 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.85 14.98 82.02 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 97.7 m -102.04 125.87 35.42 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.177 . . . . 0.0 110.187 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.811 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.6 Cg_endo -72.95 136.94 25.89 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.855 1.45 . . . . 0.0 110.528 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.606 ' CD2' HD12 ' A' ' 37' ' ' LEU . 15.1 t80 -53.06 -39.17 63.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.179 -0.951 . . . . 0.0 110.174 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.8 m -53.32 -18.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.119 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 15.2 t0 -82.41 -5.88 58.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 110.416 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 41' ' ' PHE . 22.2 mt -70.06 157.35 37.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.917 . . . . 0.0 110.067 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.05 155.95 30.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.2 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -60.48 -13.67 15.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.211 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.2 m -98.25 2.21 48.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 110.077 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.628 ' CD1' HD13 ' A' ' 37' ' ' LEU . 44.7 t80 -56.06 133.13 51.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.865 . . . . 0.0 110.139 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 35.4 mtt -111.03 138.29 47.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.006 -1.059 . . . . 0.0 109.307 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . 43.9 t -47.08 136.42 8.42 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.159 -0.963 . . . . 0.0 110.73 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.7 Cg_endo -82.8 36.18 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.124 1.592 . . . . 0.0 110.08 179.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.522 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -151.92 -50.31 0.11 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.247 -0.908 . . . . 0.0 109.588 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.488 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.5 p -118.17 8.41 12.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.389 -0.819 . . . . 0.0 110.128 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 46' ' ' CYS . 27.3 mtp180 61.1 15.02 5.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.486 -0.759 . . . . 0.0 112.084 178.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.452 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.6 m -64.81 166.76 10.97 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.874 -1.141 . . . . 0.0 109.815 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.3 Cg_endo -73.25 142.32 33.62 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.932 1.49 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.2 tttm -49.85 -31.54 12.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.777 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -62.42 -12.26 20.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 109.808 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.56 -2.14 58.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.835 . . . . 0.0 109.745 179.505 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 13.7 m-85 -88.11 139.82 30.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 110.508 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 20.1 tttt -126.12 142.45 51.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 109.371 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.688 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 9.3 p -83.29 169.44 15.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.936 -1.103 . . . . 0.0 111.023 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 7' ' ' LYS . 1.1 pt -131.98 53.37 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.797 -0.565 . . . . 0.0 110.055 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.438 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 5.2 tttm -91.8 58.52 3.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.893 . . . . 0.0 110.239 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -116.4 63.76 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 0.0 110.258 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.44 137.12 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.222 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.3 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.226 -179.97 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ttp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.215 0.531 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.603 ' C ' HG22 ' A' ' 3' ' ' ILE . 1.8 pt-20 -143.6 128.47 18.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 110.23 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.603 HG22 ' C ' ' A' ' 2' ' ' GLU . 1.0 OUTLIER 171.29 171.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 109.973 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.553 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 3.7 p30 -144.6 121.18 11.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.757 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -117.5 -88.68 0.6 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 109.807 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.3 32.41 2.25 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.539 ' HD2' HD11 ' A' ' 56' ' ' ILE . 30.9 mtmt -76.9 113.5 14.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 109.278 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.62 ' CE1' ' HB3' ' A' ' 55' ' ' SER . 8.6 m-85 -120.6 140.22 51.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 0.0 111.144 -178.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 45.6 tt0 -117.03 141.54 48.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.538 -0.726 . . . . 0.0 109.358 179.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.462 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.9 t -77.13 116.54 17.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.072 -1.017 . . . . 0.0 110.309 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -16.25 64.19 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.787 -1.195 . . . . 0.0 108.663 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -60.1 2.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.575 -0.703 . . . . 0.0 110.605 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -108.55 -3.61 17.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.061 -1.024 . . . . 0.0 110.945 -178.984 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.749 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.27 6.87 88.79 Favored Glycine 0 N--CA 1.496 2.685 0 O-C-N 121.09 -1.006 . . . . 0.0 111.611 177.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 28.0 t80 -59.17 143.01 50.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.736 -1.45 . . . . 0.0 109.723 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.4 mp -113.99 113.87 45.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.215 -0.928 . . . . 0.0 110.746 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 25.6 t80 -84.64 137.43 33.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -0.852 . . . . 0.0 109.593 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -114.73 122.6 33.53 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.788 . . . . 0.0 110.222 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.6 Cg_endo -71.08 -34.07 10.82 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.811 1.427 . . . . 0.0 110.089 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.31 -11.27 60.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 110.053 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -111.68 -38.2 4.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.28 170.98 28.28 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.624 ' OD1' HG21 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -85.19 57.15 4.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.493 -1.004 . . . . 0.0 109.702 179.099 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' ASP . 14.6 tptm -38.94 -61.33 0.75 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.454 -0.779 . . . . 0.0 110.532 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CB ' ' CB ' ' A' ' 44' ' ' PRO . 27.2 m-85 -45.88 -30.38 1.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.835 . . . . 0.0 110.459 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -95.11 -63.5 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 0.0 110.276 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.43 54.24 0.02 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.624 HG21 ' OD1' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -129.95 144.17 51.99 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.212 -1.169 . . . . 0.0 109.662 179.798 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -70.44 159.0 54.38 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.982 1.517 . . . . 0.0 110.522 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.33 164.3 36.04 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.996 1.524 . . . . 0.0 110.741 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 80.22 13.98 81.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 4.8 m -105.19 126.69 30.34 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.176 -1.191 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.679 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.1 Cg_endo -72.97 141.73 33.63 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.897 1.472 . . . . 0.0 110.533 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.572 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 51.9 t80 -52.62 -41.37 63.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 110.177 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 33' ' ' PRO . 5.8 m -54.76 -17.17 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.337 -0.852 . . . . 0.0 110.305 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 29.6 t70 -86.7 -6.78 58.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 110.272 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.606 HD13 ' CD1' ' A' ' 41' ' ' PHE . 17.7 mt -72.81 124.76 26.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.195 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' LEU . 16.0 m -43.01 164.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.172 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -72.77 -2.01 18.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.0 110.182 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' ' SD ' ' A' ' 42' ' ' MET . 7.9 p -103.11 1.49 33.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.416 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.606 ' CD1' HD13 ' A' ' 37' ' ' LEU . 47.5 t80 -56.79 130.21 44.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 110.225 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -119.21 146.09 45.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.681 179.594 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 4.4 t -55.36 129.53 68.84 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 110.494 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.583 ' CB ' ' CB ' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.49 -13.34 30.2 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.895 1.471 . . . . 0.0 109.461 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.69 -65.16 0.98 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.558 -0.714 . . . . 0.0 110.917 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.523 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 2.2 p -97.0 2.85 52.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.191 -0.943 . . . . 0.0 111.159 -179.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 1.2 tpp180 61.65 22.99 13.38 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.137 -0.977 . . . . 0.0 111.945 178.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.459 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.2 m -74.38 165.48 53.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.839 -1.163 . . . . 0.0 109.94 179.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.9 Cg_endo -73.36 143.86 35.74 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.947 1.498 . . . . 0.0 110.44 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 12.5 tttt -49.16 -25.33 2.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 110.032 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -66.74 -11.2 53.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.88 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.496 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -90.75 -2.32 57.81 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.359 -0.838 . . . . 0.0 109.538 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 6.5 m-85 -89.09 138.87 31.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -0.77 . . . . 0.0 110.52 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 20.3 mmtt -130.83 146.92 52.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 109.586 179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.62 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 4.0 p -82.55 166.17 19.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.835 -1.165 . . . . 0.0 110.456 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.544 ' CG1' ' N ' ' A' ' 57' ' ' LYS . 9.1 pt -111.51 -44.14 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.545 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.544 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 2.6 mtpt 55.15 94.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -92.77 70.53 4.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 0.0 110.191 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.5 t -106.35 89.32 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.192 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.534 HG22 ' OXT' ' A' ' 60' ' ' ILE . 84.8 mt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.202 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.217 0.532 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.68 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -175.54 174.06 2.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.22 179.923 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.525 HG13 ' CB ' ' A' ' 58' ' ' LYS . 1.4 pt -146.34 -179.41 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 110.128 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 1.0 OUTLIER -116.09 -167.68 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 110.398 -179.858 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 0.4 OUTLIER 175.26 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.822 . . . . 0.0 110.418 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.474 ' CA ' ' HG3' ' A' ' 19' ' ' PRO . . . 119.45 7.61 9.79 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.413 ' NZ ' HD11 ' A' ' 56' ' ' ILE . 1.4 mmmp? -84.26 112.12 20.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -1.112 . . . . 0.0 109.506 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.3 m-85 -125.73 150.14 47.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.926 -179.289 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 29.1 tt0 -120.32 140.2 51.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 109.243 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB3' ' N ' ' A' ' 14' ' ' GLY . 4.3 t -77.4 116.81 18.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.06 -1.025 . . . . 0.0 110.562 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.14 -16.15 63.88 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.897 -1.127 . . . . 0.0 108.511 178.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.11 -59.48 2.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.65 -0.656 . . . . 0.0 110.539 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.1 p -109.27 -3.4 17.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.058 -1.026 . . . . 0.0 110.788 -179.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.747 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 79.06 6.82 88.75 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 121.118 -0.989 . . . . 0.0 111.571 177.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.695 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 51.5 t80 -58.98 144.33 45.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.83 -1.394 . . . . 0.0 109.894 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.3 mp -116.05 113.07 42.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.761 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.589 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 40.7 t80 -81.55 123.23 28.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.743 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -102.21 118.01 59.96 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.47 -0.769 . . . . 0.0 110.294 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 46.5 Cg_endo -71.53 -30.67 14.73 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.902 1.475 . . . . 0.0 110.288 179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.82 -7.09 36.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.07 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 9.5 mttt -118.99 -35.73 3.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.884 . . . . 0.0 110.065 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.31 168.73 25.8 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' OD2' ' CE1' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -85.19 54.99 3.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.419 -1.047 . . . . 0.0 109.903 179.195 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -39.78 -58.13 1.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.574 -179.539 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.601 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -47.58 -34.05 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.412 -0.805 . . . . 0.0 110.537 -179.847 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -91.97 -65.3 1.02 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 110.239 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.96 52.99 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.548 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 1.3 mp -132.49 142.59 45.46 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.229 -1.159 . . . . 0.0 109.908 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.1 Cg_endo -69.97 161.95 44.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.871 1.458 . . . . 0.0 110.304 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.3 Cg_endo -71.92 162.99 40.24 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.993 1.523 . . . . 0.0 110.866 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 80.31 12.74 82.8 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 29' ' ' PRO . 2.2 m -101.71 126.19 34.88 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.147 -1.208 . . . . 0.0 110.219 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 46.9 Cg_endo -73.88 140.51 28.93 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.834 1.439 . . . . 0.0 110.613 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.589 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -52.13 -41.67 62.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.985 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -53.22 -18.71 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.445 -179.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 8.7 t70 -84.91 -6.66 59.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.237 -0.914 . . . . 0.0 110.118 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 41' ' ' PHE . 16.9 mt -73.67 121.94 21.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.345 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -41.34 152.74 0.05 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.413 -0.804 . . . . 0.0 110.336 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.19 -11.81 16.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 110.266 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.03 5.8 49.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.437 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.549 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 52.7 t80 -58.91 137.38 57.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 110.155 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.8 mtt -117.94 143.11 46.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 109.558 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 47' ' ' ARG . 43.2 t -59.62 125.71 80.63 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 110.169 -179.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.8 Cg_endo -71.15 -9.75 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.891 1.469 . . . . 0.0 109.899 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.695 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . . . -93.19 -53.44 4.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -0.824 . . . . 0.0 110.193 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.489 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.8 p -117.64 8.3 12.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.615 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' CYS . 11.7 ttp180 61.81 15.44 7.06 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.245 -0.91 . . . . 0.0 112.097 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.454 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -68.29 168.64 12.94 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.858 -1.151 . . . . 0.0 109.895 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 48.0 Cg_endo -73.92 141.95 30.84 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.834 1.439 . . . . 0.0 110.524 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.579 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 13.7 tttm -50.21 -28.9 8.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -0.926 . . . . 0.0 109.956 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.78 -12.17 22.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.847 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.67 -2.21 58.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.339 -0.851 . . . . 0.0 109.737 179.41 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 26.8 m-85 -85.24 136.78 33.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.717 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.87 137.31 54.09 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.6 t -85.32 172.24 11.25 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.76 -1.212 . . . . 0.0 110.489 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.413 HD11 ' NZ ' ' A' ' 7' ' ' LYS . 5.9 pt -113.16 -20.54 6.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.259 0.552 . . . . 0.0 110.379 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER 60.15 95.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.006 -179.904 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.525 ' CB ' HG13 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -49.32 116.1 1.58 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.186 -179.89 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.68 HG22 ' HB3' ' A' ' 2' ' ' GLU . 94.6 t -102.45 129.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.293 -0.879 . . . . 0.0 110.282 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 tt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.164 179.935 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' CG ' ' A' ' 2' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.222 0.534 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.789 ' HG2' HG13 ' A' ' 59' ' ' VAL . 1.6 mt-10 174.67 104.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.25 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.858 HG21 HG23 ' A' ' 56' ' ' ILE . 32.2 mm -134.79 170.6 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.936 . . . . 0.0 110.218 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER 165.68 -20.51 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.381 -0.824 . . . . 0.0 110.584 179.969 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.8 pm0 -73.49 59.1 0.59 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 110.366 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.32 31.7 13.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.557 ' HD2' HD12 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -80.43 119.95 23.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -1.127 . . . . 0.0 109.928 179.662 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 23.9 m-85 -116.4 139.46 50.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.109 -0.994 . . . . 0.0 110.22 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -113.96 135.22 54.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 109.969 179.594 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 14' ' ' GLY . 2.5 t -72.67 117.77 14.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.543 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -68.57 -15.76 63.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.776 -1.202 . . . . 0.0 108.513 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.24 -59.02 2.45 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.501 -0.75 . . . . 0.0 110.406 179.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.509 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.5 p -109.69 -0.65 18.46 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.863 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 72.7 11.84 77.74 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.075 -1.015 . . . . 0.0 111.496 177.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.6 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 17.4 t80 -63.92 147.32 52.24 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.781 -1.423 . . . . 0.0 109.685 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 15.1 mm -112.4 115.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.027 -1.046 . . . . 0.0 110.513 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 41.7 t80 -83.09 131.44 35.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.784 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -111.48 118.19 47.69 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.779 . . . . 0.0 110.198 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 43.5 Cg_endo -70.25 -30.16 20.4 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.884 1.465 . . . . 0.0 110.068 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.5 -11.61 60.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.835 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 11.7 tptt -110.48 -44.01 3.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.425 -0.797 . . . . 0.0 109.944 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.52 168.59 21.87 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.64 ' CB ' HD13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -85.2 52.46 2.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.514 -0.992 . . . . 0.0 109.748 178.974 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASP . 1.4 ttpp -39.11 -60.4 0.89 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 110.627 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CB ' ' HB2' ' A' ' 44' ' ' PRO . 32.0 m-85 -44.7 -31.22 1.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.798 . . . . 0.0 110.346 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -95.08 -62.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.277 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.75 51.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.64 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -128.53 143.8 49.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 109.725 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 28' ' ' ILE . 43.6 Cg_endo -69.88 159.69 52.39 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.958 1.504 . . . . 0.0 110.478 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.5 Cg_endo -72.35 161.35 44.62 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.038 1.546 . . . . 0.0 111.006 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 78.83 13.77 82.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 91.2 m -99.02 125.58 41.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.231 -1.158 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.76 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.7 Cg_endo -73.03 136.66 25.2 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.905 1.476 . . . . 0.0 110.481 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 50' ' ' LYS . 11.8 t80 -50.09 -42.87 50.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.76 HG22 ' HB2' ' A' ' 33' ' ' PRO . 19.1 m -53.63 -17.0 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 110.621 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 12.0 t70 -86.56 -7.84 58.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.01 -1.056 . . . . 0.0 110.281 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.472 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . 19.3 mt -68.16 158.02 34.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 110.109 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.6 m -77.86 152.71 33.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 110.002 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -61.27 -12.19 12.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.24 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.24 2.98 35.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.898 . . . . 0.0 110.552 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CZ ' ' OD2' ' A' ' 23' ' ' ASP . 46.6 t80 -58.11 137.71 56.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.015 -1.053 . . . . 0.0 109.755 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.425 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -109.75 137.61 47.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.85 -1.156 . . . . 0.0 109.837 179.786 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 38.4 t -46.66 136.55 7.57 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.284 -0.885 . . . . 0.0 110.569 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.6 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.5 Cg_endo -81.73 34.81 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.126 1.592 . . . . 0.0 110.379 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -150.81 -48.72 0.12 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.226 -0.921 . . . . 0.0 109.526 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.509 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 5.6 p -120.04 9.28 11.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 110.183 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.19 14.04 5.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.406 -0.809 . . . . 0.0 112.116 178.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.454 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.8 m -64.98 169.0 6.09 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.498 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 47.4 Cg_endo -74.21 142.69 30.88 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.762 1.401 . . . . 0.0 110.151 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 11.3 tttm -50.73 -31.81 17.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.074 -1.016 . . . . 0.0 109.618 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -64.03 -11.61 30.86 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.356 -0.84 . . . . 0.0 109.316 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.518 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -85.54 -4.1 59.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.361 -0.837 . . . . 0.0 109.865 179.641 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 22.4 m-85 -79.9 133.15 36.21 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.854 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -102.92 133.3 48.25 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.221 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -86.05 159.61 19.53 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.029 -1.045 . . . . 0.0 110.191 -179.537 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.858 HG23 HG21 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -153.57 89.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 110.028 -179.936 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HB3' ' OD1' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -113.66 64.18 0.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 110.245 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.438 ' C ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -118.8 162.62 18.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 179.866 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.789 HG13 ' HG2' ' A' ' 2' ' ' GLU . 95.4 t -148.77 116.7 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 110.248 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.637 HG22 ' OXT' ' A' ' 60' ' ' ILE . 21.6 mm . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.202 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' O ' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.214 0.531 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.704 ' O ' HG23 ' A' ' 3' ' ' ILE . 4.7 mm-40 46.28 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 2' ' ' GLU . 10.7 pt -159.09 -170.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 110.204 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 4' ' ' ASP . 24.3 p30 -142.37 158.52 43.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 110.275 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.511 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 1.2 tt0 -145.39 38.3 1.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.487 ' CA ' ' HG3' ' A' ' 19' ' ' PRO . . . 45.45 23.92 0.94 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.746 ' HG2' HD13 ' A' ' 56' ' ' ILE . 1.6 tptm -87.47 119.93 28.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -1.21 . . . . 0.0 109.854 179.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 17.9 m-85 -124.51 149.44 46.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 110.596 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -118.85 138.3 52.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.328 179.023 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 3.0 t -76.52 118.88 19.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.021 . . . . 0.0 111.042 -179.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.44 -16.26 63.45 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.361 178.036 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.13 -59.7 2.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.631 -0.668 . . . . 0.0 110.587 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.479 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.6 p -107.99 -1.78 20.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.962 -1.086 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 74.07 10.26 80.95 Favored Glycine 0 N--CA 1.494 2.559 0 O-C-N 121.092 -1.005 . . . . 0.0 111.458 177.471 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.685 ' C ' HD12 ' A' ' 16' ' ' ILE . 39.3 t80 -65.1 149.65 49.51 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.819 -1.4 . . . . 0.0 110.001 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.685 HD12 ' C ' ' A' ' 15' ' ' TYR . 1.8 mp -114.79 112.41 39.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.221 -0.925 . . . . 0.0 110.113 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 38.0 t80 -80.79 119.94 24.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.688 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.32 118.04 57.78 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.354 -0.841 . . . . 0.0 110.061 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 32' ' ' THR . 44.6 Cg_endo -72.19 -22.44 22.35 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.931 1.49 . . . . 0.0 110.423 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -10.49 59.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -112.63 -47.32 3.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.922 . . . . 0.0 110.199 -179.979 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.66 159.36 11.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.553 ' OD2' ' CZ ' ' A' ' 41' ' ' PHE . 0.9 OUTLIER -85.1 57.08 4.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -1.063 . . . . 0.0 109.983 179.415 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' ASP . 57.8 mttm -40.18 -52.97 2.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.448 -0.782 . . . . 0.0 110.464 -179.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -50.11 -39.96 44.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.487 -0.758 . . . . 0.0 110.427 -179.918 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -88.77 -67.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.09 55.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 32' ' ' THR . 1.2 mp -129.85 144.5 53.28 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.319 -1.107 . . . . 0.0 109.925 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.564 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.3 Cg_endo -71.03 166.33 29.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.974 1.513 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 43.1 Cg_endo -72.0 158.81 51.74 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.873 1.459 . . . . 0.0 111.024 -179.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.54 14.71 82.18 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.689 HG21 HG21 ' A' ' 28' ' ' ILE . 41.2 m -92.69 119.39 67.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 110.256 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.936 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.2 Cg_endo -72.68 141.56 34.39 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.876 1.461 . . . . 0.0 110.617 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.585 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 43.7 t80 -56.84 -18.48 13.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 110.028 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.936 HG22 ' HB2' ' A' ' 33' ' ' PRO . 14.6 m -73.51 -8.36 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.938 179.693 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -95.55 -7.37 38.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.549 HD12 ' CD1' ' A' ' 34' ' ' PHE . 22.5 mt -71.69 147.55 47.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 110.212 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.81 153.49 36.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.59 -16.35 5.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 p -96.96 5.01 51.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 110.303 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.553 ' CZ ' ' OD2' ' A' ' 23' ' ' ASP . 53.8 t80 -57.95 137.01 57.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.123 -0.986 . . . . 0.0 109.893 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.5 mmt -111.79 138.98 47.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.948 -1.095 . . . . 0.0 109.526 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 39.9 t -47.46 136.55 9.5 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 0.0 110.721 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HG2' ' CZ ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -82.76 36.39 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.017 1.535 . . . . 0.0 110.109 178.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -151.83 -49.36 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.877 . . . . 0.0 109.491 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.479 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 6.6 p -119.53 8.56 11.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.423 -0.798 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.74 15.38 5.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -0.805 . . . . 0.0 112.176 178.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.451 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.2 m -66.34 169.03 8.07 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.794 -1.191 . . . . 0.0 109.681 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.7 Cg_endo -73.08 140.13 30.75 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.944 1.497 . . . . 0.0 110.413 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.585 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 32.5 tttt -50.24 -31.92 15.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.123 -0.985 . . . . 0.0 109.694 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -62.14 -12.57 20.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.319 -0.863 . . . . 0.0 109.707 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.13 -3.35 59.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.759 179.399 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 43' ' ' CYS . 19.7 m-85 -84.99 139.21 31.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 110.592 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.61 137.45 53.85 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 7.4 t -85.24 172.26 11.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.564 -1.335 . . . . 0.0 110.653 -179.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.746 HD13 ' HG2' ' A' ' 7' ' ' LYS . 9.1 pt -108.74 -43.82 6.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.564 -179.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.543 ' N ' ' CG1' ' A' ' 56' ' ' ILE . 0.2 OUTLIER 58.84 97.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -62.42 74.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 -179.767 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.718 ' O ' HG13 ' A' ' 59' ' ' VAL . 12.6 p -96.79 73.77 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 110.296 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.8 tt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.137 -179.959 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.281 0.563 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.9 OUTLIER 51.52 88.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 110.256 179.974 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 1.036 HD12 HD13 ' A' ' 56' ' ' ILE . 8.1 pt -145.13 124.6 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 110.156 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 58' ' ' LYS . 2.6 m-20 -150.92 11.48 0.65 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.461 -0.774 . . . . 0.0 110.692 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 4.6 pt-20 -75.57 59.24 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -0.86 . . . . 0.0 110.799 -179.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.07 31.74 11.44 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.723 ' CB ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -80.74 124.32 28.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -1.119 . . . . 0.0 110.148 179.836 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 16.1 m-85 -113.85 139.91 48.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.145 -0.972 . . . . 0.0 110.04 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -118.06 137.43 52.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.104 -0.997 . . . . 0.0 109.828 179.563 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 14' ' ' GLY . 4.0 t -74.82 116.64 15.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 110.359 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -67.4 -15.99 63.99 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.761 -1.212 . . . . 0.0 108.62 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.22 -59.99 2.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.618 -0.676 . . . . 0.0 110.463 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.494 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.3 p -109.03 -1.93 18.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.039 -1.038 . . . . 0.0 110.967 -179.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.754 ' O ' HD12 ' A' ' 16' ' ' ILE . . . 76.4 8.61 85.81 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.374 177.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 31.3 t80 -59.11 144.27 46.15 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.849 -1.383 . . . . 0.0 109.578 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 14' ' ' GLY . 2.1 mp -113.35 113.68 44.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.221 -0.925 . . . . 0.0 110.574 -179.318 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.572 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 35.8 t80 -82.74 131.23 35.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.305 -0.872 . . . . 0.0 109.739 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 12.2 mt-10 -108.15 119.68 49.1 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.521 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 43.7 Cg_endo -71.73 -35.61 7.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.839 1.442 . . . . 0.0 110.055 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 31.4 tt0 -70.29 -6.23 33.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 110.037 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 5.4 mmtt -117.56 -37.13 3.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.094 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.97 172.36 28.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 1.1 t70 -85.23 58.52 5.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -1.013 . . . . 0.0 109.756 178.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -36.83 -64.6 0.34 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.542 -0.723 . . . . 0.0 110.728 -179.535 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HB3' ' CB ' ' A' ' 44' ' ' PRO . 1.6 m-85 -42.53 -26.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.847 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -99.98 -58.03 2.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.301 -0.875 . . . . 0.0 109.952 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.65 -8.07 1.54 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.318 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.583 HG23 ' HD2' ' A' ' 29' ' ' PRO . 1.8 mt -61.79 143.36 94.23 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.251 . . . . 0.0 109.927 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.6 Cg_endo -71.08 160.38 49.37 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.926 1.487 . . . . 0.0 110.659 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 44.4 Cg_endo -72.83 163.66 37.8 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.13 1.595 . . . . 0.0 110.801 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 76.72 14.12 82.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 86.4 m -105.73 127.23 28.87 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.28 -1.129 . . . . 0.0 110.134 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.746 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.9 Cg_endo -73.13 140.75 31.56 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.959 1.505 . . . . 0.0 110.492 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 2.6 t80 -50.05 -38.06 36.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.991 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.746 HG22 ' HB2' ' A' ' 33' ' ' PRO . 6.3 m -54.4 -17.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 110.363 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -85.05 -7.15 59.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.091 -1.006 . . . . 0.0 110.234 179.949 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.584 HD12 ' CD2' ' A' ' 34' ' ' PHE . 48.5 mt -69.06 155.94 39.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.0 110.089 179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.25 156.13 29.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.136 -0.977 . . . . 0.0 109.819 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -9.64 16.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.029 -1.044 . . . . 0.0 110.317 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 t -103.65 2.76 33.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.473 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.577 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 47.1 t80 -59.82 138.95 57.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.122 -0.987 . . . . 0.0 109.885 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 48' ' ' SER . 7.0 mtt -117.09 142.72 46.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.866 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 41.9 t -56.3 128.32 72.82 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.24 -0.913 . . . . 0.0 110.008 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' CB ' ' HB3' ' A' ' 25' ' ' PHE . 44.9 Cg_endo -71.45 -12.66 29.78 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.924 1.486 . . . . 0.0 109.856 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.34 -51.45 4.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 110.675 -179.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.494 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 7.5 p -118.83 9.39 12.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.117 -0.989 . . . . 0.0 110.939 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 61.44 12.68 4.52 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.285 -0.885 . . . . 0.0 112.296 178.347 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 19.0 p -65.12 166.41 13.08 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.832 -1.167 . . . . 0.0 109.765 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 44.4 Cg_endo -71.87 142.38 38.94 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.665 1.35 . . . . 0.0 110.097 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.598 ' CE ' ' CZ ' ' A' ' 34' ' ' PHE . 23.1 tttt -50.41 -28.9 9.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.772 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -62.76 -12.58 25.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.206 -0.933 . . . . 0.0 109.741 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -87.42 -3.45 59.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -0.809 . . . . 0.0 109.664 179.433 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 21.7 m-85 -84.01 136.99 33.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 110.362 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -120.27 139.6 52.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.882 . . . . 0.0 109.268 179.198 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 53.1 p -85.55 168.38 14.55 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.885 -1.134 . . . . 0.0 111.355 -179.392 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.036 HD13 HD12 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -139.21 83.04 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.381 0.61 . . . . 0.0 109.826 179.709 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER -106.31 68.62 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.46 -0.775 . . . . 0.0 109.881 -179.887 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.524 ' N ' ' OD2' ' A' ' 4' ' ' ASP . 6.9 mmtt -126.01 170.49 11.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 110.355 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 4.1 p -166.42 130.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 0.0 110.211 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 mm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.064 -0.969 . . . . 0.0 110.205 -179.959 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 19.6 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.215 0.531 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.566 ' C ' HG23 ' A' ' 3' ' ' ILE . 3.8 mt-10 54.4 -176.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.781 ' O ' HD12 ' A' ' 3' ' ' ILE . 2.6 pp -153.26 126.35 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' A' ' 57' ' ' LYS . 15.2 p-10 -96.2 133.38 40.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 110.147 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.31 13.95 4.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.13 -0.981 . . . . 0.0 110.118 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.438 ' HA3' ' HG3' ' A' ' 19' ' ' PRO . . . 113.0 10.97 14.7 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.537 ' O ' HG23 ' A' ' 56' ' ' ILE . 11.7 mtmt -79.11 111.47 15.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -1.173 . . . . 0.0 109.131 179.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 10.6 m-85 -121.34 143.44 49.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.139 -0.975 . . . . 0.0 111.254 -178.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.544 ' HA ' HD13 ' A' ' 16' ' ' ILE . 3.3 tm-20 -121.39 143.69 49.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 4.7 t -78.67 116.57 19.12 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.997 -1.064 . . . . 0.0 110.531 -179.544 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -15.77 63.67 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.767 -1.208 . . . . 0.0 108.415 178.295 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.02 -61.56 1.74 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.688 -0.632 . . . . 0.0 110.445 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.482 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -106.43 -3.95 20.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.931 -1.105 . . . . 0.0 110.559 -179.221 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 10' ' ' CYS . . . 80.62 2.42 89.77 Favored Glycine 0 N--CA 1.496 2.696 0 O-C-N 121.086 -1.009 . . . . 0.0 111.19 177.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.647 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 22.5 t80 -50.43 171.65 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.998 -1.295 . . . . 0.0 109.7 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 23.2 mm -139.48 130.48 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 110.344 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 55.8 t80 -105.12 120.6 41.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.363 -0.836 . . . . 0.0 109.927 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -108.88 119.0 50.27 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.099 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 31' ' ' GLY . 44.1 Cg_endo -70.72 -24.29 25.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.929 1.489 . . . . 0.0 110.316 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 8.0 tp10 -72.64 -15.53 61.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.242 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 9.9 tttt -109.84 -40.7 4.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.42 156.39 12.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 1.007 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -85.3 62.2 7.34 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.375 -1.074 . . . . 0.0 108.995 178.463 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -39.68 -48.57 2.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.467 -0.771 . . . . 0.0 111.039 -179.061 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 44' ' ' PRO . 13.4 m-85 -80.96 13.22 2.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 0.0 110.907 -179.338 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.007 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -131.55 -3.77 3.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.0 110.71 -179.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.86 38.53 7.97 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.954 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.751 ' CG2' HG21 ' A' ' 32' ' ' THR . 1.7 mp -133.21 136.46 27.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.838 -1.389 . . . . 0.0 110.25 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 46.6 Cg_endo -72.79 174.12 12.35 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.016 1.535 . . . . 0.0 110.486 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 43.6 Cg_endo -72.85 160.52 45.91 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.969 1.51 . . . . 0.0 111.039 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 75.8 11.5 84.55 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.751 HG21 ' CG2' ' A' ' 28' ' ' ILE . 54.4 m -94.54 121.38 63.4 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.232 -1.157 . . . . 0.0 110.299 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.843 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.7 Cg_endo -72.96 143.53 36.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.838 1.441 . . . . 0.0 110.456 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.668 ' CD1' HD12 ' A' ' 37' ' ' LEU . 37.9 t80 -55.97 -37.16 68.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.908 . . . . 0.0 110.05 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.843 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.9 m -55.33 -18.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.454 -0.779 . . . . 0.0 109.872 179.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 7.7 t70 -83.42 -6.66 59.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.819 . . . . 0.0 110.242 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.668 HD12 ' CD1' ' A' ' 34' ' ' PHE . 22.2 mt -73.67 146.15 44.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.128 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -75.62 162.32 28.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.841 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -64.16 -9.75 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.151 -0.968 . . . . 0.0 110.259 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 t -100.16 4.32 44.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.468 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.558 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 51.4 t80 -58.38 137.13 57.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 109.792 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 48' ' ' SER . 20.0 mtt -120.75 146.08 46.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.008 -1.058 . . . . 0.0 110.122 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 47.0 t -59.23 127.43 84.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 110.265 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 45.7 Cg_endo -71.47 -9.98 26.1 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.931 1.49 . . . . 0.0 109.754 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.647 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -95.09 -56.7 2.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 110.582 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.482 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 9.9 p -111.61 5.99 19.71 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.122 -0.986 . . . . 0.0 110.691 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 0.6 OUTLIER 62.54 16.56 8.85 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.337 -0.852 . . . . 0.0 112.072 178.512 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.448 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.6 m -69.05 167.69 19.29 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.835 -1.166 . . . . 0.0 109.804 179.47 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 46.7 Cg_endo -72.74 140.89 33.03 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.897 1.472 . . . . 0.0 110.625 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.572 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 9.6 tttm -48.25 -26.8 2.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -0.916 . . . . 0.0 109.99 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 -11.23 16.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.799 . . . . 0.0 110.156 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.401 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -93.64 0.3 56.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.257 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 13.0 m-85 -87.85 137.12 32.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 110.616 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -125.2 140.11 53.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 0.0 109.476 179.268 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 5.5 p -79.88 168.02 19.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.162 . . . . 0.0 110.626 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' A' ' 58' ' ' LYS . 2.0 pp -97.07 -27.06 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.661 -0.649 . . . . 0.0 110.49 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.46 ' C ' HD12 ' A' ' 56' ' ' ILE . 21.9 mtpp 52.18 87.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 110.2 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.631 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.6 tttt -92.69 128.0 38.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.471 ' HB ' ' HG2' ' A' ' 2' ' ' GLU . 14.9 p -61.15 152.4 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.175 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.199 179.964 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.286 0.565 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -100.47 79.96 2.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.555 ' CG1' ' N ' ' A' ' 4' ' ' ASP . 0.9 OUTLIER -174.3 171.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 110.193 -179.917 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.555 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 18.0 p-10 -166.22 125.46 1.58 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.542 -0.724 . . . . 0.0 110.349 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 19.9 tt0 -179.03 36.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.369 -0.832 . . . . 0.0 109.806 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . 92.92 -50.44 2.53 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.559 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.74 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.9 mmmt 8.51 108.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 5.9 m-85 -111.32 134.04 53.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 109.886 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 74.3 tt0 -119.72 141.69 49.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 0.0 110.111 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 6.5 t -77.9 114.24 16.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 0.0 110.402 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -14.9 62.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.805 -1.184 . . . . 0.0 108.524 178.593 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.18 -61.87 1.67 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.598 -0.689 . . . . 0.0 110.731 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 1.3 p -107.77 -4.5 18.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.015 -1.053 . . . . 0.0 110.952 -178.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 15' ' ' TYR . . . 83.18 3.83 90.03 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.622 177.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.588 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 69.3 t80 -48.39 173.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.719 -1.459 . . . . 0.0 109.023 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.588 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 11.9 mm -145.77 112.78 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.895 -1.128 . . . . 0.0 110.712 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 53.1 t80 -94.17 148.28 22.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.86 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -130.75 126.53 21.89 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 44.1 Cg_endo -71.45 -33.58 10.73 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.852 1.448 . . . . 0.0 110.285 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -72.87 -2.32 20.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 30' ' ' PRO . 5.3 ttmt -121.7 -43.08 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.047 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.72 168.17 20.89 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.763 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -85.19 56.44 3.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -1.015 . . . . 0.0 110.007 179.479 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' ASP . 32.2 tttt -41.19 -61.91 0.93 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.396 -0.815 . . . . 0.0 110.48 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CG ' ' HB2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -43.07 -30.41 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.804 . . . . 0.0 110.341 -179.981 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.09 -60.11 1.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.344 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.86 54.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.561 HD13 ' CB ' ' A' ' 23' ' ' ASP . 1.2 mp -132.96 142.05 43.24 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.314 -1.11 . . . . 0.0 109.87 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 28' ' ' ILE . 44.0 Cg_endo -69.69 160.72 48.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.914 1.481 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.455 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 42.9 Cg_endo -71.43 162.16 43.22 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.072 1.564 . . . . 0.0 111.027 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 19' ' ' PRO . . . 82.74 14.17 76.25 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 64.7 m -107.44 125.79 31.51 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.263 -1.14 . . . . 0.0 110.039 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 45.5 Cg_endo -71.91 138.09 30.69 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.884 1.465 . . . . 0.0 110.685 -179.791 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.642 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -52.98 -41.45 64.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -55.39 -17.48 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.354 -0.841 . . . . 0.0 110.19 -179.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -85.26 -5.23 59.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 109.922 179.687 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 50' ' ' LYS . 22.1 mt -72.13 127.79 33.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 109.922 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 37' ' ' LEU . 7.9 t -42.06 155.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 110.161 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 10.8 m-20 -66.72 -7.23 19.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.7 OUTLIER -100.78 3.37 42.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.568 -179.786 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.496 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 51.7 t80 -58.21 132.6 54.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.126 -0.984 . . . . 0.0 109.956 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.442 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -118.81 146.71 44.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.0 109.992 179.744 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.479 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 7.3 t -56.84 128.69 76.86 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 110.16 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.598 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 44.2 Cg_endo -71.36 -11.92 29.11 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.777 1.409 . . . . 0.0 109.628 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.82 -62.57 1.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 110.675 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.542 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 4.9 p -100.8 3.35 41.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.217 -0.927 . . . . 0.0 111.017 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 43' ' ' CYS . 2.8 tpp180 61.54 21.64 12.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.198 -0.939 . . . . 0.0 112.046 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 43' ' ' CYS . 27.2 p -74.45 165.24 55.28 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.8 -1.188 . . . . 0.0 109.702 179.259 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 44.9 Cg_endo -71.38 142.45 41.03 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.722 1.38 . . . . 0.0 110.335 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 7.4 tttm -48.09 -24.84 1.22 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.012 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.87 -9.73 31.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.932 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.498 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -92.37 -2.21 56.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.262 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.584 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 3.2 m-85 -89.91 140.04 30.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.297 -0.877 . . . . 0.0 110.443 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 47.1 tttt -129.04 145.13 51.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 109.634 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.636 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 2.7 p -81.48 165.75 20.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.015 -1.053 . . . . 0.0 110.889 -179.638 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.74 HG22 ' O ' ' A' ' 7' ' ' LYS . 3.1 tt -158.6 90.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.759 -0.588 . . . . 0.0 110.024 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -134.54 78.99 1.78 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 110.134 -179.897 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.61 161.89 27.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -0.85 . . . . 0.0 110.21 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.83 80.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 110.2 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 pt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.203 -179.925 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_